,sentence,Mot,Label
0,1,Inability,O
1,1,to,O
2,1,provide,O
3,1,written,O
4,1,informed,O
5,1,consent,O
6,2,Known,O
7,2,history,O
8,2,of,O
9,2,prior,O
10,2,intracranial,B-Condition
11,2,bleeding,I-Condition
12,3,On,O
13,3,treatment,O
14,3,with,O
15,3,a,O
16,3,P2Y12,B-Drug
17,3,receptor,I-Drug
18,3,antagonist,I-Drug
19,3,(,O
20,3,ticlopidine,B-Drug
21,3,",",O
22,3,clopidogrel,B-Drug
23,3,",",O
24,3,prasugrel,B-Drug
25,3,",",O
26,3,ticagrelor,B-Drug
27,3,),O
28,3,in,O
29,3,the,O
30,3,prior,O
31,3,10,O
32,3,days,O
33,4,Known,O
34,4,allergies,B-Condition
35,4,to,O
36,4,aspirin,B-Drug
37,4,",",O
38,4,ticagrelor,B-Drug
39,4,or,O
40,4,cangrelor,B-Drug
41,5,On,O
42,5,treatment,O
43,5,with,O
44,5,oral,O
45,5,anticoagulant,B-Drug
46,6,Treatment,O
47,6,with,O
48,6,glycoprotein,B-Drug
49,6,IIb,I-Drug
50,6,/,I-Drug
51,6,IIIa,I-Drug
52,6,inhibitors,I-Drug
53,7,Fibrinolytics,B-Procedure
54,7,within,O
55,7,24,O
56,7,hours,O
57,8,Active,B-Condition
58,8,bleeding,I-Condition
59,9,High,O
60,9,risk,O
61,9,of,O
62,9,bleeding,B-Condition
63,10,Known,O
64,10,platelet,O
65,10,count,O
66,10,<,O
67,10,80x106,O
68,10,/,O
69,10,mL,O
70,11,Known,O
71,11,hemoglobin,O
72,11,<,O
73,11,10,O
74,11,g,O
75,11,/,O
76,11,dL,O
77,12,Intubated,B-Condition
78,12,patients,O
79,12,(,O
80,12,prior,O
81,12,to,O
82,12,randomization,O
83,12,),O
84,13,Known,O
85,13,creatinine,O
86,13,clearance,O
87,13,<,O
88,13,30,O
89,13,mL,O
90,13,/,O
91,13,minute,O
92,13,or,O
93,13,on,O
94,13,hemodialysis,B-Procedure
95,13,.,O
96,14,Known,O
97,14,severe,O
98,14,hepatic,B-Condition
99,14,dysfunction,I-Condition
100,15,Patients,O
101,15,with,O
102,15,sick,B-Condition
103,15,sinus,I-Condition
104,15,syndrome,I-Condition
105,15,(,O
106,15,SSS,B-Condition
107,15,),O
108,15,or,O
109,15,high,O
110,15,degree,O
111,15,AV,B-Condition
112,15,block,I-Condition
113,15,without,O
114,15,pacemaker,B-Procedure
115,15,protection,O
116,16,Current,O
117,16,treatment,O
118,16,with,O
119,16,drugs,B-Drug
120,16,interfering,B-Mood
121,16,with,I-Mood
122,16,CYP3A4,B-Condition
123,16,metabolism,I-Condition
124,16,(,O
125,16,to,O
126,16,avoid,O
127,16,interaction,O
128,16,with,O
129,16,ticagrelor,B-Drug
130,16,):,O
131,16,Ketoconazole,B-Drug
132,16,",",O
133,16,itraconazole,B-Drug
134,16,",",O
135,16,voriconazole,B-Drug
136,16,",",O
137,16,clarithromycin,B-Drug
138,16,",",O
139,16,nefazodone,B-Drug
140,16,",",O
141,16,ritonavir,B-Drug
142,16,",",O
143,16,saquinavir,B-Drug
144,16,",",O
145,16,nelfinavir,B-Drug
146,16,",",O
147,16,indinavir,B-Drug
148,16,",",O
149,16,atazanavir,B-Drug
150,16,",",O
151,16,and,O
152,16,telithromizycin,B-Drug
153,16,.,O
154,17,Pregnant,B-Condition
155,17,or,O
156,17,lactating,B-Condition
157,17,females,B-Person
158,17,.,O
159,18,Patients,O
160,18,with,O
161,18,STEMI,B-Condition
162,18,undergoing,O
163,18,primary,B-Procedure
164,18,PPCI,I-Procedure
165,19,Age,B-Person
166,19,>,O
167,19,18,O
168,19,years,O
169,19,old,O
170,20,Known,O
171,20,hypersensitivity,B-Condition
172,20,to,O
173,20,statin,B-Drug
174,21,Treatment,O
175,21,with,O
176,21,statins,B-Drug
177,21,during,O
178,21,the,O
179,21,past,O
180,21,month,O
181,21,prior,O
182,21,to,O
183,21,study,O
184,21,.,O
185,22,Serum,O
186,22,creatinine,O
187,22,>,O
188,22,3,O
189,22,mg,O
190,22,/,O
191,22,dl,O
192,23,Significant,O
193,23,liver,B-Condition
194,23,disease,I-Condition
195,23,:,O
196,23,liver,O
197,23,enzymes,O
198,23,2.5,O
199,23,folds,O
200,23,the,O
201,23,upper,O
202,23,normal,O
203,23,limit,O
204,24,Malignancy,B-Condition
205,25,Pregnancy,B-Condition
206,25,or,O
207,25,lactation,B-Condition
208,26,older,O
209,26,than,O
210,26,18,O
211,26,years,B-Person
212,26,(,O
213,26,of,O
214,26,both,B-Person
215,26,sexes,I-Person
216,26,),O
217,27,diagnosed,O
218,27,with,O
219,27,stable,O
220,27,chronic,B-Condition
221,27,heart,I-Condition
222,27,failure,I-Condition
223,27,NYHA,O
224,27,class,O
225,27,II,O
226,27,-,O
227,27,III,O
228,28,ejection,O
229,28,fraction,O
230,28,<,O
231,28,40,O
232,28,%,O
233,28,as,O
234,28,assessed,O
235,28,by,O
236,28,2D,B-Procedure
237,28,echocardiography,I-Procedure
238,29,who,O
239,29,have,O
240,29,been,O
241,29,optimized,O
242,29,on,O
243,29,Guideline,O
244,29,Directed,O
245,29,treatment,O
246,29,for,O
247,29,heart,O
248,29,failure,O
249,29,for,O
250,29,at,O
251,29,least,O
252,29,a,O
253,29,month,O
254,29,prior,O
255,29,to,O
256,29,enrolling,O
257,29,.,O
258,30,Subjects,O
259,30,with,O
260,30,hemoglobin,B-Condition
261,30,SC,I-Condition
262,30,or,O
263,30,SB+,B-Condition
264,30,thalassemia,I-Condition
265,31,Subjects,O
266,31,on,O
267,31,chronic,O
268,31,transfusion,B-Procedure
269,31,program,I-Procedure
270,32,Subjects,O
271,32,who,O
272,32,have,O
273,32,received,O
274,32,RBC,B-Procedure
275,32,transfusions,I-Procedure
276,32,can,O
277,32,not,O
278,32,have,O
279,32,>,O
280,32,15,O
281,32,%,O
282,32,adult,O
283,32,hemoglobin,O
284,33,Known,O
285,33,positive,O
286,33,status,O
287,33,for,O
288,33,HIV,B-Condition
289,33,",",O
290,33,active,O
291,33,hepatitis,B-Condition
292,33,B,I-Condition
293,33,or,O
294,33,hepatitis,B-Condition
295,33,C,I-Condition
296,34,Pregnant,B-Condition
297,34,or,O
298,34,breast,B-Observation
299,34,feeding,I-Observation
300,34,women,B-Person
301,35,Individuals,O
302,35,with,O
303,35,a,O
304,35,history,B-Observation
305,35,of,O
306,35,malignancy,B-Condition
307,35,are,O
308,35,ineligible,O
309,35,except,O
310,35,for,O
311,35,the,O
312,35,following,O
313,35,circumstances,O
314,35,.,O
315,35,Individuals,O
316,35,with,O
317,35,a,O
318,35,history,O
319,35,of,O
320,35,malignancy,O
321,35,are,O
322,35,eligible,O
323,35,if,O
324,35,they,O
325,35,have,O
326,35,been,O
327,35,disease,B-Condition
328,35,-,I-Condition
329,35,free,I-Condition
330,35,for,O
331,35,at,O
332,35,least,O
333,35,5,O
334,35,years,O
335,35,and,O
336,35,are,O
337,35,deemed,O
338,35,by,O
339,35,the,O
340,35,investigator,O
341,35,to,O
342,35,be,O
343,35,at,O
344,35,low,B-Mood
345,35,risk,I-Mood
346,35,for,O
347,35,recurrence,B-Condition
348,35,of,I-Condition
349,35,that,I-Condition
350,35,malignancy,I-Condition
351,35,.,O
352,35,Individuals,O
353,35,with,O
354,35,the,O
355,35,following,O
356,35,cancer,O
357,35,are,O
358,35,eligible,O
359,35,if,O
360,35,diagnosed,B-Mood
361,35,and,O
362,35,adequately,B-Mood
363,35,treated,I-Mood
364,35,within,O
365,35,the,O
366,35,past,O
367,35,5,O
368,35,years,O
369,35,:,O
370,35,cervical,B-Condition
371,35,or,I-Condition
372,35,breast,I-Condition
373,35,cancer,I-Condition
374,35,in,I-Condition
375,35,situ,I-Condition
376,35,",",O
377,35,and,O
378,35,basal,B-Condition
379,35,cell,I-Condition
380,35,or,I-Condition
381,35,squamous,I-Condition
382,35,cell,I-Condition
383,35,carcinoma,I-Condition
384,35,of,I-Condition
385,35,the,I-Condition
386,35,skin,I-Condition
387,36,Subjects,O
388,36,with,O
389,36,a,O
390,36,history,B-Observation
391,36,of,O
392,36,thrombosis,B-Condition
393,36,or,O
394,36,other,O
395,36,reason,O
396,36,(,O
397,36,other,O
398,36,than,O
399,36,sickle,B-Condition
400,36,cell,I-Condition
401,36,disease,I-Condition
402,36,),O
403,36,for,O
404,36,enhanced,B-Mood
405,36,thrombotic,I-Mood
406,36,risk,I-Mood
407,37,Subjects,O
408,37,with,O
409,37,unresolved,O
410,37,infections,B-Condition
411,38,Severe,O
412,38,or,O
413,38,uncontrolled,O
414,38,medical,B-Condition
415,38,conditions,I-Condition
416,38,that,O
417,38,could,O
418,38,compromise,O
419,38,study,O
420,38,participation,O
421,39,Subjects,O
422,39,on,O
423,39,fetal,B-Drug
424,39,hemoglobin,I-Drug
425,39,inducing,I-Drug
426,39,agents,I-Drug
427,40,Subjects,O
428,40,on,O
429,40,any,O
430,40,other,O
431,40,experimental,O
432,40,treatment,O
433,40,within,O
434,40,90,O
435,40,days,O
436,40,of,O
437,40,the,O
438,40,first,O
439,40,dose,O
440,40,of,O
441,40,study,O
442,40,drug,O
443,40,or,O
444,40,who,O
445,40,have,O
446,40,not,O
447,40,recovered,O
448,40,from,O
449,40,the,O
450,40,side,O
451,40,effects,O
452,40,of,O
453,40,such,O
454,40,therapy,O
455,41,Known,O
456,41,allergic,B-Condition
457,41,reaction,I-Condition
458,41,to,O
459,41,a,O
460,41,histone,B-Drug
461,41,deacetylase,I-Drug
462,41,inhibitor,I-Drug
463,42,Subjects,O
464,42,who,O
465,42,have,O
466,42,received,O
467,42,valproic,B-Drug
468,42,acid,I-Drug
469,42,for,O
470,42,treatment,B-Procedure
471,42,of,O
472,42,epilepsy,B-Condition
473,42,within,O
474,42,30,O
475,42,days,O
476,42,of,O
477,42,enrollment,O
478,43,Subjects,O
479,43,who,O
480,43,have,O
481,43,received,O
482,43,any,O
483,43,HDAC,B-Drug
484,43,inhibitors,I-Drug
485,43,other,O
486,43,than,O
487,43,valproic,B-Drug
488,43,acid,I-Drug
489,44,Diagnosis,B-Mood
490,44,of,O
491,44,sickle,B-Condition
492,44,cell,I-Condition
493,44,disease,I-Condition
494,45,Clinically,B-Condition
495,45,significant,I-Condition
496,45,disease,I-Condition
497,45,defined,O
498,45,as,O
499,45,at,O
500,45,least,O
501,45,1,O
502,45,painful,B-Condition
503,45,episode,I-Condition
504,45,per,O
505,45,year,O
506,45,averaged,O
507,45,over,O
508,45,the,O
509,45,previous,O
510,45,3,O
511,45,years,O
512,45,or,O
513,45,a,O
514,45,history,B-Observation
515,45,of,O
516,45,priapism,B-Condition
517,45,",",O
518,45,stroke,B-Condition
519,45,",",O
520,45,acute,B-Condition
521,45,chest,I-Condition
522,45,syndrome,I-Condition
523,45,",",O
524,45,avascular,B-Condition
525,45,necrosis,I-Condition
526,45,",",O
527,45,multi,B-Condition
528,45,-,I-Condition
529,45,organ,I-Condition
530,45,failure,I-Condition
531,45,or,O
532,45,the,O
533,45,need,B-Mood
534,45,for,I-Mood
535,45,chronic,O
536,45,narcotic,B-Drug
537,45,medications,I-Drug
538,45,for,O
539,45,pain,B-Condition
540,45,from,O
541,45,sickle,B-Condition
542,45,cell,I-Condition
543,45,disease,I-Condition
544,46,Must,O
545,46,have,O
546,46,failed,O
547,46,a,O
548,46,previous,O
549,46,attempt,O
550,46,at,O
551,46,treatment,O
552,46,with,O
553,46,hydroxyurea,O
554,46,defined,O
555,46,as,O
556,46,the,O
557,46,inability,O
558,46,to,O
559,46,achieve,O
560,46,a,O
561,46,significant,O
562,46,absolute,O
563,46,increase,O
564,46,in,O
565,46,%,O
566,46,fetal,O
567,46,hemoglobin,O
568,46,or,O
569,46,the,O
570,46,inability,O
571,46,to,O
572,46,tolerate,O
573,46,hydroxyurea,O
574,46,treatment,O
575,46,due,O
576,46,to,O
577,46,severe,O
578,46,side,O
579,46,effects,O
580,46,such,O
581,46,as,O
582,46,but,O
583,46,not,O
584,46,limited,O
585,46,to,O
586,46,myelosuppression,O
587,46,",",O
588,46,gastrointestinal,O
589,46,symptoms,O
590,46,",",O
591,46,edema,O
592,46,or,O
593,46,hepatic,O
594,46,enzyme,O
595,46,elevations,O
596,46,or,O
597,46,have,O
598,46,contraindications,O
599,46,to,O
600,46,hydroxyurea,O
601,47,18,O
602,47,years,O
603,47,of,O
604,47,age,B-Person
605,47,or,O
606,47,older,O
607,48,Hematologic,O
608,48,laboratory,O
609,48,values,O
610,48,as,O
611,48,outlined,O
612,48,in,O
613,48,the,O
614,48,protocol,O
615,49,Non,O
616,49,-,O
617,49,hematologic,O
618,49,laboratory,O
619,49,values,O
620,49,as,O
621,49,outlined,O
622,49,in,O
623,49,the,O
624,49,protocol,O
625,50,Must,B-Mood
626,50,agree,I-Mood
627,50,not,I-Mood
628,50,to,I-Mood
629,50,donate,B-Procedure
630,50,blood,I-Procedure
631,50,or,I-Procedure
632,50,other,I-Procedure
633,50,bodily,I-Procedure
634,50,fluid,I-Procedure
635,50,while,O
636,50,taking,O
637,50,the,O
638,50,study,B-Drug
639,50,drug,I-Drug
640,50,and,O
641,50,for,O
642,50,28,O
643,50,days,O
644,50,thereafter,O
645,51,Women,B-Person
646,51,of,O
647,51,child,B-Condition
648,51,-,I-Condition
649,51,bearing,I-Condition
650,51,potential,I-Condition
651,51,(,O
652,51,WCBP,B-Person
653,51,),O
654,51,must,O
655,51,have,O
656,51,a,O
657,51,negative,O
658,51,serum,O
659,51,pregnancy,O
660,51,test,O
661,51,72,O
662,51,hours,O
663,51,or,O
664,51,less,O
665,51,prior,O
666,51,to,O
667,51,starting,O
668,51,treatment,B-Procedure
669,52,Women,B-Person
670,52,of,O
671,52,child,B-Condition
672,52,-,I-Condition
673,52,bearing,I-Condition
674,52,potential,I-Condition
675,52,and,O
676,52,men,B-Person
677,52,must,B-Mood
678,52,agree,I-Mood
679,52,to,I-Mood
680,52,use,O
681,52,2,O
682,52,forms,O
683,52,of,O
684,52,adequate,O
685,52,contraception,B-Procedure
686,52,prior,O
687,52,to,O
688,52,study,O
689,52,entry,O
690,52,and,O
691,52,for,O
692,52,the,O
693,52,duration,O
694,52,of,O
695,52,study,O
696,52,participation,O
697,53,Inability,B-Observation
698,53,to,I-Observation
699,53,understand,I-Observation
700,53,and,I-Observation
701,53,read,I-Observation
702,53,English,I-Observation
703,53,.,O
704,54,Women,B-Person
705,54,pregnant,B-Condition
706,54,or,O
707,54,lactating,B-Condition
708,54,.,O
709,55,persons,O
710,55,with,O
711,55,terminal,B-Condition
712,55,illness,I-Condition
713,56,Overweight,B-Condition
714,56,/,O
715,56,Obese,B-Condition
716,56,Adult,B-Person
717,56,patients,O
718,56,(,O
719,56,age,B-Person
720,56,19,O
721,56,years,O
722,56,-65,O
723,56,),O
724,57,eligible,O
725,57,based,O
726,57,on,O
727,57,WALI,B-Procedure
728,57,screening,I-Procedure
729,57,tool,I-Procedure
730,58,Administration,O
731,58,of,O
732,58,the,O
733,58,licensed,O
734,58,MF59,B-Drug
735,58,-,I-Drug
736,58,containing,I-Drug
737,58,vaccines,I-Drug
738,58,",",O
739,58,e.g.,O
740,58,Fluad,B-Drug
741,58,™,O
742,58,or,O
743,58,Addigrip,B-Drug
744,58,™,O
745,58,or,O
746,58,virosome,B-Drug
747,58,-,I-Drug
748,58,based,I-Drug
749,58,influenza,I-Drug
750,58,vaccines,I-Drug
751,58,such,O
752,58,as,O
753,58,Inflexal,B-Drug
754,58,V,I-Drug
755,58,™,O
756,58,",",O
757,58,InfectoVac,B-Drug
758,58,Flu,I-Drug
759,58,™,O
760,58,or,O
761,58,Invivac,B-Drug
762,58,™,O
763,58,during,O
764,58,the,O
765,58,2006,O
766,58,-,O
767,58,2007,O
768,58,influenza,O
769,58,season,O
770,58,.,O
771,59,Administration,O
772,59,of,O
773,59,licensed,B-Drug
774,59,vaccines,I-Drug
775,59,within,O
776,59,2,O
777,59,weeks,O
778,59,(,O
779,59,for,O
780,59,inactivated,B-Drug
781,59,vaccines,I-Drug
782,59,),O
783,59,or,O
784,59,4,O
785,59,weeks,O
786,59,(,O
787,59,for,O
788,59,live,B-Drug
789,59,vaccines,I-Drug
790,59,),O
791,59,prior,O
792,59,to,O
793,59,enrolment,O
794,59,in,O
795,59,this,O
796,59,study,O
797,59,.,O
798,60,Planned,O
799,60,administration,O
800,60,of,O
801,60,a,O
802,60,vaccine,B-Drug
803,60,not,O
804,60,foreseen,O
805,60,by,O
806,60,the,O
807,60,study,O
808,60,protocol,O
809,60,up,O
810,60,to,O
811,60,30,O
812,60,days,O
813,60,after,O
814,60,the,O
815,60,second,O
816,60,vaccination,B-Drug
817,60,with,O
818,60,H5N1,B-Drug
819,60,vaccine,I-Drug
820,60,.,O
821,61,Chronic,O
822,61,administration,O
823,61,(,O
824,61,defined,O
825,61,as,O
826,61,more,O
827,61,than,O
828,61,14,O
829,61,days,O
830,61,),O
831,61,of,O
832,61,immunosuppressants,B-Drug
833,61,or,O
834,61,other,B-Drug
835,61,immune,I-Drug
836,61,-,I-Drug
837,61,modifying,I-Drug
838,61,drugs,I-Drug
839,61,within,O
840,61,six,O
841,61,months,O
842,61,prior,O
843,61,to,O
844,61,the,O
845,61,first,O
846,61,administration,O
847,61,of,O
848,61,the,O
849,61,study,O
850,61,vaccine,O
851,61,.,O
852,62,Any,O
853,62,confirmed,O
854,62,or,O
855,62,suspected,O
856,62,immunosuppressive,B-Condition
857,62,or,I-Condition
858,62,immunodeficient,I-Condition
859,62,condition,I-Condition
860,62,",",O
861,62,based,O
862,62,on,O
863,62,medical,O
864,62,history,O
865,62,and,O
866,62,physical,O
867,62,examination,O
868,62,(,O
869,62,no,O
870,62,laboratory,O
871,62,testing,O
872,62,required,O
873,62,),O
874,62,.,O
875,63,History,B-Observation
876,63,of,O
877,63,chronic,B-Condition
878,63,alcohol,I-Condition
879,63,consumption,I-Condition
880,63,and/or,O
881,63,drug,B-Condition
882,63,abuse,I-Condition
883,63,.,O
884,64,History,B-Observation
885,64,of,O
886,64,hypersensitivity,B-Condition
887,64,to,I-Condition
888,64,vaccines,I-Condition
889,64,.,O
890,65,History,B-Observation
891,65,of,O
892,65,allergic,B-Condition
893,65,disease,I-Condition
894,65,or,I-Condition
895,65,reactions,I-Condition
896,65,likely,O
897,65,to,O
898,65,be,O
899,65,exacerbated,O
900,65,by,O
901,65,any,O
902,65,component,O
903,65,of,O
904,65,the,O
905,65,vaccine,O
906,65,(,O
907,65,including,O
908,65,egg,B-Condition
909,65,and,I-Condition
910,65,thiomersal,I-Condition
911,65,allergy,I-Condition
912,65,),O
913,65,.,O
914,66,Acute,O
915,66,clinically,O
916,66,significant,O
917,66,pulmonary,B-Condition
918,66,",",I-Condition
919,66,cardiovascular,I-Condition
920,66,",",I-Condition
921,66,hepatic,I-Condition
922,66,or,I-Condition
923,66,renal,I-Condition
924,66,functional,I-Condition
925,66,abnormality,I-Condition
926,66,",",O
927,66,as,O
928,66,determined,O
929,66,by,O
930,66,physical,O
931,66,examination,O
932,66,or,O
933,66,laboratory,O
934,66,screening,O
935,66,tests,O
936,66,.,O
937,67,Acute,B-Condition
938,67,disease,I-Condition
939,67,at,O
940,67,the,O
941,67,time,O
942,67,of,O
943,67,enrolment,O
944,67,.,O
945,68,Serious,O
946,68,chronic,B-Condition
947,68,disease,I-Condition
948,68,including,O
949,68,any,O
950,68,medically,O
951,68,significant,O
952,68,chronic,B-Condition
953,68,pulmonary,I-Condition
954,68,",",I-Condition
955,68,cardiovascular,I-Condition
956,68,",",I-Condition
957,68,renal,I-Condition
958,68,",",I-Condition
959,68,neurological,I-Condition
960,68,",",I-Condition
961,68,psychiatric,I-Condition
962,68,or,I-Condition
963,68,metabolic,I-Condition
964,68,disorder,I-Condition
965,68,",",O
966,68,as,O
967,68,determined,O
968,68,by,O
969,68,medical,O
970,68,history,O
971,68,and,O
972,68,physical,O
973,68,examination,O
974,68,.,O
975,69,Administration,O
976,69,of,O
977,69,immunoglobulins,B-Drug
978,69,and/or,O
979,69,any,B-Drug
980,69,blood,I-Drug
981,69,products,I-Drug
982,69,within,O
983,69,the,O
984,69,three,O
985,69,months,O
986,69,preceding,O
987,69,the,O
988,69,first,O
989,69,vaccination,B-Procedure
990,69,or,O
991,69,during,O
992,69,the,O
993,69,study,O
994,69,.,O
995,70,Use,O
996,70,of,O
997,70,any,O
998,70,investigational,O
999,70,or,O
1000,70,non,O
1001,70,-,O
1002,70,registered,O
1003,70,product,B-Drug
1004,70,(,O
1005,70,drug,B-Drug
1006,70,or,O
1007,70,vaccine,B-Drug
1008,70,),O
1009,70,other,O
1010,70,than,O
1011,70,the,O
1012,70,study,B-Drug
1013,70,vaccine(s,I-Drug
1014,70,),I-Drug
1015,70,within,O
1016,70,30,O
1017,70,days,O
1018,70,prior,O
1019,70,to,O
1020,70,the,O
1021,70,first,O
1022,70,vaccination,B-Procedure
1023,70,",",O
1024,70,or,O
1025,70,planned,B-Mood
1026,70,use,B-Procedure
1027,70,during,O
1028,70,the,O
1029,70,study,O
1030,70,period,O
1031,70,.,O
1032,71,Any,O
1033,71,condition,B-Condition
1034,71,which,O
1035,71,",",O
1036,71,in,O
1037,71,the,O
1038,71,opinion,O
1039,71,of,O
1040,71,the,O
1041,71,investigator,O
1042,71,",",O
1043,71,prevents,O
1044,71,the,O
1045,71,subject,O
1046,71,from,O
1047,71,participation,O
1048,71,in,O
1049,71,the,O
1050,71,study,O
1051,71,.,O
1052,72,Subjects,O
1053,72,who,O
1054,72,the,O
1055,72,investigator,O
1056,72,believes,O
1057,72,that,O
1058,72,they,O
1059,72,can,B-Observation
1060,72,and,I-Observation
1061,72,will,I-Observation
1062,72,comply,I-Observation
1063,72,with,I-Observation
1064,72,the,I-Observation
1065,72,requirements,I-Observation
1066,72,of,I-Observation
1067,72,the,I-Observation
1068,72,protocol,I-Observation
1069,72,should,O
1070,72,be,O
1071,72,enrolled,O
1072,72,in,O
1073,72,the,O
1074,72,study,O
1075,72,.,O
1076,73,A,O
1077,73,male,B-Person
1078,73,or,O
1079,73,female,B-Person
1080,73,aged,B-Person
1081,73,61,O
1082,73,years,O
1083,73,or,O
1084,73,above,O
1085,73,at,O
1086,73,the,O
1087,73,time,O
1088,73,of,O
1089,73,the,O
1090,73,first,O
1091,73,vaccination,O
1092,73,.,O
1093,74,Written,B-Observation
1094,74,informed,I-Observation
1095,74,consent,I-Observation
1096,74,obtained,O
1097,74,from,O
1098,74,the,O
1099,74,subject,O
1100,74,.,O
1101,75,Healthy,B-Condition
1102,75,subjects,O
1103,75,or,O
1104,75,subjects,O
1105,75,with,O
1106,75,well,O
1107,75,controlled,O
1108,75,underlying,B-Condition
1109,75,disease,I-Condition
1110,75,.,O
1111,76,Presence,O
1112,76,of,O
1113,76,a,O
1114,76,significant,O
1115,76,medical,B-Condition
1116,76,or,I-Condition
1117,76,psychiatric,I-Condition
1118,76,condition,I-Condition
1119,76,(,O
1120,76,Examples,O
1121,76,include,O
1122,76,:,O
1123,76,Diagnosis,O
1124,76,and,O
1125,76,treatment,B-Procedure
1126,76,of,O
1127,76,tuberculosis,B-Condition
1128,76,(,I-Condition
1129,76,TB,I-Condition
1130,76,),I-Condition
1131,76,or,O
1132,76,HIV,B-Condition
1133,76,;,O
1134,76,renal,B-Condition
1135,76,insufficiency,I-Condition
1136,76,;,O
1137,76,hepatic,B-Condition
1138,76,disease,I-Condition
1139,76,;,O
1140,76,oral,B-Drug
1141,76,or,I-Drug
1142,76,parenteral,I-Drug
1143,76,medication,I-Drug
1144,76,known,O
1145,76,to,O
1146,76,affect,O
1147,76,the,O
1148,76,immune,O
1149,76,function,O
1150,76,",",O
1151,76,such,O
1152,76,as,O
1153,76,corticosteroids,B-Drug
1154,76,",",O
1155,76,other,O
1156,76,immunosuppressant,B-Drug
1157,76,drugs,I-Drug
1158,76,;,O
1159,76,or,O
1160,76,behavioural,B-Condition
1161,76,or,I-Condition
1162,76,memory,I-Condition
1163,76,issues,I-Condition
1164,76,),O
1165,77,Ever,O
1166,77,having,O
1167,77,received,O
1168,77,oral,B-Drug
1169,77,cholera,I-Drug
1170,77,vaccine,I-Drug
1171,77,.,O
1172,78,Receipt,O
1173,78,of,O
1174,78,an,O
1175,78,investigational,O
1176,78,product,O
1177,78,(,O
1178,78,within,O
1179,78,30,O
1180,78,days,O
1181,78,before,O
1182,78,vaccination,O
1183,78,),O
1184,78,.,O
1185,79,History,B-Observation
1186,79,of,O
1187,79,diarrhoea,B-Condition
1188,79,in,O
1189,79,7,O
1190,79,days,O
1191,79,prior,O
1192,79,to,O
1193,79,first,O
1194,79,dose,O
1195,79,of,O
1196,79,vaccine,O
1197,79,(,O
1198,79,defined,O
1199,79,as,O
1200,79,=3,O
1201,79,unformed,O
1202,79,loose,O
1203,79,stools,O
1204,79,in,O
1205,79,24,O
1206,79,hours,O
1207,79,),O
1208,79,.,O
1209,80,History,B-Observation
1210,80,of,O
1211,80,chronic,B-Condition
1212,80,diarrhea,I-Condition
1213,80,(,O
1214,80,lasting,O
1215,80,for,O
1216,80,more,O
1217,80,than,O
1218,80,2,O
1219,80,weeks,O
1220,80,in,O
1221,80,the,O
1222,80,past,O
1223,80,6,O
1224,80,months,O
1225,80,),O
1226,81,Current,O
1227,81,use,O
1228,81,of,O
1229,81,laxatives,B-Drug
1230,81,",",O
1231,81,antacids,B-Drug
1232,81,",",O
1233,81,or,O
1234,81,other,O
1235,81,agents,B-Drug
1236,81,to,I-Drug
1237,81,lower,I-Drug
1238,81,stomach,I-Drug
1239,81,acidity,I-Drug
1240,81,?,O
1241,82,Planning,O
1242,82,to,O
1243,82,become,O
1244,82,pregnant,O
1245,82,in,O
1246,82,the,O
1247,82,next,O
1248,82,2,O
1249,82,years,O
1250,82,.,O
1251,83,Age,B-Person
1252,83,=,O
1253,83,1,O
1254,83,year,O
1255,83,",",O
1256,83,stratified,O
1257,83,into,O
1258,83,different,O
1259,83,age,O
1260,83,groups,O
1261,84,Living,B-Person
1262,84,in,O
1263,84,the,O
1264,84,Waya,O
1265,84,Clinic,O
1266,84,Catchment,O
1267,84,Area,O
1268,85,Good,B-Condition
1269,85,health,I-Condition
1270,85,condition,I-Condition
1271,85,",",O
1272,85,without,O
1273,85,clinically,O
1274,85,significant,O
1275,85,medical,B-Observation
1276,85,history,I-Observation
1277,85,(,O
1278,85,by,O
1279,85,participant,O
1280,85,or,O
1281,85,guardian,O
1282,85,",",O
1283,85,in,O
1284,85,case,O
1285,85,of,O
1286,85,minor,O
1287,85,),O
1288,86,Not,O
1289,86,pregnant,B-Condition
1290,86,for,O
1291,86,female,B-Person
1292,86,subjects,O
1293,86,.,O
1294,87,Available,O
1295,87,to,O
1296,87,participate,O
1297,87,for,O
1298,87,the,O
1299,87,study,O
1300,87,duration,O
1301,87,",",O
1302,87,including,O
1303,87,all,O
1304,87,planned,O
1305,87,follow,O
1306,87,-,O
1307,87,up,O
1308,87,visits,O
1309,87,for,O
1310,87,up,O
1311,87,to,O
1312,87,9,O
1313,87,months,O
1314,87,from,O
1315,87,screening,O
1316,87,.,O
1317,88,Signed,O
1318,88,informed,O
1319,88,consent,O
1320,89,NA,O
1321,90,Patients,O
1322,90,undergoing,O
1323,90,elective,O
1324,90,abdominal,B-Procedure
1325,90,surgery,I-Procedure
1326,90,with,O
1327,90,an,O
1328,90,expected,O
1329,90,blood,O
1330,90,loss,O
1331,90,of,O
1332,90,=,O
1333,90,500,O
1334,90,ml,O
1335,91,ASA,O
1336,91,Physical,O
1337,91,Status,O
1338,91,II,O
1339,91,-,O
1340,91,III,O
1341,92,Signed,O
1342,92,written,O
1343,92,informed,O
1344,92,consent,O
1345,92,form,O
1346,93,Body,O
1347,93,weight,O
1348,93,=,O
1349,93,140,O
1350,93,kg,O
1351,94,Sepsis,B-Condition
1352,95,Burns,B-Condition
1353,96,Renal,B-Condition
1354,96,impairment,I-Condition
1355,96,(,O
1356,96,AKIN,O
1357,96,stage,O
1358,96,=,O
1359,96,1,O
1360,96,),O
1361,96,or,O
1362,96,acute,O
1363,96,and/or,O
1364,96,chronic,O
1365,96,renal,B-Procedure
1366,96,replacement,I-Procedure
1367,96,therapy,I-Procedure
1368,97,Intracranial,B-Condition
1369,97,or,I-Condition
1370,97,cerebral,I-Condition
1371,97,haemorrhage,I-Condition
1372,98,Critically,B-Condition
1373,98,ill,I-Condition
1374,98,patients,O
1375,98,(,O
1376,98,typically,B-Mood
1377,98,admitted,B-Procedure
1378,98,to,O
1379,98,the,O
1380,98,intensive,O
1381,98,care,O
1382,98,unit,O
1383,98,),O
1384,99,Hyperhydration,B-Condition
1385,100,Pulmonary,B-Condition
1386,100,oedema,I-Condition
1387,101,Dehydration,B-Condition
1388,102,Hyperkalaemia,B-Condition
1389,103,Severe,O
1390,103,hypernatraemia,B-Condition
1391,104,Severe,O
1392,104,hyperchloraemia,B-Condition
1393,105,Severely,O
1394,105,impaired,B-Condition
1395,105,hepatic,I-Condition
1396,105,function,I-Condition
1397,106,Congestive,B-Condition
1398,106,heart,I-Condition
1399,106,failure,I-Condition
1400,107,Severe,O
1401,107,coagulopathy,B-Condition
1402,108,Organ,B-Procedure
1403,108,transplant,I-Procedure
1404,108,patients,O
1405,109,Metabolic,B-Condition
1406,109,alkalosis,I-Condition
1407,110,Simultaneous,O
1408,110,participation,O
1409,110,in,O
1410,110,another,O
1411,110,interventional,O
1412,110,clinical,O
1413,110,trial,O
1414,110,(,O
1415,110,drugs,O
1416,110,or,O
1417,110,medical,O
1418,110,devices,O
1419,110,studies,O
1420,110,),O
1421,111,Aged,B-Person
1422,111,under,O
1423,111,18,O
1424,111,",",O
1425,112,Lack,O
1426,112,of,O
1427,112,informed,B-Observation
1428,112,consent,I-Observation
1429,112,signed,I-Observation
1430,112,",",O
1431,113,Radiofrequency,B-Procedure
1432,113,treatment,I-Procedure
1433,113,history,B-Observation
1434,113,",",O
1435,114,on,O
1436,114,going,O
1437,114,neoplastic,B-Condition
1438,114,history,B-Observation
1439,114,with,O
1440,114,a,O
1441,114,short,O
1442,114,prognosis,O
1443,114,",",O
1444,115,Concomitant,O
1445,115,participation,B-Observation
1446,115,in,I-Observation
1447,115,another,I-Observation
1448,115,clinical,I-Observation
1449,115,study,I-Observation
1450,116,Contraindication,B-Condition
1451,116,to,O
1452,116,general,B-Procedure
1453,116,anesthesia,I-Procedure
1454,116,",",O
1455,117,Patient,O
1456,117,with,O
1457,117,an,O
1458,117,esophageal,O
1459,117,location,O
1460,117,of,O
1461,117,scleroderma,B-Condition
1462,118,Presence,O
1463,118,of,O
1464,118,a,O
1465,118,cardiac,O
1466,118,pacemaker,O
1467,118,or,O
1468,118,stimulator,O
1469,119,Pregnant,B-Observation
1470,119,women,B-Person
1471,119,or,O
1472,119,likely,B-Mood
1473,119,to,I-Mood
1474,119,be,I-Mood
1475,119,in,O
1476,119,the,O
1477,119,absence,O
1478,119,of,O
1479,119,effective,O
1480,119,contraception,O
1481,119,",",O
1482,120,Esophageal,B-Condition
1483,120,stenosis,I-Condition
1484,120,preventing,B-Mood
1485,120,the,I-Mood
1486,120,passage,B-Procedure
1487,120,of,I-Procedure
1488,120,an,I-Procedure
1489,120,endoscope,I-Procedure
1490,120,",",O
1491,121,Histology,B-Procedure
1492,121,other,O
1493,121,than,O
1494,121,glandular,B-Condition
1495,121,neoplasia,I-Condition
1496,121,",",O
1497,122,History,B-Observation
1498,122,of,O
1499,122,or,O
1500,122,current,O
1501,122,history,O
1502,122,of,O
1503,122,esophageal,B-Condition
1504,122,cancer,I-Condition
1505,122,invading,O
1506,122,the,O
1507,122,submucosal,O
1508,122,layer,O
1509,122,of,O
1510,122,the,O
1511,122,esophagus,O
1512,122,or,O
1513,122,more,O
1514,122,",",O
1515,123,Surgical,B-Procedure
1516,123,treatment,I-Procedure
1517,123,history,B-Observation
1518,123,(,O
1519,123,except,O
1520,123,anti,B-Procedure
1521,123,-,I-Procedure
1522,123,reflux,I-Procedure
1523,123,treatment,I-Procedure
1524,123,),O
1525,123,or,O
1526,123,esophageal,B-Procedure
1527,123,radiotherapy,I-Procedure
1528,123,",",O
1529,124,previous,O
1530,124,esophageal,B-Procedure
1531,124,treatment,I-Procedure
1532,124,by,O
1533,124,another,O
1534,124,method,O
1535,124,ablation,B-Procedure
1536,124,:,O
1537,124,photodynamic,B-Procedure
1538,124,therapy,I-Procedure
1539,124,",",O
1540,124,argon,B-Procedure
1541,124,plasma,I-Procedure
1542,124,coagulation,I-Procedure
1543,124,",",O
1544,124,laser,B-Procedure
1545,124,",",O
1546,124,....,O
1547,125,Esophageal,B-Condition
1548,125,varices,I-Condition
1549,125,observed,O
1550,125,in,O
1551,125,endoscopy,B-Procedure
1552,125,",",O
1553,126,Coagulopathy,B-Condition
1554,126,or,O
1555,126,taking,O
1556,126,anticoagulants,B-Drug
1557,126,responsible,O
1558,126,an,O
1559,126,INR,O
1560,126,>,O
1561,126,1.3,O
1562,126,or,O
1563,126,a,O
1564,126,platelet,O
1565,126,count,O
1566,126,<,O
1567,126,"75,000",O
1568,126,per,O
1569,126,microL,O
1570,126,",",O
1571,127,Life,O
1572,127,expectancy,O
1573,127,of,O
1574,127,less,O
1575,127,than,O
1576,127,3,O
1577,127,years,O
1578,127,",",O
1579,127,due,O
1580,127,to,O
1581,127,intercurrent,B-Condition
1582,127,disease,I-Condition
1583,127,",",O
1584,127,especially,O
1585,127,neoplastic,B-Condition
1586,127,",",O
1587,128,Liver,B-Condition
1588,128,cirrhosis,I-Condition
1589,128,(,O
1590,128,Child,O
1591,128,-,O
1592,128,Pugh,O
1593,128,all,O
1594,128,stages,O
1595,128,),O
1596,129,Respiratory,B-Condition
1597,129,failure,I-Condition
1598,129,:,O
1599,130,Renal,B-Condition
1600,130,failure,I-Condition
1601,130,(,O
1602,130,Cl,O
1603,130,Cr,O
1604,130,<,O
1605,130,60,O
1606,130,mL,O
1607,130,/min,O
1608,130,"/1,73",O
1609,130,m,O
1610,130,),O
1611,130,",",O
1612,131,Heart,B-Condition
1613,131,attack,I-Condition
1614,131,within,O
1615,131,the,O
1616,131,last,O
1617,131,six,O
1618,131,months,O
1619,131,or,O
1620,131,progressive,B-Condition
1621,131,coronary,I-Condition
1622,131,artery,I-Condition
1623,131,disease,I-Condition
1624,131,",",O
1625,132,Severe,O
1626,132,distal,B-Condition
1627,132,arteriopathie,I-Condition
1628,132,>,O
1629,132,stage,O
1630,132,II,O
1631,132,of,O
1632,132,Leriche,O
1633,132,and,O
1634,132,Fontaine,O
1635,133,Age,B-Person
1636,133,over,O
1637,133,18,O
1638,133,years,O
1639,133,",",O
1640,134,General,O
1641,134,Condition,O
1642,134,WHO,O
1643,134,0,O
1644,134,",",O
1645,134,1,O
1646,134,or,O
1647,134,2,O
1648,134,",",O
1649,135,ASA,O
1650,135,Class,O
1651,135,I,O
1652,135,and,O
1653,135,II,O
1654,135,",",O
1655,135,eligible,B-Mood
1656,135,for,I-Mood
1657,135,endoscopic,O
1658,135,or,O
1659,135,surgical,B-Procedure
1660,135,treatment,I-Procedure
1661,135,with,O
1662,135,curative,O
1663,135,intent,O
1664,135,",",O
1665,136,Histological,B-Procedure
1666,136,diagnosis,I-Procedure
1667,136,of,O
1668,136,high,O
1669,136,grade,O
1670,136,glandular,B-Condition
1671,136,epithelial,I-Condition
1672,136,neoplasia,I-Condition
1673,136,(,O
1674,136,Vienna,O
1675,136,4,O
1676,136,-,O
1677,136,1,O
1678,136,to,O
1679,136,4,O
1680,136,-,O
1681,136,46,O
1682,136,),O
1683,136,",",O
1684,136,possibly,O
1685,136,multifocal,O
1686,136,or,O
1687,136,stage,O
1688,136,0,O
1689,136,(,O
1690,136,Tis,O
1691,136,",",O
1692,136,N0,O
1693,136,",",O
1694,136,M0,O
1695,136,),O
1696,136,",",O
1697,137,Endoscopic,B-Procedure
1698,137,and,O
1699,137,histological,B-Procedure
1700,137,confirmed,O
1701,137,diagnosis,O
1702,137,of,O
1703,137,intestinal,B-Condition
1704,137,metaplasia,I-Condition
1705,137,",",O
1706,138,Histological,B-Procedure
1707,138,diagnosis,B-Condition
1708,138,confirmed,O
1709,138,by,O
1710,138,two,O
1711,138,endoscopies,B-Procedure
1712,138,with,O
1713,138,biopsies,B-Procedure
1714,138,and,O
1715,138,two,O
1716,138,pathological,B-Procedure
1717,138,readings,I-Procedure
1718,138,;,O
1719,138,biopsies,O
1720,138,should,O
1721,138,be,O
1722,138,carried,O
1723,138,out,O
1724,138,according,O
1725,138,to,O
1726,138,the,O
1727,138,protocol,O
1728,138,of,O
1729,138,the,O
1730,138,SFED,O
1731,138,(,O
1732,138,four,O
1733,138,-,O
1734,138,quadrant,O
1735,138,biopsies,O
1736,138,every,O
1737,138,cm,O
1738,138,),O
1739,138,with,O
1740,138,at,O
1741,138,least,O
1742,138,once,O
1743,138,acetic,O
1744,138,acid,O
1745,138,for,O
1746,138,staining,O
1747,138,.,O
1748,138,Operators,O
1749,138,describe,O
1750,138,Barrett,O
1751,138,'s,O
1752,138,esophagus,O
1753,138,using,O
1754,138,he,O
1755,138,SFED,O
1756,138,planimetric,O
1757,138,model,O
1758,138,.,O
1759,138,The,O
1760,138,final,O
1761,138,exam,O
1762,138,will,O
1763,138,be,O
1764,138,no,O
1765,138,more,O
1766,138,than,O
1767,138,two,O
1768,138,months,O
1769,138,before,O
1770,138,the,O
1771,138,date,O
1772,138,of,O
1773,138,treatment,O
1774,138,and,O
1775,138,should,O
1776,138,have,O
1777,138,been,O
1778,138,achieved,O
1779,138,in,O
1780,138,investigator,O
1781,138,establishment,O
1782,138,",",O
1783,139,Minimum,O
1784,139,1,O
1785,139,cm,O
1786,139,",",O
1787,140,Maximum,O
1788,140,12,O
1789,140,cm,O
1790,140,.,O
1791,141,the,O
1792,141,resected,B-Condition
1793,141,lesion,I-Condition
1794,141,must,O
1795,141,have,O
1796,141,been,O
1797,141,well,O
1798,141,differentiated,O
1799,141,and,O
1800,141,confined,O
1801,141,to,O
1802,141,the,O
1803,141,mucosa,O
1804,141,(,O
1805,141,m2,O
1806,141,maximum,O
1807,141,),O
1808,141,on,O
1809,141,histological,B-Procedure
1810,141,analysis,I-Procedure
1811,141,",",O
1812,142,resection,B-Condition
1813,142,should,O
1814,142,be,O
1815,142,more,O
1816,142,than,O
1817,142,two,O
1818,142,months,O
1819,142,",",O
1820,143,resection,B-Condition
1821,143,must,O
1822,143,have,O
1823,143,been,O
1824,143,macroscopically,O
1825,143,complete,O
1826,143,laterally,O
1827,143,",",O
1828,144,resection,B-Condition
1829,144,must,O
1830,144,have,O
1831,144,been,O
1832,144,histologically,B-Procedure
1833,144,complete,O
1834,144,in,O
1835,144,depth,O
1836,144,",",O
1837,145,resection,B-Condition
1838,145,must,O
1839,145,have,O
1840,145,been,O
1841,145,histologically,B-Procedure
1842,145,complete,O
1843,145,laterally,O
1844,145,with,O
1845,145,regard,O
1846,145,to,O
1847,145,the,O
1848,145,microinvasive,B-Condition
1849,145,cancer,I-Condition
1850,145,",",O
1851,145,that,O
1852,145,is,O
1853,145,to,O
1854,145,say,O
1855,145,with,O
1856,145,a,O
1857,145,clear,O
1858,145,margin,O
1859,145,of,O
1860,145,safety,O
1861,145,(,O
1862,145,margin,O
1863,145,may,O
1864,145,be,O
1865,145,high,O
1866,145,-,O
1867,145,grade,O
1868,145,dysplasia,O
1869,145,provided,O
1870,145,that,O
1871,145,the,O
1872,145,latter,O
1873,145,has,O
1874,145,not,O
1875,145,macroscopic,O
1876,145,translation,O
1877,145,),O
1878,145,",",O
1879,146,At,O
1880,146,least,O
1881,146,one,O
1882,146,endoscopic,O
1883,146,and,O
1884,146,histologic,O
1885,146,follow,O
1886,146,-,O
1887,146,up,O
1888,146,should,O
1889,146,be,O
1890,146,conducted,O
1891,146,with,O
1892,146,dye,O
1893,146,in,O
1894,146,a,O
1895,146,period,O
1896,146,of,O
1897,146,less,O
1898,146,than,O
1899,146,two,O
1900,146,months,O
1901,146,before,O
1902,146,the,O
1903,146,date,O
1904,146,of,O
1905,146,treatment,O
1906,146,",",O
1907,146,and,O
1908,146,at,O
1909,146,the,O
1910,146,investigator,O
1911,146,establishment,O
1912,146,.,O
1913,147,Patient,O
1914,147,may,O
1915,147,take,O
1916,147,an,O
1917,147,inhibitor,O
1918,147,of,O
1919,147,proton,O
1920,147,pump,O
1921,147,equivalent,O
1922,147,to,O
1923,147,2,O
1924,147,times,O
1925,147,40,O
1926,147,mg,O
1927,147,of,O
1928,147,esomeprazole,O
1929,147,",",O
1930,148,No,O
1931,148,mediastinal,O
1932,148,or,O
1933,148,celiac,O
1934,148,",",O
1935,148,or,O
1936,148,suspected,O
1937,148,metastatic,O
1938,148,lymph,B-Condition
1939,148,nodes,I-Condition
1940,148,by,O
1941,148,EUS,B-Procedure
1942,148,",",O
1943,149,Affiliation,B-Observation
1944,149,to,I-Observation
1945,149,a,I-Observation
1946,149,social,I-Observation
1947,149,security,I-Observation
1948,149,system,I-Observation
1949,149,or,O
1950,149,similar,O
1951,149,",",O
1952,150,Lack,O
1953,150,of,O
1954,150,participation,B-Observation
1955,150,in,I-Observation
1956,150,another,I-Observation
1957,150,clinical,I-Observation
1958,150,study,I-Observation
1959,150,",",O
1960,151,Informed,B-Observation
1961,151,consent,I-Observation
1962,151,signed,I-Observation
1963,151,.,O
1964,152,Patients,O
1965,152,with,O
1966,152,pulmonary,B-Condition
1967,152,arterial,I-Condition
1968,152,hypertension,I-Condition
1969,152,(,I-Condition
1970,152,PAH,I-Condition
1971,152,),I-Condition
1972,153,Patients,O
1973,153,with,O
1974,153,chronic,B-Condition
1975,153,thromboembolic,I-Condition
1976,153,pulmonary,I-Condition
1977,153,hypertension,I-Condition
1978,153,(,I-Condition
1979,153,CTEPH,I-Condition
1980,153,),I-Condition
1981,154,All,O
1982,154,prevalent,O
1983,154,patients,O
1984,154,(,O
1985,154,diagnosed,O
1986,154,>,O
1987,154,12,O
1988,154,month,O
1989,154,ago,O
1990,154,),O
1991,154,with,O
1992,154,PAH,B-Condition
1993,154,or,O
1994,154,distal,O
1995,154,CTEPH,B-Condition
1996,154,who,O
1997,154,had,O
1998,154,a,O
1999,154,consultation,O
2000,154,at,O
2001,154,the,O
2002,154,PH,O
2003,154,centre,O
2004,154,in,O
2005,154,Zurich,O
2006,154,between,O
2007,154,November,O
2008,154,2015,O
2009,154,and,O
2010,154,November,O
2011,154,2016,O
2012,154,),O
2013,155,Pregnancy,B-Condition
2014,155,and,O
2015,155,lactation,B-Condition
2016,156,Patients,O
2017,156,with,O
2018,156,diabetes,B-Condition
2019,156,",",O
2020,156,Ischemic,B-Condition
2021,156,heart,I-Condition
2022,156,disease,I-Condition
2023,156,(,I-Condition
2024,156,IHD,I-Condition
2025,156,),I-Condition
2026,156,",",O
2027,156,stroke,B-Condition
2028,156,",",O
2029,156,malignancy,B-Condition
2030,156,and,O
2031,156,psychiatric,B-Condition
2032,156,diseases,I-Condition
2033,156,are,O
2034,156,excluded,O
2035,156,from,O
2036,156,study,O
2037,156,.,O
2038,157,The,O
2039,157,patients,O
2040,157,receiving,O
2041,157,vitamin,B-Drug
2042,157,supplements,I-Drug
2043,157,or,O
2044,157,who,O
2045,157,had,O
2046,157,clinical,B-Condition
2047,157,evidence,I-Condition
2048,157,for,I-Condition
2049,157,an,I-Condition
2050,157,acute,I-Condition
2051,157,illness,I-Condition
2052,157,",",O
2053,157,renal,B-Condition
2054,157,dysfunction,I-Condition
2055,157,",",O
2056,157,thyroid,B-Condition
2057,157,dysfunction,I-Condition
2058,157,",",O
2059,157,chronic,B-Condition
2060,157,inflammatory,I-Condition
2061,157,diseases,I-Condition
2062,157,",",O
2063,157,inborn,B-Condition
2064,157,errors,I-Condition
2065,157,of,I-Condition
2066,157,homocysteine,I-Condition
2067,157,",",I-Condition
2068,157,cobalamin,I-Condition
2069,157,or,I-Condition
2070,157,folate,I-Condition
2071,157,metabolism,I-Condition
2072,157,",",O
2073,157,or,O
2074,157,any,O
2075,157,other,O
2076,157,condition,B-Condition
2077,157,known,I-Condition
2078,157,to,I-Condition
2079,157,interfere,I-Condition
2080,157,with,I-Condition
2081,157,homocysteine,I-Condition
2082,157,metabolism,I-Condition
2083,157,will,O
2084,157,be,O
2085,157,excluded,O
2086,158,Patients,O
2087,158,who,O
2088,158,are,O
2089,158,already,O
2090,158,involved,O
2091,158,in,O
2092,158,any,O
2093,158,other,O
2094,158,trial,O
2095,158,.,O
2096,159,Patients,O
2097,159,not,O
2098,159,willing,O
2099,159,to,O
2100,159,fill,O
2101,159,consent/,O
2102,159,assent,O
2103,159,form,O
2104,159,are,O
2105,159,also,O
2106,159,excluded,O
2107,159,from,O
2108,159,study,O
2109,159,.,O
2110,160,Diagnosed,O
2111,160,epileptic,B-Condition
2112,160,patients,O
2113,160,of,O
2114,160,either,O
2115,160,sex,O
2116,160,with,O
2117,160,age,B-Person
2118,160,between,O
2119,160,10,O
2120,160,-,O
2121,160,19,O
2122,160,yrs,O
2123,160,(,O
2124,160,<,O
2125,160,19yrs,O
2126,160,),O
2127,160,",",O
2128,160,coming,O
2129,160,to,O
2130,160,the,O
2131,160,medicine,O
2132,160,Out,O
2133,160,Patient,O
2134,160,/In,O
2135,160,Patient,O
2136,160,Departments,O
2137,160,and,O
2138,160,undergoing,O
2139,160,AED,B-Procedure
2140,160,therapy,I-Procedure
2141,160,for,O
2142,160,more,O
2143,160,than,O
2144,160,6,O
2145,160,months,O
2146,160,.,O
2147,161,Epileptics,O
2148,161,with,O
2149,161,high,O
2150,161,homocysteine,O
2151,161,levels,O
2152,161,i.e.,O
2153,161,>,O
2154,161,10.9,O
2155,161,µmol,O
2156,161,/,O
2157,161,L,O
2158,161,(,O
2159,161,Normal,O
2160,161,homocysteine,O
2161,161,levels,O
2162,161,are,O
2163,161,4.3,O
2164,161,-,O
2165,161,9.9,O
2166,161,µmol,O
2167,161,/,O
2168,161,L,O
2169,161,for,O
2170,161,male,O
2171,161,and,O
2172,161,3.3,O
2173,161,-,O
2174,161,7.2,O
2175,161,µmol,O
2176,161,/,O
2177,161,L,O
2178,161,for,O
2179,161,female,O
2180,161,adolescent,O
2181,161,and,O
2182,161,a,O
2183,161,high,O
2184,161,homocysteine,O
2185,161,concentration,O
2186,161,is,O
2187,161,deaned,O
2188,161,as,O
2189,161,at,O
2190,161,least,O
2191,161,11.4,O
2192,161,µmol,O
2193,161,/,O
2194,161,L,O
2195,161,for,O
2196,161,male,O
2197,161,and,O
2198,161,at,O
2199,161,least,O
2200,161,10.4,O
2201,161,µmol,O
2202,161,/,O
2203,161,L,O
2204,161,for,O
2205,161,female,O
2206,161,.,O
2207,161,Gender,O
2208,161,mean,O
2209,161,of,O
2210,161,high,O
2211,161,homocysteine,O
2212,161,concentration,O
2213,161,is,O
2214,161,10.9,O
2215,161,µmol,O
2216,161,/,O
2217,161,L,O
2218,161,),O
2219,161,[,O
2220,161,5,O
2221,161,],O
2222,162,1,O
2223,162,.,O
2224,162,Currently,O
2225,162,pregnant,B-Condition
2226,162,or,O
2227,162,last,O
2228,162,pregnancy,B-Condition
2229,162,outcome,I-Condition
2230,162,within,O
2231,162,3,O
2232,162,months,O
2233,162,prior,O
2234,162,to,O
2235,162,enrolment,O
2236,163,2,O
2237,163,.,O
2238,163,Currently,O
2239,163,breast,B-Condition
2240,163,-,I-Condition
2241,163,feeding,I-Condition
2242,164,3,O
2243,164,.,O
2244,164,Participated,O
2245,164,in,O
2246,164,any,O
2247,164,other,O
2248,164,research,O
2249,164,study,O
2250,164,within,O
2251,164,60,O
2252,164,days,O
2253,164,prior,O
2254,164,to,O
2255,164,screening,O
2256,165,4,O
2257,165,.,O
2258,165,Previously,O
2259,165,participated,O
2260,165,in,O
2261,165,any,O
2262,165,HIV,O
2263,165,vaccine,O
2264,165,study,O
2265,166,5,O
2266,166,.,O
2267,166,Untreated,O
2268,166,urogenital,B-Condition
2269,166,infections,I-Condition
2270,166,(,O
2271,166,either,O
2272,166,symptomatic,B-Condition
2273,166,or,O
2274,166,asymptomatic,B-Condition
2275,166,),O
2276,166,within,O
2277,166,2,O
2278,166,weeks,O
2279,166,prior,O
2280,166,to,O
2281,166,enrollment,O
2282,167,6,O
2283,167,.,O
2284,167,Presence,O
2285,167,of,O
2286,167,abnormal,B-Condition
2287,167,physical,I-Condition
2288,167,finding,I-Condition
2289,167,on,I-Condition
2290,167,the,I-Condition
2291,167,vulva,I-Condition
2292,167,",",I-Condition
2293,167,vaginal,I-Condition
2294,167,walls,I-Condition
2295,167,or,I-Condition
2296,167,cervix,I-Condition
2297,167,during,O
2298,167,pelvic,B-Procedure
2299,167,/,I-Procedure
2300,167,speculum,I-Procedure
2301,167,examination,I-Procedure
2302,167,and/or,O
2303,167,colposcopy,B-Procedure
2304,168,7,O
2305,168,.,O
2306,168,History,B-Observation
2307,168,of,O
2308,168,significant,O
2309,168,urogenital,B-Condition
2310,168,or,I-Condition
2311,168,uterine,I-Condition
2312,168,prolapse,I-Condition
2313,168,",",O
2314,168,undiagnosed,O
2315,168,vaginal,B-Condition
2316,168,bleeding,I-Condition
2317,168,",",O
2318,168,urethral,B-Condition
2319,168,obstruction,I-Condition
2320,169,8,O
2321,169,.,O
2322,169,Pap,O
2323,169,smear,O
2324,169,result,O
2325,169,at,O
2326,169,screening,O
2327,169,that,O
2328,169,requires,O
2329,169,cryotherapy,B-Procedure
2330,169,",",O
2331,169,biopsy,B-Procedure
2332,169,",",O
2333,169,treatment,B-Procedure
2334,169,(,O
2335,169,other,O
2336,169,than,O
2337,169,for,O
2338,169,infection,O
2339,169,),O
2340,169,",",O
2341,169,or,O
2342,169,further,B-Procedure
2343,169,evaluation,I-Procedure
2344,170,9,O
2345,170,.,O
2346,170,Any,O
2347,170,Grade,O
2348,170,2,O
2349,170,",",O
2350,170,3,O
2351,170,or,O
2352,170,4,O
2353,170,baseline,O
2354,170,haematology,B-Condition
2355,170,",",I-Condition
2356,170,chemistry,I-Condition
2357,170,or,I-Condition
2358,170,urinalysis,I-Condition
2359,170,laboratory,I-Condition
2360,170,abnormality,I-Condition
2361,170,according,O
2362,170,to,O
2363,170,the,O
2364,170,DAIDS,O
2365,170,Table,O
2366,170,for,O
2367,170,Grading,O
2368,170,Adverse,O
2369,170,Experiences,O
2370,171,10,O
2371,171,.,O
2372,171,Unexplained,O
2373,171,",",O
2374,171,undiagnosed,O
2375,171,abnormal,O
2376,171,bleeding,B-Condition
2377,171,per,I-Condition
2378,171,vagina,I-Condition
2379,171,",",O
2380,171,bleeding,B-Condition
2381,171,per,I-Condition
2382,171,vagina,I-Condition
2383,171,during,O
2384,171,or,O
2385,171,following,O
2386,171,vaginal,O
2387,171,intercourse,O
2388,171,",",O
2389,171,or,O
2390,171,gynaecologic,B-Procedure
2391,171,surgery,I-Procedure
2392,171,within,O
2393,171,90,O
2394,171,days,O
2395,171,prior,O
2396,171,to,O
2397,171,enrollment,O
2398,172,11,O
2399,172,.,O
2400,172,Any,O
2401,172,history,B-Observation
2402,172,of,O
2403,172,anaphylaxis,B-Condition
2404,172,or,O
2405,172,severe,O
2406,172,allergy,B-Condition
2407,172,resulting,O
2408,172,in,O
2409,172,angioedema,B-Condition
2410,172,;,O
2411,172,or,O
2412,172,a,O
2413,172,history,B-Observation
2414,172,of,O
2415,172,sensitivity,B-Condition
2416,172,/,I-Condition
2417,172,allergy,I-Condition
2418,172,to,I-Condition
2419,172,latex,I-Condition
2420,173,12,O
2421,173,.,O
2422,173,Any,O
2423,173,serious,O
2424,173,acute,O
2425,173,",",O
2426,173,chronic,O
2427,173,or,O
2428,173,progressive,O
2429,173,disease,B-Condition
2430,174,13,O
2431,174,.,O
2432,174,Any,O
2433,174,condition(s,O
2434,174,),O
2435,174,that,O
2436,174,",",O
2437,174,in,O
2438,174,the,O
2439,174,opinion,O
2440,174,of,O
2441,174,the,O
2442,174,investigator,O
2443,174,",",O
2444,174,might,O
2445,174,interfere,O
2446,174,with,O
2447,174,adherence,O
2448,174,to,O
2449,174,study,O
2450,174,requirements,O
2451,174,or,O
2452,174,evaluation,O
2453,174,of,O
2454,174,the,O
2455,174,study,O
2456,174,objectives,O
2457,175,1,O
2458,175,.,O
2459,175,Women,B-Person
2460,175,18,O
2461,175,to,O
2462,175,40,O
2463,175,years,O
2464,175,of,O
2465,175,age,B-Person
2466,175,inclusive,O
2467,175,who,O
2468,175,can,B-Observation
2469,175,give,I-Observation
2470,175,written,I-Observation
2471,175,informed,I-Observation
2472,175,consent,I-Observation
2473,176,2,O
2474,176,.,O
2475,176,Available,O
2476,176,for,O
2477,176,all,O
2478,176,visits,O
2479,176,and,O
2480,176,consent,O
2481,176,to,O
2482,176,follow,O
2483,176,all,O
2484,176,procedures,O
2485,176,scheduled,O
2486,176,for,O
2487,176,the,O
2488,176,study,O
2489,177,3,O
2490,177,.,O
2491,177,Agree,O
2492,177,to,O
2493,177,daily,O
2494,177,application,O
2495,177,of,O
2496,177,gel,B-Drug
2497,177,and,O
2498,177,monitoring,B-Procedure
2499,177,as,O
2500,177,per,O
2501,177,Daily,O
2502,177,Monitored,O
2503,177,Adherence,O
2504,177,(,O
2505,177,DMA,O
2506,177,),O
2507,177,method,O
2508,178,4,O
2509,178,.,O
2510,178,Healthy,B-Condition
2511,178,and,O
2512,178,self,B-Observation
2513,178,-,I-Observation
2514,178,reported,I-Observation
2515,178,sexually,B-Condition
2516,178,active,I-Condition
2517,179,5,O
2518,179,.,O
2519,179,HIV,B-Condition
2520,179,-,I-Condition
2521,179,negative,I-Condition
2522,179,as,O
2523,179,determined,O
2524,179,by,O
2525,179,a,O
2526,179,HIV,O
2527,179,rapid,O
2528,179,test,O
2529,179,at,O
2530,179,time,O
2531,179,of,O
2532,179,enrollment,O
2533,180,6,O
2534,180,.,O
2535,180,On,O
2536,180,a,O
2537,180,stable,O
2538,180,form,O
2539,180,of,O
2540,180,contraception,O
2541,180,and,O
2542,180,willing,O
2543,180,to,O
2544,180,continue,O
2545,180,on,O
2546,180,this,O
2547,180,stable,O
2548,180,method,O
2549,180,of,O
2550,180,contraception,O
2551,180,",",O
2552,180,OR,O
2553,180,",",O
2554,180,Have,O
2555,180,undergone,O
2556,180,surgical,O
2557,180,sterilisation,O
2558,180,at,O
2559,180,least,O
2560,180,3,O
2561,180,months,O
2562,180,prior,O
2563,180,to,O
2564,180,enrollment,O
2565,181,7,O
2566,181,.,O
2567,181,In,O
2568,181,the,O
2569,181,absence,O
2570,181,of,O
2571,181,the,O
2572,181,use,O
2573,181,of,O
2574,181,exogenous,B-Drug
2575,181,hormone(s,I-Drug
2576,181,),O
2577,181,",",O
2578,181,have,O
2579,181,a,O
2580,181,self,O
2581,181,-,O
2582,181,reported,O
2583,181,regular,B-Condition
2584,181,menstrual,I-Condition
2585,181,cycle,I-Condition
2586,181,defined,O
2587,181,as,O
2588,181,having,O
2589,181,a,O
2590,181,minimum,O
2591,181,of,O
2592,181,21,O
2593,181,days,O
2594,181,and,O
2595,181,a,O
2596,181,maximum,O
2597,181,of,O
2598,181,36,O
2599,181,days,O
2600,181,between,O
2601,181,menses,O
2602,182,8,O
2603,182,.,O
2604,182,Upon,O
2605,182,pelvic,B-Procedure
2606,182,/,I-Procedure
2607,182,speculum,I-Procedure
2608,182,examination,I-Procedure
2609,182,and,O
2610,182,colposcopy,B-Procedure
2611,182,at,O
2612,182,the,O
2613,182,time,O
2614,182,of,O
2615,182,enrollment,O
2616,182,",",O
2617,182,the,O
2618,182,cervix,B-Observation
2619,182,and,O
2620,182,vagina,B-Observation
2621,182,appear,O
2622,182,normal,O
2623,182,as,O
2624,182,determined,O
2625,182,by,O
2626,182,the,O
2627,182,investigator,O
2628,183,9,O
2629,183,.,O
2630,183,Asymptomatic,B-Mood
2631,183,for,O
2632,183,genital,B-Condition
2633,183,infections,I-Condition
2634,183,at,O
2635,183,the,O
2636,183,time,O
2637,183,of,O
2638,183,enrollment,O
2639,184,10,O
2640,184,.,O
2641,184,Willing,B-Mood
2642,184,to,O
2643,184,refrain,O
2644,184,from,O
2645,184,use,O
2646,184,of,O
2647,184,vaginal,B-Drug
2648,184,products,I-Drug
2649,184,or,O
2650,184,objects,O
2651,184,within,O
2652,184,14,O
2653,184,days,O
2654,184,prior,O
2655,184,to,O
2656,184,enrollment,O
2657,184,and,O
2658,184,for,O
2659,184,the,O
2660,184,duration,O
2661,184,of,O
2662,184,the,O
2663,184,study,O
2664,185,11,O
2665,185,.,O
2666,185,Willing,B-Mood
2667,185,to,O
2668,185,answer,O
2669,185,acceptability,B-Observation
2670,185,and,I-Observation
2671,185,adherence,I-Observation
2672,185,questionnaires,I-Observation
2673,185,throughout,O
2674,185,the,O
2675,185,study,O
2676,186,12,O
2677,186,.,O
2678,186,Willing,O
2679,186,to,O
2680,186,refrain,O
2681,186,from,O
2682,186,participation,O
2683,186,in,O
2684,186,any,O
2685,186,other,O
2686,186,research,O
2687,186,study,O
2688,186,for,O
2689,186,the,O
2690,186,duration,O
2691,186,of,O
2692,186,this,O
2693,186,study,O
2694,187,13,O
2695,187,.,O
2696,187,Willing,O
2697,187,to,O
2698,187,provide,O
2699,187,adequate,O
2700,187,locator,O
2701,187,information,O
2702,187,for,O
2703,187,study,O
2704,187,retention,O
2705,187,purposes,O
2706,187,and,O
2707,187,be,O
2708,187,reachable,O
2709,187,per,O
2710,187,local,O
2711,187,standard,O
2712,187,procedures,O
2713,188,hematology,B-Condition
2714,188,diseases,I-Condition
2715,189,clotting,B-Condition
2716,189,factor,I-Condition
2717,189,deficiency,I-Condition
2718,190,healthy,B-Condition
2719,191,no,O
2720,191,allergy,B-Condition
2721,191,known,O
2722,191,to,O
2723,191,these,B-Drug
2724,191,drugs,I-Drug
2725,192,second,O
2726,192,trimester,O
2727,192,abortion,B-Condition
2728,193,Inability,B-Condition
2729,193,to,O
2730,193,use,O
2731,193,verbal,B-Procedure
2732,193,or,I-Procedure
2733,193,pictorial,I-Procedure
2734,193,pain,I-Procedure
2735,193,scoring,I-Procedure
2736,193,scales,I-Procedure
2737,194,hypersensitivity,B-Condition
2738,194,to,O
2739,194,selective,B-Drug
2740,194,5,I-Drug
2741,194,-,I-Drug
2742,194,HT,I-Drug
2743,194,receptor,I-Drug
2744,194,antagonists,I-Drug
2745,195,diagnosed,O
2746,195,congenital,B-Condition
2747,195,long,I-Condition
2748,195,QT,I-Condition
2749,195,syndrome,I-Condition
2750,196,severe,O
2751,196,hepatic,B-Condition
2752,196,impairment,I-Condition
2753,197,pregnancy,B-Condition
2754,197,or,O
2755,197,nursing,B-Condition
2756,197,mothers,O
2757,198,3,B-Person
2758,198,-,I-Person
2759,198,17,I-Person
2760,198,years,I-Person
2761,199,weight,O
2762,199,<,O
2763,199,/=,O
2764,199,100,O
2765,199,kg,O
2766,200,scheduled,O
2767,200,for,O
2768,200,urologic,B-Procedure
2769,200,or,I-Procedure
2770,200,orthopedic,I-Procedure
2771,200,procedure,I-Procedure
2772,200,necessitating,O
2773,200,intrathecal,O
2774,200,morphine,B-Drug
2775,201,ability,B-Condition
2776,201,to,O
2777,201,use,O
2778,201,verbal,B-Procedure
2779,201,or,I-Procedure
2780,201,pictorial,I-Procedure
2781,201,pain,I-Procedure
2782,201,assessment,I-Procedure
2783,201,tools,I-Procedure
2784,201,and,I-Procedure
2785,201,techniques,I-Procedure
2786,202,informed,O
2787,202,consent,O
2788,202,and,O
2789,202,(,O
2790,202,if,O
2791,202,applicable,O
2792,202,),O
2793,202,assent,O
2794,203,A,O
2795,203,previous,B-Observation
2796,203,history,I-Observation
2797,203,of,O
2798,203,intolerance,B-Condition
2799,203,to,O
2800,203,the,O
2801,203,study,B-Drug
2802,203,drug,I-Drug
2803,203,or,O
2804,203,related,B-Drug
2805,203,compounds,I-Drug
2806,203,and,O
2807,203,additives,O
2808,204,History,O
2809,204,of,O
2810,204,alcoholism,B-Condition
2811,204,",",O
2812,204,drug,B-Condition
2813,204,abuse,I-Condition
2814,204,",",O
2815,204,psychiatric,B-Condition
2816,204,",",I-Condition
2817,204,psychological,I-Condition
2818,204,or,I-Condition
2819,204,other,I-Condition
2820,204,emotional,I-Condition
2821,204,problems,I-Condition
2822,204,that,O
2823,204,are,O
2824,204,likely,O
2825,204,to,O
2826,204,invalidate,O
2827,204,informed,O
2828,204,consent,O
2829,205,Sleep,B-Condition
2830,205,apnoea,I-Condition
2831,206,Chronic,B-Condition
2832,206,obstructive,I-Condition
2833,206,pulmonary,I-Condition
2834,206,disease,I-Condition
2835,207,BMI,O
2836,207,=,O
2837,207,35,O
2838,207,or,O
2839,207,weight,O
2840,207,<,O
2841,207,50,O
2842,207,kg,O
2843,208,SpO2,O
2844,208,<,O
2845,208,90,O
2846,208,%,O
2847,209,Concomitant,O
2848,209,drug,O
2849,209,therapy,O
2850,209,known,O
2851,209,to,O
2852,209,cause,O
2853,209,significant,O
2854,209,enzyme,B-Observation
2855,209,induction,I-Observation
2856,209,or,I-Observation
2857,209,inhibition,I-Observation
2858,209,of,I-Observation
2859,209,CYP,I-Observation
2860,209,3A4,I-Observation
2861,209,.,O
2862,210,Pregnancy,B-Condition
2863,210,or,O
2864,210,nursing,B-Condition
2865,210,.,O
2866,211,ASA,O
2867,211,I,O
2868,211,-,O
2869,211,III,O
2870,212,Colonoscopy,B-Procedure
2871,213,Written,O
2872,213,informed,O
2873,213,consent,O
2874,213,from,O
2875,213,participating,O
2876,213,subject,O
2877,214,IIEF,O
2878,214,<,O
2879,214,21,O
2880,215,Operations,B-Procedure
2881,215,in,O
2882,215,the,O
2883,215,past,O
2884,215,6,O
2885,215,months,O
2886,215,which,O
2887,215,could,O
2888,215,limit,B-Condition
2889,215,the,I-Condition
2890,215,erectile,I-Condition
2891,215,function,I-Condition
2892,216,Erectile,B-Condition
2893,216,dysfunction,I-Condition
2894,216,in,O
2895,216,the,O
2896,216,history,B-Observation
2897,216,or,O
2898,216,current,O
2899,216,medication,B-Drug
2900,216,for,O
2901,216,erectile,B-Condition
2902,216,dysfunction,I-Condition
2903,217,Current,O
2904,217,involvement,O
2905,217,in,O
2906,217,another,O
2907,217,comparable,O
2908,217,study,O
2909,217,.,O
2910,218,Localized,O
2911,218,intermediate,O
2912,218,-,O
2913,218,risk,O
2914,218,or,O
2915,218,high,O
2916,218,-,O
2917,218,risk,O
2918,218,prostate,B-Condition
2919,218,cancer,I-Condition
2920,218,cT3,O
2921,219,Gleason,O
2922,219,score,O
2923,219,=,O
2924,219,7,O
2925,219,(,O
2926,219,3,O
2927,219,+,O
2928,219,4,O
2929,219,and/or,O
2930,219,4,O
2931,219,+,O
2932,219,3,O
2933,219,),O
2934,219,and/or,O
2935,220,PSA,O
2936,220,=,O
2937,220,20,O
2938,220,ng,O
2939,220,/,O
2940,220,ml,O
2941,221,intact,B-Condition
2942,221,preoperative,I-Condition
2943,221,erectile,I-Condition
2944,221,function,I-Condition
2945,221,with,O
2946,221,an,O
2947,221,IIEF,O
2948,221,=,O
2949,221,21,O
2950,221,(,O
2951,221,IIEF-6,B-Observation
2952,221,),O
2953,221,.,O
2954,222,Columbia,O
2955,222,-,O
2956,222,Suicide,O
2957,222,Severity,O
2958,222,Rating,O
2959,222,Scale,O
2960,222,(,O
2961,222,C,O
2962,222,-,O
2963,222,SSRS,O
2964,222,),O
2965,222,for,O
2966,222,suicidal,B-Condition
2967,222,ideation,I-Condition
2968,222,and,I-Condition
2969,222,behavior,I-Condition
2970,222,in,O
2971,222,past,O
2972,222,year,O
2973,222,.,O
2974,223,Hypersensitivity,B-Condition
2975,223,to,O
2976,223,morphine,B-Drug
2977,223,",",O
2978,223,naltrexone,B-Drug
2979,223,.,O
2980,224,A,O
2981,224,life,B-Observation
2982,224,expectancy,I-Observation
2983,224,(,O
2984,224,assessed,O
2985,224,by,O
2986,224,investigator,O
2987,224,),O
2988,224,of,O
2989,224,less,O
2990,224,than,O
2991,224,6,O
2992,224,months,O
2993,224,or,O
2994,224,is,O
2995,224,no,O
2996,224,longer,O
2997,224,capable,O
2998,224,of,O
2999,224,taking,O
3000,224,medication,O
3001,224,orally,O
3002,224,.,O
3003,225,Undergone,O
3004,225,surgery,B-Procedure
3005,225,within,O
3006,225,3,O
3007,225,days,O
3008,225,prior,O
3009,225,to,O
3010,225,the,O
3011,225,first,O
3012,225,day,O
3013,225,of,O
3014,225,dosing,O
3015,225,.,O
3016,226,Children,B-Person
3017,226,7,O
3018,226,-,O
3019,226,17,O
3020,226,with,O
3021,226,moderate,O
3022,226,to,O
3023,226,severe,O
3024,226,pain,B-Condition
3025,226,requiring,O
3026,226,around,B-Procedure
3027,226,the,I-Procedure
3028,226,clock,I-Procedure
3029,226,treatment,I-Procedure
3030,226,with,O
3031,226,an,O
3032,226,opioid,B-Drug
3033,226,analgesic,I-Drug
3034,226,.,O
3035,227,Be,O
3036,227,an,O
3037,227,experienced,O
3038,227,opioid,O
3039,227,user,O
3040,227,",",O
3041,227,defined,O
3042,227,as,O
3043,227,any,O
3044,227,subject,O
3045,227,treated,O
3046,227,with,O
3047,227,opioid,B-Drug
3048,227,therapy,I-Drug
3049,227,",",O
3050,227,equivalent,O
3051,227,or,O
3052,227,equal,O
3053,227,to,O
3054,227,>,O
3055,227,20,O
3056,227,mg,O
3057,227,per,O
3058,227,day,O
3059,227,of,O
3060,227,morphine,B-Drug
3061,227,",",O
3062,227,for,O
3063,227,a,O
3064,227,period,O
3065,227,of,O
3066,227,3,O
3067,227,consecutive,O
3068,227,days,O
3069,227,immediately,O
3070,227,prior,O
3071,227,to,O
3072,227,first,O
3073,227,day,O
3074,227,of,O
3075,227,dosing,O
3076,227,.,O
3077,228,diabetes,B-Condition
3078,228,mellitus,I-Condition
3079,229,secondary,B-Condition
3080,229,hypertension,I-Condition
3081,230,pregnancy,B-Condition
3082,231,Caucasian,B-Person
3083,231,patients,O
3084,231,affected,O
3085,231,by,O
3086,231,uncomplicated,O
3087,231,",",O
3088,231,essential,B-Condition
3089,231,hypertension,I-Condition
3090,231,",",O
3091,231,not,O
3092,231,well,O
3093,231,controlled,O
3094,231,by,O
3095,231,concomitant,O
3096,231,administration,O
3097,231,of,O
3098,231,ACE,B-Drug
3099,231,-,I-Drug
3100,231,I,I-Drug
3101,231,or,O
3102,231,ARBs,B-Drug
3103,231,and,O
3104,231,diuretics,B-Drug
3105,231,at,O
3106,231,the,O
3107,231,maximum,O
3108,231,dosage,O
3109,231,.,O
3110,232,1,O
3111,232,),O
3112,232,Refusal,B-Mood
3113,232,of,O
3114,232,epidural,O
3115,232,catheter,O
3116,232,2,O
3117,232,),O
3118,232,Pregnancy,B-Condition
3119,232,3,O
3120,232,),O
3121,232,Bleeding,B-Condition
3122,232,History,B-Observation
3123,232,4,O
3124,232,),O
3125,232,Inability,O
3126,232,to,O
3127,232,understand,O
3128,232,how,O
3129,232,to,O
3130,232,use,O
3131,232,the,O
3132,232,PCA,O
3133,232,device,O
3134,232,5,O
3135,232,),O
3136,232,Medication,B-Drug
3137,232,interfering,O
3138,232,with,O
3139,232,blood,O
3140,232,coagulation,O
3141,232,6,O
3142,232,),O
3143,232,Patients,O
3144,232,allergic,B-Condition
3145,232,to,O
3146,232,local,B-Drug
3147,232,anesthetics,I-Drug
3148,232,7,O
3149,232,),O
3150,232,Patient,O
3151,232,refusal,O
3152,232,to,O
3153,232,participate,O
3154,232,in,O
3155,232,study,O
3156,232,8),O
3157,232,Developmental,B-Condition
3158,232,delay,I-Condition
3159,233,Patients,O
3160,233,age,B-Person
3161,233,8-,O
3162,233,18,O
3163,233,years,O
3164,233,2,O
3165,233,),O
3166,233,Patients,O
3167,233,undergoing,O
3168,233,minimally,B-Procedure
3169,233,invasive,I-Procedure
3170,233,pectus,I-Procedure
3171,233,excavatum,I-Procedure
3172,233,repair,I-Procedure
3173,233,via,O
3174,233,Nuss,O
3175,233,procedure,O
3176,233,3,O
3177,233,),O
3178,233,American,O
3179,233,Society,O
3180,233,of,O
3181,233,Anesthesiology,O
3182,233,Status,O
3183,233,I,O
3184,233,-,O
3185,233,III,O
3186,234,Age,B-Person
3187,234,less,O
3188,234,than,O
3189,234,15,O
3190,234,or,O
3191,234,greater,O
3192,234,than,O
3193,234,25,O
3194,234,and,O
3195,234,not,O
3196,234,participating,B-Observation
3197,234,in,I-Observation
3198,234,the,I-Observation
3199,234,day,I-Observation
3200,234,care,I-Observation
3201,234,center,I-Observation
3202,235,100,O
3203,235,orphans,O
3204,235,/,O
3205,235,vulnerable,O
3206,235,youth,O
3207,235,aged,O
3208,235,15,O
3209,235,to,O
3210,235,25,O
3211,235,will,O
3212,235,be,O
3213,235,recruited,O
3214,235,through,O
3215,235,their,O
3216,235,participation,O
3217,235,at,O
3218,235,the,O
3219,235,day,O
3220,235,care,O
3221,235,center,O
3222,235,",",O
3223,235,on,O
3224,235,a,O
3225,235,voluntary,O
3226,235,basis,O
3227,235,.,O
3228,236,1,O
3229,236,.,O
3230,236,Does,O
3231,236,not,O
3232,236,have,O
3233,236,a,O
3234,236,documented,O
3235,236,history,B-Observation
3236,236,of,O
3237,236,generalized,B-Condition
3238,236,seizures,I-Condition
3239,236,.,O
3240,237,2,O
3241,237,.,O
3242,237,Has,O
3243,237,not,O
3244,237,had,O
3245,237,a,O
3246,237,GTC,B-Condition
3247,237,seizure,I-Condition
3248,237,within,O
3249,237,the,O
3250,237,last,O
3251,237,year,O
3252,237,AND,O
3253,237,is,O
3254,237,not,O
3255,237,expected,O
3256,237,to,O
3257,237,have,O
3258,237,a,O
3259,237,reduction,B-Procedure
3260,237,of,I-Procedure
3261,237,anti,I-Procedure
3262,237,-,I-Procedure
3263,237,epileptic,I-Procedure
3264,237,drugs,I-Procedure
3265,237,during,O
3266,237,their,O
3267,237,hospital,O
3268,237,admission,O
3269,237,.,O
3270,238,3,O
3271,238,.,O
3272,238,Intracranial,O
3273,238,EEG,O
3274,238,electrodes,O
3275,238,are,O
3276,238,being,O
3277,238,used,O
3278,239,4,O
3279,239,.,O
3280,239,The,O
3281,239,subject,O
3282,239,'s,O
3283,239,upper,O
3284,239,arm,O
3285,239,circumference,O
3286,239,not,O
3287,239,adequate,O
3288,239,for,O
3289,239,proper,O
3290,239,fit,O
3291,239,of,O
3292,239,the,O
3293,239,EMG,O
3294,239,monitor,O
3295,239,(,O
3296,239,less,O
3297,239,than,O
3298,239,14,O
3299,239,cm,O
3300,239,),O
3301,239,.,O
3302,240,5,O
3303,240,.,O
3304,240,Pregnant,B-Condition
3305,240,female,B-Person
3306,240,.,O
3307,241,6,O
3308,241,.,O
3309,241,Subject,O
3310,241,/,O
3311,241,Caregiver,O
3312,241,is,O
3313,241,unable,O
3314,241,to,O
3315,241,provide,O
3316,241,consent,O
3317,241,.,O
3318,242,1,O
3319,242,.,O
3320,242,Subject,O
3321,242,has,O
3322,242,a,O
3323,242,history,B-Observation
3324,242,of,O
3325,242,GTC,B-Condition
3326,242,seizures,I-Condition
3327,242,",",O
3328,242,either,O
3329,242,primary,B-Condition
3330,242,GTC,I-Condition
3331,242,or,O
3332,242,partial,B-Condition
3333,242,onset,I-Condition
3334,242,seizures,I-Condition
3335,242,with,O
3336,242,secondary,B-Condition
3337,242,generalization,I-Condition
3338,242,.,O
3339,243,2,O
3340,243,.,O
3341,243,Is,O
3342,243,being,O
3343,243,admitted,B-Procedure
3344,243,to,I-Procedure
3345,243,a,I-Procedure
3346,243,hospital,I-Procedure
3347,243,for,O
3348,243,routine,O
3349,243,vEEG,B-Procedure
3350,243,monitoring,I-Procedure
3351,243,related,O
3352,243,to,O
3353,243,seizures,B-Condition
3354,243,.,O
3355,244,3,O
3356,244,.,O
3357,244,Male,B-Person
3358,244,or,O
3359,244,female,B-Person
3360,244,between,O
3361,244,the,B-Person
3362,244,ages,I-Person
3363,244,of,O
3364,244,2,O
3365,244,-,O
3366,244,99,O
3367,244,.,O
3368,245,4,O
3369,245,.,O
3370,245,Has,O
3371,245,an,O
3372,245,upper,O
3373,245,arm,O
3374,245,circumference,O
3375,245,which,O
3376,245,is,O
3377,245,adequate,O
3378,245,for,O
3379,245,proper,O
3380,245,fit,O
3381,245,of,O
3382,245,the,O
3383,245,EMG,O
3384,245,monitor,O
3385,245,(,O
3386,245,at,O
3387,245,least,O
3388,245,14,O
3389,245,cm,O
3390,245,),O
3391,245,.,O
3392,246,5,O
3393,246,.,O
3394,246,If,O
3395,246,female,B-Person
3396,246,and,O
3397,246,of,O
3398,246,childbearing,B-Condition
3399,246,potential,I-Condition
3400,246,",",O
3401,246,has,O
3402,246,a,O
3403,246,negative,O
3404,246,pregnancy,O
3405,246,test,O
3406,246,.,O
3407,247,6,O
3408,247,.,O
3409,247,Can,O
3410,247,understand,O
3411,247,and,O
3412,247,sign,O
3413,247,written,O
3414,247,informed,O
3415,247,consent,O
3416,247,",",O
3417,247,or,O
3418,247,will,O
3419,247,have,O
3420,247,a,O
3421,247,parent,O
3422,247,or,O
3423,247,a,O
3424,247,legally,O
3425,247,authorized,O
3426,247,representative,O
3427,247,(,O
3428,247,LAR,O
3429,247,),O
3430,247,who,O
3431,247,can,O
3432,247,do,O
3433,247,so,O
3434,247,",",O
3435,247,prior,O
3436,247,to,O
3437,247,the,O
3438,247,performance,O
3439,247,of,O
3440,247,any,O
3441,247,study,O
3442,247,assessments,O
3443,247,.,O
3444,248,7,O
3445,248,.,O
3446,248,Subject,O
3447,248,and/or,O
3448,248,Primary,O
3449,248,Caregiver,O
3450,248,must,O
3451,248,be,O
3452,248,competent,O
3453,248,to,O
3454,248,follow,O
3455,248,all,O
3456,248,study,O
3457,248,procedures,O
3458,248,.,O
3459,249,8,O
3460,249,.,O
3461,249,Is,O
3462,249,able,O
3463,249,to,O
3464,249,read,O
3465,249,",",O
3466,249,speak,O
3467,249,",",O
3468,249,and,O
3469,249,understand,O
3470,249,English,O
3471,249,.,O
3472,250,contra,B-Condition
3473,250,-,I-Condition
3474,250,indications,I-Condition
3475,250,of,O
3476,250,radiotherapy,B-Procedure
3477,251,angioplasty,B-Procedure
3478,251,with,I-Procedure
3479,251,stenting,I-Procedure
3480,252,over,B-Person
3481,252,18,I-Person
3482,252,years,I-Person
3483,253,successful,O
3484,253,angioplasty,O
3485,253,(,O
3486,253,residual,O
3487,253,stenosis,O
3488,253,<,O
3489,253,30,O
3490,253,%,O
3491,253,),O
3492,253,on,O
3493,253,a,O
3494,253,significant,O
3495,253,stenosis,B-Condition
3496,253,(,O
3497,253,maximal,O
3498,253,systolic,O
3499,253,speed,O
3500,253,3,O
3501,253,times,O
3502,253,>,O
3503,253,from,O
3504,253,basal,O
3505,253,maximal,O
3506,253,systolic,O
3507,253,speed,O
3508,253,",",O
3509,253,stenosis,O
3510,253,>,O
3511,253,70,O
3512,253,%,O
3513,253,on,O
3514,253,angiography,B-Procedure
3515,253,),O
3516,253,on,O
3517,253,the,O
3518,253,venous,O
3519,253,-,O
3520,253,prosthesis,O
3521,253,anastomosis,O
3522,253,or,O
3523,253,on,O
3524,253,the,O
3525,253,venous,O
3526,253,segment,O
3527,253,5,O
3528,253,cm,O
3529,253,after,O
3530,253,the,O
3531,253,anastomosis,O
3532,253,of,O
3533,253,a,O
3534,253,prosthetic,O
3535,253,haemodialysis,O
3536,253,vascular,O
3537,253,access,O
3538,253,(,O
3539,253,at,O
3540,253,least,O
3541,253,1,O
3542,253,month,O
3543,253,old,O
3544,253,),O
3545,254,social,B-Observation
3546,254,security,I-Observation
3547,254,affiliation,I-Observation
3548,255,signed,B-Observation
3549,255,informed,I-Observation
3550,255,consent,I-Observation
3551,256,Lifetime,O
3552,256,history,O
3553,256,of,O
3554,256,Bipolar,B-Condition
3555,256,Disorder,I-Condition
3556,256,",",O
3557,256,Dementia,B-Condition
3558,256,",",O
3559,256,Autism,B-Condition
3560,256,Spectrum,I-Condition
3561,256,Disorder,I-Condition
3562,256,",",O
3563,256,Schizophrenia,B-Condition
3564,256,",",O
3565,256,or,O
3566,256,any,O
3567,256,other,O
3568,256,Psychotic,B-Condition
3569,256,Disorder,I-Condition
3570,256,.,O
3571,257,Psychotic,B-Condition
3572,257,symptoms,I-Condition
3573,257,occurring,O
3574,257,at,O
3575,257,any,O
3576,257,time,O
3577,257,during,O
3578,257,the,O
3579,257,current,O
3580,257,major,B-Condition
3581,257,depressive,I-Condition
3582,257,episode,I-Condition
3583,257,.,O
3584,258,Current,O
3585,258,(,O
3586,258,past,O
3587,258,12,O
3588,258,months,O
3589,258,),O
3590,258,diagnosis,O
3591,258,of,O
3592,258,Panic,B-Condition
3593,258,disorder,I-Condition
3594,258,",",O
3595,258,Obsessive,B-Condition
3596,258,Compulsive,I-Condition
3597,258,Disorder,I-Condition
3598,258,",",O
3599,258,Posttraumatic,B-Condition
3600,258,Stress,I-Condition
3601,258,Disorder,I-Condition
3602,258,",",O
3603,258,Anorexia,B-Condition
3604,258,Nervosa,I-Condition
3605,258,",",O
3606,258,or,O
3607,258,Bulimia,B-Condition
3608,258,Nervosa,I-Condition
3609,258,.,O
3610,259,Alcohol,B-Condition
3611,259,or,I-Condition
3612,259,Drug,I-Condition
3613,259,Dependence,I-Condition
3614,259,within,I-Condition
3615,259,12,I-Condition
3616,259,months,I-Condition
3617,259,or,I-Condition
3618,259,Abuse,I-Condition
3619,259,within,O
3620,259,3,O
3621,259,months,O
3622,259,(,O
3623,259,excluding,O
3624,259,nicotine,B-Drug
3625,259,and,O
3626,259,caffeine,B-Drug
3627,259,),O
3628,259,of,O
3629,259,baseline,O
3630,259,visit,O
3631,259,",",O
3632,259,as,O
3633,259,assessed,O
3634,259,by,O
3635,259,history,O
3636,259,and,O
3637,259,urine,O
3638,259,drug,O
3639,259,screen,O
3640,259,.,O
3641,260,Clinical,O
3642,260,evidence,O
3643,260,of,O
3644,260,a,O
3645,260,severe,O
3646,260,Personality,B-Condition
3647,260,Disorder,I-Condition
3648,260,",",O
3649,260,as,O
3650,260,assessed,O
3651,260,by,O
3652,260,the,O
3653,260,study,O
3654,260,psychiatrist,O
3655,260,",",O
3656,260,which,O
3657,260,would,O
3658,260,impede,O
3659,260,participation,O
3660,260,or,O
3661,260,completion,O
3662,260,of,O
3663,260,the,O
3664,260,trial,O
3665,260,.,O
3666,261,Known,O
3667,261,neurological,B-Condition
3668,261,disorders,I-Condition
3669,261,or,O
3670,261,documented,O
3671,261,serious,O
3672,261,head,B-Condition
3673,261,injury,I-Condition
3674,261,.,O
3675,262,Serious,O
3676,262,and,O
3677,262,unstable,O
3678,262,medical,B-Condition
3679,262,illnesses,I-Condition
3680,262,including,O
3681,262,cardiovascular,B-Condition
3682,262,disease,I-Condition
3683,262,and,O
3684,262,cancer,B-Condition
3685,262,.,O
3686,263,Active,O
3687,263,medical,O
3688,263,conditions,O
3689,263,with,O
3690,263,known,O
3691,263,mood,O
3692,263,changes,O
3693,263,(,O
3694,263,endocrine,B-Condition
3695,263,",",I-Condition
3696,263,autoimmune,I-Condition
3697,263,disorders,I-Condition
3698,263,),O
3699,263,.,O
3700,264,Current,O
3701,264,diabetes,B-Condition
3702,264,mellitus,I-Condition
3703,264,.,O
3704,265,For,O
3705,265,women,O
3706,265,",",O
3707,265,pregnancy,O
3708,265,",",O
3709,265,lactation,O
3710,265,",",O
3711,265,or,O
3712,265,unwillingness,O
3713,265,to,O
3714,265,comply,O
3715,265,with,O
3716,265,birth,O
3717,265,control,O
3718,265,requirements,O
3719,265,.,O
3720,266,Use,O
3721,266,of,O
3722,266,any,O
3723,266,of,O
3724,266,the,O
3725,266,following,O
3726,266,treatments,B-Procedure
3727,266,or,O
3728,266,any,O
3729,266,other,O
3730,266,alternative,B-Procedure
3731,266,therapy,I-Procedure
3732,266,within,O
3733,266,2,O
3734,266,weeks,O
3735,266,of,O
3736,266,the,O
3737,266,pre,O
3738,266,-,O
3739,266,treatment,O
3740,266,PET,O
3741,266,scan,O
3742,266,that,O
3743,266,may,O
3744,266,have,O
3745,266,beneficial,O
3746,266,effects,O
3747,266,on,O
3748,266,mood,B-Condition
3749,266,",",O
3750,266,including,O
3751,266,St,B-Drug
3752,266,John,I-Drug
3753,266,'s,I-Drug
3754,266,Wort,I-Drug
3755,266,",",O
3756,266,S,B-Drug
3757,266,-,I-Drug
3758,266,adenosyl,I-Drug
3759,266,methionine,I-Drug
3760,266,(,O
3761,266,SAMe,B-Drug
3762,266,),O
3763,266,",",O
3764,266,n-3,B-Drug
3765,266,fatty,I-Drug
3766,266,acids,I-Drug
3767,266,",",O
3768,266,or,O
3769,266,light,B-Procedure
3770,266,therapy,I-Procedure
3771,266,.,O
3772,267,Use,O
3773,267,of,O
3774,267,antidepressant,B-Drug
3775,267,medication,I-Drug
3776,267,within,O
3777,267,1,O
3778,267,month,O
3779,267,of,O
3780,267,the,O
3781,267,pre,O
3782,267,-,O
3783,267,treatment,O
3784,267,PET,B-Procedure
3785,267,scan,I-Procedure
3786,267,(,O
3787,267,within,O
3788,267,5,O
3789,267,weeks,O
3790,267,for,O
3791,267,fluoxetine,B-Drug
3792,267,and,O
3793,267,protryptyline,B-Drug
3794,267,),O
3795,267,.,O
3796,268,Failure,O
3797,268,to,O
3798,268,achieve,O
3799,268,a,O
3800,268,much,O
3801,268,improved,O
3802,268,status,O
3803,268,(,O
3804,268,i.e.,O
3805,268,equivalent,O
3806,268,to,O
3807,268,>,O
3808,268,50,O
3809,268,%,O
3810,268,symptom,O
3811,268,reduction,O
3812,268,),O
3813,268,with,O
3814,268,any,O
3815,268,lifetime,O
3816,268,treatment,O
3817,268,course,O
3818,268,of,O
3819,268,CBT,O
3820,268,(,O
3821,268,defined,O
3822,268,as,O
3823,268,a,O
3824,268,minimum,O
3825,268,of,O
3826,268,4,O
3827,268,sessions,O
3828,268,of,O
3829,268,a,O
3830,268,specified,O
3831,268,manual,O
3832,268,-,O
3833,268,driven,O
3834,268,therapy,O
3835,268,by,O
3836,268,a,O
3837,268,CBT,O
3838,268,-,O
3839,268,trained,O
3840,268,therapist,O
3841,268,),O
3842,268,or,O
3843,268,escitalopram,O
3844,268,(,O
3845,268,defined,O
3846,268,as,O
3847,268,a,O
3848,268,minimum,O
3849,268,of,O
3850,268,6,O
3851,268,weeks,O
3852,268,of,O
3853,268,at,O
3854,268,least,O
3855,268,10,O
3856,268,mg,O
3857,268,/,O
3858,268,day,O
3859,268,),O
3860,268,.,O
3861,269,Clinically,O
3862,269,significant,O
3863,269,active,O
3864,269,suicidal,B-Condition
3865,269,ideation,I-Condition
3866,269,or,O
3867,269,self,B-Condition
3868,269,-,I-Condition
3869,269,injurious,I-Condition
3870,269,behavior,I-Condition
3871,269,necessitating,O
3872,269,immediate,O
3873,269,treatment,B-Procedure
3874,269,",",O
3875,269,as,O
3876,269,determined,O
3877,269,by,O
3878,269,the,O
3879,269,investigator,O
3880,269,.,O
3881,270,Received,O
3882,270,electroconvulsive,B-Procedure
3883,270,therapy,I-Procedure
3884,270,in,O
3885,270,the,O
3886,270,past,O
3887,270,6,O
3888,270,months,O
3889,270,or,O
3890,270,during,O
3891,270,the,O
3892,270,current,O
3893,270,depressive,B-Condition
3894,270,episode,I-Condition
3895,270,.,O
3896,271,Currently,O
3897,271,responding,O
3898,271,to,O
3899,271,medication,O
3900,271,treatment,O
3901,271,",",O
3902,271,without,O
3903,271,clinical,O
3904,271,reasons,O
3905,271,to,O
3906,271,change,O
3907,271,.,O
3908,272,Current,O
3909,272,treatment,O
3910,272,with,O
3911,272,weekly,O
3912,272,individual,O
3913,272,or,O
3914,272,group,O
3915,272,psychotherapy,B-Procedure
3916,272,of,O
3917,272,any,O
3918,272,type,O
3919,272,targeted,O
3920,272,at,O
3921,272,depressive,B-Condition
3922,272,symptoms,I-Condition
3923,272,.,O
3924,273,QTc,O
3925,273,>,O
3926,273,500,O
3927,273,milliseconds,O
3928,273,on,O
3929,273,EKG,B-Procedure
3930,273,at,O
3931,273,screening,O
3932,273,.,O
3933,274,Contraindications,B-Condition
3934,274,for,O
3935,274,MRI,B-Procedure
3936,274,",",O
3937,274,including,O
3938,274,",",O
3939,274,but,O
3940,274,not,O
3941,274,limited,O
3942,274,to,O
3943,274,pacemaker,O
3944,274,",",O
3945,274,aneurysm,O
3946,274,clips,O
3947,274,",",O
3948,274,neurostimulators,O
3949,274,",",O
3950,274,cochlear,O
3951,274,implants,O
3952,274,",",O
3953,274,metal,O
3954,274,in,O
3955,274,eyes,O
3956,274,",",O
3957,274,steel,O
3958,274,worker,O
3959,274,",",O
3960,274,intra,O
3961,274,-,O
3962,274,uterine,O
3963,274,devices,O
3964,274,for,O
3965,274,birth,O
3966,274,control,O
3967,274,.,O
3968,275,Maintenance,O
3969,275,or,O
3970,275,prophylactic,O
3971,275,therapy,O
3972,275,for,O
3973,275,stable,O
3974,275,medical,O
3975,275,conditions,O
3976,275,.,O
3977,276,Hypnotic,B-Drug
3978,276,medication,I-Drug
3979,276,prescribed,O
3980,276,or,O
3981,276,approved,O
3982,276,by,O
3983,276,the,O
3984,276,study,O
3985,276,physician,O
3986,276,",",O
3987,276,(,O
3988,276,up,O
3989,276,to,O
3990,276,a,O
3991,276,three,O
3992,276,doses,O
3993,276,per,O
3994,276,week,O
3995,276,),O
3996,276,for,O
3997,276,insomnia,B-Condition
3998,276,",",O
3999,276,as,O
4000,276,long,O
4001,276,if,O
4002,276,not,O
4003,276,the,O
4004,276,night,O
4005,276,before,O
4006,276,a,O
4007,276,PET,O
4008,276,/,O
4009,276,MRI,O
4010,276,or,O
4011,276,clinic,O
4012,276,ratings,O
4013,276,visit,O
4014,276,.,O
4015,276,Antipsychotic,B-Drug
4016,276,medications,I-Drug
4017,276,",",O
4018,276,whether,O
4019,276,prescribed,O
4020,276,for,O
4021,276,sleep,O
4022,276,or,O
4023,276,other,O
4024,276,indications,O
4025,276,",",O
4026,276,are,O
4027,276,prohibited,O
4028,276,.,O
4029,277,Men,B-Condition
4030,277,or,I-Condition
4031,277,women,I-Condition
4032,277,aged,I-Condition
4033,277,18,I-Condition
4034,277,-,I-Condition
4035,277,60,I-Condition
4036,277,years,I-Condition
4037,277,.,I-Condition
4038,278,Primary,I-Condition
4039,278,psychiatric,I-Condition
4040,278,diagnosis,I-Condition
4041,278,of,I-Condition
4042,278,Major,I-Condition
4043,278,Depressive,I-Condition
4044,278,Disorder,I-Condition
4045,278,",",I-Condition
4046,278,without,I-Condition
4047,278,psychotic,I-Condition
4048,278,features,I-Condition
4049,278,",",I-Condition
4050,278,confirmed,O
4051,278,via,O
4052,278,SCID,O
4053,278,-,O
4054,278,IV,O
4055,278,structured,O
4056,278,diagnostic,O
4057,278,interview,O
4058,278,.,O
4059,279,Screening,O
4060,279,Hamilton,O
4061,279,Depression,O
4062,279,Rating,O
4063,279,Scale,O
4064,279,(,O
4065,279,HAMD,O
4066,279,),O
4067,279,=,O
4068,279,18,O
4069,279,;,O
4070,279,and,O
4071,279,Baseline,O
4072,279,HAMD,O
4073,279,=,O
4074,279,15,O
4075,279,.,O
4076,280,If,O
4077,280,the,O
4078,280,patient,O
4079,280,is,O
4080,280,a,O
4081,280,woman,O
4082,280,of,O
4083,280,child,O
4084,280,-,O
4085,280,bearing,O
4086,280,potential,O
4087,280,",",O
4088,280,she,O
4089,280,must,O
4090,280,agree,O
4091,280,to,O
4092,280,use,O
4093,280,an,O
4094,280,acceptable,O
4095,280,form,O
4096,280,of,O
4097,280,birth,O
4098,280,control,O
4099,280,for,O
4100,280,duration,O
4101,280,of,O
4102,280,study,O
4103,280,participation,O
4104,280,.,O
4105,281,Able,O
4106,281,to,O
4107,281,understand,O
4108,281,and,O
4109,281,provide,O
4110,281,informed,O
4111,281,consent,O
4112,281,for,O
4113,281,participation,O
4114,281,.,O
4115,282,1,O
4116,282,.,O
4117,282,Clinically,O
4118,282,significant,O
4119,282,microvascular,B-Condition
4120,282,complications,I-Condition
4121,282,:,O
4122,282,nephropathy,B-Condition
4123,282,(,O
4124,282,estimated,O
4125,282,glomerular,O
4126,282,filtration,O
4127,282,rate,O
4128,282,below,O
4129,282,40,O
4130,282,ml,O
4131,282,/,O
4132,282,min,O
4133,282,),O
4134,282,",",O
4135,282,neuropathy,B-Condition
4136,282,(,O
4137,282,especially,O
4138,282,diagnosed,O
4139,282,gastroparesis,B-Condition
4140,282,),O
4141,282,or,O
4142,282,severe,B-Condition
4143,282,proliferative,I-Condition
4144,282,retinopathy,I-Condition
4145,282,as,O
4146,282,judged,O
4147,282,by,O
4148,282,the,O
4149,282,investigator,O
4150,282,.,O
4151,283,2,O
4152,283,.,O
4153,283,Recent,O
4154,283,(,O
4155,283,<,O
4156,283,3,O
4157,283,months,O
4158,283,),O
4159,283,acute,B-Condition
4160,283,macrovascular,I-Condition
4161,283,event,I-Condition
4162,283,e.g.,O
4163,283,acute,B-Condition
4164,283,coronary,I-Condition
4165,283,syndrome,I-Condition
4166,283,or,O
4167,283,cardiac,B-Condition
4168,283,surgery,I-Condition
4169,283,.,O
4170,284,3,O
4171,284,.,O
4172,284,Ongoing,O
4173,284,pregnancy,B-Condition
4174,284,.,O
4175,285,4,O
4176,285,.,O
4177,285,Severe,O
4178,285,hypoglycemic,B-Condition
4179,285,episode,I-Condition
4180,285,within,O
4181,285,1,O
4182,285,month,O
4183,285,of,O
4184,285,screening,O
4185,285,.,O
4186,286,5,O
4187,286,.,O
4188,286,Agents,B-Drug
4189,286,affecting,I-Drug
4190,286,gastric,I-Drug
4191,286,emptying,I-Drug
4192,286,(,O
4193,286,Motilium,B-Drug
4194,286,®,O
4195,286,",",O
4196,286,Prandase,B-Drug
4197,286,®,O
4198,286,",",O
4199,286,Victoza,B-Drug
4200,286,®,O
4201,286,",",O
4202,286,Byetta,B-Drug
4203,286,®,O
4204,286,and,O
4205,286,Symlin,B-Drug
4206,286,®,O
4207,286,),O
4208,286,as,O
4209,286,well,O
4210,286,as,O
4211,286,oral,B-Drug
4212,286,anti,I-Drug
4213,286,-,I-Drug
4214,286,diabetic,I-Drug
4215,286,agents,I-Drug
4216,286,(,O
4217,286,Metformin,B-Drug
4218,286,",",O
4219,286,SGLT-2,B-Drug
4220,286,inhibitors,I-Drug
4221,286,and,O
4222,286,DPP-4,B-Drug
4223,286,inhibitors,I-Drug
4224,286,),O
4225,286,if,O
4226,286,not,O
4227,286,at,O
4228,286,a,O
4229,286,stable,O
4230,286,dose,O
4231,286,for,O
4232,286,3,O
4233,286,months,O
4234,286,.,O
4235,286,Otherwise,O
4236,286,",",O
4237,286,these,O
4238,286,medications,O
4239,286,are,O
4240,286,acceptable,O
4241,286,and,O
4242,286,will,O
4243,286,be,O
4244,286,kept,O
4245,286,stable,O
4246,286,during,O
4247,286,the,O
4248,286,entire,O
4249,286,protocol,O
4250,286,.,O
4251,287,6,O
4252,287,.,O
4253,287,Oral,B-Drug
4254,287,steroids,I-Drug
4255,287,unless,O
4256,287,patients,O
4257,287,present,O
4258,287,a,O
4259,287,low,O
4260,287,stable,O
4261,287,dose,O
4262,287,(,O
4263,287,e.g.,O
4264,287,10,O
4265,287,mg,O
4266,287,or,O
4267,287,less,O
4268,287,of,O
4269,287,prednisone,B-Drug
4270,287,per,O
4271,287,day,O
4272,287,or,O
4273,287,physiological,O
4274,287,doses,O
4275,287,",",O
4276,287,less,O
4277,287,than,O
4278,287,35,O
4279,287,mg,O
4280,287,/,O
4281,287,day,O
4282,287,",",O
4283,287,of,O
4284,287,hydrocortisone,B-Drug
4285,287,Cortef,B-Drug
4286,287,®,O
4287,287,),O
4288,287,.,O
4289,287,Inhale,B-Drug
4290,287,steroids,I-Drug
4291,287,at,O
4292,287,stable,O
4293,287,dose,O
4294,287,in,O
4295,287,the,O
4296,287,last,O
4297,287,month,O
4298,287,are,O
4299,287,acceptable,O
4300,287,.,O
4301,288,7,O
4302,288,.,O
4303,288,Other,B-Condition
4304,288,serious,I-Condition
4305,288,medical,I-Condition
4306,288,illness,I-Condition
4307,288,likely,O
4308,288,to,O
4309,288,interfere,O
4310,288,with,O
4311,288,study,O
4312,288,participation,O
4313,288,or,O
4314,288,with,O
4315,288,the,O
4316,288,ability,O
4317,288,to,O
4318,288,complete,O
4319,288,the,O
4320,288,trial,O
4321,288,by,O
4322,288,the,O
4323,288,judgment,O
4324,288,of,O
4325,288,the,O
4326,288,investigator,O
4327,288,(,O
4328,288,e.g.,O
4329,288,unstable,O
4330,288,psychiatric,B-Condition
4331,288,condition,I-Condition
4332,288,),O
4333,288,.,O
4334,289,8,O
4335,289,.,O
4336,289,Failure,O
4337,289,to,O
4338,289,comply,O
4339,289,with,O
4340,289,team,O
4341,289,'s,O
4342,289,recommendations,O
4343,289,(,O
4344,289,e.g.,O
4345,289,not,O
4346,289,willing,O
4347,289,to,O
4348,289,change,O
4349,289,pump,O
4350,289,parameters,O
4351,289,",",O
4352,289,follow,O
4353,289,algorithm,O
4354,289,'s,O
4355,289,suggestions,O
4356,289,",",O
4357,289,etc,O
4358,289,),O
4359,289,.,O
4360,290,9,O
4361,290,.,O
4362,290,Living,O
4363,290,or,O
4364,290,planned,O
4365,290,travel,O
4366,290,outside,O
4367,290,Montreal,O
4368,290,(,O
4369,290,>,O
4370,290,1h,O
4371,290,of,O
4372,290,driving,O
4373,290,),O
4374,290,area,O
4375,290,during,O
4376,290,closed,B-Procedure
4377,290,-,I-Procedure
4378,290,loop,I-Procedure
4379,290,procedures,I-Procedure
4380,290,.,O
4381,291,1,O
4382,291,.,O
4383,291,Males,B-Person
4384,291,and,O
4385,291,females,B-Person
4386,291,≥,O
4387,291,18,O
4388,291,years,O
4389,291,old,B-Person
4390,291,.,O
4391,292,2,O
4392,292,.,O
4393,292,Clinical,O
4394,292,diagnosis,O
4395,292,of,O
4396,292,type,B-Condition
4397,292,1,I-Condition
4398,292,diabetes,I-Condition
4399,292,for,O
4400,292,at,O
4401,292,least,O
4402,292,one,O
4403,292,year,O
4404,292,.,O
4405,293,3,O
4406,293,.,O
4407,293,The,O
4408,293,subject,O
4409,293,will,O
4410,293,have,O
4411,293,been,O
4412,293,on,O
4413,293,insulin,B-Procedure
4414,293,pump,I-Procedure
4415,293,therapy,I-Procedure
4416,293,for,O
4417,293,at,O
4418,293,least,O
4419,293,3,O
4420,293,months,O
4421,293,and,O
4422,293,currently,O
4423,293,using,O
4424,293,a,O
4425,293,fast,B-Drug
4426,293,actin,I-Drug
4427,293,insulin,I-Drug
4428,293,analog,I-Drug
4429,293,(,O
4430,293,Lispro,B-Drug
4431,293,",",O
4432,293,Aspart,B-Drug
4433,293,or,O
4434,293,Guilisine,B-Drug
4435,293,),O
4436,293,.,O
4437,294,4,O
4438,294,.,O
4439,294,Last,O
4440,294,(,O
4441,294,less,O
4442,294,than,O
4443,294,3,O
4444,294,months,O
4445,294,),O
4446,294,HbA1c,O
4447,294,≤,O
4448,294,10,O
4449,294,%,O
4450,294,.,O
4451,295,5,O
4452,295,.,O
4453,295,Currently,O
4454,295,using,O
4455,295,carbohydrate,B-Procedure
4456,295,counting,I-Procedure
4457,295,as,O
4458,295,the,O
4459,295,meal,B-Procedure
4460,295,insulin,I-Procedure
4461,295,dose,I-Procedure
4462,295,strategy,I-Procedure
4463,295,.,O
4464,296,Inpatient,B-Observation
4465,296,status,I-Observation
4466,296,",",O
4467,296,airway,B-Condition
4468,296,abnormalities,I-Condition
4469,296,",",O
4470,296,allergy,B-Condition
4471,296,to,O
4472,296,any,O
4473,296,study,B-Drug
4474,296,medications,I-Drug
4475,296,",",O
4476,296,eggs,B-Drug
4477,296,and,O
4478,296,soy,B-Drug
4479,296,",",O
4480,296,and,O
4481,296,mitochondrial,B-Condition
4482,296,disorders,I-Condition
4483,296,.,O
4484,297,All,O
4485,297,subjects,O
4486,297,with,O
4487,297,any,O
4488,297,cardiac,B-Condition
4489,297,disease,I-Condition
4490,297,or,O
4491,297,history,B-Observation
4492,297,of,O
4493,297,cardiac,B-Condition
4494,297,arrhythmias,I-Condition
4495,297,will,O
4496,297,be,O
4497,297,excluded,O
4498,297,.,O
4499,298,All,O
4500,298,children,O
4501,298,scheduled,O
4502,298,for,O
4503,298,outpatient,O
4504,298,MRI,B-Procedure
4505,298,scans,I-Procedure
4506,298,with,O
4507,298,expected,O
4508,298,duration,O
4509,298,of,O
4510,298,scan,O
4511,298,between,O
4512,298,30,O
4513,298,minutes,O
4514,298,and,O
4515,298,75,O
4516,298,minutes,O
4517,298,.,O
4518,299,previous,O
4519,299,unusual,B-Condition
4520,299,response,I-Condition
4521,299,to,O
4522,299,esmolol,B-Drug
4523,300,inclusion,O
4524,300,in,O
4525,300,other,O
4526,300,randomized,O
4527,300,studies,O
4528,301,esmolol,B-Drug
4529,301,administration,O
4530,301,in,O
4531,301,the,O
4532,301,previous,O
4533,301,30,O
4534,301,days,O
4535,302,emergency,O
4536,302,operation,B-Procedure
4537,303,end,O
4538,303,diastolic,O
4539,303,diameter,O
4540,303,>,O
4541,303,60,O
4542,303,mm,O
4543,303,and/or,O
4544,303,an,O
4545,303,ejection,O
4546,303,fraction,O
4547,303,<,O
4548,303,50,O
4549,303,%,O
4550,304,written,O
4551,304,informed,O
4552,304,consent,O
4553,305,age,B-Person
4554,305,>,O
4555,305,18,O
4556,305,years,O
4557,306,Surgeries,O
4558,306,that,O
4559,306,include,O
4560,306,:,O
4561,306,intradetrusor,O
4562,306,Botox,B-Drug
4563,306,",",O
4564,306,vaginal,B-Procedure
4565,306,mesh,I-Procedure
4566,306,excision,I-Procedure
4567,306,",",O
4568,306,and,O
4569,306,fistula,B-Procedure
4570,306,repair,I-Procedure
4571,307,Pregnancy,B-Condition
4572,308,History,B-Observation
4573,308,of,O
4574,308,nephrolithiasis,B-Condition
4575,309,Allergy,B-Condition
4576,309,to,O
4577,309,study,B-Drug
4578,309,medications,I-Drug
4579,310,Congenital,O
4580,310,urogenital,B-Condition
4581,310,anomaly,I-Condition
4582,311,Neurogenic,B-Condition
4583,311,bladder,I-Condition
4584,312,Adult,B-Person
4585,312,women,B-Person
4586,312,at,O
4587,312,least,O
4588,312,18,O
4589,312,years,O
4590,312,of,O
4591,312,age,B-Person
4592,313,Elective,O
4593,313,Female,O
4594,313,Pelvic,O
4595,313,Medicine,B-Drug
4596,313,and,O
4597,313,Reconstructive,B-Procedure
4598,313,Surgery,I-Procedure
4599,313,or,O
4600,313,Gynecologic,O
4601,313,Minimally,O
4602,313,Invasive,O
4603,313,surgeries,B-Procedure
4604,313,including,O
4605,313,hysterectomy,B-Procedure
4606,313,",",O
4607,313,suburethral,B-Procedure
4608,313,sling,I-Procedure
4609,313,",",O
4610,313,and,O
4611,313,pelvic,B-Procedure
4612,313,organ,I-Procedure
4613,313,prolapse,I-Procedure
4614,313,repair,I-Procedure
4615,313,that,O
4616,313,require,B-Mood
4617,313,cystoscopy,B-Procedure
4618,313,.,O
4619,314,Patients,O
4620,314,with,O
4621,314,systolic,O
4622,314,blood,O
4623,314,pressure,O
4624,314,<,O
4625,314,100,O
4626,314,mmHg,O
4627,314,or,O
4628,314,basal,O
4629,314,heart,O
4630,314,rate,O
4631,314,<,O
4632,314,60,O
4633,314,/,O
4634,314,min,O
4635,315,Portal,B-Condition
4636,315,vein,I-Condition
4637,315,thrombosis,I-Condition
4638,316,Uncontrolled,O
4639,316,ascites,B-Condition
4640,316,or,O
4641,316,hepatic,B-Condition
4642,316,encephalopathy,I-Condition
4643,317,Severe,O
4644,317,coagulation,B-Condition
4645,317,disorder,I-Condition
4646,317,:,O
4647,317,prothrombin,O
4648,317,time,O
4649,317,<,O
4650,317,40,O
4651,317,%,O
4652,317,(,O
4653,317,or,O
4654,317,INR,O
4655,317,>,O
4656,317,1.7,O
4657,317,),O
4658,317,or,O
4659,317,platelet,O
4660,317,count,O
4661,317,<,O
4662,317,"30,000",O
4663,317,/,O
4664,317,mm3,O
4665,318,Medium,O
4666,318,or,O
4667,318,large,O
4668,318,sized,O
4669,318,gastric,B-Condition
4670,318,or,I-Condition
4671,318,duodenal,I-Condition
4672,318,varices,I-Condition
4673,319,Coexisting,O
4674,319,malignancy,B-Condition
4675,320,Severe,O
4676,320,cardiovascular,B-Condition
4677,320,disorder,I-Condition
4678,320,",",O
4679,320,renal,B-Condition
4680,320,failure,I-Condition
4681,320,",",O
4682,320,peritonitis,B-Condition
4683,320,",",O
4684,320,sepsis,B-Condition
4685,321,Severe,O
4686,321,erosive,B-Condition
4687,321,esophagitis,I-Condition
4688,321,",",O
4689,321,severe,O
4690,321,esophageal,B-Condition
4691,321,stricture,I-Condition
4692,321,",",O
4693,321,active,O
4694,321,gastric,B-Condition
4695,321,or,I-Condition
4696,321,duodenal,I-Condition
4697,321,ulcer,I-Condition
4698,322,Contraindication,B-Condition
4699,322,to,O
4700,322,beta,B-Drug
4701,322,-,I-Drug
4702,322,blocker,I-Drug
4703,323,Pregnancy,B-Condition
4704,324,Refusal,O
4705,324,to,O
4706,324,give,O
4707,324,consent,O
4708,324,to,O
4709,324,participate,O
4710,324,in,O
4711,324,the,O
4712,324,trial,O
4713,325,Liver,B-Condition
4714,325,cirrhosis,I-Condition
4715,326,Age,B-Person
4716,326,between,O
4717,326,18,O
4718,326,and,O
4719,326,70,O
4720,326,years,O
4721,327,Esophageal,B-Condition
4722,327,varices,I-Condition
4723,327,with,O
4724,327,high,B-Observation
4725,327,bleeding,I-Observation
4726,327,risk,I-Observation
4727,327,:,O
4728,327,more,O
4729,327,than,O
4730,327,F2,O
4731,327,and,O
4732,327,red,B-Condition
4733,327,color,I-Condition
4734,327,sign,I-Condition
4735,328,No,O
4736,328,previous,O
4737,328,history,O
4738,328,of,O
4739,328,upper,B-Condition
4740,328,gastrointestinal,I-Condition
4741,328,bleeding,I-Condition
4742,329,No,O
4743,329,previous,O
4744,329,history,O
4745,329,of,O
4746,329,endoscopic,B-Procedure
4747,329,",",I-Procedure
4748,329,radiologic,I-Procedure
4749,329,",",I-Procedure
4750,329,or,I-Procedure
4751,329,surgical,I-Procedure
4752,329,therapy,I-Procedure
4753,329,for,O
4754,329,varices,B-Condition
4755,329,or,O
4756,329,ascites,B-Condition
4757,330,Do,O
4758,330,not,O
4759,330,take,O
4760,330,beta,B-Drug
4761,330,-,I-Drug
4762,330,blocker,I-Drug
4763,330,",",O
4764,330,ACE,B-Drug
4765,330,inhibitor,I-Drug
4766,330,",",O
4767,330,or,O
4768,330,nitrate,B-Drug
4769,331,Child,O
4770,331,-,O
4771,331,Pugh,O
4772,331,score,O
4773,331,<,O
4774,331,12,O
4775,332,Exclusion,O
4776,332,criteria,O
4777,332,are,O
4778,332,pregnancy,B-Condition
4779,332,",",O
4780,332,patients,O
4781,332,with,O
4782,332,contraindications,B-Condition
4783,332,to,O
4784,332,regional,B-Procedure
4785,332,anesthesia,I-Procedure
4786,332,",",O
4787,332,allergy,B-Condition
4788,332,to,O
4789,332,LAs,B-Drug
4790,332,",",O
4791,332,patients,O
4792,332,taking,O
4793,332,opioids,B-Drug
4794,332,regularly,O
4795,332,due,O
4796,332,to,O
4797,332,chronic,B-Condition
4798,332,pain,I-Condition
4799,332,",",O
4800,332,use,O
4801,332,of,O
4802,332,anticoagulation,B-Drug
4803,332,drugs,I-Drug
4804,332,other,O
4805,332,than,O
4806,332,acetylsalicylic,B-Drug
4807,332,acid,I-Drug
4808,332,or,O
4809,332,dipyridamole,B-Drug
4810,332,",",O
4811,332,atrioventricular,B-Condition
4812,332,block,I-Condition
4813,332,",",O
4814,332,diabetes,B-Condition
4815,332,.,O
4816,333,.,O
4817,333,Inclusion,O
4818,333,criteria,O
4819,333,are,O
4820,333,American,O
4821,333,Society,O
4822,333,of,O
4823,333,Anesthesiologists,O
4824,333,(,O
4825,333,ASA,O
4826,333,),O
4827,333,physical,O
4828,333,status,O
4829,333,I,O
4830,333,-,O
4831,333,III,O
4832,333,",",O
4833,333,age,B-Person
4834,333,between,O
4835,333,18,O
4836,333,and,O
4837,333,70,O
4838,333,years,O
4839,333,and,O
4840,333,body,O
4841,333,mass,O
4842,333,index,O
4843,333,(,O
4844,333,BMI,O
4845,333,),O
4846,333,between,O
4847,333,20,O
4848,333,and,O
4849,333,35,O
4850,333,kg,O
4851,333,/,O
4852,333,m2,O
4853,333,.,O
4854,334,Type,B-Condition
4855,334,1,I-Condition
4856,334,diabetes,I-Condition
4857,334,",",O
4858,334,Secondary,B-Condition
4859,334,diabetes,I-Condition
4860,334,",",O
4861,334,gestational,B-Condition
4862,334,diabetes,I-Condition
4863,335,Ongoing,O
4864,335,dementia,B-Condition
4865,335,treatment,B-Procedure
4866,335,or,O
4867,335,anti,B-Drug
4868,335,-,I-Drug
4869,335,depressive,I-Drug
4870,335,disorder,I-Drug
4871,335,medication,I-Drug
4872,336,Uncontrolled,O
4873,336,psychiatric,O
4874,336,disorder,O
4875,337,BDI,O
4876,337,=,O
4877,337,30,O
4878,337,points,O
4879,338,Heavy,O
4880,338,alcoholics,B-Condition
4881,339,Underlying,O
4882,339,chronic,B-Condition
4883,339,liver,I-Condition
4884,339,disease,I-Condition
4885,339,(,O
4886,339,hemochromatosis,B-Condition
4887,339,",",O
4888,339,liver,B-Condition
4889,339,cell,I-Condition
4890,339,carcinoma,I-Condition
4891,339,",",O
4892,339,autoimmune,B-Condition
4893,339,liver,I-Condition
4894,339,disease,I-Condition
4895,339,",",O
4896,339,liver,B-Condition
4897,339,cirrhosis,I-Condition
4898,339,",",O
4899,339,chronic,B-Condition
4900,339,viral,I-Condition
4901,339,hepatitis,I-Condition
4902,339,),O
4903,340,Allergy,B-Condition
4904,340,or,O
4905,340,hypersensitivity,B-Condition
4906,340,to,O
4907,340,target,B-Drug
4908,340,medication,I-Drug
4909,340,or,O
4910,340,any,O
4911,340,of,O
4912,340,its,O
4913,340,components,O
4914,341,Renal,B-Condition
4915,341,failure,I-Condition
4916,341,",",O
4917,341,moderate,O
4918,341,or,O
4919,341,severe,O
4920,341,renal,B-Condition
4921,341,impairment,I-Condition
4922,341,(,O
4923,341,estimated,O
4924,341,glomerular,O
4925,341,filtration,O
4926,341,rate,O
4927,341,<,O
4928,341,30,O
4929,341,mL,O
4930,341,/,O
4931,341,min/1.73,O
4932,341,m2,O
4933,341,),O
4934,341,",",O
4935,341,or,O
4936,341,ongoing,O
4937,341,dialysis,B-Procedure
4938,342,Abnormal,O
4939,342,liver,O
4940,342,function,O
4941,342,(,O
4942,342,AST,O
4943,342,/,O
4944,342,ALT,O
4945,342,>,O
4946,342,x3,O
4947,342,upper,O
4948,342,normal,O
4949,342,limit,O
4950,342,),O
4951,343,History,O
4952,343,of,O
4953,343,alcohol,B-Condition
4954,343,or,I-Condition
4955,343,drug,I-Condition
4956,343,abuse,I-Condition
4957,343,in,O
4958,343,the,O
4959,343,previous,O
4960,343,3,O
4961,343,months,O
4962,344,Premenopausal,B-Condition
4963,344,women,B-Person
4964,344,who,O
4965,344,are,O
4966,344,nursing,B-Condition
4967,344,or,O
4968,344,pregnant,B-Condition
4969,345,Human,B-Condition
4970,345,immunodeficiency,I-Condition
4971,345,virus,I-Condition
4972,345,(,I-Condition
4973,345,HIV,I-Condition
4974,345,),I-Condition
4975,345,or,O
4976,345,human,B-Condition
4977,345,immunodeficiency,I-Condition
4978,345,virus,I-Condition
4979,345,(,I-Condition
4980,345,AIDS,I-Condition
4981,345,),I-Condition
4982,346,chronic,B-Condition
4983,346,pancreatitis,I-Condition
4984,346,or,O
4985,346,pancreatic,B-Condition
4986,346,cancer,I-Condition
4987,347,Type,B-Condition
4988,347,2,I-Condition
4989,347,diabetic,I-Condition
4990,347,patients,O
4991,348,Age,B-Person
4992,348,=,O
4993,348,50,O
4994,349,Glycemic,O
4995,349,control,O
4996,349,:,O
4997,349,HbA1c,O
4998,349,=,O
4999,349,10.0,O
5000,349,%,O
5001,350,10,O
5002,350,=,O
5003,350,Beck,O
5004,350,Depression,O
5005,350,Inventory,O
5006,350,(,O
5007,350,BDI,O
5008,350,),O
5009,350,<,O
5010,350,30,O
5011,350,points,O
5012,351,Participants,O
5013,351,who,O
5014,351,can,O
5015,351,undergo,O
5016,351,contraception,O
5017,351,in,O
5018,351,case,O
5019,351,of,O
5020,351,being,O
5021,351,in,O
5022,351,childbearing,O
5023,351,period,O
5024,352,Understands,O
5025,352,the,O
5026,352,study,O
5027,352,procedure,O
5028,352,",",O
5029,352,alternatives,O
5030,352,",",O
5031,352,and,O
5032,352,risks,O
5033,352,and,O
5034,352,voluntarily,O
5035,352,agrees,O
5036,352,to,O
5037,352,participate,O
5038,352,by,O
5039,352,giving,O
5040,352,written,O
5041,352,informed,O
5042,352,concent,O
5043,353,Women,O
5044,353,who,O
5045,353,are,O
5046,353,pregnant,O
5047,353,",",O
5048,353,lactating,O
5049,353,or,O
5050,353,breast,O
5051,353,feeding,O
5052,353,or,O
5053,353,have,O
5054,353,a,O
5055,353,positive,O
5056,353,serum,O
5057,353,pregnancy,O
5058,353,test,O
5059,353,at,O
5060,353,enrollment,O
5061,353,or,O
5062,353,positive,O
5063,353,urine,O
5064,353,pregnancy,O
5065,353,test,O
5066,353,on,O
5067,353,the,O
5068,353,morning,O
5069,353,of,O
5070,353,the,O
5071,353,first,O
5072,353,day,O
5073,353,of,O
5074,353,any,O
5075,353,study,O
5076,353,session,O
5077,354,Smokers,B-Person
5078,354,(,O
5079,354,current,O
5080,354,use,O
5081,354,or,O
5082,354,use,O
5083,354,over,O
5084,354,the,O
5085,354,previous,O
5086,354,2,O
5087,354,months,O
5088,354,of,O
5089,354,nicotine,O
5090,354,-,O
5091,354,containing,O
5092,354,substances,O
5093,354,",",O
5094,354,including,O
5095,354,tobacco,O
5096,354,products,O
5097,354,(,O
5098,354,e.g.,O
5099,354,cigarettes,O
5100,354,",",O
5101,354,cigars,O
5102,354,",",O
5103,354,chewing,O
5104,354,tobacco,O
5105,354,",",O
5106,354,gum,O
5107,354,",",O
5108,354,patch,O
5109,354,or,O
5110,354,electronic,O
5111,354,cigarettes,O
5112,354,),O
5113,355,Participation,O
5114,355,in,O
5115,355,any,O
5116,355,ongoing,O
5117,355,investigational,O
5118,355,drug,O
5119,355,trial,O
5120,355,/,O
5121,355,study,O
5122,355,or,O
5123,355,clinical,O
5124,355,drug,O
5125,355,trial,O
5126,355,/,O
5127,355,study,O
5128,356,History,O
5129,356,of,O
5130,356,chronic,B-Condition
5131,356,obstructive,I-Condition
5132,356,pulmonary,I-Condition
5133,356,disease,I-Condition
5134,356,or,O
5135,356,cor,B-Condition
5136,356,pulmonale,I-Condition
5137,356,",",I-Condition
5138,356,or,O
5139,356,substantially,O
5140,356,decreased,B-Condition
5141,356,respiratory,I-Condition
5142,356,reserve,I-Condition
5143,356,",",O
5144,356,hypoxia,B-Condition
5145,356,",",O
5146,356,hypercapnia,B-Condition
5147,356,or,O
5148,356,pre,O
5149,356,-,O
5150,356,existing,O
5151,356,respiratory,B-Condition
5152,356,depression,I-Condition
5153,357,Active,O
5154,357,positive,O
5155,357,Hepatitis,O
5156,357,B,O
5157,357,",",O
5158,357,C,O
5159,357,and,O
5160,357,HIV,O
5161,357,serologies,O
5162,358,Positive,O
5163,358,urine,O
5164,358,drug,O
5165,358,screening,O
5166,358,test,O
5167,359,Use,O
5168,359,of,O
5169,359,any,O
5170,359,prescription,O
5171,359,medication,O
5172,359,during,O
5173,359,the,O
5174,359,session,O
5175,359,0,O
5176,359,to,O
5177,359,30,O
5178,359,days,O
5179,359,or,O
5180,359,over,O
5181,359,-,O
5182,359,the,O
5183,359,counter,O
5184,359,medication,O
5185,359,e.g.,O
5186,359,antihistamines,O
5187,359,or,O
5188,359,topical,O
5189,359,corticosteroids,O
5190,359,(,O
5191,359,vitamin,O
5192,359,",",O
5193,359,herbal,O
5194,359,supplements,O
5195,359,and,O
5196,359,birth,O
5197,359,control,O
5198,359,medications,O
5199,359,not,O
5200,359,included,O
5201,359,),O
5202,359,during,O
5203,359,the,O
5204,359,session,O
5205,359,0,O
5206,359,to,O
5207,359,3,O
5208,359,days,O
5209,359,before,O
5210,359,entry,O
5211,359,to,O
5212,359,the,O
5213,359,study,O
5214,360,Use,O
5215,360,of,O
5216,360,medications,O
5217,360,or,O
5218,360,treatments,O
5219,360,that,O
5220,360,would,O
5221,360,significantly,O
5222,360,influence,O
5223,360,or,O
5224,360,exaggerate,O
5225,360,responses,O
5226,360,to,O
5227,360,the,O
5228,360,test,O
5229,360,product,O
5230,360,or,O
5231,360,that,O
5232,360,would,O
5233,360,alter,O
5234,360,inflammatory,O
5235,360,or,O
5236,360,immune,O
5237,360,response,O
5238,360,to,O
5239,360,the,O
5240,360,product,O
5241,360,or,O
5242,360,agents,O
5243,360,deemed,O
5244,360,to,O
5245,360,be,O
5246,360,immunosuppressive,O
5247,360,as,O
5248,360,determined,O
5249,360,by,O
5250,360,physician,O
5251,360,investigator,O
5252,360,with,O
5253,360,72,O
5254,360,hours,O
5255,360,prior,O
5256,360,to,O
5257,360,dosing,O
5258,360,(,O
5259,360,e.g.,O
5260,360,antihistamines,O
5261,360,",",O
5262,360,systemic,O
5263,360,or,O
5264,360,topical,O
5265,360,corticosteroids,O
5266,360,(,O
5267,360,within,O
5268,360,3,O
5269,360,weeks,O
5270,360,prior,O
5271,360,to,O
5272,360,dosing,O
5273,360,),O
5274,360,",",O
5275,360,cyclosporine,O
5276,360,",",O
5277,360,tacrolimus,O
5278,360,",",O
5279,360,cytotoxic,O
5280,360,drugs,O
5281,360,",",O
5282,360,immune,O
5283,360,globulin,O
5284,360,",",O
5285,360,Bacillus,O
5286,360,Calmette,O
5287,360,-,O
5288,360,Guerin,O
5289,360,(,O
5290,360,BCG,O
5291,360,),O
5292,360,",",O
5293,360,monoclonal,O
5294,360,antibodies,O
5295,360,",",O
5296,360,radiation,O
5297,360,therapy,O
5298,360,),O
5299,361,Use,O
5300,361,of,O
5301,361,monoamine,B-Drug
5302,361,oxidase,I-Drug
5303,361,inhibitors,I-Drug
5304,361,21,O
5305,361,days,O
5306,361,prior,O
5307,361,to,O
5308,361,study,O
5309,362,Current,O
5310,362,use,O
5311,362,of,O
5312,362,mixed,O
5313,362,agonist,O
5314,362,/,O
5315,362,antagonist,O
5316,362,(,O
5317,362,such,O
5318,362,as,O
5319,362,pentazocine,B-Drug
5320,362,",",O
5321,362,nalbuphine,B-Drug
5322,362,or,O
5323,362,butorphanol,B-Drug
5324,362,),O
5325,362,and,O
5326,362,partial,O
5327,362,agonist,O
5328,362,(,O
5329,362,buprenorphine,B-Drug
5330,362,),O
5331,362,analgesics,O
5332,363,Current,O
5333,363,use,O
5334,363,of,O
5335,363,anticholinergics,B-Drug
5336,363,or,O
5337,363,other,O
5338,363,medications,O
5339,363,with,O
5340,363,anticholinergic,O
5341,363,activity,O
5342,364,Consumption,O
5343,364,of,O
5344,364,beverages,O
5345,364,containing,O
5346,364,alcohol,O
5347,364,",",O
5348,364,grapefruit,O
5349,364,juice,O
5350,364,",",O
5351,364,Seville,O
5352,364,oranges,O
5353,364,",",O
5354,364,or,O
5355,364,quinine,O
5356,364,(,O
5357,364,e.g.,O
5358,364,tonic,O
5359,364,water,O
5360,364,),O
5361,364,or,O
5362,364,foods,O
5363,364,containing,O
5364,364,poppy,O
5365,364,seeds,O
5366,364,in,O
5367,364,the,O
5368,364,last,O
5369,364,72,O
5370,364,hours,O
5371,364,.,O
5372,365,Donation,O
5373,365,or,O
5374,365,loss,O
5375,365,of,O
5376,365,greater,O
5377,365,than,O
5378,365,one,O
5379,365,pint,O
5380,365,of,O
5381,365,blood,O
5382,365,within,O
5383,365,60,O
5384,365,days,O
5385,365,of,O
5386,365,entry,O
5387,365,to,O
5388,365,the,O
5389,365,study,O
5390,366,Any,O
5391,366,prior,O
5392,366,serious,O
5393,366,adverse,O
5394,366,reaction,O
5395,366,or,O
5396,366,hypersensitivity,B-Condition
5397,366,to,O
5398,366,fentanyl,B-Drug
5399,366,",",O
5400,366,morphine,B-Drug
5401,366,",",O
5402,366,codeine,B-Drug
5403,366,",",O
5404,366,hydrocodone,B-Drug
5405,366,",",O
5406,366,hydromorphone,B-Drug
5407,366,",",O
5408,366,oxycodone,B-Drug
5409,366,",",O
5410,366,oxymorphone,B-Drug
5411,366,",",O
5412,366,naltrexone,B-Drug
5413,366,or,O
5414,366,naloxone,B-Drug
5415,366,or,O
5416,366,any,O
5417,366,of,O
5418,366,the,O
5419,366,inactive,O
5420,366,ingredients,O
5421,366,in,O
5422,366,the,O
5423,366,TDDS,O
5424,366,(,O
5425,366,polyester,O
5426,366,/,O
5427,366,ethyl,O
5428,366,vinyl,O
5429,366,acetate,O
5430,366,",",O
5431,366,polyacrylate,O
5432,366,adhesive,O
5433,366,",",O
5434,366,silicone,O
5435,366,adhesive,O
5436,366,",",O
5437,366,dimethicone,O
5438,366,NF,O
5439,366,",",O
5440,366,or,O
5441,366,polyolefin,O
5442,366,),O
5443,367,Have,O
5444,367,a,O
5445,367,diagnosis,O
5446,367,of,O
5447,367,schizophrenia,B-Condition
5448,367,or,O
5449,367,other,O
5450,367,major,B-Condition
5451,367,psychiatric,I-Condition
5452,367,diagnosis,I-Condition
5453,367,or,O
5454,367,mental,B-Condition
5455,367,illness,I-Condition
5456,367,(,O
5457,367,e.g.,O
5458,367,major,B-Condition
5459,367,depression,I-Condition
5460,367,),O
5461,368,Medical,O
5462,368,history,O
5463,368,of,O
5464,368,personal,O
5465,368,drug,O
5466,368,or,O
5467,368,alcohol,O
5468,368,addiction,B-Condition
5469,368,or,O
5470,368,abuse,B-Condition
5471,369,Any,O
5472,369,condition,O
5473,369,that,O
5474,369,would,O
5475,369,",",O
5476,369,in,O
5477,369,the,O
5478,369,opinion,O
5479,369,of,O
5480,369,the,O
5481,369,MAI,O
5482,369,",",O
5483,369,place,O
5484,369,the,O
5485,369,subject,O
5486,369,at,O
5487,369,an,O
5488,369,unacceptable,O
5489,369,risk,O
5490,369,of,O
5491,369,injury,O
5492,369,or,O
5493,369,render,O
5494,369,the,O
5495,369,subject,O
5496,369,unable,O
5497,369,to,O
5498,369,meet,O
5499,369,the,O
5500,369,requirements,O
5501,369,of,O
5502,369,the,O
5503,369,protocol,O
5504,370,Inability,O
5505,370,to,O
5506,370,communicate,O
5507,370,or,O
5508,370,cooperate,O
5509,370,with,O
5510,370,the,O
5511,370,investigators,O
5512,371,Subject,O
5513,371,has,O
5514,371,an,O
5515,371,obvious,O
5516,371,difference,O
5517,371,in,O
5518,371,skin,O
5519,371,color,O
5520,371,between,O
5521,371,arms,O
5522,371,or,O
5523,371,the,O
5524,371,presence,O
5525,371,of,O
5526,371,a,O
5527,371,skin,O
5528,371,condition,O
5529,371,",",O
5530,371,excessive,O
5531,371,hair,O
5532,371,at,O
5533,371,the,O
5534,371,application,O
5535,371,site,O
5536,371,(,O
5537,371,upper,O
5538,371,arm,O
5539,371,),O
5540,371,",",O
5541,371,sunburn,O
5542,371,",",O
5543,371,raised,O
5544,371,moles,O
5545,371,and,O
5546,371,scars,O
5547,371,",",O
5548,371,open,O
5549,371,sore,O
5550,371,",",O
5551,371,scar,O
5552,371,tissue,O
5553,371,",",O
5554,371,tattoo,O
5555,371,",",O
5556,371,or,O
5557,371,coloration,O
5558,371,that,O
5559,371,would,O
5560,371,interfere,O
5561,371,with,O
5562,371,placement,O
5563,371,of,O
5564,371,test,O
5565,371,articles,O
5566,371,",",O
5567,371,skin,O
5568,371,assessment,O
5569,371,",",O
5570,371,or,O
5571,371,reactions,O
5572,371,to,O
5573,371,drug,O
5574,372,Failure,O
5575,372,to,O
5576,372,pass,O
5577,372,opioid,O
5578,372,dependence,O
5579,372,challenge,O
5580,372,test,O
5581,372,on,O
5582,372,the,O
5583,372,first,O
5584,372,day,O
5585,372,study,O
5586,372,day,O
5587,372,of,O
5588,372,any,O
5589,372,study,O
5590,372,session,O
5591,372,(,O
5592,372,i.e.,O
5593,372,",",O
5594,372,before,O
5595,372,taking,O
5596,372,the,O
5597,372,first,O
5598,372,dose,O
5599,372,of,O
5600,372,naltrexone,O
5601,372,hydrochloride,O
5602,372,),O
5603,372,.,O
5604,372,Each,O
5605,372,subject,O
5606,372,will,O
5607,372,be,O
5608,372,injected,O
5609,372,subcutaneously,O
5610,372,with,O
5611,372,naloxone,O
5612,372,hydrochloride,O
5613,372,(,O
5614,372,0.8,O
5615,372,mg,O
5616,372,injection,O
5617,372,),O
5618,372,and,O
5619,372,will,O
5620,372,be,O
5621,372,observed,O
5622,372,for,O
5623,372,45,O
5624,372,minutes,O
5625,372,for,O
5626,372,signs,O
5627,372,and,O
5628,372,symptoms,O
5629,372,of,O
5630,372,opioid,O
5631,372,withdrawal,O
5632,372,.,O
5633,373,Within,O
5634,373,4,O
5635,373,weeks,O
5636,373,prior,O
5637,373,to,O
5638,373,dosing,O
5639,373,",",O
5640,373,use,O
5641,373,of,O
5642,373,medications,O
5643,373,or,O
5644,373,treatments,O
5645,373,that,O
5646,373,would,O
5647,373,significantly,O
5648,373,influence,O
5649,373,or,O
5650,373,exaggerate,O
5651,373,responses,O
5652,373,to,O
5653,373,the,O
5654,373,test,O
5655,373,product,O
5656,373,or,O
5657,373,that,O
5658,373,would,O
5659,373,alter,O
5660,373,inflammatory,O
5661,373,or,O
5662,373,immune,O
5663,373,response,O
5664,373,to,O
5665,373,the,O
5666,373,product,O
5667,373,or,O
5668,373,agents,O
5669,373,deemed,O
5670,373,to,O
5671,373,be,O
5672,373,immunosuppressive,O
5673,373,as,O
5674,373,determined,O
5675,373,by,O
5676,373,physician,O
5677,373,investigator,O
5678,374,Men,B-Person
5679,374,or,O
5680,374,non,O
5681,374,-,O
5682,374,pregnant,O
5683,374,women,B-Person
5684,374,of,O
5685,374,any,O
5686,374,ethnic,O
5687,374,background,O
5688,374,between,O
5689,374,the,O
5690,374,age,B-Person
5691,374,of,O
5692,374,18,O
5693,374,and,O
5694,374,45,O
5695,374,years,O
5696,374,old,O
5697,375,Subjects,O
5698,375,must,O
5699,375,be,O
5700,375,non,B-Person
5701,375,-,I-Person
5702,375,smokers,I-Person
5703,375,(,O
5704,375,must,O
5705,375,have,O
5706,375,refrained,O
5707,375,from,O
5708,375,the,O
5709,375,use,O
5710,375,of,O
5711,375,nicotine,O
5712,375,-,O
5713,375,containing,O
5714,375,substances,O
5715,375,",",O
5716,375,including,O
5717,375,tobacco,O
5718,375,products,O
5719,375,(,O
5720,375,e.g.,O
5721,375,cigarettes,O
5722,375,",",O
5723,375,cigars,O
5724,375,",",O
5725,375,chewing,O
5726,375,tobacco,O
5727,375,",",O
5728,375,gum,O
5729,375,",",O
5730,375,patch,O
5731,375,or,O
5732,375,electronic,O
5733,375,cigarettes,O
5734,375,),O
5735,375,over,O
5736,375,the,O
5737,375,previous,O
5738,375,2,O
5739,375,months,O
5740,375,and,O
5741,375,are,O
5742,375,not,O
5743,375,currently,O
5744,375,using,O
5745,375,tobacco,O
5746,375,products,O
5747,376,Provide,O
5748,376,written,O
5749,376,informed,O
5750,376,consent,O
5751,376,before,O
5752,376,initiation,O
5753,376,of,O
5754,376,any,O
5755,376,study,O
5756,376,procedures,O
5757,377,Available,O
5758,377,for,O
5759,377,follow,O
5760,377,-,O
5761,377,up,O
5762,377,for,O
5763,377,the,O
5764,377,planned,O
5765,377,duration,O
5766,377,of,O
5767,377,the,O
5768,377,study,O
5769,378,Able,O
5770,378,to,O
5771,378,communicate,O
5772,378,well,O
5773,378,with,O
5774,378,the,O
5775,378,investigators,O
5776,379,Able,O
5777,379,to,O
5778,379,adhere,O
5779,379,to,O
5780,379,the,O
5781,379,study,O
5782,379,protocol,O
5783,379,schedule,O
5784,379,",",O
5785,379,study,O
5786,379,restrictions,O
5787,379,and,O
5788,379,examination,O
5789,379,schedule,O
5790,380,Subjects,O
5791,380,who,O
5792,380,are,O
5793,380,within,O
5794,380,their,O
5795,380,ideal,O
5796,380,body,O
5797,380,weight,O
5798,380,(,O
5799,380,BMI,O
5800,380,between,O
5801,380,>,O
5802,380,17,O
5803,380,and,O
5804,380,=,O
5805,380,28,O
5806,380,kg,O
5807,380,/,O
5808,380,m2,O
5809,380,),O
5810,381,Subjects,O
5811,381,deemed,O
5812,381,to,O
5813,381,be,O
5814,381,healthy,O
5815,381,as,O
5816,381,judged,O
5817,381,by,O
5818,381,the,O
5819,381,Medically,O
5820,381,Accountable,O
5821,381,Investigator,O
5822,381,(,O
5823,381,MAI,O
5824,381,),O
5825,381,and,O
5826,381,determined,O
5827,381,by,O
5828,381,medical,O
5829,381,history,O
5830,381,",",O
5831,381,physical,O
5832,381,examination,O
5833,381,and,O
5834,381,medication,O
5835,381,history,O
5836,382,Subjects,O
5837,382,have,O
5838,382,no,O
5839,382,history,O
5840,382,of,O
5841,382,the,O
5842,382,following,O
5843,382,:,O
5844,382,ongoing,O
5845,382,acute,O
5846,382,or,O
5847,382,intermittent,O
5848,382,pain,B-Condition
5849,382,",",O
5850,382,postoperative,O
5851,382,pain,B-Condition
5852,382,",",O
5853,382,respiratory,B-Condition
5854,382,compromise,I-Condition
5855,382,",",O
5856,382,acute,O
5857,382,or,O
5858,382,severe,O
5859,382,asthma,B-Condition
5860,382,",",O
5861,382,or,O
5862,382,constipation,B-Condition
5863,382,(,O
5864,382,less,O
5865,382,than,O
5866,382,1,O
5867,382,bowel,O
5868,382,movement,O
5869,382,every,O
5870,382,2,O
5871,382,days,O
5872,382,),O
5873,383,Negative,O
5874,383,urine,O
5875,383,drug,O
5876,383,screening,O
5877,383,test,O
5878,383,at,O
5879,383,the,O
5880,383,time,O
5881,383,of,O
5882,383,screening,O
5883,384,Have,O
5884,384,normal,O
5885,384,screening,O
5886,384,laboratories,O
5887,384,for,O
5888,384,white,O
5889,384,blood,O
5890,384,cells,O
5891,384,(,O
5892,384,WBC,O
5893,384,),O
5894,384,",",O
5895,384,hemoglobin,O
5896,384,(,O
5897,384,Hgb,O
5898,384,),O
5899,384,",",O
5900,384,platelets,O
5901,384,",",O
5902,384,sodium,O
5903,384,",",O
5904,384,potassium,O
5905,384,",",O
5906,384,chloride,O
5907,384,",",O
5908,384,bicarbonate,O
5909,384,",",O
5910,384,blood,O
5911,384,urea,O
5912,384,nitrogen,O
5913,384,(,O
5914,384,BUN,O
5915,384,),O
5916,384,",",O
5917,384,creatinine,O
5918,384,",",O
5919,384,ALT,O
5920,384,(,O
5921,384,liver,O
5922,384,function,O
5923,384,),O
5924,384,",",O
5925,384,AST,O
5926,384,(,O
5927,384,liver,O
5928,384,function,O
5929,384,),O
5930,384,and,O
5931,384,bilirubin,O
5932,385,Have,O
5933,385,normal,O
5934,385,screening,O
5935,385,laboratories,O
5936,385,for,O
5937,385,urine,O
5938,385,protein,O
5939,385,and,O
5940,385,urine,O
5941,385,glucose,O
5942,386,Female,O
5943,386,subjects,O
5944,386,must,O
5945,386,be,O
5946,386,of,O
5947,386,non,O
5948,386,-,O
5949,386,childbearing,O
5950,386,potential,O
5951,386,(,O
5952,386,as,O
5953,386,defined,O
5954,386,as,O
5955,386,surgically,O
5956,386,sterile,O
5957,386,[,O
5958,386,i.e.,O
5959,386,history,O
5960,386,of,O
5961,386,hysterectomy,O
5962,386,or,O
5963,386,tubal,O
5964,386,ligation,O
5965,386,],O
5966,386,or,O
5967,386,postmenopausal,O
5968,386,for,O
5969,386,more,O
5970,386,than,O
5971,386,1,O
5972,386,year,O
5973,386,[,O
5974,386,no,O
5975,386,bleeding,O
5976,386,for,O
5977,386,12,O
5978,386,consecutive,O
5979,386,months,O
5980,386,],O
5981,386,",",O
5982,386,or,O
5983,386,if,O
5984,386,of,O
5985,386,childbearing,O
5986,386,potential,O
5987,386,must,O
5988,386,be,O
5989,386,non,O
5990,386,-,O
5991,386,pregnant,O
5992,386,at,O
5993,386,the,O
5994,386,time,O
5995,386,of,O
5996,386,enrollment,O
5997,386,and,O
5998,386,on,O
5999,386,the,O
6000,386,morning,O
6001,386,of,O
6002,386,the,O
6003,386,first,O
6004,386,day,O
6005,386,of,O
6006,386,each,O
6007,386,study,O
6008,386,session,O
6009,386,",",O
6010,386,and,O
6011,386,must,O
6012,386,agree,O
6013,386,to,O
6014,386,use,O
6015,386,hormonal,O
6016,386,or,O
6017,386,barrier,O
6018,386,birth,O
6019,386,control,O
6020,386,such,O
6021,386,as,O
6022,386,implants,O
6023,386,",",O
6024,386,injectables,O
6025,386,",",O
6026,386,combined,O
6027,386,oral,O
6028,386,contraceptives,O
6029,386,",",O
6030,386,some,O
6031,386,intrauterine,O
6032,386,devices,O
6033,386,(,O
6034,386,IUDs,O
6035,386,),O
6036,386,",",O
6037,386,sexual,O
6038,386,abstinence,O
6039,386,or,O
6040,386,a,O
6041,386,vasectomized,O
6042,386,parter,O
6043,387,Agrees,O
6044,387,not,O
6045,387,to,O
6046,387,participate,O
6047,387,in,O
6048,387,another,O
6049,387,clinical,O
6050,387,study,O
6051,387,/,O
6052,387,trial,O
6053,387,during,O
6054,387,the,O
6055,387,study,O
6056,387,period,O
6057,387,or,O
6058,387,to,O
6059,387,participate,O
6060,387,in,O
6061,387,an,O
6062,387,investigational,O
6063,387,drug,O
6064,387,study,O
6065,387,for,O
6066,387,at,O
6067,387,least,O
6068,387,one,O
6069,387,month,O
6070,387,after,O
6071,387,last,O
6072,387,study,O
6073,387,session,O
6074,388,Agrees,O
6075,388,not,O
6076,388,to,O
6077,388,donate,O
6078,388,blood,O
6079,388,to,O
6080,388,a,O
6081,388,blood,O
6082,388,bank,O
6083,388,throughout,O
6084,388,participation,O
6085,388,in,O
6086,388,the,O
6087,388,study,O
6088,388,and,O
6089,388,for,O
6090,388,at,O
6091,388,least,O
6092,388,3,O
6093,388,months,O
6094,388,after,O
6095,388,last,O
6096,388,study,O
6097,388,day,O
6098,389,Have,O
6099,389,a,O
6100,389,normal,O
6101,389,ECG,O
6102,389,;,O
6103,389,must,O
6104,389,not,O
6105,389,have,O
6106,389,the,O
6107,389,following,O
6108,389,to,O
6109,389,be,O
6110,389,acceptable,O
6111,389,:,O
6112,389,pathologic,B-Observation
6113,389,Q,I-Observation
6114,389,wave,I-Observation
6115,389,abnormalities,I-Observation
6116,389,",",O
6117,389,significant,O
6118,389,ST,B-Observation
6119,389,-,I-Observation
6120,389,T,I-Observation
6121,389,wave,I-Observation
6122,389,changes,I-Observation
6123,389,",",O
6124,389,left,B-Condition
6125,389,ventricular,I-Condition
6126,389,hypertrophy,I-Condition
6127,389,",",O
6128,389,right,B-Condition
6129,389,bundle,I-Condition
6130,389,branch,I-Condition
6131,389,block,I-Condition
6132,389,",",O
6133,389,left,B-Condition
6134,389,bundle,I-Condition
6135,389,branch,I-Condition
6136,389,block,I-Condition
6137,389,.,O
6138,389,(,O
6139,389,sinus,O
6140,389,rhythm,O
6141,389,is,O
6142,389,between,O
6143,389,55,O
6144,389,-,O
6145,389,100,O
6146,389,beats,O
6147,389,per,O
6148,389,minute,O
6149,389,),O
6150,390,Temperature,O
6151,390,35,O
6152,390,-,O
6153,390,37.9,O
6154,390,°,O
6155,390,C,O
6156,390,(,O
6157,390,95,O
6158,390,-,O
6159,390,100.3,O
6160,390,°,O
6161,390,F,O
6162,390,),O
6163,391,Systolic,O
6164,391,blood,O
6165,391,pressure,O
6166,391,90,O
6167,391,-,O
6168,391,140,O
6169,391,mmHg,O
6170,392,Diastolic,O
6171,392,blood,O
6172,392,pressure,O
6173,392,60,O
6174,392,-,O
6175,392,90,O
6176,392,mmHg,O
6177,393,Heart,O
6178,393,rate,O
6179,393,55,O
6180,393,-,O
6181,393,100,O
6182,393,beats,O
6183,393,per,O
6184,393,minute,O
6185,394,Respiration,O
6186,394,rate,O
6187,394,12,O
6188,394,-,O
6189,394,18,O
6190,394,breaths,O
6191,394,per,O
6192,394,minute,O
6193,395,Prior,O
6194,395,trombosis,B-Condition
6195,395,or,O
6196,395,myocardial,B-Condition
6197,395,infarction,I-Condition
6198,395,",",O
6199,395,congenital,B-Condition
6200,395,coagulation,I-Condition
6201,395,disorder,I-Condition
6202,395,",",O
6203,395,use,O
6204,395,of,O
6205,395,anti,B-Drug
6206,395,-,I-Drug
6207,395,coagulants,I-Drug
6208,395,prior,O
6209,395,to,O
6210,395,surgery,O
6211,395,",",O
6212,395,prior,O
6213,395,thoracic,B-Procedure
6214,395,surgery,I-Procedure
6215,395,",",O
6216,395,pregnancy,B-Condition
6217,395,",",O
6218,395,pre,O
6219,395,-,O
6220,395,operative,O
6221,395,fibrinogen,O
6222,395,concentration,O
6223,395,<,O
6224,395,1g,O
6225,395,/,O
6226,395,L,O
6227,396,Elective,B-Procedure
6228,396,surgery,I-Procedure
6229,396,for,O
6230,396,thoracic,B-Condition
6231,396,aneurysm,I-Condition
6232,397,Rheumatoid,B-Condition
6233,397,arthritis,I-Condition
6234,398,Diabetes,B-Condition
6235,398,or,O
6236,398,immediate,B-Observation
6237,398,family,I-Observation
6238,398,history,I-Observation
6239,398,of,O
6240,398,diabetes,B-Condition
6241,399,Coronary,B-Condition
6242,399,artery,I-Condition
6243,399,disease,I-Condition
6244,400,Congestive,B-Condition
6245,400,heart,I-Condition
6246,400,failure,I-Condition
6247,401,Pulmonary,B-Condition
6248,401,disorders,I-Condition
6249,401,",",O
6250,401,including,O
6251,401,COPD,B-Condition
6252,401,and,O
6253,401,asthma,B-Condition
6254,402,Malabsorptive,B-Condition
6255,402,GI,I-Condition
6256,402,disease,I-Condition
6257,402,",",O
6258,402,such,O
6259,402,as,O
6260,402,celiac,B-Condition
6261,402,disease,I-Condition
6262,402,",",O
6263,402,or,O
6264,402,gastric,B-Procedure
6265,402,bypass,I-Procedure
6266,403,Significant,O
6267,403,hepatic,B-Condition
6268,403,disease,I-Condition
6269,404,Renal,B-Condition
6270,404,insufficiency,I-Condition
6271,404,(,O
6272,404,eGFR,O
6273,404,<,O
6274,404,60,O
6275,404,mL,O
6276,404,/,O
6277,404,kg,O
6278,404,/,O
6279,404,min,O
6280,404,),O
6281,405,Anemia,B-Condition
6282,405,(,O
6283,405,hematocrit,O
6284,405,<,O
6285,405,34,O
6286,405,%,O
6287,405,),O
6288,405,as,O
6289,405,measured,O
6290,405,at,O
6291,405,screening,O
6292,405,visit,O
6293,406,Pregnant,B-Condition
6294,406,females,B-Person
6295,407,Consumption,O
6296,407,of,O
6297,407,daily,O
6298,407,medications,B-Drug
6299,407,that,O
6300,407,alter,O
6301,407,glucose,O
6302,407,metabolism,O
6303,407,of,O
6304,407,GI,O
6305,407,function,O
6306,407,(,O
6307,407,glucocorticoids,B-Drug
6308,407,",",O
6309,407,psychotropics,B-Drug
6310,407,",",O
6311,407,narcotics,B-Drug
6312,407,",",O
6313,407,metoclopramide,B-Drug
6314,407,),O
6315,408,Consumption,O
6316,408,or,O
6317,408,injection,B-Procedure
6318,408,of,O
6319,408,insulin,B-Drug
6320,409,Apparent,O
6321,409,sensitivity,B-Condition
6322,409,to,O
6323,409,any,O
6324,409,of,O
6325,409,the,O
6326,409,study,B-Drug
6327,409,peptides,I-Drug
6328,409,as,O
6329,409,determined,O
6330,409,by,O
6331,409,the,O
6332,409,skin,B-Procedure
6333,409,test,I-Procedure
6334,410,Diagnosis,O
6335,410,or,O
6336,410,h,O
6337,410,/,O
6338,410,o,O
6339,410,PTSD,B-Condition
6340,410,",",O
6341,410,depression,B-Condition
6342,410,",",O
6343,410,substance,B-Condition
6344,410,use,I-Condition
6345,410,",",O
6346,410,mental,B-Condition
6347,410,health,I-Condition
6348,410,problems,I-Condition
6349,410,",",O
6350,410,sleep,B-Condition
6351,410,disorders,I-Condition
6352,410,",",O
6353,410,HPA,B-Condition
6354,410,disruption,I-Condition
6355,410,and/or,O
6356,410,TBI,B-Condition
6357,411,Body,O
6358,411,Mass,O
6359,411,Index,O
6360,411,(,O
6361,411,BMI,O
6362,411,),O
6363,411,=,O
6364,411,35,O
6365,411,kg,O
6366,411,/,O
6367,411,m2,O
6368,412,HbA1c,O
6369,412,=,O
6370,412,5.7,O
6371,412,%,O
6372,413,Ability,B-Observation
6373,413,to,I-Observation
6374,413,speak,I-Observation
6375,413,and,I-Observation
6376,413,understand,I-Observation
6377,413,English,I-Observation
6378,414,Exclusion,O
6379,414,Criteria,O
6380,414,:,O
6381,414,coronary,B-Condition
6382,414,artery,I-Condition
6383,414,disease,I-Condition
6384,414,",",O
6385,414,diabetes,B-Condition
6386,414,mellitus,I-Condition
6387,414,",",O
6388,414,contraindications,B-Condition
6389,414,to,O
6390,414,cardiac,B-Procedure
6391,414,magnetic,I-Procedure
6392,414,resonance,I-Procedure
6393,414,imaging,I-Procedure
6394,414,(,I-Procedure
6395,414,CMR,I-Procedure
6396,414,),I-Procedure
6397,414,",",O
6398,414,weight,O
6399,414,>,O
6400,414,350,O
6401,414,lbs,O
6402,414,",",O
6403,414,inability,B-Observation
6404,414,to,I-Observation
6405,414,lie,I-Observation
6406,414,flat,I-Observation
6407,414,for,I-Observation
6408,414,imaging,I-Observation
6409,414,",",O
6410,414,anemia,B-Condition
6411,414,",",O
6412,414,contraindications,B-Condition
6413,414,to,O
6414,414,regadenoson,B-Drug
6415,414,or,O
6416,414,aminophylline,B-Drug
6417,415,HEALTHY,B-Condition
6418,415,:,O
6419,415,known,O
6420,415,cardiovascular,B-Condition
6421,415,disease,I-Condition
6422,415,",",O
6423,415,cardiac,B-Condition
6424,415,risk,I-Condition
6425,415,factors,I-Condition
6426,415,or,O
6427,415,use,O
6428,415,of,O
6429,415,cardiac,B-Drug
6430,415,medications,I-Drug
6431,416,HYPERTENSIVE,B-Condition
6432,416,:,O
6433,416,known,O
6434,416,cardiovascular,B-Condition
6435,416,disease,I-Condition
6436,416,or,I-Condition
6437,416,risk,I-Condition
6438,416,factors,I-Condition
6439,416,aside,I-Condition
6440,416,from,I-Condition
6441,416,hypertension,I-Condition
6442,416,or,O
6443,416,use,O
6444,416,of,O
6445,416,cardiac,B-Drug
6446,416,medications,I-Drug
6447,417,HFpEF,B-Condition
6448,417,:,O
6449,417,prior,B-Observation
6450,417,history,I-Observation
6451,417,of,I-Observation
6452,417,LVEF,O
6453,417,below,O
6454,417,50,O
6455,417,%,O
6456,417,",",O
6457,417,acute,O
6458,417,decompensated,B-Condition
6459,417,HF,I-Condition
6460,417,",",O
6461,417,moderate,O
6462,417,or,O
6463,417,greater,O
6464,417,valvular,B-Condition
6465,417,disease,I-Condition
6466,417,",",O
6467,417,significant,O
6468,417,cardiac,B-Condition
6469,417,arrhythmias,I-Condition
6470,417,",",O
6471,417,pericardial,B-Condition
6472,417,disease,I-Condition
6473,417,",",O
6474,417,congenital,B-Condition
6475,417,heart,I-Condition
6476,417,disease,I-Condition
6477,417,",",O
6478,417,primary,B-Condition
6479,417,pulmonary,I-Condition
6480,417,hypertension,I-Condition
6481,418,estimated,O
6482,418,glomerular,O
6483,418,filtration,O
6484,418,rate,O
6485,418,(,O
6486,418,eGFR,O
6487,418,),O
6488,418,>,O
6489,418,60,O
6490,418,ml,O
6491,418,/,O
6492,418,min,O
6493,419,preserved,O
6494,419,left,O
6495,419,ventricular,O
6496,419,ejection,O
6497,419,fraction,O
6498,419,(,O
6499,419,>,O
6500,419,=,O
6501,419,50,O
6502,419,%,O
6503,419,),O
6504,419,on,O
6505,419,echocardiography,B-Procedure
6506,420,HEALTHY,B-Condition
6507,420,:,O
6508,420,normal,O
6509,420,cardiac,O
6510,420,structure,O
6511,420,and,O
6512,420,function,O
6513,420,on,O
6514,420,echocardiography,B-Procedure
6515,420,",",O
6516,420,BP,O
6517,420,<,O
6518,420,140/90,O
6519,421,HYPERTENSIVE,B-Condition
6520,421,:,O
6521,421,history,B-Observation
6522,421,of,O
6523,421,BP,O
6524,421,>,O
6525,421,140/90,O
6526,421,",",O
6527,421,1,O
6528,421,or,O
6529,421,more,O
6530,421,antihypertensive,B-Drug
6531,421,medications,I-Drug
6532,421,",",O
6533,421,LV,O
6534,421,ejection,O
6535,421,fraction,O
6536,421,(,O
6537,421,LVEF,O
6538,421,),O
6539,421,at,O
6540,421,least,O
6541,421,50,O
6542,421,%,O
6543,421,",",O
6544,421,current,O
6545,421,BP,O
6546,421,<,O
6547,421,160/90,O
6548,422,HFpEF,B-Condition
6549,422,:,O
6550,422,physician,O
6551,422,-,O
6552,422,confirmed,O
6553,422,diagnosis,O
6554,422,of,O
6555,422,HF,B-Condition
6556,422,",",O
6557,422,symptomatic,O
6558,422,HF,B-Condition
6559,422,",",O
6560,422,LVEF,O
6561,422,at,O
6562,422,least,O
6563,422,50,O
6564,422,%,O
6565,422,",",O
6566,422,elevated,O
6567,422,LV,O
6568,422,filling,O
6569,422,pressure,O
6570,422,by,O
6571,422,catheterization,B-Procedure
6572,422,",",O
6573,422,echocardiographic,O
6574,422,criteria,O
6575,422,or,O
6576,422,B,O
6577,422,-,O
6578,422,type,O
6579,422,-,O
6580,422,natriuretic,O
6581,422,peptide,O
6582,422,>,O
6583,422,100,O
6584,422,",",O
6585,422,current,O
6586,422,BP,O
6587,422,<,O
6588,422,160/90,O
6589,423,Active,O
6590,423,or,O
6591,423,past,O
6592,423,psychotic,B-Condition
6593,423,disorder,I-Condition
6594,423,",",O
6595,423,including,O
6596,423,a,O
6597,423,history,O
6598,423,of,O
6599,423,psychotic,B-Condition
6600,423,affective,I-Condition
6601,423,state,I-Condition
6602,424,Mental,B-Condition
6603,424,Retardation,I-Condition
6604,424,or,O
6605,424,Autistic,B-Condition
6606,424,Spectrum,I-Condition
6607,424,Disorder,I-Condition
6608,425,Prominent,B-Condition
6609,425,personality,I-Condition
6610,425,disorder,I-Condition
6611,426,Cardiac,B-Condition
6612,426,or,I-Condition
6613,426,neurologic,I-Condition
6614,426,active,I-Condition
6615,426,medical,I-Condition
6616,426,condition,I-Condition
6617,426,",",O
6618,426,including,O
6619,426,past,O
6620,426,CVA,B-Condition
6621,426,/,O
6622,426,TIA,B-Condition
6623,426,(,O
6624,426,Cardiovascular,B-Condition
6625,426,Accident,I-Condition
6626,426,/,O
6627,426,Transient,B-Condition
6628,426,Ischemic,I-Condition
6629,426,Attack,I-Condition
6630,426,),O
6631,426,or,O
6632,426,any,O
6633,426,other,O
6634,426,unstable,O
6635,426,medical,B-Condition
6636,426,condition,I-Condition
6637,426,.,O
6638,427,Chronic,O
6639,427,nasal,B-Condition
6640,427,congestion,I-Condition
6641,428,Active,O
6642,428,or,O
6643,428,recent,O
6644,428,drug,B-Condition
6645,428,or,I-Condition
6646,428,alcohol,I-Condition
6647,428,abuse,I-Condition
6648,429,Substantial,O
6649,429,suicidality,B-Condition
6650,429,in,O
6651,429,a,O
6652,429,patient,O
6653,429,requiring,O
6654,429,admission,B-Procedure
6655,429,but,O
6656,429,refuses,O
6657,429,to,O
6658,429,do,O
6659,429,so,O
6660,429,",",O
6661,429,and,O
6662,429,signs,O
6663,429,an,O
6664,429,"""",O
6665,429,against,O
6666,429,medical,O
6667,429,advice,O
6668,429,"""",O
6669,429,release,O
6670,429,form,O
6671,429,as,O
6672,429,part,O
6673,429,of,O
6674,429,clinical,O
6675,429,evaluation,O
6676,429,",",O
6677,429,and,O
6678,429,does,O
6679,429,not,O
6680,429,answer,O
6681,429,the,O
6682,429,terms,O
6683,429,for,O
6684,429,involuntary,O
6685,429,admission,O
6686,429,.,O
6687,430,Age,B-Person
6688,430,18,O
6689,430,-,O
6690,430,65,O
6691,431,Diagnosis,O
6692,431,of,O
6693,431,MDD,B-Condition
6694,431,(,O
6695,431,Major,B-Condition
6696,431,Depressive,I-Condition
6697,431,Disorder,I-Condition
6698,431,),O
6699,431,",",O
6700,431,made,O
6701,431,or,O
6702,431,affirmed,O
6703,431,by,O
6704,431,a,O
6705,431,senior,O
6706,431,psychiatrist,O
6707,431,in,O
6708,431,Shalvata,O
6709,432,MADRS,O
6710,432,score,O
6711,432,>,O
6712,432,20,O
6713,433,Treated,B-Procedure
6714,433,with,O
6715,433,conventional,B-Drug
6716,433,anti,I-Drug
6717,433,-,I-Drug
6718,433,depressant,I-Drug
6719,433,",",O
6720,433,administered,O
6721,433,within,O
6722,433,a,O
6723,433,formal,O
6724,433,psychiatric,O
6725,433,clinic,O
6726,433,or,O
6727,433,by,O
6728,433,a,O
6729,433,certified,O
6730,433,psychiatrist,O
6731,433,.,O
6732,434,American,O
6733,434,Association,O
6734,434,of,O
6735,434,Anesthesiology,O
6736,434,class,O
6737,434,1,O
6738,434,-,O
6739,434,3,O
6740,435,American,O
6741,435,Heart,O
6742,435,Association,O
6743,435,class,O
6744,435,>,O
6745,435,3,O
6746,436,BMI,O
6747,436,>,O
6748,436,37,O
6749,437,Insulin,B-Drug
6750,437,treated,O
6751,437,diabetes,B-Condition
6752,438,Pregnancy,B-Condition
6753,438,or,O
6754,438,breast,B-Observation
6755,438,feeding,I-Observation
6756,439,Sensistivity,B-Condition
6757,439,/,O
6758,439,allergy,B-Condition
6759,439,against,O
6760,439,anesthetic,B-Drug
6761,439,agents,I-Drug
6762,440,Inadequate,B-Observation
6763,440,understanding,I-Observation
6764,440,about,I-Observation
6765,440,the,I-Observation
6766,440,study,I-Observation
6767,441,Depressed,B-Condition
6768,441,kidney,I-Condition
6769,441,function,I-Condition
6770,441,and/or,O
6771,441,AKI,B-Condition
6772,442,Depressed,B-Condition
6773,442,liver,I-Condition
6774,442,function,I-Condition
6775,443,Genetic,O
6776,443,malignant,B-Condition
6777,443,hyperthermia,I-Condition
6778,444,Scheduled,B-Mood
6779,444,back,B-Procedure
6780,444,surgery,I-Procedure
6781,445,Formal,O
6782,445,indication,B-Condition
6783,445,to,O
6784,445,oral,B-Drug
6785,445,anticoagulation,I-Drug
6786,445,beside,O
6787,445,atrial,B-Condition
6788,445,fibrillation,I-Condition
6789,445,(,O
6790,445,mechanic,O
6791,445,heart,O
6792,445,valves,O
6793,445,",",O
6794,445,recurrent,B-Condition
6795,445,thrombophlebitis,I-Condition
6796,445,",",O
6797,445,antiphospholipid,B-Condition
6798,445,syndrome,I-Condition
6799,445,),O
6800,446,Life,B-Observation
6801,446,expectancy,I-Observation
6802,446,<,O
6803,446,6,O
6804,446,months,O
6805,446,(,O
6806,446,e.g.,O
6807,446,",",O
6808,446,terminal,B-Condition
6809,446,cancer,I-Condition
6810,446,),O
6811,447,Live,B-Procedure
6812,447,donor,I-Procedure
6813,447,transplantation,I-Procedure
6814,447,scheduled,B-Mood
6815,447,within,O
6816,447,6,O
6817,447,months,O
6818,448,Pregnancy,O
6819,448,(,O
6820,448,ß,O
6821,448,-,O
6822,448,HCG,O
6823,448,blood,O
6824,448,-,O
6825,448,based,O
6826,448,assay)or,O
6827,448,nursing,O
6828,448,(,O
6829,448,lactating,O
6830,448,),O
6831,448,women,O
6832,449,Women,O
6833,449,of,O
6834,449,child,O
6835,449,bearing,O
6836,449,potential,O
6837,449,",",O
6838,449,unless,O
6839,449,they,O
6840,449,are,O
6841,449,using,O
6842,449,an,O
6843,449,effective,O
6844,449,method,O
6845,449,of,O
6846,449,birth,O
6847,449,control,O
6848,450,Patient,O
6849,450,under,O
6850,450,legal,O
6851,450,guardianship,O
6852,451,Patients,O
6853,451,under,O
6854,451,law,O
6855,451,protection,O
6856,452,Known,O
6857,452,hypersensibility,B-Condition
6858,452,to,O
6859,452,coumadin,B-Drug
6860,452,or,O
6861,452,indoine,B-Drug
6862,452,derivatives,O
6863,452,or,O
6864,452,to,O
6865,452,any,O
6866,452,excipients,O
6867,452,(,O
6868,452,CI,O
6869,452,to,O
6870,452,oral,O
6871,452,AVK,O
6872,452,),O
6873,453,Severe,O
6874,453,liver,B-Condition
6875,453,failure,I-Condition
6876,453,(,O
6877,453,CI,O
6878,453,to,O
6879,453,oral,O
6880,453,AVK,O
6881,453,),O
6882,454,Adult,B-Person
6883,454,patients,O
6884,454,(=,O
6885,454,18,O
6886,454,years,B-Person
6887,454,),O
6888,455,Patient,O
6889,455,on,O
6890,455,hemodialysis,B-Procedure
6891,455,treatment,O
6892,455,for,O
6893,455,at,O
6894,455,least,O
6895,455,1,O
6896,455,month,O
6897,456,Patient,O
6898,456,with,O
6899,456,a,O
6900,456,history,O
6901,456,of,O
6902,456,",",O
6903,456,or,O
6904,456,presenting,O
6905,456,a,O
6906,456,new,O
6907,456,episode,O
6908,456,of,O
6909,456,atrial,B-Condition
6910,456,fibrillation,I-Condition
6911,456,(,O
6912,456,either,O
6913,456,permanent,O
6914,456,or,O
6915,456,paroxysmal,O
6916,456,),O
6917,456,.,O
6918,457,Patient,O
6919,457,with,O
6920,457,a,O
6921,457,CHADS2VASC,O
6922,457,score,O
6923,457,=,O
6924,457,2,O
6925,458,Patient,O
6926,458,with,O
6927,458,high,O
6928,458,risk,B-Observation
6929,458,of,I-Observation
6930,458,bleeding,I-Observation
6931,458,as,O
6932,458,defined,O
6933,458,by,O
6934,458,(,O
6935,458,1,O
6936,458,),O
6937,458,HASBLED,O
6938,458,score,O
6939,458,=3,O
6940,458,OR,O
6941,458,(,O
6942,458,2,O
6943,458,),O
6944,458,HASBLED,O
6945,458,=,O
6946,458,CHADS2VASC,O
6947,458,score,O
6948,458,",",O
6949,458,OR,O
6950,458,(,O
6951,458,3,O
6952,458,),O
6953,458,recent,O
6954,458,history,O
6955,458,of,O
6956,458,severe,B-Condition
6957,458,bleeding,I-Condition
6958,458,(,O
6959,458,type,O
6960,458,3a,O
6961,458,",",O
6962,458,3b,O
6963,458,",",O
6964,458,3c,O
6965,458,),O
6966,458,",",O
6967,458,particularly,O
6968,458,cerebral,O
6969,458,or,O
6970,458,gastrointestinal,O
6971,458,",",O
6972,458,OR,O
6973,458,(,O
6974,458,4,O
6975,458,),O
6976,458,prior,O
6977,458,recurrent,O
6978,458,(,O
6979,458,>,O
6980,458,2,O
6981,458,),O
6982,458,history,O
6983,458,of,O
6984,458,falls,B-Observation
6985,458,.,O
6986,459,Patient,O
6987,459,capable,O
6988,459,of,O
6989,459,understanding,O
6990,459,information,O
6991,459,about,O
6992,459,the,O
6993,459,study,O
6994,459,and,O
6995,459,of,O
6996,459,giving,O
6997,459,his,O
6998,459,/,O
6999,459,her,O
7000,459,consent,O
7001,460,Patient,O
7002,460,informed,O
7003,460,of,O
7004,460,the,O
7005,460,preliminary,O
7006,460,medical,O
7007,460,exam,O
7008,460,results,O
7009,461,Patient,O
7010,461,with,O
7011,461,healthcare,O
7012,461,insurance,O
7013,462,Written,O
7014,462,consent,O
7015,462,signed,O
7016,463,Renal,B-Condition
7017,463,insufficiency,I-Condition
7018,463,(,O
7019,463,>,O
7020,463,265,O
7021,463,µmol,O
7022,463,/,O
7023,463,l,O
7024,463,),O
7025,464,Incapability,O
7026,464,to,O
7027,464,give,O
7028,464,informed,O
7029,464,consent,O
7030,465,Cardiogenic,B-Condition
7031,465,shock,I-Condition
7032,465,of,O
7033,465,patient,O
7034,465,with,O
7035,465,KILLIP,O
7036,465,III,O
7037,465,or,O
7038,465,IV,O
7039,466,pregnant,B-Condition
7040,466,or,O
7041,466,breast,B-Observation
7042,466,feeding,I-Observation
7043,466,females,B-Person
7044,467,insufficient,O
7045,467,contraception,B-Procedure
7046,467,(,O
7047,467,only,O
7048,467,for,O
7049,467,substudy,O
7050,467,3,O
7051,467,),O
7052,468,Patients,O
7053,468,with,O
7054,468,heart,B-Procedure
7055,468,transplantation,I-Procedure
7056,469,Patient,O
7057,469,with,O
7058,469,coronary,B-Condition
7059,469,artery,I-Condition
7060,469,disease,I-Condition
7061,470,Age,B-Person
7062,470,between,O
7063,470,18,O
7064,470,and,O
7065,470,80,O
7066,470,years,O
7067,471,Intranasal,B-Procedure
7068,471,steroid,I-Procedure
7069,471,use,I-Procedure
7070,471,within,O
7071,471,the,O
7072,471,last,O
7073,471,three,O
7074,471,months,O
7075,472,Current,O
7076,472,systemic,B-Procedure
7077,472,steroid,I-Procedure
7078,472,use,I-Procedure
7079,473,Prior,O
7080,473,septal,B-Procedure
7081,473,surgery,I-Procedure
7082,474,Individuals,O
7083,474,who,O
7084,474,are,O
7085,474,pregnant,B-Condition
7086,474,or,O
7087,474,actively,O
7088,474,breastfeeding,B-Observation
7089,475,Age,B-Person
7090,475,greater,O
7091,475,than,O
7092,475,18,O
7093,476,NOSE,O
7094,476,score,O
7095,476,greater,O
7096,476,than,O
7097,476,55,O
7098,477,Nasal,B-Condition
7099,477,septal,I-Condition
7100,477,deviation,I-Condition
7101,477,on,O
7102,477,exam,O
7103,478,History,O
7104,478,of,O
7105,478,acute,B-Condition
7106,478,coronary,I-Condition
7107,478,syndrome,I-Condition
7108,478,in,O
7109,478,the,O
7110,478,past,O
7111,478,30,O
7112,478,days,O
7113,478,.,O
7114,479,History,O
7115,479,of,O
7116,479,congesting,B-Condition
7117,479,heart,I-Condition
7118,479,failure,I-Condition
7119,479,with,O
7120,479,left,O
7121,479,ventricular,O
7122,479,ejection,O
7123,479,fraction,O
7124,479,<,O
7125,479,30,O
7126,479,%,O
7127,479,or,O
7128,479,exacerbation,B-Condition
7129,479,in,O
7130,479,the,O
7131,479,past,O
7132,479,30,O
7133,479,days,O
7134,479,.,O
7135,480,Current,O
7136,480,dialysis,B-Procedure
7137,480,treatment,I-Procedure
7138,480,.,O
7139,481,Known,O
7140,481,furosemide,B-Drug
7141,481,hypersensitivity,B-Condition
7142,481,.,O
7143,482,Contraindications,B-Condition
7144,482,to,O
7145,482,placement,B-Procedure
7146,482,of,I-Procedure
7147,482,a,I-Procedure
7148,482,Foley,I-Procedure
7149,482,catheter,I-Procedure
7150,482,in,O
7151,482,the,O
7152,482,bladder,O
7153,482,.,O
7154,483,Subject,O
7155,483,is,O
7156,483,65,O
7157,483,years,O
7158,483,old,B-Person
7159,483,who,O
7160,483,is,O
7161,483,able,O
7162,483,and,O
7163,483,willing,O
7164,483,to,O
7165,483,give,O
7166,483,an,O
7167,483,informed,O
7168,483,consent,O
7169,483,.,O
7170,484,Patients,O
7171,484,undergoing,O
7172,484,planned,O
7173,484,trans,B-Procedure
7174,484,-,I-Procedure
7175,484,femoral,I-Procedure
7176,484,TAVI,I-Procedure
7177,484,.,O
7178,485,Calculated,O
7179,485,eGFR,O
7180,485,below,O
7181,485,60ml,O
7182,485,/,O
7183,485,min/1.73m2,O
7184,485,(,O
7185,485,MDRD,O
7186,485,),O
7187,486,Incompletely,O
7188,486,cured,O
7189,486,pre,B-Condition
7190,486,-,I-Condition
7191,486,existing,I-Condition
7192,486,diseases,I-Condition
7193,486,for,O
7194,486,which,O
7195,486,it,O
7196,486,can,O
7197,486,be,O
7198,486,assumed,O
7199,486,that,O
7200,486,the,O
7201,486,absorption,O
7202,486,",",O
7203,486,distribution,O
7204,486,",",O
7205,486,metabolism,O
7206,486,",",O
7207,486,elimination,O
7208,486,or,O
7209,486,effects,O
7210,486,of,O
7211,486,the,O
7212,486,study,O
7213,486,drugs,O
7214,486,will,O
7215,486,not,O
7216,486,be,O
7217,486,normal,O
7218,487,Known,O
7219,487,or,O
7220,487,suspected,O
7221,487,liver,B-Condition
7222,487,diseases,I-Condition
7223,488,Clinically,O
7224,488,relevant,O
7225,488,findings(e.g,B-Condition
7226,488,.,O
7227,488,blood,O
7228,488,pressure,O
7229,488,",",O
7230,488,electrocardiogram(ECG,B-Procedure
7231,488,),I-Procedure
7232,488,;,O
7233,488,physical,B-Procedure
7234,488,and,I-Procedure
7235,488,gynecological,I-Procedure
7236,488,examination,I-Procedure
7237,488,",",O
7238,488,laboratory,B-Procedure
7239,488,examination,I-Procedure
7240,488,),O
7241,489,Body,O
7242,489,mass,O
7243,489,index,O
7244,489,(,O
7245,489,BMI,O
7246,489,):,O
7247,489,18,O
7248,489,≤,O
7249,489,BMI,O
7250,489,≤,O
7251,489,32,O
7252,489,kg,O
7253,489,/,O
7254,489,m²,O
7255,490,Postmenopausal,B-Condition
7256,490,state,I-Condition
7257,490,revealed,O
7258,490,by,O
7259,490,:,O
7260,491,Medical,O
7261,491,history,O
7262,491,",",O
7263,491,if,O
7264,491,applicable,O
7265,491,(,O
7266,491,natural,B-Condition
7267,491,menopause,I-Condition
7268,491,at,O
7269,491,least,O
7270,491,12,O
7271,491,months,O
7272,491,prior,O
7273,491,to,O
7274,491,first,O
7275,491,study,O
7276,491,drug,O
7277,491,administration,O
7278,491,;,O
7279,491,or,O
7280,491,surgical,B-Condition
7281,491,menopause,I-Condition
7282,491,by,O
7283,491,bilateral,B-Procedure
7284,491,ovariectomy,I-Procedure
7285,491,at,O
7286,491,least,O
7287,491,3,O
7288,491,months,O
7289,491,prior,O
7290,491,to,O
7291,491,first,O
7292,491,study,O
7293,491,drug,O
7294,491,administration,O
7295,491,),O
7296,491,",",O
7297,491,in,O
7298,491,addition,O
7299,491,:,O
7300,491,in,O
7301,491,women,B-Person
7302,491,<,O
7303,491,65,O
7304,491,years,B-Person
7305,491,old,I-Person
7306,491,",",O
7307,491,follicle,O
7308,491,stimulating,O
7309,491,hormone,O
7310,491,(,O
7311,491,FSH,O
7312,491,),O
7313,491,>,O
7314,491,40,O
7315,491,IU,O
7316,491,/,O
7317,491,L,O
7318,492,Neurological,B-Condition
7319,492,Congenital,I-Condition
7320,492,malformations,I-Condition
7321,492,and/or,O
7322,492,those,O
7323,492,known,O
7324,492,to,O
7325,492,impair,B-Condition
7326,492,intestinal,I-Condition
7327,492,motility,I-Condition
7328,493,Additional,O
7329,493,congenital,O
7330,493,gastrointestinal,B-Condition
7331,493,abnormalities,I-Condition
7332,493,requiring,B-Mood
7333,493,surgical,B-Procedure
7334,493,intervention,I-Procedure
7335,494,Congenital,O
7336,494,Cyanotic,B-Condition
7337,494,heart,I-Condition
7338,494,disease,I-Condition
7339,495,Surgical,B-Procedure
7340,495,Closure,I-Procedure
7341,495,of,O
7342,495,abdominal,B-Condition
7343,495,wall,I-Condition
7344,495,defect,I-Condition
7345,495,with,O
7346,495,prosthetic,O
7347,495,material,O
7348,495,(,O
7349,495,e.g.,O
7350,495,prosthetic,O
7351,495,or,O
7352,495,bio,O
7353,495,-,O
7354,495,prosthetic,O
7355,495,mesh,O
7356,495,),O
7357,496,Diagnosis,O
7358,496,of,O
7359,496,uncomplicated,O
7360,496,gastroschisis,B-Condition
7361,497,Gestational,O
7362,497,age,O
7363,497,>,O
7364,497,33,O
7365,497,weeks,O
7366,497,at,O
7367,497,time,O
7368,497,of,O
7369,497,delivery,O
7370,498,Weight,O
7371,498,>,O
7372,498,1900,O
7373,498,g,O
7374,498,at,O
7375,498,time,O
7376,498,of,O
7377,498,delivery,O
7378,499,Transfer,B-Procedure
7379,499,of,O
7380,499,patient,O
7381,499,to,O
7382,499,Riley,O
7383,499,Hospital,O
7384,499,for,O
7385,499,Children,O
7386,499,prior,O
7387,499,to,O
7388,499,any,O
7389,499,abdominal,B-Procedure
7390,499,surgery,I-Procedure
7391,500,Diagnosis,O
7392,500,of,O
7393,500,brainstem,B-Condition
7394,500,glioma,I-Condition
7395,501,Concurrent,O
7396,501,administration,O
7397,501,of,O
7398,501,any,O
7399,501,other,O
7400,501,anti,B-Procedure
7401,501,-,I-Procedure
7402,501,tumor,I-Procedure
7403,501,therapy,I-Procedure
7404,502,Pre,O
7405,502,-,O
7406,502,existing,O
7407,502,uncontrolled,B-Condition
7408,502,diarrhea,I-Condition
7409,503,Cohort,O
7410,503,1,O
7411,503,:,O
7412,503,Recurrent,B-Condition
7413,503,or,I-Condition
7414,503,refractory,I-Condition
7415,503,medulloblastoma,I-Condition
7416,503,in,O
7417,503,which,O
7418,503,current,O
7419,503,standard,B-Procedure
7420,503,treatment,I-Procedure
7421,503,approaches,O
7422,503,have,O
7423,503,failed,O
7424,503,;,O
7425,503,biopsy,O
7426,503,is,O
7427,503,not,B-Mood
7428,503,required,I-Mood
7429,503,for,O
7430,503,recurrent,O
7431,503,disease,O
7432,503,.,O
7433,504,Cohort,O
7434,504,2,O
7435,504,:,O
7436,504,Newly,O
7437,504,-,O
7438,504,diagnosed,O
7439,504,high,B-Condition
7440,504,-,I-Condition
7441,504,grade,I-Condition
7442,504,glioma,I-Condition
7443,504,(,O
7444,504,World,O
7445,504,Health,O
7446,504,Organization,O
7447,504,[,O
7448,504,WHO,O
7449,504,],O
7450,504,grade,O
7451,504,3,O
7452,504,or,O
7453,504,4,O
7454,504,),O
7455,505,Life,O
7456,505,expectancy,O
7457,505,≥,O
7458,505,3,O
7459,505,months,O
7460,506,Patient,O
7461,506,diagnosed,O
7462,506,with,O
7463,506,dementia,B-Condition
7464,506,.,O
7465,507,Patients,O
7466,507,with,O
7467,507,serious,O
7468,507,and,O
7469,507,unstable,O
7470,507,illnesses,O
7471,507,including,O
7472,507,current,O
7473,507,hepatic,B-Condition
7474,507,",",O
7475,507,renal,B-Condition
7476,507,",",O
7477,507,gastroenterologic,B-Condition
7478,507,",",O
7479,507,respiratory,B-Condition
7480,507,",",O
7481,507,cardiovascular,B-Condition
7482,507,(,O
7483,507,including,O
7484,507,ischemic,B-Condition
7485,507,heart,I-Condition
7486,507,disease,I-Condition
7487,507,and,O
7488,507,congestive,B-Condition
7489,507,heart,I-Condition
7490,507,failure,I-Condition
7491,507,),O
7492,507,",",O
7493,507,endocrinologic,B-Condition
7494,507,",",O
7495,507,neurologic,B-Condition
7496,507,(,O
7497,507,including,O
7498,507,stroke,B-Condition
7499,507,",",O
7500,507,transient,B-Condition
7501,507,ischemic,I-Condition
7502,507,attack,I-Condition
7503,507,",",O
7504,507,subarachnoidal,B-Condition
7505,507,bleeding,I-Condition
7506,507,",",O
7507,507,brain,B-Condition
7508,507,tumor,I-Condition
7509,507,",",O
7510,507,encephalopathy,B-Condition
7511,507,",",O
7512,507,and,O
7513,507,meningitis,B-Condition
7514,507,),O
7515,507,.,O
7516,508,Patients,O
7517,508,with,O
7518,508,a,O
7519,508,history,O
7520,508,of,O
7521,508,allergic,B-Condition
7522,508,reactions,I-Condition
7523,508,to,O
7524,508,loxapine,B-Drug
7525,508,or,O
7526,508,amoxapine,B-Drug
7527,509,Patients,O
7528,509,who,O
7529,509,have,O
7530,509,received,O
7531,509,an,O
7532,509,investigational,O
7533,509,drug,O
7534,509,within,O
7535,509,30,O
7536,509,days,O
7537,509,prior,O
7538,509,to,O
7539,509,the,O
7540,509,current,O
7541,509,agitation,O
7542,509,episode,O
7543,509,must,O
7544,509,be,O
7545,509,excluded,O
7546,509,.,O
7547,510,Patients,O
7548,510,who,O
7549,510,are,O
7550,510,considered,O
7551,510,by,O
7552,510,the,O
7553,510,investigator,O
7554,510,",",O
7555,510,for,O
7556,510,any,O
7557,510,reason,O
7558,510,",",O
7559,510,to,O
7560,510,be,O
7561,510,unable,O
7562,510,to,O
7563,510,self,O
7564,510,-,O
7565,510,administer,O
7566,510,the,O
7567,510,inhalation,O
7568,510,device,O
7569,510,.,O
7570,511,Male,B-Person
7571,511,and,O
7572,511,female,B-Person
7573,511,patients,O
7574,511,between,O
7575,511,the,O
7576,511,ages,B-Person
7577,511,of,O
7578,511,18,O
7579,511,-,O
7580,511,65,O
7581,511,years,O
7582,511,",",O
7583,511,inclusive,O
7584,512,Patients,O
7585,512,(,O
7586,512,or,O
7587,512,legal,O
7588,512,representative,O
7589,512,),O
7590,512,willing,O
7591,512,and,O
7592,512,able,O
7593,512,to,O
7594,512,provide,O
7595,512,written,O
7596,512,Informed,O
7597,512,Consent,O
7598,512,Form,O
7599,512,.,O
7600,513,Psychiatric,O
7601,513,patients,O
7602,513,already,O
7603,513,diagnosed,O
7604,513,of,O
7605,513,schizophrenia,B-Condition
7606,513,or,O
7607,513,bipolar,B-Condition
7608,513,disorder,I-Condition
7609,513,",",O
7610,513,according,O
7611,513,to,O
7612,513,the,O
7613,513,Diagnostic,O
7614,513,and,O
7615,513,Statistical,O
7616,513,Manual,O
7617,513,of,O
7618,513,Mental,O
7619,513,Disorders-,O
7620,513,IV,O
7621,513,",",O
7622,513,Diagnostic,O
7623,513,and,O
7624,513,Statistical,O
7625,513,Manual,O
7626,513,of,O
7627,513,Mental,O
7628,513,Disorders-,O
7629,513,V,O
7630,513,or,O
7631,513,International,O
7632,513,Code,O
7633,513,of,O
7634,513,Disease,O
7635,513,criteria,O
7636,513,.,O
7637,514,Patients,O
7638,514,with,O
7639,514,an,O
7640,514,on,O
7641,514,-,O
7642,514,going,O
7643,514,agitation,B-Condition
7644,514,episode,I-Condition
7645,514,",",O
7646,514,or,O
7647,514,with,O
7648,514,a,O
7649,514,previous,O
7650,514,one,O
7651,514,within,O
7652,514,the,O
7653,514,6,O
7654,514,months,O
7655,514,prior,O
7656,514,to,O
7657,514,screening,O
7658,514,",",O
7659,514,attended,O
7660,514,and,O
7661,514,managed,O
7662,514,in,O
7663,514,the,O
7664,514,hospital,O
7665,514,setting,O
7666,514,.,O
7667,515,Previously,O
7668,515,treated,O
7669,515,with,O
7670,515,ADASUVE,B-Drug
7671,515,®,O
7672,515,with,O
7673,515,a,O
7674,515,positive,O
7675,515,outcome,O
7676,515,(,O
7677,515,responders,O
7678,515,),O
7679,515,according,O
7680,515,to,O
7681,515,(,O
7682,515,CGI,O
7683,515,-,O
7684,515,I,O
7685,515,),O
7686,515,scale,O
7687,515,(,O
7688,515,defined,O
7689,515,as,O
7690,515,having,O
7691,515,a,O
7692,515,CGI,O
7693,515,-,O
7694,515,I,O
7695,515,score,O
7696,515,of,O
7697,515,1,O
7698,515,or,O
7699,515,2,O
7700,515,at,O
7701,515,2,O
7702,515,hours,O
7703,515,after,O
7704,515,administration,O
7705,515,of,O
7706,515,the,O
7707,515,inhalation,O
7708,515,),O
7709,516,Patients,O
7710,516,free,O
7711,516,of,O
7712,516,active,O
7713,516,respiratory,B-Condition
7714,516,disease,I-Condition
7715,516,such,O
7716,516,as,O
7717,516,acute,B-Condition
7718,516,respiratory,I-Condition
7719,516,signs,I-Condition
7720,516,/,I-Condition
7721,516,symptoms,I-Condition
7722,516,(,O
7723,516,e.g.,O
7724,516,",",O
7725,516,wheezing,B-Condition
7726,516,),O
7727,516,or,O
7728,516,with,O
7729,516,active,O
7730,516,airways,B-Condition
7731,516,disease,I-Condition
7732,516,(,O
7733,516,asthma,B-Condition
7734,516,",",O
7735,516,chronic,B-Condition
7736,516,obstructive,I-Condition
7737,516,pulmonary,I-Condition
7738,516,disease,I-Condition
7739,516,or,O
7740,516,emphysema,B-Condition
7741,516,),O
7742,516,.,O
7743,517,Requirement,O
7744,517,of,O
7745,517,family,O
7746,517,or,O
7747,517,other,O
7748,517,caregiver,O
7749,517,support,O
7750,517,at,O
7751,517,study,O
7752,517,investigator,O
7753,517,criteria,O
7754,517,(,O
7755,517,defined,O
7756,517,as,O
7757,517,a,O
7758,517,patient,O
7759,517,'s,O
7760,517,relative,O
7761,517,or,O
7762,517,caregiver,O
7763,517,(,O
7764,517,male,O
7765,517,or,O
7766,517,female,O
7767,517,),O
7768,517,=,O
7769,517,80,O
7770,517,year,O
7771,517,old,O
7772,517,",",O
7773,517,who,O
7774,517,spend,O
7775,517,=,O
7776,517,3,O
7777,517,consecutive,O
7778,517,hours,O
7779,517,with,O
7780,517,patient,O
7781,517,",",O
7782,517,with,O
7783,517,good,O
7784,517,physical,O
7785,517,and,O
7786,517,psychological,O
7787,517,health,O
7788,517,status,O
7789,517,and,O
7790,517,without,O
7791,517,physical,O
7792,517,limitations,O
7793,517,",",O
7794,517,reading,O
7795,517,and,O
7796,517,writing,O
7797,517,educational,O
7798,517,level,O
7799,517,and,O
7800,517,able,O
7801,517,to,O
7802,517,understand,O
7803,517,and,O
7804,517,follow,O
7805,517,the,O
7806,517,study,O
7807,517,procedures,O
7808,517,),O
7809,517,.,O
7810,518,Availability,O
7811,518,of,O
7812,518,patient,O
7813,518,'s,O
7814,518,medical,O
7815,518,records,O
7816,518,data,O
7817,518,about,O
7818,518,the,O
7819,518,previous,O
7820,518,treatment,O
7821,518,with,O
7822,518,ADASUVE,O
7823,518,®,O
7824,518,at,O
7825,518,hospital,O
7826,518,setting,O
7827,518,.,O
7828,519,If,O
7829,519,a,O
7830,519,female,O
7831,519,is,O
7832,519,of,O
7833,519,childbearing,O
7834,519,potential,O
7835,519,and,O
7836,519,sexually,O
7837,519,active,O
7838,519,(,O
7839,519,except,O
7840,519,if,O
7841,519,female,O
7842,519,is,O
7843,519,surgically,O
7844,519,sterile,O
7845,519,or,O
7846,519,post,O
7847,519,-,O
7848,519,menopausal,O
7849,519,with,O
7850,519,history,O
7851,519,of,O
7852,519,no,O
7853,519,menses,O
7854,519,for,O
7855,519,at,O
7856,519,least,O
7857,519,24,O
7858,519,months,O
7859,519,),O
7860,519,",",O
7861,519,patient,O
7862,519,must,O
7863,519,be,O
7864,519,non,O
7865,519,-,O
7866,519,lactating,O
7867,519,and,O
7868,519,non,O
7869,519,-,O
7870,519,pregnant,O
7871,519,(,O
7872,519,with,O
7873,519,a,O
7874,519,negative,O
7875,519,pregnancy,O
7876,519,test,O
7877,519,result,O
7878,519,at,O
7879,519,baseline,O
7880,519,visit,O
7881,519,),O
7882,519,and,O
7883,519,have,O
7884,519,to,O
7885,519,agree,O
7886,519,to,O
7887,519,use,O
7888,519,a,O
7889,519,medically,O
7890,519,acceptable,O
7891,519,and,O
7892,519,effective,O
7893,519,birth,O
7894,519,control,O
7895,519,method,O
7896,519,throughout,O
7897,519,the,O
7898,519,study,O
7899,519,and,O
7900,519,for,O
7901,519,one,O
7902,519,week,O
7903,519,following,O
7904,519,the,O
7905,519,end,O
7906,519,of,O
7907,519,the,O
7908,519,study,O
7909,519,.,O
7910,520,History,B-Observation
7911,520,of,O
7912,520,any,O
7913,520,chemotherapy,B-Procedure
7914,520,for,O
7915,520,MBC,B-Condition
7916,520,.,O
7917,521,An,O
7918,521,interval,O
7919,521,of,O
7920,521,<,O
7921,521,6,O
7922,521,months,O
7923,521,from,O
7924,521,the,O
7925,521,completion,O
7926,521,of,O
7927,521,cytotoxic,B-Procedure
7928,521,chemotherapy,I-Procedure
7929,521,in,O
7930,521,the,O
7931,521,neo,O
7932,521,-,O
7933,521,adjuvant,O
7934,521,or,O
7935,521,adjuvant,O
7936,521,setting,O
7937,521,until,O
7938,521,the,O
7939,521,time,O
7940,521,of,O
7941,521,metastatic,B-Condition
7942,521,diagnosis,I-Condition
7943,521,.,O
7944,522,Trastuzumab,B-Drug
7945,522,≤,O
7946,522,21,O
7947,522,days,O
7948,522,prior,O
7949,522,to,O
7950,522,randomization,O
7951,522,.,O
7952,523,Hormone,B-Procedure
7953,523,therapy,I-Procedure
7954,523,<,O
7955,523,7,O
7956,523,days,O
7957,523,prior,O
7958,523,to,O
7959,523,randomization,O
7960,523,.,O
7961,524,Current,O
7962,524,peripheral,B-Condition
7963,524,neuropathy,I-Condition
7964,524,of,O
7965,524,Grade,O
7966,524,≥,O
7967,524,3,O
7968,524,.,O
7969,525,History,O
7970,525,of,O
7971,525,other,O
7972,525,malignancy,B-Condition
7973,525,within,O
7974,525,the,O
7975,525,last,O
7976,525,5,O
7977,525,years,O
7978,525,",",O
7979,525,except,O
7980,525,for,O
7981,525,appropriately,O
7982,525,treated,B-Procedure
7983,525,carcinoma,B-Condition
7984,525,in,I-Condition
7985,525,situ,I-Condition
7986,525,of,I-Condition
7987,525,the,I-Condition
7988,525,cervix,I-Condition
7989,525,",",O
7990,525,non,B-Condition
7991,525,-,I-Condition
7992,525,melanoma,I-Condition
7993,525,skin,I-Condition
7994,525,carcinoma,I-Condition
7995,525,",",O
7996,525,Stage,O
7997,525,I,O
7998,525,uterine,B-Condition
7999,525,cancer,I-Condition
8000,525,",",O
8001,525,or,O
8002,525,other,O
8003,525,cancers,O
8004,525,with,O
8005,525,a,O
8006,525,similar,O
8007,525,outcome,O
8008,525,as,O
8009,525,those,O
8010,525,previously,O
8011,525,mentioned,O
8012,525,.,O
8013,526,Previous,O
8014,526,radiotherapy,B-Procedure
8015,526,for,O
8016,526,the,O
8017,526,treatment,O
8018,526,of,O
8019,526,unresectable,O
8020,526,",",O
8021,526,locally,O
8022,526,advanced,O
8023,526,or,O
8024,526,metastatic,O
8025,526,breast,B-Condition
8026,526,cancer,I-Condition
8027,526,is,O
8028,526,not,O
8029,526,allowed,O
8030,526,if,O
8031,526,more,O
8032,526,than,O
8033,526,25,O
8034,526,%,O
8035,526,of,O
8036,526,marrow,O
8037,526,-,O
8038,526,bearing,O
8039,526,bone,O
8040,526,has,O
8041,526,been,O
8042,526,irradiated,O
8043,526,or,O
8044,526,the,O
8045,526,last,O
8046,526,fraction,O
8047,526,of,O
8048,526,radiotherapy,O
8049,526,has,O
8050,526,been,O
8051,526,administered,O
8052,526,within,O
8053,526,approximately,O
8054,526,3,O
8055,526,weeks,O
8056,526,prior,O
8057,526,to,O
8058,526,randomization,O
8059,526,.,O
8060,527,Brain,B-Condition
8061,527,metastases,I-Condition
8062,527,that,O
8063,527,are,O
8064,527,untreated,O
8065,527,",",O
8066,527,symptomatic,O
8067,527,",",O
8068,527,or,O
8069,527,require,O
8070,527,therapy,O
8071,527,to,O
8072,527,control,O
8073,527,symptoms,O
8074,527,or,O
8075,527,any,O
8076,527,radiation,B-Procedure
8077,527,",",O
8078,527,surgery,B-Procedure
8079,527,",",O
8080,527,or,O
8081,527,other,B-Procedure
8082,527,therapy,I-Procedure
8083,527,to,I-Procedure
8084,527,control,I-Procedure
8085,527,symptoms,I-Procedure
8086,527,from,O
8087,527,brain,B-Condition
8088,527,metastases,I-Condition
8089,527,within,O
8090,527,2,O
8091,527,months,O
8092,527,prior,O
8093,527,to,O
8094,527,randomization,O
8095,527,.,O
8096,528,History,O
8097,528,of,O
8098,528,exposure,O
8099,528,to,O
8100,528,the,O
8101,528,following,O
8102,528,cumulative,O
8103,528,doses,O
8104,528,of,O
8105,528,anthracyclines,B-Drug
8106,528,:,O
8107,528,Doxorubicin,B-Drug
8108,528,or,O
8109,528,liposomal,B-Drug
8110,528,doxorubicin,I-Drug
8111,528,>,O
8112,528,500,O
8113,528,mg,O
8114,528,/,O
8115,528,m^2,O
8116,528,;,O
8117,528,epirubicin,B-Drug
8118,528,>,O
8119,528,900,O
8120,528,mg,O
8121,528,/,O
8122,528,m^2,O
8123,528,;,O
8124,528,mitoxantrone,B-Drug
8125,528,>,O
8126,528,120mg,O
8127,528,/,O
8128,528,m^2,O
8129,528,and,O
8130,528,idarubicin,B-Drug
8131,528,>,O
8132,528,90,O
8133,528,mg,O
8134,528,/,O
8135,528,m^2,O
8136,528,.,O
8137,529,Current,O
8138,529,unstable,B-Condition
8139,529,angina,I-Condition
8140,529,.,O
8141,530,History,O
8142,530,of,O
8143,530,symptomatic,O
8144,530,congestive,B-Condition
8145,530,heart,I-Condition
8146,530,failure,I-Condition
8147,530,",",O
8148,530,or,O
8149,530,ventricular,B-Condition
8150,530,arrhythmia,I-Condition
8151,530,requiring,O
8152,530,treatment,B-Procedure
8153,530,.,O
8154,531,History,O
8155,531,of,O
8156,531,myocardial,B-Condition
8157,531,infarction,I-Condition
8158,531,within,O
8159,531,6,O
8160,531,months,O
8161,531,prior,O
8162,531,to,O
8163,531,randomization,O
8164,531,.,O
8165,532,Left,O
8166,532,ventricular,O
8167,532,ejection,O
8168,532,fraction,O
8169,532,(,O
8170,532,LVEF,O
8171,532,),O
8172,532,below,O
8173,532,50,O
8174,532,%,O
8175,532,within,O
8176,532,approximately,O
8177,532,28,O
8178,532,days,O
8179,532,prior,O
8180,532,to,O
8181,532,randomization,O
8182,532,.,O
8183,533,History,B-Observation
8184,533,of,O
8185,533,decreased,O
8186,533,LVEF,O
8187,533,or,O
8188,533,symptomatic,O
8189,533,congestive,B-Condition
8190,533,heart,I-Condition
8191,533,failure,I-Condition
8192,533,(,I-Condition
8193,533,CHF,I-Condition
8194,533,),I-Condition
8195,533,with,O
8196,533,previous,O
8197,533,adjuvant,O
8198,533,trastuzumab,B-Drug
8199,533,treatment,O
8200,533,.,O
8201,534,Cardiac,O
8202,534,troponin,O
8203,534,I,O
8204,534,≥,O
8205,534,0.2,O
8206,534,ng,O
8207,534,/,O
8208,534,mL,O
8209,534,within,O
8210,534,28,O
8211,534,days,O
8212,534,of,O
8213,534,randomization,O
8214,534,.,O
8215,535,Severe,O
8216,535,dyspnea,B-Condition
8217,535,at,O
8218,535,rest,O
8219,535,because,O
8220,535,of,O
8221,535,complications,B-Condition
8222,535,of,O
8223,535,advanced,B-Condition
8224,535,malignancy,I-Condition
8225,535,or,O
8226,535,requiring,O
8227,535,current,O
8228,535,continuous,B-Procedure
8229,535,oxygen,I-Procedure
8230,535,therapy,I-Procedure
8231,535,.,O
8232,536,Current,O
8233,536,severe,O
8234,536,",",O
8235,536,uncontrolled,O
8236,536,systemic,B-Condition
8237,536,disease,I-Condition
8238,536,(,O
8239,536,eg,O
8240,536,",",O
8241,536,clinically,O
8242,536,significant,O
8243,536,cardiovascular,B-Condition
8244,536,",",I-Condition
8245,536,pulmonary,I-Condition
8246,536,",",I-Condition
8247,536,or,I-Condition
8248,536,metabolic,I-Condition
8249,536,disease,I-Condition
8250,536,;,O
8251,536,wound,B-Condition
8252,536,healing,I-Condition
8253,536,disorders,I-Condition
8254,536,;,O
8255,536,ulcers,B-Condition
8256,536,;,O
8257,536,or,O
8258,536,bone,B-Condition
8259,536,fractures,I-Condition
8260,536,),O
8261,536,.,O
8262,537,Major,O
8263,537,surgical,B-Procedure
8264,537,procedure,I-Procedure
8265,537,or,O
8266,537,significant,O
8267,537,traumatic,B-Condition
8268,537,injury,I-Condition
8269,537,within,O
8270,537,approximately,O
8271,537,28,O
8272,537,days,O
8273,537,prior,O
8274,537,to,O
8275,537,randomization,O
8276,537,or,O
8277,537,anticipation,B-Mood
8278,537,of,I-Mood
8279,537,the,I-Mood
8280,537,need,I-Mood
8281,537,for,O
8282,537,major,B-Procedure
8283,537,surgery,I-Procedure
8284,537,during,O
8285,537,the,O
8286,537,course,O
8287,537,of,O
8288,537,study,O
8289,537,treatment,B-Procedure
8290,537,.,O
8291,538,Current,O
8292,538,pregnancy,B-Condition
8293,538,or,O
8294,538,lactation,B-Condition
8295,538,.,O
8296,539,History,B-Observation
8297,539,of,I-Observation
8298,539,receiving,O
8299,539,any,O
8300,539,investigational,B-Procedure
8301,539,treatment,I-Procedure
8302,539,within,O
8303,539,approximately,O
8304,539,28,O
8305,539,days,O
8306,539,prior,O
8307,539,to,O
8308,539,randomization,O
8309,539,.,O
8310,540,Current,O
8311,540,known,O
8312,540,infection,O
8313,540,with,O
8314,540,human,B-Condition
8315,540,immunodeficiency,I-Condition
8316,540,virus,I-Condition
8317,540,(,I-Condition
8318,540,HIV,I-Condition
8319,540,),I-Condition
8320,540,",",O
8321,540,active,O
8322,540,hepatitis,B-Condition
8323,540,B,I-Condition
8324,540,and/or,I-Condition
8325,540,hepatitis,I-Condition
8326,540,C,I-Condition
8327,540,virus,I-Condition
8328,540,.,O
8329,541,History,B-Observation
8330,541,of,I-Observation
8331,541,intolerance,B-Condition
8332,541,(,O
8333,541,including,O
8334,541,Grade,O
8335,541,3,O
8336,541,-,O
8337,541,4,O
8338,541,infusion,B-Condition
8339,541,reaction,I-Condition
8340,541,),O
8341,541,or,O
8342,541,hypersensitivity,B-Condition
8343,541,to,O
8344,541,trastuzumab,B-Drug
8345,541,",",O
8346,541,murine,B-Drug
8347,541,proteins,I-Drug
8348,541,",",O
8349,541,or,O
8350,541,docetaxel,B-Drug
8351,541,.,O
8352,542,Known,O
8353,542,hypersensitivity,B-Condition
8354,542,to,O
8355,542,any,O
8356,542,of,O
8357,542,the,O
8358,542,study,B-Drug
8359,542,drugs,I-Drug
8360,542,",",O
8361,542,including,O
8362,542,the,O
8363,542,excipients,O
8364,542,",",O
8365,542,or,O
8366,542,any,O
8367,542,drugs,B-Drug
8368,542,formulated,I-Drug
8369,542,in,I-Drug
8370,542,polysorbate,I-Drug
8371,542,80,I-Drug
8372,542,.,O
8373,543,Assessed,O
8374,543,by,O
8375,543,the,O
8376,543,investigator,O
8377,543,to,O
8378,543,be,O
8379,543,unable,B-Observation
8380,543,or,I-Observation
8381,543,unwilling,I-Observation
8382,543,to,I-Observation
8383,543,comply,I-Observation
8384,543,with,I-Observation
8385,543,the,I-Observation
8386,543,requirements,I-Observation
8387,543,of,I-Observation
8388,543,the,I-Observation
8389,543,protocol,I-Observation
8390,543,.,O
8391,544,Histologically,O
8392,544,or,O
8393,544,cytologically,O
8394,544,confirmed,O
8395,544,adenocarcinoma,B-Condition
8396,544,of,I-Condition
8397,544,the,I-Condition
8398,544,breast,I-Condition
8399,544,with,O
8400,544,locally,O
8401,544,advanced,O
8402,544,or,O
8403,544,metastatic,B-Condition
8404,544,disease,I-Condition
8405,544,",",O
8406,544,and,O
8407,544,a,O
8408,544,candidate,B-Condition
8409,544,for,I-Condition
8410,544,chemotherapy,I-Condition
8411,544,.,O
8412,545,Human,O
8413,545,epidermal,O
8414,545,growth,O
8415,545,factor,O
8416,545,receptor,O
8417,545,2,O
8418,545,(,O
8419,545,HER2)-positive,O
8420,545,.,O
8421,546,No,O
8422,546,prior,O
8423,546,chemotherapy,B-Procedure
8424,546,for,O
8425,546,their,O
8426,546,metastatic,B-Condition
8427,546,breast,I-Condition
8428,546,cancer,I-Condition
8429,546,(,I-Condition
8430,546,MBC,I-Condition
8431,546,),I-Condition
8432,546,.,O
8433,547,Measurable,B-Condition
8434,547,disease,I-Condition
8435,547,.,O
8436,548,Age,B-Person
8437,548,≥,O
8438,548,18,O
8439,548,years,O
8440,548,.,O
8441,549,For,O
8442,549,women,B-Person
8443,549,of,O
8444,549,childbearing,B-Condition
8445,549,potential,I-Condition
8446,549,and,O
8447,549,men,B-Person
8448,549,with,B-Observation
8449,549,partners,I-Observation
8450,549,of,I-Observation
8451,549,childbearing,I-Observation
8452,549,potential,I-Observation
8453,549,",",O
8454,549,agreement,O
8455,549,to,O
8456,549,use,O
8457,549,a,O
8458,549,highly,O
8459,549,effective,O
8460,549,",",O
8461,549,non,O
8462,549,-,O
8463,549,hormonal,O
8464,549,form,O
8465,549,of,O
8466,549,contraception,B-Procedure
8467,549,or,O
8468,549,2,O
8469,549,effective,O
8470,549,forms,O
8471,549,of,O
8472,549,non,B-Procedure
8473,549,-,I-Procedure
8474,549,hormonal,I-Procedure
8475,549,contraception,I-Procedure
8476,549,by,O
8477,549,the,O
8478,549,patient,O
8479,549,and/or,O
8480,549,partner,O
8481,549,.,O
8482,549,Contraception,B-Procedure
8483,549,use,O
8484,549,must,O
8485,549,continue,O
8486,549,for,O
8487,549,the,O
8488,549,duration,O
8489,549,of,O
8490,549,study,O
8491,549,treatment,O
8492,549,and,O
8493,549,for,O
8494,549,at,O
8495,549,least,O
8496,549,6,O
8497,549,months,O
8498,549,after,O
8499,549,the,O
8500,549,last,O
8501,549,dose,O
8502,549,of,O
8503,549,study,O
8504,549,treatment,O
8505,549,.,O
8506,549,Male,B-Person
8507,549,patients,O
8508,549,whose,O
8509,549,partners,B-Observation
8510,549,are,I-Observation
8511,549,pregnant,I-Observation
8512,549,should,O
8513,549,use,O
8514,549,condoms,O
8515,549,for,O
8516,549,the,O
8517,549,duration,O
8518,549,of,O
8519,549,the,O
8520,549,study,O
8521,549,.,O
8522,550,Moderate,O
8523,550,or,O
8524,550,severe,O
8525,550,endometriosis,B-Condition
8526,550,.,O
8527,551,Hydrosalpinx,B-Condition
8528,551,.,O
8529,552,Uterine,B-Condition
8530,552,abnormalities,I-Condition
8531,552,.,O
8532,553,Myoma,B-Condition
8533,553,.,O
8534,554,Previous,O
8535,554,uterine,B-Procedure
8536,554,surgery,I-Procedure
8537,554,.,O
8538,555,Women,B-Person
8539,555,subjected,O
8540,555,to,O
8541,555,ICSI,B-Procedure
8542,555,through,O
8543,555,controlled,B-Procedure
8544,555,ovarian,I-Procedure
8545,555,hyperstimulation,I-Procedure
8546,555,(,I-Procedure
8547,555,COH,I-Procedure
8548,555,),I-Procedure
8549,555,with,O
8550,555,pituitary,B-Procedure
8551,555,downregulation,I-Procedure
8552,555,by,I-Procedure
8553,555,GnRHa,I-Procedure
8554,555,.,O
8555,556,Revision,B-Observation
8556,556,cases,I-Observation
8557,557,Uncontrolled,O
8558,557,bleeding,B-Condition
8559,557,tendency,I-Condition
8560,557,(,O
8561,557,prothrombin,O
8562,557,conc,O
8563,557,.,O
8564,557,Less,O
8565,557,than,O
8566,557,70,O
8567,557,%,O
8568,557,),O
8569,558,History,B-Observation
8570,558,of,O
8571,558,deep,B-Condition
8572,558,venous,I-Condition
8573,558,thrombosis,I-Condition
8574,559,Sever,O
8575,559,liver,B-Condition
8576,559,impairment,I-Condition
8577,559,(,O
8578,559,liver,B-Condition
8579,559,failure,I-Condition
8580,559,),O
8581,560,Sever,O
8582,560,renal,B-Condition
8583,560,impairment,I-Condition
8584,560,(,O
8585,560,S.,O
8586,560,creatinine,O
8587,560,more,O
8588,560,than,O
8589,560,3,O
8590,560,),O
8591,561,Primary,O
8592,561,total,B-Condition
8593,561,hip,I-Condition
8594,561,arthroplasty,I-Condition
8595,561,(,O
8596,561,THA,B-Condition
8597,561,),O
8598,562,Systemic,B-Condition
8599,562,diseases,I-Condition
8600,562,(,O
8601,562,diabetes,O
8602,562,",",O
8603,562,renal,O
8604,562,diseases,O
8605,562,",",O
8606,562,rheumatic,O
8607,562,diseases,O
8608,562,",",O
8609,562,osteoporosis,O
8610,562,and,O
8611,562,cardiovascular,O
8612,562,diseases,O
8613,562,),O
8614,563,Pregnant,B-Condition
8615,563,and,O
8616,563,lactating,B-Condition
8617,563,women,B-Person
8618,564,HIV/,B-Condition
8619,564,AIDS,B-Condition
8620,565,periodontal,B-Procedure
8621,565,treatment,I-Procedure
8622,565,in,O
8623,565,the,O
8624,565,last,O
8625,565,year,O
8626,565,(,O
8627,565,before,O
8628,565,baseline,B-Procedure
8629,565,appointment,I-Procedure
8630,565,),O
8631,566,Medication,O
8632,566,:,O
8633,566,Immunosuppressive,B-Drug
8634,566,drugs,I-Drug
8635,566,",",O
8636,566,antibiotics,B-Drug
8637,566,in,O
8638,566,the,O
8639,566,past,O
8640,566,three,O
8641,566,months,O
8642,566,(,O
8643,566,before,O
8644,566,baseline,B-Procedure
8645,566,appointment,I-Procedure
8646,566,),O
8647,566,),O
8648,567,orthodontic,O
8649,567,appliance,O
8650,568,Moderate,O
8651,568,to,O
8652,568,advanced,O
8653,568,generalized,B-Condition
8654,568,chronic,I-Condition
8655,568,periodontitis,I-Condition
8656,569,Body,O
8657,569,mass,O
8658,569,index,O
8659,569,:,O
8660,569,>,O
8661,569,18.5,O
8662,569,kg,O
8663,569,/,O
8664,569,m2,O
8665,570,Minimum,O
8666,570,of,O
8667,570,12,O
8668,570,natural,B-Observation
8669,570,teeth,I-Observation
8670,571,Smokers,B-Condition
8671,571,",",O
8672,571,non,B-Condition
8673,571,-,I-Condition
8674,571,smokers,I-Condition
8675,571,or,O
8676,571,former,B-Condition
8677,571,-,I-Condition
8678,571,smokers,I-Condition
8679,572,IBS,B-Condition
8680,572,subtype,I-Condition
8681,572,with,O
8682,572,constipation,B-Condition
8683,573,medication,O
8684,573,:,O
8685,573,antidepressants,B-Drug
8686,573,or,O
8687,573,H1,B-Drug
8688,573,-,I-Drug
8689,573,receptor,I-Drug
8690,573,antagonists,I-Drug
8691,574,pregnancy,B-Condition
8692,574,",",O
8693,574,breast,B-Observation
8694,574,feeding,I-Observation
8695,575,co,O
8696,575,-,O
8697,575,morbidity,O
8698,575,:,O
8699,575,severe,O
8700,575,kidney-,B-Condition
8701,575,and/or,I-Condition
8702,575,liver,I-Condition
8703,575,disease,I-Condition
8704,575,or,O
8705,575,other,O
8706,575,gastrointestinal,B-Condition
8707,575,diseases,I-Condition
8708,576,Irritable,B-Condition
8709,576,Bowel,I-Condition
8710,576,Syndrome,I-Condition
8711,576,(,I-Condition
8712,576,IBS,I-Condition
8713,576,),I-Condition
8714,576,(,O
8715,576,ROME,O
8716,576,III,O
8717,576,criteria,O
8718,576,):,O
8719,576,subtype,O
8720,576,with,O
8721,576,diarrhea,B-Condition
8722,576,or,O
8723,576,mixed,O
8724,576,form,O
8725,577,age,B-Person
8726,577,18,O
8727,577,-,O
8728,577,65,O
8729,577,years,O
8730,578,contraindication,B-Condition
8731,578,to,O
8732,578,ketamine,B-Drug
8733,578,and,O
8734,578,lidocaine,B-Drug
8735,579,patients,O
8736,579,involved,O
8737,579,to,O
8738,579,other,O
8739,579,studies,O
8740,580,more,O
8741,580,or,O
8742,580,equal,O
8743,580,to,O
8744,580,American,O
8745,580,Society,O
8746,580,of,O
8747,580,Anesthesiologist,O
8748,580,(,O
8749,580,ASA,O
8750,580,),O
8751,580,class,O
8752,580,III,O
8753,581,not,B-Observation
8754,581,alert,I-Observation
8755,582,patients,O
8756,582,who,O
8757,582,need,O
8758,582,suturing,B-Procedure
8759,582,for,O
8760,582,laceration,B-Condition
8761,582,under,O
8762,582,procedural,B-Procedure
8763,582,anesthesia,I-Procedure
8764,582,using,O
8765,582,ketamine,B-Drug
8766,583,•,O
8767,583,Patients,O
8768,583,without,O
8769,583,PN,B-Procedure
8770,583,during,O
8771,583,their,O
8772,583,hospitalization,B-Procedure
8773,584,Patients,O
8774,584,with,O
8775,584,PN,B-Procedure
8776,584,during,O
8777,584,their,O
8778,584,hospitalization,B-Procedure
8779,585,Patients,O
8780,585,hospitalized,B-Procedure
8781,585,in,O
8782,585,medical,O
8783,585,",",O
8784,585,surgical,O
8785,585,or,O
8786,585,ICU,O
8787,585,wards,O
8788,586,Signed,O
8789,586,informed,O
8790,586,consent,O
8791,586,either,O
8792,586,from,O
8793,586,the,O
8794,586,patient,O
8795,586,",",O
8796,586,their,O
8797,586,legally,O
8798,586,authorized,O
8799,586,representative,O
8800,586,or,O
8801,586,a,O
8802,586,direct,O
8803,586,family,O
8804,586,member,O
8805,587,Chronic,B-Condition
8806,587,pain,I-Condition
8807,587,or,O
8808,587,narcotic,B-Drug
8809,587,usage,O
8810,587,during,O
8811,587,the,O
8812,587,preceding,O
8813,587,30,O
8814,587,days,O
8815,588,Infection,B-Condition
8816,588,at,O
8817,588,or,O
8818,588,near,O
8819,588,the,O
8820,588,intended,O
8821,588,needle,O
8822,588,insertion,O
8823,588,site,O
8824,589,Complex,B-Condition
8825,589,or,I-Condition
8826,589,altered,I-Condition
8827,589,abdominal,I-Condition
8828,589,wall,I-Condition
8829,589,anatomy,I-Condition
8830,590,Weight,O
8831,590,<,O
8832,590,45,O
8833,590,kg,O
8834,591,Patients,O
8835,591,undergoing,O
8836,591,laparoscopic,B-Procedure
8837,591,assisted,I-Procedure
8838,591,donor,I-Procedure
8839,591,nephrectomy,I-Procedure
8840,592,Patients,O
8841,592,that,O
8842,592,have,O
8843,592,elected,B-Mood
8844,592,to,I-Mood
8845,592,have,I-Mood
8846,592,a,O
8847,592,nerve,B-Procedure
8848,592,block,I-Procedure
8849,593,18,O
8850,593,years,O
8851,593,of,O
8852,593,age,B-Person
8853,593,or,O
8854,593,older,O
8855,594,Patients,O
8856,594,of,O
8857,594,ASA,O
8858,594,status,O
8859,594,I,O
8860,594,-,O
8861,594,III,O
8862,595,Parents,B-Observation
8863,595,refusal,I-Observation
8864,596,Cognitive,B-Condition
8865,596,impairment,I-Condition
8866,597,Difficulty,B-Condition
8867,597,in,I-Condition
8868,597,communication,I-Condition
8869,597,due,O
8870,597,to,O
8871,597,language,B-Condition
8872,597,issues,I-Condition
8873,598,Psychiatric,B-Condition
8874,598,disorder,I-Condition
8875,599,Severe,B-Condition
8876,599,systematic,I-Condition
8877,599,disorder,I-Condition
8878,600,Known,B-Condition
8879,600,allergy,I-Condition
8880,600,to,O
8881,600,any,B-Drug
8882,600,drug,I-Drug
8883,600,used,I-Drug
8884,601,Children,B-Person
8885,601,undergoing,O
8886,601,ENT,B-Procedure
8887,601,surgery,I-Procedure
8888,601,under,O
8889,601,general,B-Procedure
8890,601,anaesthesia,I-Procedure
8891,601,.,O
8892,602,patient,B-Observation
8893,602,refusal,I-Observation
8894,603,age,B-Person
8895,603,less,O
8896,603,than,O
8897,603,40,O
8898,603,or,O
8899,603,over,O
8900,603,80,O
8901,603,years,O
8902,604,combined,B-Procedure
8903,604,surgical,I-Procedure
8904,604,procedures,I-Procedure
8905,605,emergency,B-Procedure
8906,605,surgery,I-Procedure
8907,606,Left,O
8908,606,ventricular,O
8909,606,ejection,O
8910,606,fraction,O
8911,606,less,O
8912,606,than,O
8913,606,50,O
8914,606,per,O
8915,606,cent,O
8916,607,calculated,O
8917,607,creatinine,O
8918,607,clearance,O
8919,607,less,O
8920,607,than,O
8921,607,60,O
8922,607,mL,O
8923,607,per,O
8924,607,minute,O
8925,608,age,B-Person
8926,608,over,O
8927,608,40,O
8928,609,composite,B-Procedure
8929,609,head,I-Procedure
8930,609,and,I-Procedure
8931,609,neck,I-Procedure
8932,609,tumor,I-Procedure
8933,609,resection,I-Procedure
8934,610,treated,O
8935,610,hypertension,B-Condition
8936,611,hypertension,B-Drug
8937,611,medications,I-Drug
8938,611,taken,O
8939,611,on,O
8940,611,morning,O
8941,611,of,O
8942,611,surgery,O
8943,611,(,O
8944,611,except,O
8945,611,diuretics,B-Drug
8946,611,),O
8947,612,Patients,O
8948,612,who,O
8949,612,are,O
8950,612,recipients,O
8951,612,of,O
8952,612,multiple,O
8953,612,solid,B-Procedure
8954,612,organ,I-Procedure
8955,612,or,I-Procedure
8956,612,islet,I-Procedure
8957,612,cell,I-Procedure
8958,612,tissue,I-Procedure
8959,612,transplants,I-Procedure
8960,612,",",O
8961,612,or,O
8962,612,have,O
8963,612,previously,O
8964,612,received,O
8965,612,an,O
8966,612,organ,B-Procedure
8967,612,or,I-Procedure
8968,612,tissue,I-Procedure
8969,612,transplant,I-Procedure
8970,612,.,O
8971,612,Patients,O
8972,612,who,O
8973,612,have,O
8974,612,a,O
8975,612,combined,B-Procedure
8976,612,liver,I-Procedure
8977,612,-,I-Procedure
8978,612,kidney,I-Procedure
8979,612,transplant,I-Procedure
8980,612,.,O
8981,613,History,B-Observation
8982,613,of,O
8983,613,malignancy,B-Condition
8984,613,of,O
8985,613,any,O
8986,613,organ,O
8987,613,system,O
8988,613,(,O
8989,613,other,O
8990,613,than,O
8991,613,localized,B-Condition
8992,613,basal,I-Condition
8993,613,cell,I-Condition
8994,613,carcinoma,I-Condition
8995,613,of,I-Condition
8996,613,the,I-Condition
8997,613,skin,I-Condition
8998,613,),O
8999,613,",",O
9000,613,treated,O
9001,613,or,O
9002,613,untreated,O
9003,613,",",O
9004,613,within,O
9005,613,the,O
9006,613,past,O
9007,613,5,O
9008,613,years,O
9009,613,",",O
9010,613,regardless,O
9011,613,of,O
9012,613,whether,O
9013,613,there,O
9014,613,is,O
9015,613,evidence,O
9016,613,of,O
9017,613,local,O
9018,613,recurrence,O
9019,613,or,O
9020,613,metastases,O
9021,613,.,O
9022,614,Existence,O
9023,614,of,O
9024,614,any,O
9025,614,surgical,B-Condition
9026,614,",",I-Condition
9027,614,medical,I-Condition
9028,614,or,I-Condition
9029,614,mental,I-Condition
9030,614,conditions,I-Condition
9031,614,",",O
9032,614,other,O
9033,614,than,O
9034,614,the,O
9035,614,current,O
9036,614,transplantation,B-Procedure
9037,614,",",O
9038,614,which,O
9039,614,",",O
9040,614,in,O
9041,614,the,O
9042,614,opinion,O
9043,614,of,O
9044,614,the,O
9045,614,investigator,O
9046,614,",",O
9047,614,might,O
9048,614,interfere,O
9049,614,with,O
9050,614,the,O
9051,614,objectives,O
9052,614,of,O
9053,614,the,O
9054,614,study,O
9055,614,.,O
9056,615,Pregnant,B-Condition
9057,615,or,O
9058,615,nursing,B-Observation
9059,615,(,O
9060,615,lactating,B-Observation
9061,615,),O
9062,615,women,B-Person
9063,615,.,O
9064,616,Liver,B-Person
9065,616,Transplant,I-Person
9066,616,Recipients,I-Person
9067,616,have,O
9068,616,received,O
9069,616,liver,B-Procedure
9070,616,transplantations,I-Procedure
9071,616,for,O
9072,616,at,O
9073,616,least,O
9074,616,6,O
9075,616,+,O
9076,616,1,O
9077,616,months,O
9078,616,prior,O
9079,616,to,O
9080,616,enrollment,O
9081,617,Liver,B-Person
9082,617,Transplant,I-Person
9083,617,Recipients,I-Person
9084,617,have,O
9085,617,no,O
9086,617,acute,O
9087,617,rejection,B-Condition
9088,617,episodes,I-Condition
9089,617,within,O
9090,617,3,O
9091,617,months,O
9092,617,prior,O
9093,617,to,O
9094,617,the,O
9095,617,enrollment,O
9096,617,and,O
9097,617,are,O
9098,617,clinically,B-Condition
9099,617,stable,I-Condition
9100,618,Liver,B-Person
9101,618,Transplant,I-Person
9102,618,Recipients,I-Person
9103,618,have,O
9104,618,been,O
9105,618,treated,O
9106,618,with,O
9107,618,twice,O
9108,618,-,O
9109,618,daily,O
9110,618,regimen,O
9111,618,of,O
9112,618,tacrolimus(TAC,B-Drug
9113,618,),I-Drug
9114,618,plus,O
9115,618,everolimus(EVR,B-Drug
9116,618,),I-Drug
9117,618,and,O
9118,618,TAC,O
9119,618,and,O
9120,618,EVR,O
9121,618,trough,O
9122,618,levels,O
9123,618,have,O
9124,618,stayed,O
9125,618,within,O
9126,618,targeted,O
9127,618,ranges,O
9128,618,for,O
9129,618,at,O
9130,618,least,O
9131,618,6,O
9132,618,weeks,O
9133,618,prior,O
9134,618,to,O
9135,618,enrollment,O
9136,619,Provide,O
9137,619,written,B-Observation
9138,619,informed,I-Observation
9139,619,consent,I-Observation
9140,619,prior,O
9141,619,to,O
9142,619,inclusion,O
9143,619,.,O
9144,620,Liver,B-Person
9145,620,transplant,I-Person
9146,620,recipients,I-Person
9147,620,who,O
9148,620,are,O
9149,620,18,O
9150,620,-,O
9151,620,65,O
9152,620,years,O
9153,620,of,O
9154,620,age,B-Person
9155,620,of,O
9156,620,a,O
9157,620,primary,B-Procedure
9158,620,liver,I-Procedure
9159,620,transplant,I-Procedure
9160,621,Allograft,O
9161,621,functioning,O
9162,621,at,O
9163,621,an,O
9164,621,acceptable,O
9165,621,level,O
9166,621,as,O
9167,621,defined,O
9168,621,by,O
9169,621,the,O
9170,621,AST,O
9171,621,",",O
9172,621,ALT,O
9173,621,",",O
9174,621,Total,O
9175,621,Bilirubin,O
9176,621,levels,O
9177,621,=3,O
9178,621,times,O
9179,621,ULN,O
9180,621,prior,O
9181,621,to,O
9182,621,enrollment,O
9183,621,.,O
9184,622,Abbreviated,O
9185,622,MDRD,O
9186,622,eGFR,O
9187,622,=,O
9188,622,30,O
9189,622,mL,O
9190,622,/,O
9191,622,min/1.73m2,O
9192,622,.,O
9193,623,Breast,B-Condition
9194,623,Carcinoma,I-Condition
9195,624,Idiopathic,B-Condition
9196,624,Granulomatous,I-Condition
9197,624,Mastitis,I-Condition
9198,625,Subject,O
9199,625,is,O
9200,625,pregnant,O
9201,625,",",O
9202,625,or,O
9203,625,lactating,O
9204,625,",",O
9205,625,or,O
9206,625,of,O
9207,625,childbearing,O
9208,625,potential,O
9209,625,(,O
9210,625,to,O
9211,625,be,O
9212,625,considered,O
9213,625,of,O
9214,625,non,O
9215,625,-,O
9216,625,childbearing,O
9217,625,potential,O
9218,625,",",O
9219,625,a,O
9220,625,female,O
9221,625,must,O
9222,625,be,O
9223,625,post,O
9224,625,-,O
9225,625,menopausal,O
9226,625,for,O
9227,625,at,O
9228,625,least,O
9229,625,1,O
9230,625,year,O
9231,625,",",O
9232,625,surgically,O
9233,625,sterile,O
9234,625,",",O
9235,625,or,O
9236,625,using,O
9237,625,an,O
9238,625,effective,O
9239,625,method,O
9240,625,of,O
9241,625,contraception,O
9242,625,or,O
9243,625,abstinence,O
9244,625,from,O
9245,625,at,O
9246,625,least,O
9247,625,4,O
9248,625,weeks,O
9249,625,prior,O
9250,625,to,O
9251,625,the,O
9252,625,first,O
9253,625,vaccination,O
9254,625,and,O
9255,625,until,O
9256,625,at,O
9257,625,least,O
9258,625,4,O
9259,625,weeks,O
9260,625,after,O
9261,625,the,O
9262,625,last,O
9263,625,vaccination,O
9264,625,.,O
9265,626,Participation,O
9266,626,in,O
9267,626,the,O
9268,626,4,O
9269,626,weeks,O
9270,626,preceding,O
9271,626,the,O
9272,626,first,O
9273,626,trial,O
9274,626,vaccination,O
9275,626,",",O
9276,626,or,O
9277,626,planned,O
9278,626,participation,O
9279,626,during,O
9280,626,the,O
9281,626,present,O
9282,626,trial,O
9283,626,period,O
9284,626,",",O
9285,626,in,O
9286,626,another,O
9287,626,clinical,O
9288,626,trial,O
9289,626,investigating,O
9290,626,a,O
9291,626,vaccine,O
9292,626,",",O
9293,626,drug,O
9294,626,",",O
9295,626,medical,O
9296,626,device,O
9297,626,",",O
9298,626,or,O
9299,626,medical,O
9300,626,procedure,O
9301,626,.,O
9302,627,Previous,B-Observation
9303,627,history,I-Observation
9304,627,of,O
9305,627,receiving,O
9306,627,the,O
9307,627,rabies,B-Drug
9308,627,vaccine,I-Drug
9309,627,.,O
9310,628,Previous,B-Observation
9311,628,history,I-Observation
9312,628,of,O
9313,628,receiving,O
9314,628,rabies,B-Drug
9315,628,immune,I-Drug
9316,628,globulin,I-Drug
9317,628,.,O
9318,629,Any,O
9319,629,major,B-Condition
9320,629,psychiatric,I-Condition
9321,629,disorder,I-Condition
9322,629,",",O
9323,629,such,O
9324,629,as,O
9325,629,severe,O
9326,629,depression,B-Condition
9327,629,",",O
9328,629,severe,O
9329,629,anxiety,B-Condition
9330,629,disorder,I-Condition
9331,629,",",O
9332,629,psychosis,B-Condition
9333,629,",",O
9334,629,schizophrenia,B-Condition
9335,629,",",O
9336,629,other,O
9337,629,major,B-Condition
9338,629,psychiatric,I-Condition
9339,629,disorders,I-Condition
9340,629,",",O
9341,629,or,O
9342,629,seizures,B-Condition
9343,629,.,O
9344,629,History,O
9345,629,of,O
9346,629,mild,O
9347,629,depression,B-Condition
9348,629,or,O
9349,629,anxiety,B-Condition
9350,629,disorder,I-Condition
9351,629,that,O
9352,629,are,O
9353,629,well,O
9354,629,controlled,O
9355,629,are,O
9356,629,not,O
9357,629,exclusion,O
9358,629,criteria,O
9359,629,.,O
9360,630,Use,O
9361,630,of,O
9362,630,any,O
9363,630,immunosuppressive,B-Drug
9364,630,drug,I-Drug
9365,630,at,O
9366,630,the,O
9367,630,time,O
9368,630,of,O
9369,630,the,O
9370,630,study,O
9371,630,or,O
9372,630,30,O
9373,630,days,O
9374,630,previously,O
9375,630,.,O
9376,630,Topical,B-Drug
9377,630,steroids,I-Drug
9378,630,will,O
9379,630,not,O
9380,630,be,O
9381,630,considered,O
9382,630,an,O
9383,630,immunosuppressive,O
9384,630,drug,O
9385,630,and,O
9386,630,their,O
9387,630,use,O
9388,630,will,O
9389,630,not,O
9390,630,be,O
9391,630,considered,O
9392,630,an,O
9393,630,exclusion,O
9394,630,criteria,O
9395,630,.,O
9396,631,Any,O
9397,631,immunosuppressive,B-Condition
9398,631,disorder,I-Condition
9399,631,",",O
9400,631,such,O
9401,631,as,O
9402,631,HIV,B-Condition
9403,631,infection,I-Condition
9404,631,",",O
9405,631,common,B-Condition
9406,631,variable,I-Condition
9407,631,immunodeficiency,I-Condition
9408,631,",",O
9409,631,active,O
9410,631,cancers,B-Condition
9411,631,or,O
9412,631,chemotherapy,B-Procedure
9413,631,.,O
9414,632,History,B-Observation
9415,632,of,O
9416,632,renal,B-Condition
9417,632,insufficiency,I-Condition
9418,632,or,O
9419,632,requiring,B-Mood
9420,632,dialysis,B-Procedure
9421,632,.,O
9422,633,Have,O
9423,633,any,O
9424,633,condition,O
9425,633,that,O
9426,633,would,O
9427,633,",",O
9428,633,in,O
9429,633,the,O
9430,633,opinion,O
9431,633,of,O
9432,633,the,O
9433,633,site,O
9434,633,investigator,O
9435,633,",",O
9436,633,place,O
9437,633,the,O
9438,633,subject,O
9439,633,at,O
9440,633,an,O
9441,633,unacceptable,O
9442,633,risk,O
9443,633,of,O
9444,633,injury,O
9445,633,or,O
9446,633,render,O
9447,633,the,O
9448,633,subject,O
9449,633,unable,O
9450,633,to,O
9451,633,meet,O
9452,633,the,O
9453,633,requirements,O
9454,633,of,O
9455,633,the,O
9456,633,protocol,O
9457,633,.,O
9458,634,Identified,O
9459,634,as,O
9460,634,an,O
9461,634,employee,O
9462,634,of,O
9463,634,the,O
9464,634,Investigator,O
9465,634,or,O
9466,634,study,O
9467,634,center,O
9468,634,",",O
9469,634,with,O
9470,634,direct,O
9471,634,involvement,O
9472,634,in,O
9473,634,the,O
9474,634,proposed,O
9475,634,study,O
9476,634,or,O
9477,634,other,O
9478,634,studies,O
9479,634,under,O
9480,634,the,O
9481,634,direction,O
9482,634,of,O
9483,634,that,O
9484,634,Investigator,O
9485,634,or,O
9486,634,study,O
9487,634,center,O
9488,634,",",O
9489,634,as,O
9490,634,well,O
9491,634,as,O
9492,634,family,O
9493,634,members,O
9494,634,(,O
9495,634,i.e.,O
9496,634,",",O
9497,634,immediate,O
9498,634,",",O
9499,634,husband,O
9500,634,",",O
9501,634,wife,O
9502,634,and,O
9503,634,their,O
9504,634,children,O
9505,634,",",O
9506,634,adopted,O
9507,634,or,O
9508,634,natural,O
9509,634,),O
9510,634,of,O
9511,634,the,O
9512,634,employee,O
9513,634,or,O
9514,634,the,O
9515,634,Investigator,O
9516,634,.,O
9517,635,Previous,O
9518,635,adverse,B-Condition
9519,635,reaction,I-Condition
9520,635,to,O
9521,635,any,O
9522,635,of,O
9523,635,the,O
9524,635,antimalarial,B-Drug
9525,635,drugs,I-Drug
9526,635,used,O
9527,635,in,O
9528,635,this,O
9529,635,study,O
9530,635,.,O
9531,636,Provide,O
9532,636,signed,O
9533,636,and,O
9534,636,dated,O
9535,636,informed,O
9536,636,consent,O
9537,636,form,O
9538,636,.,O
9539,637,Willing,O
9540,637,to,O
9541,637,comply,O
9542,637,with,O
9543,637,all,O
9544,637,study,O
9545,637,procedures,O
9546,637,and,O
9547,637,be,O
9548,637,available,O
9549,637,for,O
9550,637,the,O
9551,637,duration,O
9552,637,of,O
9553,637,the,O
9554,637,study,O
9555,637,.,O
9556,638,Male,B-Person
9557,638,or,O
9558,638,female,B-Person
9559,638,",",O
9560,638,aged,B-Person
9561,638,=,O
9562,638,18,O
9563,638,to,O
9564,638,=,O
9565,638,60,O
9566,638,years,O
9567,638,on,O
9568,638,day,O
9569,638,of,O
9570,638,inclusion,O
9571,638,.,O
9572,639,In,O
9573,639,good,B-Condition
9574,639,general,I-Condition
9575,639,health,I-Condition
9576,639,based,O
9577,639,on,O
9578,639,medical,B-Observation
9579,639,history,I-Observation
9580,639,and,O
9581,639,physical,B-Procedure
9582,639,exam,I-Procedure
9583,640,A1C,O
9584,640,>,O
9585,640,7.0,O
9586,640,%,O
9587,641,2hr,O
9588,641,glucose,O
9589,641,during,O
9590,641,OGTT,O
9591,641,>,O
9592,641,200,O
9593,641,mg,O
9594,641,/,O
9595,641,dL,O
9596,642,Total,O
9597,642,cholesterol,O
9598,642,>,O
9599,642,280,O
9600,642,mg,O
9601,642,/,O
9602,642,dL,O
9603,643,Previous,O
9604,643,diabetic,B-Condition
9605,643,history,B-Observation
9606,643,",",O
9607,643,coronary,B-Condition
9608,643,artery,I-Condition
9609,643,disease,I-Condition
9610,644,Allergy,B-Condition
9611,644,to,O
9612,644,rosuvastatin,B-Drug
9613,644,or,O
9614,644,parvastatin,B-Drug
9615,645,Baseline,O
9616,645,ALT,O
9617,645,more,O
9618,645,than,O
9619,645,3,O
9620,645,times,O
9621,645,UNL,O
9622,646,Serum,O
9623,646,Cr,O
9624,646,>,O
9625,646,2.0,O
9626,646,mg,O
9627,646,/,O
9628,646,dL,O
9629,647,Pregnancy,B-Condition
9630,647,",",O
9631,647,breast,B-Observation
9632,647,feeding,I-Observation
9633,647,or,O
9634,647,plan,B-Mood
9635,647,to,I-Mood
9636,647,be,I-Mood
9637,647,pregnant,B-Condition
9638,647,woman,B-Person
9639,647,.,O
9640,648,Age,B-Person
9641,648,35,O
9642,648,-,O
9643,648,70,O
9644,648,years,O
9645,648,old,O
9646,649,Fasting,O
9647,649,blood,O
9648,649,glucose,O
9649,649,100,O
9650,649,-,O
9651,649,125,O
9652,649,mg,O
9653,649,/,O
9654,649,dL,O
9655,650,NA,O
9656,651,Patients,O
9657,651,with,O
9658,651,angina,B-Condition
9659,651,or,O
9660,651,silent,O
9661,651,ischemia,B-Condition
9662,651,and,O
9663,651,documented,O
9664,651,ischemia,B-Condition
9665,652,Patients,O
9666,652,who,O
9667,652,are,O
9668,652,eligible,O
9669,652,for,O
9670,652,intracoronary,B-Procedure
9671,652,stenting,I-Procedure
9672,653,Age,B-Person
9673,653,>,O
9674,653,18,O
9675,653,years,O
9676,654,De,O
9677,654,novo,O
9678,654,lesion,O
9679,654,CTO,B-Condition
9680,655,Reference,O
9681,655,vessel,O
9682,655,size,O
9683,655,2.5,O
9684,655,mm,O
9685,655,by,O
9686,655,visual,O
9687,655,estimation,O
9688,656,At,O
9689,656,least,O
9690,656,one,O
9691,656,CTO,B-Condition
9692,656,lesions,I-Condition
9693,656,located,O
9694,656,in,O
9695,656,proximal,O
9696,656,or,O
9697,656,mid,O
9698,656,epicardial,O
9699,656,coronary,B-Condition
9700,656,artery,I-Condition
9701,656,.,O
9702,656,(,O
9703,656,If,O
9704,656,the,O
9705,656,patient,O
9706,656,has,O
9707,656,two,O
9708,656,CTO,O
9709,656,lesions,O
9710,656,",",O
9711,656,one,O
9712,656,CTO,O
9713,656,lesion,O
9714,656,should,O
9715,656,be,O
9716,656,located,O
9717,656,in,O
9718,656,proximal,O
9719,656,or,O
9720,656,mid,O
9721,656,epicardial,O
9722,656,coronary,O
9723,656,artery,O
9724,656,),O
9725,657,Angiographically,O
9726,657,defined,O
9727,657,total,B-Condition
9728,657,occlusion,I-Condition
9729,657,over,O
9730,657,3,O
9731,657,months,O
9732,658,If,O
9733,658,no,O
9734,658,definite,O
9735,658,symptom,O
9736,658,with,O
9737,658,total,O
9738,658,occlusion,O
9739,658,",",O
9740,658,two,O
9741,658,experienced,O
9742,658,operators,O
9743,658,decide,O
9744,658,CTO,O
9745,658,in,O
9746,658,consideration,O
9747,658,of,O
9748,658,angiographical,O
9749,658,morphology,O
9750,658,(,O
9751,658,degree,O
9752,658,of,O
9753,658,calcification,O
9754,658,",",O
9755,658,bridging,O
9756,658,collaterals,O
9757,658,",",O
9758,658,non,O
9759,658,-,O
9760,658,tapered,O
9761,658,stump,O
9762,658,",",O
9763,658,angiographic,O
9764,658,filling,O
9765,658,from,O
9766,658,collaterals,O
9767,658,),O
9768,659,Amiodarone,B-Drug
9769,660,P,B-Drug
9770,660,-,I-Drug
9771,660,glycoprotein,I-Drug
9772,660,(,I-Drug
9773,660,P,I-Drug
9774,660,-,I-Drug
9775,660,gp,I-Drug
9776,660,),I-Drug
9777,660,inducers,I-Drug
9778,660,(,O
9779,660,e.g.,O
9780,660,",",O
9781,660,rifampin,B-Drug
9782,660,",",O
9783,660,St.,B-Drug
9784,660,John,I-Drug
9785,660,'s,I-Drug
9786,660,wort,I-Drug
9787,660,),O
9788,661,Liver,B-Procedure
9789,661,biopsy,I-Procedure
9790,661,at,O
9791,661,any,O
9792,661,time,O
9793,661,showing,O
9794,661,mHAI,O
9795,661,stage,O
9796,661,4,O
9797,661,or,O
9798,661,higher,O
9799,661,fibrosis,O
9800,661,OR,O
9801,662,FibroScan,B-Procedure
9802,662,within,O
9803,662,12,O
9804,662,months,O
9805,662,demonstrating,O
9806,662,liver,O
9807,662,stiffness,O
9808,662,of,O
9809,662,=,O
9810,662,9.5,O
9811,662,kilo,O
9812,662,Pascal,O
9813,662,or,O
9814,663,AST,O
9815,663,to,O
9816,663,platelet,O
9817,663,ratio,O
9818,663,index,O
9819,663,(,O
9820,663,APRI,O
9821,663,),O
9822,663,=,O
9823,663,2.0,O
9824,663,and,O
9825,663,Fibrosis-4,O
9826,663,(,O
9827,663,FIB-4,O
9828,663,),O
9829,663,=,O
9830,663,3.25,O
9831,664,NOTE,O
9832,664,:,O
9833,664,If,O
9834,664,APRI,O
9835,664,and,O
9836,664,FIB-4,O
9837,664,are,O
9838,664,discordant,O
9839,664,one,O
9840,664,of,O
9841,664,the,O
9842,664,other,O
9843,664,forms,O
9844,664,of,O
9845,664,fibrosis,O
9846,664,staging,O
9847,664,must,O
9848,664,be,O
9849,664,used,O
9850,664,.,O
9851,665,Known,O
9852,665,allergy,B-Condition
9853,665,/,O
9854,665,sensitivity,B-Condition
9855,665,or,O
9856,665,any,O
9857,665,hypersensitivity,B-Condition
9858,665,to,O
9859,665,components,B-Drug
9860,665,of,I-Drug
9861,665,study,I-Drug
9862,665,drugs,I-Drug
9863,665,or,O
9864,665,their,O
9865,665,formulation,O
9866,665,.,O
9867,666,Hemochromatosis,B-Condition
9868,667,Alpha-1,B-Condition
9869,667,antitrypsin,I-Condition
9870,667,deficiency,I-Condition
9871,668,Wilson,B-Condition
9872,668,'s,I-Condition
9873,668,disease,I-Condition
9874,669,Autoimmune,B-Condition
9875,669,hepatitis,I-Condition
9876,670,Alcoholic,B-Condition
9877,670,liver,I-Condition
9878,670,disease,I-Condition
9879,671,Drug,B-Condition
9880,671,-,I-Condition
9881,671,related,I-Condition
9882,671,liver,I-Condition
9883,671,disease,I-Condition
9884,672,Severe,O
9885,672,NC,B-Condition
9886,672,confounding,I-Condition
9887,672,conditions,I-Condition
9888,672,(,O
9889,672,stroke,B-Condition
9890,672,",",O
9891,672,head,B-Condition
9892,672,injury,I-Condition
9893,672,",",O
9894,672,or,O
9895,672,developmental,B-Condition
9896,672,learning,I-Condition
9897,672,disability,I-Condition
9898,672,),O
9899,672,.,O
9900,673,Regular,O
9901,673,use,O
9902,673,of,O
9903,673,anti,B-Drug
9904,673,-,I-Drug
9905,673,inflammatory,I-Drug
9906,673,drugs,I-Drug
9907,673,.,O
9908,674,Current,O
9909,674,or,O
9910,674,recent,O
9911,674,treatment,B-Procedure
9912,674,with,O
9913,674,pegylated,B-Drug
9914,674,interferon,I-Drug
9915,674,(,O
9916,674,PEG,B-Drug
9917,674,-,I-Drug
9918,674,IFN,I-Drug
9919,674,),O
9920,674,.,O
9921,675,Other,O
9922,675,active,B-Condition
9923,675,inflammatory,I-Condition
9924,675,process,I-Condition
9925,675,(,O
9926,675,major,B-Condition
9927,675,infection,I-Condition
9928,675,",",O
9929,675,malignancy,B-Condition
9930,675,",",O
9931,675,rheumatoid,B-Condition
9932,675,arthritis,I-Condition
9933,675,/,O
9934,675,autoimmune,B-Condition
9935,675,disorder,I-Condition
9936,675,),O
9937,675,within,O
9938,675,the,O
9939,675,prior,O
9940,675,28,O
9941,675,days,O
9942,675,.,O
9943,676,Contraindications,B-Condition
9944,676,to,O
9945,676,magnetic,B-Procedure
9946,676,resonance,I-Procedure
9947,676,imaging,I-Procedure
9948,676,(,I-Procedure
9949,676,MRI,I-Procedure
9950,676,),I-Procedure
9951,676,.,O
9952,677,Bleeding,B-Condition
9953,677,diathesis,I-Condition
9954,677,",",O
9955,677,thrombocytopenia,B-Condition
9956,677,",",O
9957,677,or,O
9958,677,use,O
9959,677,of,O
9960,677,anticoagulants,B-Drug
9961,677,that,O
9962,677,would,O
9963,677,contraindicate,B-Condition
9964,677,lumbar,B-Procedure
9965,677,puncture,I-Procedure
9966,677,.,O
9967,678,Uncontrolled,O
9968,678,or,O
9969,678,active,O
9970,678,depression,B-Condition
9971,678,or,O
9972,678,other,O
9973,678,psychiatric,B-Condition
9974,678,disorder,I-Condition
9975,678,that,O
9976,678,in,O
9977,678,the,O
9978,678,opinion,O
9979,678,of,O
9980,678,the,O
9981,678,site,O
9982,678,investigator,O
9983,678,might,O
9984,678,preclude,O
9985,678,adherence,O
9986,678,to,O
9987,678,study,O
9988,678,requirements,O
9989,678,or,O
9990,678,impact,O
9991,678,NC,O
9992,678,functioning,O
9993,678,and,O
9994,678,assessments,O
9995,678,.,O
9996,679,Active,O
9997,679,drug,B-Condition
9998,679,or,I-Condition
9999,679,alcohol,I-Condition
10000,679,use,I-Condition
10001,679,or,I-Condition
10002,679,dependence,I-Condition
10003,679,that,O
10004,679,",",O
10005,679,in,O
10006,679,the,O
10007,679,opinion,O
10008,679,of,O
10009,679,the,O
10010,679,site,O
10011,679,investigator,O
10012,679,",",O
10013,679,would,O
10014,679,interfere,O
10015,679,with,O
10016,679,adherence,O
10017,679,to,O
10018,679,study,O
10019,679,requirements,O
10020,679,.,O
10021,680,Presence,O
10022,680,of,O
10023,680,active,O
10024,680,or,O
10025,680,acute,O
10026,680,AIDS,B-Condition
10027,680,-,I-Condition
10028,680,defining,I-Condition
10029,680,opportunistic,I-Condition
10030,680,infections,I-Condition
10031,680,within,O
10032,680,12,O
10033,680,weeks,O
10034,680,prior,O
10035,680,to,O
10036,680,study,O
10037,680,entry,O
10038,680,.,O
10039,681,Adult,B-Person
10040,681,(=,O
10041,681,18,O
10042,681,years,O
10043,681,old,B-Person
10044,681,),O
10045,681,subjects,O
10046,681,with,O
10047,681,chronic,O
10048,681,genotype,O
10049,681,1,O
10050,681,HCV,B-Condition
10051,681,and,O
10052,681,NCI,B-Condition
10053,681,with,O
10054,681,a,O
10055,681,GDS,O
10056,681,greater,O
10057,681,than,O
10058,681,or,O
10059,681,equal,O
10060,681,to,O
10061,681,0.5,O
10062,681,(,O
10063,681,n=60,O
10064,681,),O
10065,681,.,O
10066,682,Presence,O
10067,682,of,O
10068,682,chronic,O
10069,682,HCV,B-Condition
10070,682,infection,I-Condition
10071,682,based,O
10072,682,on,O
10073,682,chart,O
10074,682,review,O
10075,682,will,O
10076,682,be,O
10077,682,defined,O
10078,682,as,O
10079,682,positive,O
10080,682,for,O
10081,682,anti,O
10082,682,-,O
10083,682,HCV,O
10084,682,antibody,O
10085,682,or,O
10086,682,HCV,O
10087,682,RNA,O
10088,682,at,O
10089,682,least,O
10090,682,6,O
10091,682,months,O
10092,682,before,O
10093,682,screening,O
10094,682,.,O
10095,683,For,O
10096,683,the,O
10097,683,HIV,O
10098,683,/,O
10099,683,HCV,O
10100,683,co,O
10101,683,-,O
10102,683,infected,O
10103,683,group,O
10104,683,only,O
10105,683,",",O
10106,683,subjects,O
10107,683,must,O
10108,683,have,O
10109,683,HIV,O
10110,683,.,O
10111,683,HIV,O
10112,683,status,O
10113,683,will,O
10114,683,be,O
10115,683,obtained,O
10116,683,through,O
10117,683,self,O
10118,683,report,O
10119,683,.,O
10120,683,Self,O
10121,683,report,O
10122,683,will,O
10123,683,be,O
10124,683,confirmed,O
10125,683,at,O
10126,683,screening,O
10127,683,using,O
10128,683,a,O
10129,683,HIV-1,O
10130,683,point,O
10131,683,of,O
10132,683,care,O
10133,683,test,O
10134,683,.,O
10135,683,In,O
10136,683,the,O
10137,683,event,O
10138,683,that,O
10139,683,point,O
10140,683,of,O
10141,683,care,O
10142,683,test,O
10143,683,and,O
10144,683,self,O
10145,683,-,O
10146,683,report,O
10147,683,are,O
10148,683,discordant,O
10149,683,",",O
10150,683,then,O
10151,683,HIV,O
10152,683,status,O
10153,683,will,O
10154,683,be,O
10155,683,confirmed,O
10156,683,by,O
10157,683,a,O
10158,683,licensed,O
10159,683,Western,O
10160,683,blot,O
10161,683,or,O
10162,683,a,O
10163,683,second,O
10164,683,antibody,O
10165,683,test,O
10166,683,.,O
10167,684,HIV,B-Condition
10168,684,/,O
10169,684,HCV,B-Condition
10170,684,co,B-Condition
10171,684,-,I-Condition
10172,684,infected,I-Condition
10173,684,subjects,O
10174,684,(,O
10175,684,n=12,O
10176,684,),O
10177,684,must,O
10178,684,also,O
10179,684,have,O
10180,684,a,O
10181,684,HIV,O
10182,684,RNA,O
10183,684,measurement,O
10184,684,<,O
10185,684,50,O
10186,684,copies,O
10187,684,/,O
10188,684,mL,O
10189,684,at,O
10190,684,the,O
10191,684,pre,O
10192,684,-,O
10193,684,treatment,O
10194,684,visit,O
10195,684,.,O
10196,685,Platelets,O
10197,685,>,O
10198,685,"150,000",O
10199,686,Aspartate,O
10200,686,aminotransferase,O
10201,686,(,O
10202,686,AST)/Alanine,O
10203,686,aminotransferase,O
10204,686,(,O
10205,686,ALT,O
10206,686,),O
10207,686,<,O
10208,686,10x,O
10209,686,upper,O
10210,686,limit,O
10211,686,of,O
10212,686,normal,O
10213,687,Creatinine,O
10214,687,clearance,O
10215,687,>,O
10216,687,30,O
10217,687,milliliters,O
10218,687,/,O
10219,687,minute/1.73,O
10220,687,centimeter,O
10221,687,squared,O
10222,688,Recent,O
10223,688,participation,O
10224,688,(,O
10225,688,within,O
10226,688,28,O
10227,688,days,O
10228,688,),O
10229,688,in,O
10230,688,other,O
10231,688,research,O
10232,688,studies,O
10233,689,Recent,O
10234,689,significant,O
10235,689,blood,B-Procedure
10236,689,donation,I-Procedure
10237,689,or,O
10238,689,plasma,B-Procedure
10239,689,donation,I-Procedure
10240,690,Pregnant,B-Condition
10241,690,or,O
10242,690,lactating,B-Condition
10243,691,Test,O
10244,691,positive,O
10245,691,at,O
10246,691,screening,O
10247,691,for,O
10248,691,human,O
10249,691,immunodeficiency,O
10250,691,virus,O
10251,691,(,O
10252,691,HIV,O
10253,691,),O
10254,691,",",O
10255,691,hepatitis,O
10256,691,B,O
10257,691,surface,O
10258,691,antigen,O
10259,691,(,O
10260,691,HbsAg,O
10261,691,),O
10262,691,",",O
10263,691,or,O
10264,691,hepatitis,O
10265,691,C,O
10266,691,virus,O
10267,691,(,O
10268,691,HCV,O
10269,691,),O
10270,692,Recent,O
10271,692,(,O
10272,692,2,O
10273,692,-,O
10274,692,year,O
10275,692,),O
10276,692,history,B-Observation
10277,692,or,O
10278,692,evidence,B-Mood
10279,692,of,O
10280,692,alcoholism,B-Condition
10281,692,or,O
10282,692,drug,B-Condition
10283,692,abuse,I-Condition
10284,693,History,O
10285,693,or,O
10286,693,presence,O
10287,693,of,O
10288,693,significant,O
10289,693,cardiovascular,O
10290,693,",",O
10291,693,pulmonary,O
10292,693,",",O
10293,693,hepatic,O
10294,693,",",O
10295,693,gallbladder,O
10296,693,or,O
10297,693,biliary,O
10298,693,tract,O
10299,693,",",O
10300,693,renal,O
10301,693,",",O
10302,693,hematologic,O
10303,693,",",O
10304,693,gastrointestinal,O
10305,693,",",O
10306,693,endocrine,O
10307,693,",",O
10308,693,immunologic,O
10309,693,",",O
10310,693,dermatologic,O
10311,693,",",O
10312,693,neurologic,O
10313,693,",",O
10314,693,or,O
10315,693,psychiatric,O
10316,693,disease,O
10317,694,Subjects,O
10318,694,who,O
10319,694,have,O
10320,694,used,O
10321,694,any,O
10322,694,drugs,B-Drug
10323,694,or,I-Drug
10324,694,substances,I-Drug
10325,694,known,I-Drug
10326,694,to,I-Drug
10327,694,inhibit,I-Drug
10328,694,or,I-Drug
10329,694,induce,I-Drug
10330,694,cytochrome,I-Drug
10331,694,(,I-Drug
10332,694,CYP,I-Drug
10333,694,),I-Drug
10334,694,P450,I-Drug
10335,694,enzymes,I-Drug
10336,694,and/or,I-Drug
10337,694,P,I-Drug
10338,694,-,I-Drug
10339,694,glycoprotein,I-Drug
10340,694,(,I-Drug
10341,694,P,I-Drug
10342,694,-,I-Drug
10343,694,gp,I-Drug
10344,694,),I-Drug
10345,694,within,O
10346,694,28,O
10347,694,days,O
10348,694,prior,O
10349,694,to,O
10350,694,the,O
10351,694,first,O
10352,694,dose,O
10353,694,and,O
10354,694,throughout,O
10355,694,the,O
10356,694,study,O
10357,695,Drug,O
10358,695,allergies,B-Condition
10359,695,to,O
10360,695,quinine,B-Drug
10361,695,sulfate,I-Drug
10362,695,or,O
10363,695,rosiglitazone,B-Drug
10364,696,Healthy,B-Condition
10365,696,adults,B-Person
10366,696,18,O
10367,696,-,O
10368,696,45,O
10369,696,years,O
10370,696,of,B-Person
10371,696,age,I-Person
10372,697,Non,O
10373,697,-,O
10374,697,smoking,B-Condition
10375,698,Non,O
10376,698,-,O
10377,698,pregnant,B-Condition
10378,698,(,O
10379,698,post,B-Condition
10380,698,-,I-Condition
10381,698,menopausal,I-Condition
10382,698,",",O
10383,698,surgically,B-Condition
10384,698,sterile,I-Condition
10385,698,or,O
10386,698,using,O
10387,698,effective,O
10388,698,contraceptive,B-Procedure
10389,698,measures,I-Procedure
10390,698,),O
10391,699,Body,O
10392,699,mass,O
10393,699,index,O
10394,699,(,O
10395,699,BMI,O
10396,699,),O
10397,699,less,O
10398,699,than,O
10399,699,or,O
10400,699,equal,O
10401,699,to,O
10402,699,32,O
10403,700,Medically,B-Condition
10404,700,healthy,I-Condition
10405,700,on,O
10406,700,the,O
10407,700,basis,O
10408,700,of,O
10409,700,medical,B-Observation
10410,700,history,I-Observation
10411,700,and,O
10412,700,physical,B-Procedure
10413,700,examination,I-Procedure
10414,701,Hemoglobin,O
10415,701,>,O
10416,701,or,O
10417,701,=,O
10418,701,to,O
10419,701,11.5g,O
10420,701,/,O
10421,701,dL,O
10422,702,Completion,O
10423,702,of,O
10424,702,the,O
10425,702,screening,B-Procedure
10426,702,process,I-Procedure
10427,702,within,O
10428,702,28,O
10429,702,days,O
10430,702,prior,O
10431,702,to,O
10432,702,dosing,O
10433,703,Provision,O
10434,703,of,O
10435,703,voluntary,O
10436,703,written,O
10437,703,informed,O
10438,703,consent,O
10439,704,Target,B-Condition
10440,704,lesion,I-Condition
10441,704,located,O
10442,704,in,O
10443,704,the,O
10444,704,left,O
10445,704,main,O
10446,704,stem,O
10447,705,STEMI,B-Condition
10448,706,Restenosis,B-Condition
10449,707,Cardiogenic,B-Condition
10450,707,shock,I-Condition
10451,708,Malignancies,B-Condition
10452,708,or,O
10453,708,other,O
10454,708,comorbid,B-Condition
10455,708,conditions,I-Condition
10456,708,with,O
10457,708,life,B-Observation
10458,708,expectancy,I-Observation
10459,708,less,O
10460,708,than,O
10461,708,12,O
10462,708,months,O
10463,708,or,O
10464,708,that,O
10465,708,may,B-Mood
10466,708,result,O
10467,708,in,O
10468,708,protocol,B-Observation
10469,708,noncompliance,I-Observation
10470,709,Known,O
10471,709,allergy,B-Condition
10472,709,to,O
10473,709,the,O
10474,709,study,B-Drug
10475,709,medications,I-Drug
10476,709,(,O
10477,709,probucol,B-Drug
10478,709,",",O
10479,709,sirolimus,B-Drug
10480,709,",",O
10481,709,zotarolimus,B-Drug
10482,709,),O
10483,710,Pregnancy,B-Condition
10484,710,(,O
10485,710,present,O
10486,710,",",O
10487,710,suspected,B-Mood
10488,710,",",O
10489,710,or,O
10490,710,planned,B-Mood
10491,710,),O
10492,711,Patients,O
10493,711,older,O
10494,711,than,O
10495,711,18,O
10496,711,years,B-Person
10497,712,Ischemic,B-Condition
10498,712,symptoms,I-Condition
10499,712,or,O
10500,712,evidence,B-Mood
10501,712,of,O
10502,712,myocardial,B-Condition
10503,712,ischemia,I-Condition
10504,712,(,O
10505,712,inducible,O
10506,712,or,O
10507,712,spontaneous,O
10508,712,),O
10509,712,in,O
10510,712,the,O
10511,712,presence,O
10512,712,of,O
10513,712,>,O
10514,712,50,O
10515,712,%,O
10516,712,de,O
10517,712,novo,O
10518,712,stenosis,B-Condition
10519,712,located,O
10520,712,in,O
10521,712,native,O
10522,712,coronary,O
10523,712,vessels,O
10524,713,FEV1,O
10525,713,>,O
10526,713,=,O
10527,713,80,O
10528,713,%,O
10529,713,or,O
10530,713,FEV1,O
10531,713,<,O
10532,713,20,O
10533,713,%,O
10534,713,of,O
10535,713,predicted,O
10536,713,value,O
10537,713,post,O
10538,713,-,O
10539,713,bronchodilator,B-Drug
10540,713,.,O
10541,714,FEV1,O
10542,714,/,O
10543,714,SVC>=70,O
10544,714,%,O
10545,715,History,B-Observation
10546,715,of,O
10547,715,lung,B-Procedure
10548,715,transplant,I-Procedure
10549,715,.,O
10550,716,Any,O
10551,716,lung,B-Procedure
10552,716,surgery,I-Procedure
10553,716,within,O
10554,716,the,O
10555,716,past,O
10556,716,two,O
10557,716,years,O
10558,716,.,O
10559,717,On,O
10560,717,any,O
10561,717,thoracic,B-Observation
10562,717,surgery,I-Observation
10563,717,waiting,I-Observation
10564,717,list,I-Observation
10565,717,.,O
10566,718,End,O
10567,718,of,O
10568,718,last,O
10569,718,exacerbation,B-Condition
10570,718,less,O
10571,718,than,O
10572,718,6,O
10573,718,weeks,O
10574,718,prior,O
10575,718,to,O
10576,718,screening,O
10577,718,/,O
10578,718,re,O
10579,718,-,O
10580,718,screening,O
10581,718,visit,O
10582,718,.,O
10583,719,Clinically,O
10584,719,significant,O
10585,719,intercurrent,B-Condition
10586,719,illnesses,I-Condition
10587,719,(,O
10588,719,except,O
10589,719,for,O
10590,719,respiratory,B-Condition
10591,719,or,I-Condition
10592,719,liver,I-Condition
10593,719,disease,I-Condition
10594,719,secondary,O
10595,719,to,O
10596,719,AAT,B-Condition
10597,719,deficiency,I-Condition
10598,719,),O
10599,719,",",O
10600,719,including,O
10601,719,:,O
10602,719,cardiac,B-Condition
10603,719,",",O
10604,719,hepatic,B-Condition
10605,719,",",O
10606,719,renal,B-Condition
10607,719,",",O
10608,719,endocrine,B-Condition
10609,719,",",O
10610,719,neurological,B-Condition
10611,719,",",O
10612,719,hematological,B-Condition
10613,719,",",O
10614,719,neoplastic,B-Condition
10615,719,",",O
10616,719,immunological,B-Condition
10617,719,",",O
10618,719,skeletal,B-Condition
10619,719,or,O
10620,719,other,B-Condition
10621,719,),O
10622,719,that,O
10623,719,in,O
10624,719,the,O
10625,719,opinion,O
10626,719,of,O
10627,719,the,O
10628,719,investigator,O
10629,719,",",O
10630,719,could,O
10631,719,interfere,O
10632,719,with,O
10633,719,the,O
10634,719,safety,O
10635,719,",",O
10636,719,compliance,O
10637,719,or,O
10638,719,other,O
10639,719,aspects,O
10640,719,of,O
10641,719,this,O
10642,719,study,O
10643,719,.,O
10644,719,Patients,O
10645,719,with,O
10646,719,well,O
10647,719,-,O
10648,719,controlled,O
10649,719,",",O
10650,719,chronic,O
10651,719,diseases,O
10652,719,could,O
10653,719,possibly,O
10654,719,be,O
10655,719,included,O
10656,719,after,O
10657,719,consultation,O
10658,719,with,O
10659,719,the,O
10660,719,treating,O
10661,719,physician,O
10662,719,and,O
10663,719,the,O
10664,719,sponsor,O
10665,719,.,O
10666,720,Active,B-Condition
10667,720,smoking,I-Condition
10668,720,during,O
10669,720,the,O
10670,720,last,O
10671,720,12,O
10672,720,months,O
10673,720,from,O
10674,720,screening,O
10675,720,date,O
10676,720,.,O
10677,721,Pregnancy,B-Condition
10678,721,or,O
10679,721,lactation,B-Condition
10680,721,.,O
10681,722,Woman,B-Person
10682,722,of,O
10683,722,child,B-Condition
10684,722,-,I-Condition
10685,722,bearing,I-Condition
10686,722,potential,I-Condition
10687,722,not,O
10688,722,taking,O
10689,722,adequate,O
10690,722,contraception,B-Procedure
10691,722,deemed,O
10692,722,reliable,O
10693,722,by,O
10694,722,the,O
10695,722,investigator,O
10696,722,.,O
10697,723,Presence,O
10698,723,of,O
10699,723,psychiatric/,B-Condition
10700,723,mental,I-Condition
10701,723,disorder,I-Condition
10702,723,or,O
10703,723,any,O
10704,723,other,B-Condition
10705,723,medical,I-Condition
10706,723,disorder,I-Condition
10707,723,which,O
10708,723,might,O
10709,723,impair,B-Observation
10710,723,the,I-Observation
10711,723,patient,I-Observation
10712,723,'s,I-Observation
10713,723,ability,I-Observation
10714,723,to,I-Observation
10715,723,give,I-Observation
10716,723,informed,I-Observation
10717,723,consent,I-Observation
10718,723,or,O
10719,723,to,O
10720,723,comply,O
10721,723,with,O
10722,723,the,O
10723,723,requirements,O
10724,723,of,O
10725,723,the,O
10726,723,study,O
10727,723,protocol,O
10728,723,.,O
10729,724,Evidence,O
10730,724,of,O
10731,724,ongoing,O
10732,724,viral,B-Condition
10733,724,infection,I-Condition
10734,724,with,O
10735,724,HCV,B-Condition
10736,724,",",O
10737,724,HBV,B-Condition
10738,724,and/or,O
10739,724,HIV,B-Condition
10740,724,.,O
10741,725,Evidence,O
10742,725,of,O
10743,725,alcohol,B-Condition
10744,725,abuse,I-Condition
10745,725,or,O
10746,725,history,B-Observation
10747,725,of,O
10748,725,alcohol,O
10749,725,abuse,B-Condition
10750,725,or,I-Condition
10751,725,illegal,I-Condition
10752,725,and/or,I-Condition
10753,725,legally,I-Condition
10754,725,prescribed,I-Condition
10755,725,drugs,I-Condition
10756,725,.,O
10757,726,IgA,B-Condition
10758,726,Deficiency,I-Condition
10759,727,History,B-Observation
10760,727,of,O
10761,727,life,B-Condition
10762,727,threatening,I-Condition
10763,727,allergy,I-Condition
10764,727,",",O
10765,727,anaphylactic,B-Condition
10766,727,reaction,I-Condition
10767,727,",",O
10768,727,or,O
10769,727,systemic,B-Condition
10770,727,response,I-Condition
10771,727,to,I-Condition
10772,727,human,I-Condition
10773,727,plasma,I-Condition
10774,727,derived,I-Condition
10775,727,products,I-Condition
10776,727,.,O
10777,728,Participation,O
10778,728,in,O
10779,728,another,O
10780,728,clinical,O
10781,728,trial,O
10782,728,within,O
10783,728,30,O
10784,728,days,O
10785,728,prior,O
10786,728,to,O
10787,728,baseline,O
10788,728,visit,O
10789,728,.,O
10790,729,Inability,O
10791,729,to,O
10792,729,attend,O
10793,729,scheduled,O
10794,729,clinic,O
10795,729,visits,O
10796,729,and/or,O
10797,729,comply,O
10798,729,with,O
10799,729,the,O
10800,729,study,O
10801,729,protocol,O
10802,729,.,O
10803,730,Any,O
10804,730,other,O
10805,730,factor,O
10806,730,that,O
10807,730,",",O
10808,730,in,O
10809,730,the,O
10810,730,opinion,O
10811,730,of,O
10812,730,the,O
10813,730,investigator,O
10814,730,",",O
10815,730,would,O
10816,730,prevent,O
10817,730,the,O
10818,730,patient,O
10819,730,from,O
10820,730,complying,O
10821,730,with,O
10822,730,the,O
10823,730,requirements,O
10824,730,of,O
10825,730,the,O
10826,730,protocol,O
10827,730,.,O
10828,731,Diagnosis,O
10829,731,of,O
10830,731,emphysema,B-Condition
10831,731,confirmed,O
10832,731,by,O
10833,731,CT,B-Procedure
10834,731,scan,I-Procedure
10835,731,.,O
10836,731,If,O
10837,731,a,O
10838,731,report,B-Observation
10839,731,of,I-Observation
10840,731,past,I-Observation
10841,731,CT,I-Observation
10842,731,scan,I-Observation
10843,731,is,O
10844,731,not,O
10845,731,available,O
10846,731,at,O
10847,731,site,O
10848,731,documenting,O
10849,731,then,O
10850,731,a,O
10851,731,CT,B-Procedure
10852,731,scan,I-Procedure
10853,731,is,O
10854,731,to,O
10855,731,be,O
10856,731,performed,O
10857,731,at,O
10858,731,screening,O
10859,732,Male,B-Person
10860,732,or,O
10861,732,female,B-Person
10862,732,patients,O
10863,732,at,O
10864,732,least,O
10865,732,18,O
10866,732,years,O
10867,732,of,O
10868,732,age,B-Person
10869,732,.,O
10870,733,Able,O
10871,733,and,O
10872,733,willing,O
10873,733,to,O
10874,733,sign,O
10875,733,an,O
10876,733,informed,O
10877,733,consent,O
10878,733,.,O
10879,734,Patient,O
10880,734,with,O
10881,734,record,O
10882,734,of,O
10883,734,congenital,B-Condition
10884,734,AAT,I-Condition
10885,734,deficiency,I-Condition
10886,734,of,I-Condition
10887,734,phenotype,I-Condition
10888,734,PiZZ,I-Condition
10889,734,(,I-Condition
10890,734,homozygote,I-Condition
10891,734,),I-Condition
10892,734,or,O
10893,734,other,O
10894,734,rare,B-Condition
10895,734,phenotypes,I-Condition
10896,734,related,I-Condition
10897,734,to,I-Condition
10898,734,AAT,I-Condition
10899,734,deficiency,I-Condition
10900,734,and,O
10901,734,with,O
10902,734,AAT,O
10903,734,serum,O
10904,734,level,O
10905,734,≤,O
10906,734,11,O
10907,734,micromole,O
10908,734,.,O
10909,734,For,O
10910,734,patients,O
10911,734,receiving,O
10912,734,IV,B-Procedure
10913,734,AAT,I-Procedure
10914,734,augmentation,I-Procedure
10915,734,therapy,I-Procedure
10916,734,the,O
10917,734,serum,O
10918,734,AAT,O
10919,734,level,O
10920,734,threshold,O
10921,734,does,O
10922,734,not,O
10923,734,apply,O
10924,734,.,O
10925,735,FEV1,O
10926,735,/,O
10927,735,SVC,O
10928,735,<,O
10929,735,70,O
10930,735,%,O
10931,735,of,O
10932,735,predicted,O
10933,735,value,O
10934,735,post,O
10935,735,bronchodilator,B-Drug
10936,735,(,O
10937,735,SVC,O
10938,735,is,O
10939,735,slow,O
10940,735,VC,O
10941,735,),O
10942,735,and,O
10943,735,FEV1,O
10944,735,<,O
10945,735,80,O
10946,735,%,O
10947,735,of,O
10948,735,predicted,O
10949,735,value,O
10950,735,post,O
10951,735,-,O
10952,735,bronchodilator,B-Drug
10953,736,History,O
10954,736,of,O
10955,736,at,O
10956,736,least,O
10957,736,two,O
10958,736,moderate,O
10959,736,or,O
10960,736,severe,O
10961,736,exacerbations,B-Condition
10962,736,that,O
10963,736,required,O
10964,736,change,B-Observation
10965,736,in,I-Observation
10966,736,treatment,I-Observation
10967,736,(,O
10968,736,antibiotics,B-Drug
10969,736,",",O
10970,736,systemic,B-Drug
10971,736,steroids,I-Drug
10972,736,",",O
10973,736,hospitalization,B-Procedure
10974,736,),O
10975,736,in,O
10976,736,the,O
10977,736,last,O
10978,736,18,O
10979,736,months,O
10980,736,prior,O
10981,736,to,O
10982,736,date,O
10983,736,of,O
10984,736,screening,O
10985,736,",",O
10986,736,with,O
10987,736,at,O
10988,736,least,O
10989,736,one,O
10990,736,of,O
10991,736,these,O
10992,736,occurring,O
10993,736,within,O
10994,736,the,O
10995,736,last,O
10996,736,12,O
10997,736,months,O
10998,736,prior,O
10999,736,to,O
11000,736,screening,O
11001,736,.,O
11002,737,Ability,O
11003,737,to,O
11004,737,comply,B-Observation
11005,737,with,I-Observation
11006,737,completion,I-Observation
11007,737,of,I-Observation
11008,737,electronic,I-Observation
11009,737,diary,I-Observation
11010,737,.,O
11011,738,Ability,O
11012,738,to,O
11013,738,self,B-Observation
11014,738,-,I-Observation
11015,738,administer,I-Observation
11016,738,inhaled,I-Observation
11017,738,AAT,I-Observation
11018,738,.,O
11019,739,No,O
11020,739,significant,O
11021,739,abnormalities,O
11022,739,in,O
11023,739,serum,O
11024,739,hematology,O
11025,739,",",O
11026,739,serum,O
11027,739,chemistry,O
11028,739,and,O
11029,739,serum,O
11030,739,inflammatory,O
11031,739,/,O
11032,739,immunogenic,O
11033,739,markers,O
11034,739,according,O
11035,739,to,O
11036,739,the,O
11037,739,Principal,O
11038,739,Investigator,O
11039,739,'s,O
11040,739,judgment,O
11041,739,",",O
11042,739,taking,O
11043,739,into,O
11044,739,considerations,O
11045,739,the,O
11046,739,potential,O
11047,739,effects,O
11048,739,of,O
11049,739,the,O
11050,739,AAT,O
11051,739,deficiency,O
11052,739,.,O
11053,740,No,O
11054,740,significant,O
11055,740,abnormalities,O
11056,740,in,O
11057,740,urinalysis,O
11058,740,according,O
11059,740,to,O
11060,740,the,O
11061,740,Principal,O
11062,740,Investigator,O
11063,740,'s,O
11064,740,judgment,O
11065,740,",",O
11066,740,taking,O
11067,740,into,O
11068,740,considerations,O
11069,740,the,O
11070,740,potential,O
11071,740,effects,O
11072,740,of,O
11073,740,the,O
11074,740,AAT,O
11075,740,deficiency,O
11076,740,.,O
11077,741,No,O
11078,741,significant,O
11079,741,abnormalities,B-Condition
11080,741,in,I-Condition
11081,741,ECG,I-Condition
11082,741,per,O
11083,741,investigator,O
11084,741,judgment,O
11085,741,.,O
11086,742,Negative,O
11087,742,for,O
11088,742,HBsAg,O
11089,742,and,O
11090,742,for,O
11091,742,antibodies,O
11092,742,to,O
11093,742,HCV,O
11094,742,",",O
11095,742,HIV-1,O
11096,742,.,O
11097,743,AAT,B-Condition
11098,743,deficient,I-Condition
11099,743,patients,O
11100,743,who,O
11101,743,are,O
11102,743,either,O
11103,743,naïve,B-Condition
11104,743,(,O
11105,743,not,O
11106,743,receiving,O
11107,743,IV,B-Procedure
11108,743,augmentation,I-Procedure
11109,743,therapy,I-Procedure
11110,743,),O
11111,743,or,O
11112,743,AAT,O
11113,743,deficient,O
11114,743,patients,O
11115,743,(,O
11116,743,receiving,O
11117,743,IV,B-Procedure
11118,743,augmentation,I-Procedure
11119,743,therapy,I-Procedure
11120,743,),O
11121,743,",",O
11122,743,if,O
11123,743,they,O
11124,743,have,O
11125,743,been,O
11126,743,stable,O
11127,743,on,O
11128,743,regular,O
11129,743,therapy,B-Procedure
11130,743,for,O
11131,743,at,O
11132,743,least,O
11133,743,3,O
11134,743,months,O
11135,743,prior,O
11136,743,to,O
11137,743,the,O
11138,743,screening,O
11139,743,visit,O
11140,743,and,O
11141,743,are,O
11142,743,willing,B-Observation
11143,743,to,I-Observation
11144,743,continue,I-Observation
11145,743,the,O
11146,743,same,O
11147,743,regime,O
11148,743,throughout,O
11149,743,this,O
11150,743,trial,O
11151,743,.,O
11152,743,Note,O
11153,743,that,O
11154,743,only,O
11155,743,sites,O
11156,743,in,O
11157,743,Germany,O
11158,743,can,O
11159,743,recruit,O
11160,743,patients,O
11161,743,who,O
11162,743,are,O
11163,743,currently,O
11164,743,being,O
11165,743,treated,O
11166,743,with,O
11167,743,IV,O
11168,743,AAT.Patients,O
11169,743,who,O
11170,743,stopped,O
11171,743,IV,O
11172,743,augmentation,O
11173,743,treatment,O
11174,743,6,O
11175,743,months,O
11176,743,prior,O
11177,743,to,O
11178,743,screening,O
11179,743,date,O
11180,743,and,O
11181,743,will,O
11182,743,not,O
11183,743,re,O
11184,743,-,O
11185,743,start,O
11186,743,this,O
11187,743,treatment,O
11188,743,for,O
11189,743,the,O
11190,743,course,O
11191,743,of,O
11192,743,the,O
11193,743,study,O
11194,743,will,O
11195,743,be,O
11196,743,considered,O
11197,743,Naïve,O
11198,743,.,O
11199,744,Non,O
11200,744,-,O
11201,744,pregnant,B-Condition
11202,744,",",O
11203,744,non,O
11204,744,-,O
11205,744,lactating,B-Condition
11206,744,female,B-Person
11207,744,patients,O
11208,744,",",O
11209,744,whose,O
11210,744,screening,O
11211,744,pregnancy,O
11212,744,test,O
11213,744,is,O
11214,744,negative,O
11215,744,and,O
11216,744,who,O
11217,744,are,O
11218,744,using,O
11219,744,contraceptive,O
11220,744,methods,O
11221,744,deemed,O
11222,744,reliable,O
11223,744,by,O
11224,744,the,O
11225,744,investigator,O
11226,744,",",O
11227,744,or,O
11228,744,who,O
11229,744,are,O
11230,744,at,O
11231,744,least,O
11232,744,2,O
11233,744,years,O
11234,744,post,B-Condition
11235,744,-,I-Condition
11236,744,menopausal,I-Condition
11237,744,or,O
11238,744,surgically,B-Condition
11239,744,sterilized,I-Condition
11240,744,.,O
11241,745,Patients,O
11242,745,with,O
11243,745,liver,B-Condition
11244,745,cirrhosis,I-Condition
11245,745,",",O
11246,745,Hepatocellular,B-Condition
11247,745,Carcinoma,I-Condition
11248,745,or,O
11249,745,other,O
11250,745,malignancies,B-Condition
11251,745,.,O
11252,746,Patients,O
11253,746,with,O
11254,746,other,O
11255,746,factors,O
11256,746,causing,O
11257,746,liver,O
11258,746,diseases,O
11259,746,.,O
11260,747,Pregnant,O
11261,747,and,O
11262,747,lactating,O
11263,747,women,O
11264,747,.,O
11265,748,Patients,O
11266,748,with,O
11267,748,concomitant,O
11268,748,HIV,B-Condition
11269,748,infection,I-Condition
11270,748,or,O
11271,748,congenital,B-Condition
11272,748,immune,I-Condition
11273,748,deficiency,I-Condition
11274,748,diseases,I-Condition
11275,748,.,I-Condition
11276,749,Patients,O
11277,749,with,O
11278,749,diabetes,B-Condition
11279,749,",",O
11280,749,autoimmune,B-Condition
11281,749,diseases,I-Condition
11282,749,.,O
11283,750,Patients,O
11284,750,with,O
11285,750,important,O
11286,750,organ,B-Condition
11287,750,dysfunctions,I-Condition
11288,750,.,O
11289,751,Patients,O
11290,751,with,O
11291,751,serious,O
11292,751,complications,B-Condition
11293,751,(,O
11294,751,e.g.,O
11295,751,",",O
11296,751,infection,B-Condition
11297,751,",",O
11298,751,hepatic,B-Condition
11299,751,encephalopathy,I-Condition
11300,751,",",O
11301,751,hepatorenal,B-Condition
11302,751,syndrome,I-Condition
11303,751,",",O
11304,751,gastrointestinal,B-Condition
11305,751,bleeding,I-Condition
11306,751,.,O
11307,751,),O
11308,752,Patients,O
11309,752,who,O
11310,752,receive,O
11311,752,antineoplastic,B-Procedure
11312,752,or,I-Procedure
11313,752,immunomodulatory,I-Procedure
11314,752,therapy,I-Procedure
11315,752,in,O
11316,752,the,O
11317,752,past,O
11318,752,12,O
11319,752,months,O
11320,752,.,O
11321,753,Patients,O
11322,753,who,O
11323,753,ca,O
11324,753,n't,O
11325,753,come,O
11326,753,back,O
11327,753,to,O
11328,753,clinic,O
11329,753,for,O
11330,753,follow,O
11331,753,-,O
11332,753,up,O
11333,753,on,O
11334,753,schedule,O
11335,753,.,O
11336,754,CHB,B-Condition
11337,754,patients,O
11338,754,who,O
11339,754,had,O
11340,754,received,O
11341,754,NAs,B-Drug
11342,754,for,O
11343,754,more,O
11344,754,than,O
11345,754,12,O
11346,754,months,O
11347,754,.,O
11348,755,Hepatitis,O
11349,755,B,O
11350,755,e,O
11351,755,antigen,O
11352,755,(,O
11353,755,HBeAg)-negative,O
11354,755,and,O
11355,755,anti,O
11356,755,-,O
11357,755,HBeAg,O
11358,755,positive,O
11359,755,.,O
11360,756,Hepatitis,O
11361,756,B,O
11362,756,surface,O
11363,756,antigen,O
11364,756,(,O
11365,756,HBsAg,O
11366,756,),O
11367,756,positive,O
11368,756,and,O
11369,756,<,O
11370,756,1500,O
11371,756,IU,O
11372,756,/,O
11373,756,mL.,O
11374,757,Hepatitis,O
11375,757,B,O
11376,757,virus,O
11377,757,DNA,O
11378,757,not,O
11379,757,detectable(Roche,O
11380,757,Cobas,O
11381,757,),O
11382,757,.,O
11383,758,HCV,B-Condition
11384,758,",",I-Condition
11385,758,HIV,I-Condition
11386,758,",",I-Condition
11387,758,HDV,I-Condition
11388,758,coinfection,I-Condition
11389,758,.,O
11390,759,Uncontrolled,O
11391,759,HCC,B-Condition
11392,759,",",O
11393,759,malignancy,B-Condition
11394,759,or,O
11395,759,decompensated,O
11396,759,liver,B-Condition
11397,759,cirrhosis,I-Condition
11398,759,(,O
11399,759,CTP,O
11400,759,score,O
11401,759,=,O
11402,759,7,O
11403,759,),O
11404,759,.,O
11405,760,Uremia,B-Condition
11406,760,patients,O
11407,760,or,O
11408,760,Creatinine,O
11409,760,=,O
11410,760,2,O
11411,760,mg,O
11412,760,/,O
11413,760,dl,O
11414,760,.,O
11415,761,HBsAg,O
11416,761,-,O
11417,761,positive,O
11418,761,for,O
11419,761,more,O
11420,761,than,O
11421,761,6,O
11422,761,months,O
11423,761,(,O
11424,761,HBeAg,O
11425,761,-,O
11426,761,positive,O
11427,761,or,O
11428,761,HBeAg,O
11429,761,-,O
11430,761,negative,O
11431,761,),O
11432,761,.,O
11433,762,Age,B-Person
11434,762,>,O
11435,762,20,O
11436,762,y,O
11437,762,/,O
11438,762,o.,O
11439,763,Under,O
11440,763,lamivudine,B-Drug
11441,763,/,O
11442,763,adefovir,B-Drug
11443,763,treatment,O
11444,763,for,O
11445,763,more,O
11446,763,than,O
11447,763,1,O
11448,763,year,O
11449,763,due,O
11450,763,to,O
11451,763,previous,O
11452,763,lamivudine,B-Observation
11453,763,resistance,I-Observation
11454,763,(,O
11455,763,LAM,B-Observation
11456,763,-,I-Observation
11457,763,R,I-Observation
11458,763,),O
11459,763,",",O
11460,763,current,O
11461,763,HBV,O
11462,763,DNA,O
11463,763,is,O
11464,763,undetectable,O
11465,763,(,O
11466,763,<,O
11467,763,20,O
11468,763,IU,O
11469,763,/,O
11470,763,ml,O
11471,763,),O
11472,763,during,O
11473,763,enrollment,O
11474,763,.,O
11475,764,Prior,O
11476,764,chemotherapy,B-Procedure
11477,764,Prior,O
11478,764,treatment,B-Procedure
11479,764,with,O
11480,764,gefitinib,B-Drug
11481,764,",",O
11482,764,erlotinib,B-Drug
11483,764,",",O
11484,764,or,O
11485,764,other,O
11486,764,drugs,B-Drug
11487,764,that,I-Drug
11488,764,target,I-Drug
11489,764,EGFR,I-Drug
11490,764,Patients,O
11491,764,must,O
11492,764,not,O
11493,764,be,O
11494,764,receiving,O
11495,764,any,O
11496,764,other,O
11497,764,investigational,O
11498,764,agents,O
11499,764,Any,O
11500,764,evidence,O
11501,764,of,O
11502,764,interstitial,B-Condition
11503,764,lung,I-Condition
11504,764,disease,I-Condition
11505,765,Pathologic,B-Procedure
11506,765,confirmation,O
11507,765,of,O
11508,765,lung,B-Condition
11509,765,adenocarcinoma,I-Condition
11510,765,with,O
11511,765,measurable,O
11512,765,disease,O
11513,765,",",O
11514,765,defined,O
11515,765,as,O
11516,765,at,O
11517,765,least,O
11518,765,one,O
11519,765,lesion,B-Condition
11520,765,that,O
11521,765,can,O
11522,765,be,O
11523,765,accurately,O
11524,765,measured,O
11525,765,in,O
11526,765,at,O
11527,765,least,O
11528,765,one,O
11529,765,dimension,O
11530,765,(,O
11531,765,longest,O
11532,765,diameter,O
11533,765,to,O
11534,765,be,O
11535,765,recorded,O
11536,765,on,O
11537,765,CT,O
11538,765,),O
11539,765,;,O
11540,765,Patients,O
11541,765,must,O
11542,765,have,O
11543,765,previously,O
11544,765,untreated,O
11545,765,locally,O
11546,765,advanced,O
11547,765,or,O
11548,765,metastatic,O
11549,765,NSCLC,B-Condition
11550,765,;,O
11551,765,Patients,O
11552,765,must,O
11553,765,have,O
11554,765,lung,B-Condition
11555,765,cancer,I-Condition
11556,765,with,O
11557,765,a,O
11558,765,documented,O
11559,765,EGFR,O
11560,765,activating,O
11561,765,mutation,O
11562,765,(,O
11563,765,exon,B-Condition
11564,765,19,I-Condition
11565,765,deletion,I-Condition
11566,765,",",O
11567,765,L858R,B-Condition
11568,765,),O
11569,765,.,O
11570,766,Prior,O
11571,766,treatment,O
11572,766,with,O
11573,766,a,O
11574,766,bisphosphonate,B-Drug
11575,767,Abnormal,O
11576,767,renal,O
11577,767,function,O
11578,767,as,O
11579,767,evidenced,O
11580,767,by,O
11581,767,a,O
11582,767,calculated,O
11583,767,creatinine,O
11584,767,clearance,O
11585,767,<,O
11586,767,30,O
11587,767,ml,O
11588,767,/,O
11589,767,minute,O
11590,767,.,O
11591,768,Corrected,O
11592,768,(,O
11593,768,adjusted,O
11594,768,for,O
11595,768,serum,O
11596,768,albumin,O
11597,768,),O
11598,768,serum,O
11599,768,calcium,O
11600,768,concentration,O
11601,768,<,O
11602,768,8.0,O
11603,768,mg,O
11604,768,/,O
11605,768,dl,O
11606,768,(,O
11607,768,2.00,O
11608,768,mmol,O
11609,768,/,O
11610,768,L,O
11611,768,),O
11612,768,or,O
11613,768,≥,O
11614,768,12.0,O
11615,768,mg,O
11616,768,/,O
11617,768,dl,O
11618,768,(,O
11619,768,3.00,O
11620,768,mmol,O
11621,768,/,O
11622,768,L,O
11623,768,),O
11624,768,.,O
11625,769,Patients,O
11626,769,with,O
11627,769,clinically,B-Observation
11628,769,symptomatic,I-Observation
11629,769,brain,B-Condition
11630,769,metastases,I-Condition
11631,770,History,B-Observation
11632,770,of,O
11633,770,diseases,B-Condition
11634,770,with,I-Condition
11635,770,influence,I-Condition
11636,770,on,I-Condition
11637,770,bone,I-Condition
11638,770,metabolism,I-Condition
11639,770,such,O
11640,770,as,O
11641,770,Paget,B-Condition
11642,770,'s,I-Condition
11643,770,disease,I-Condition
11644,770,and,O
11645,770,primary,B-Condition
11646,770,hyperparathyroidism,I-Condition
11647,771,Severe,O
11648,771,physical,B-Condition
11649,771,or,I-Condition
11650,771,psychological,I-Condition
11651,771,concomitant,I-Condition
11652,771,diseases,I-Condition
11653,771,that,O
11654,771,might,O
11655,771,impair,O
11656,771,compliance,O
11657,771,with,O
11658,771,the,O
11659,771,provisions,O
11660,771,of,O
11661,771,the,O
11662,771,study,O
11663,771,protocol,O
11664,771,or,O
11665,771,that,O
11666,771,might,O
11667,771,impair,O
11668,771,the,O
11669,771,assessment,O
11670,771,of,O
11671,771,drug,O
11672,771,or,O
11673,771,patient,O
11674,771,safety,O
11675,771,",",O
11676,771,e.g.,O
11677,771,clinically,O
11678,771,significant,O
11679,771,ascites,B-Condition
11680,771,",",O
11681,771,cardiac,B-Condition
11682,771,failure,I-Condition
11683,771,",",O
11684,771,NYHA,O
11685,771,III,O
11686,771,or,O
11687,771,IV,O
11688,771,",",O
11689,771,clinically,O
11690,771,relevant,O
11691,771,pathologic,B-Observation
11692,771,findings,I-Observation
11693,771,in,O
11694,771,ECG,B-Procedure
11695,772,Known,O
11696,772,hypersensitivity,B-Condition
11697,772,to,O
11698,772,zoledronic,B-Drug
11699,772,acid,I-Drug
11700,772,or,O
11701,772,other,B-Drug
11702,772,bisphosphonates,I-Drug
11703,773,Use,O
11704,773,of,O
11705,773,other,B-Drug
11706,773,investigational,I-Drug
11707,773,drugs,I-Drug
11708,773,30,O
11709,773,days,O
11710,773,prior,O
11711,773,to,O
11712,773,the,O
11713,773,date,O
11714,773,of,O
11715,773,randomization,O
11716,774,Known,O
11717,774,history,B-Observation
11718,774,or,O
11719,774,present,O
11720,774,abuse,B-Condition
11721,774,of,I-Condition
11722,774,alcohol,I-Condition
11723,774,or,I-Condition
11724,774,drugs,I-Condition
11725,775,Subjects,O
11726,775,who,O
11727,775,",",O
11728,775,in,O
11729,775,the,O
11730,775,opinion,O
11731,775,of,O
11732,775,the,O
11733,775,investigator,O
11734,775,",",O
11735,775,are,O
11736,775,unlikely,O
11737,775,to,O
11738,775,cooperate,O
11739,775,fully,O
11740,775,during,O
11741,775,the,O
11742,775,study,O
11743,776,Current,O
11744,776,active,O
11745,776,dental,B-Condition
11746,776,problems,I-Condition
11747,776,including,O
11748,776,infection,B-Condition
11749,776,of,I-Condition
11750,776,the,I-Condition
11751,776,teeth,I-Condition
11752,776,or,I-Condition
11753,776,jawbone,I-Condition
11754,776,(,I-Condition
11755,776,maxilla,I-Condition
11756,776,or,I-Condition
11757,776,mandibular,I-Condition
11758,776,),O
11759,776,;,O
11760,776,dental,B-Condition
11761,776,or,I-Condition
11762,776,fixture,I-Condition
11763,776,trauma,I-Condition
11764,776,",",O
11765,776,or,O
11766,776,a,O
11767,776,current,O
11768,776,or,O
11769,776,prior,O
11770,776,diagnosis,O
11771,776,of,O
11772,776,osteonecrosis,B-Condition
11773,776,of,I-Condition
11774,776,the,I-Condition
11775,776,jaw,I-Condition
11776,776,(,I-Condition
11777,776,ONJ,I-Condition
11778,776,),I-Condition
11779,776,",",O
11780,776,of,O
11781,776,exposed,B-Condition
11782,776,bone,I-Condition
11783,776,in,I-Condition
11784,776,the,I-Condition
11785,776,mouth,I-Condition
11786,776,",",O
11787,776,or,O
11788,776,of,O
11789,776,slow,B-Condition
11790,776,healing,I-Condition
11791,776,after,I-Condition
11792,776,dental,I-Condition
11793,776,procedures,I-Condition
11794,776,.,O
11795,777,Recent,O
11796,777,(,O
11797,777,within,O
11798,777,6,O
11799,777,weeks,O
11800,777,),O
11801,777,or,O
11802,777,planned,B-Observation
11803,777,dental,B-Procedure
11804,777,or,I-Procedure
11805,777,jaw,I-Procedure
11806,777,surgery,I-Procedure
11807,777,(,O
11808,777,e.g.,O
11809,777,extraction,B-Procedure
11810,777,",",O
11811,777,implants,B-Procedure
11812,777,),O
11813,778,Other,O
11814,778,protocol,O
11815,778,defined,O
11816,778,inclusion,O
11817,778,/,O
11818,778,exclusion,O
11819,778,criteria,O
11820,778,may,O
11821,778,apply,O
11822,778,.,O
11823,779,Patients,O
11824,779,with,O
11825,779,histologically,O
11826,779,confirmed,O
11827,779,diagnosis,O
11828,779,of,O
11829,779,prostate,B-Condition
11830,779,cancer,I-Condition
11831,779,who,O
11832,779,have,O
11833,779,not,O
11834,779,yet,O
11835,779,developed,O
11836,779,bone,B-Condition
11837,779,metastases,I-Condition
11838,780,Prostate,B-Condition
11839,780,cancer,I-Condition
11840,780,patients,O
11841,780,with,O
11842,780,a,O
11843,780,rise,O
11844,780,in,O
11845,780,PSA,O
11846,780,under,O
11847,780,hormone,B-Procedure
11848,780,therapy,I-Procedure
11849,780,.,O
11850,781,PSA,O
11851,781,criteria,O
11852,781,:,O
11853,782,Patients,O
11854,782,who,O
11855,782,have,O
11856,782,undergone,O
11857,782,prostatectomy,B-Procedure
11858,782,:,O
11859,782,any,O
11860,782,rise,O
11861,782,in,O
11862,782,PSA,O
11863,782,or,O
11864,783,Patients,O
11865,783,without,O
11866,783,prostatectomy,B-Procedure
11867,783,:,O
11868,783,2,O
11869,783,consecutive,O
11870,783,rises,O
11871,783,in,O
11872,783,PSA,O
11873,783,levels,O
11874,783,relative,O
11875,783,to,O
11876,783,a,O
11877,783,previous,O
11878,783,reference,O
11879,783,value,O
11880,783,",",O
11881,783,separated,O
11882,783,by,O
11883,783,one,O
11884,783,month,O
11885,783,.,O
11886,783,The,O
11887,783,first,O
11888,783,measurement,B-Procedure
11889,783,must,O
11890,783,occur,O
11891,783,one,O
11892,783,month,O
11893,783,after,O
11894,783,the,O
11895,783,reference,O
11896,783,value,O
11897,783,and,O
11898,783,must,O
11899,783,be,O
11900,783,above,O
11901,783,the,O
11902,783,reference,O
11903,783,value,O
11904,783,.,O
11905,783,The,O
11906,783,second,O
11907,783,confirmatory,O
11908,783,measurement,B-Procedure
11909,783,taken,O
11910,783,one,O
11911,783,month,O
11912,783,after,O
11913,783,the,O
11914,783,first,O
11915,783,measurement,O
11916,783,must,O
11917,783,be,O
11918,783,greater,O
11919,783,than,O
11920,783,the,O
11921,783,first,O
11922,783,measurement,O
11923,783,.,O
11924,784,Previous,O
11925,784,chemotherapy,B-Procedure
11926,784,or,O
11927,784,radiotherapy,B-Procedure
11928,784,must,O
11929,784,have,O
11930,784,been,O
11931,784,performed,O
11932,784,≥,O
11933,784,8,O
11934,784,weeks,O
11935,784,prior,O
11936,784,to,O
11937,784,study,O
11938,784,entry,O
11939,784,.,O
11940,785,Eastern,O
11941,785,Cooperative,O
11942,785,Oncology,O
11943,785,Group,O
11944,785,(,O
11945,785,ECOG,O
11946,785,),O
11947,785,score,O
11948,785,of,O
11949,785,0,O
11950,785,",",O
11951,785,1,O
11952,785,or,O
11953,785,2,O
11954,785,(,O
11955,785,patients,O
11956,785,that,O
11957,785,spend,O
11958,785,less,O
11959,785,than,O
11960,785,50,O
11961,785,%,O
11962,785,of,O
11963,785,time,O
11964,785,in,O
11965,785,bed,O
11966,785,during,O
11967,785,the,O
11968,785,day,O
11969,785,),O
11970,786,Adequate,O
11971,786,liver,O
11972,786,function,O
11973,786,-,O
11974,786,serum,O
11975,786,total,O
11976,786,bilirubin,O
11977,786,concentration,O
11978,786,less,O
11979,786,than,O
11980,786,1.5,O
11981,786,x,O
11982,786,upper,O
11983,786,limit,O
11984,786,of,O
11985,786,normal,O
11986,786,value,O
11987,787,Age,B-Person
11988,787,:,O
11989,787,≥,O
11990,787,18,O
11991,787,years,O
11992,788,Patient,O
11993,788,has,O
11994,788,given,O
11995,788,written,O
11996,788,informed,O
11997,788,consent,O
11998,788,prior,O
11999,788,to,O
12000,788,any,O
12001,788,study,O
12002,788,-,O
12003,788,specific,O
12004,788,procedures,O
12005,788,.,O
12006,788,Patients,O
12007,788,with,O
12008,788,psychiatric,B-Condition
12009,788,or,I-Condition
12010,788,addictive,I-Condition
12011,788,disorders,I-Condition
12012,788,which,O
12013,788,prevent,O
12014,788,them,O
12015,788,from,O
12016,788,giving,B-Observation
12017,788,their,I-Observation
12018,788,informed,I-Observation
12019,788,consent,I-Observation
12020,788,must,O
12021,788,not,O
12022,788,enter,O
12023,788,the,O
12024,788,study,O
12025,788,.,O
12026,789,1,O
12027,789,.,O
12028,789,Need,O
12029,789,for,O
12030,789,combined,B-Procedure
12031,789,organ,I-Procedure
12032,789,transplantation,I-Procedure
12033,789,with,O
12034,789,an,O
12035,789,extra,O
12036,789,-,O
12037,789,renal,O
12038,789,organ,O
12039,789,and/or,O
12040,789,islet,B-Procedure
12041,789,cell,I-Procedure
12042,789,transplant,I-Procedure
12043,789,.,O
12044,790,2,O
12045,790,.,O
12046,790,Recipients,O
12047,790,of,O
12048,790,previous,O
12049,790,non,B-Procedure
12050,790,-,I-Procedure
12051,790,renal,I-Procedure
12052,790,solid,I-Procedure
12053,790,organ,I-Procedure
12054,790,and/or,I-Procedure
12055,790,islet,I-Procedure
12056,790,cell,I-Procedure
12057,790,transplantation,I-Procedure
12058,790,.,O
12059,791,3,O
12060,791,.,O
12061,791,Infection,B-Condition
12062,791,with,I-Condition
12063,791,HIV,I-Condition
12064,791,.,O
12065,792,4,O
12066,792,.,O
12067,792,Inability,O
12068,792,or,O
12069,792,unwillingness,O
12070,792,of,O
12071,792,a,O
12072,792,participant,O
12073,792,and/or,O
12074,792,guardian,O
12075,792,to,O
12076,792,provide,O
12077,792,informed,O
12078,792,consent,O
12079,793,1,O
12080,793,.,O
12081,793,Male,B-Person
12082,793,and,O
12083,793,female,B-Person
12084,793,recipients,O
12085,793,of,O
12086,793,all,O
12087,793,races,O
12088,793,",",O
12089,793,≥18,O
12090,793,years,O
12091,793,of,O
12092,793,age,B-Person
12093,793,.,O
12094,794,2,O
12095,794,.,O
12096,794,Patients,O
12097,794,undergoing,O
12098,794,primary,O
12099,794,or,O
12100,794,subsequent,O
12101,794,deceased,B-Procedure
12102,794,-,I-Procedure
12103,794,donor,I-Procedure
12104,794,or,I-Procedure
12105,794,living,I-Procedure
12106,794,donor,I-Procedure
12107,794,kidney,I-Procedure
12108,794,transplantation,I-Procedure
12109,794,.,O
12110,795,3,O
12111,795,.,O
12112,795,Subject,O
12113,795,and/or,O
12114,795,guardian,O
12115,795,must,O
12116,795,be,O
12117,795,able,O
12118,795,to,O
12119,795,provide,O
12120,795,informed,O
12121,795,consent,O
12122,795,.,O
12123,796,4,O
12124,796,.,O
12125,796,Subject,O
12126,796,and/or,O
12127,796,guardian,O
12128,796,must,O
12129,796,be,O
12130,796,able,O
12131,796,to,O
12132,796,comply,O
12133,796,with,O
12134,796,the,O
12135,796,study,O
12136,796,protocol,O
12137,796,.,O
12138,797,ASA,B-Condition
12139,797,3,I-Condition
12140,797,+,I-Condition
12141,798,No,O
12142,798,current,O
12143,798,treatment,B-Observation
12144,798,plan,I-Observation
12145,798,at,O
12146,798,OHSU,O
12147,799,Severely,O
12148,799,carious,B-Condition
12149,799,teeth,I-Condition
12150,799,resulting,O
12151,799,in,O
12152,799,inability,B-Condition
12153,799,to,I-Condition
12154,799,isolate,I-Condition
12155,799,for,I-Condition
12156,799,procedure,I-Condition
12157,800,Unable,O
12158,800,to,O
12159,800,understand,O
12160,800,or,O
12161,800,sign,O
12162,800,consent,O
12163,800,form,O
12164,801,ASA,B-Condition
12165,801,1,I-Condition
12166,802,ASA,B-Condition
12167,802,2,I-Condition
12168,803,Pts,O
12169,803,have,O
12170,803,current,O
12171,803,treatment,B-Observation
12172,803,plan,I-Observation
12173,803,at,I-Observation
12174,803,OHSU,I-Observation
12175,803,for,O
12176,803,extraction,O
12177,803,of,O
12178,803,some,O
12179,803,or,O
12180,803,all,O
12181,803,of,O
12182,803,remaining,O
12183,803,teeth,O
12184,803,and,O
12185,803,scheduled,B-Mood
12186,803,for,I-Mood
12187,803,delivery,O
12188,803,of,O
12189,803,a,O
12190,803,removable,O
12191,803,appliance,O
12192,803,post,O
12193,803,extraction,O
12194,804,Teeth,O
12195,804,used,O
12196,804,are,O
12197,804,able,O
12198,804,to,O
12199,804,be,O
12200,804,isolated,O
12201,804,with,O
12202,804,rubber,O
12203,804,dam,O
12204,805,Understand,O
12205,805,and,O
12206,805,sign,O
12207,805,consent,O
12208,805,form,O
12209,806,Pre,O
12210,806,-,O
12211,806,existing,O
12212,806,eye,B-Condition
12213,806,diseases,I-Condition
12214,806,(,O
12215,806,glaucoma,B-Condition
12216,806,),O
12217,806,.,O
12218,807,Insufficient,B-Observation
12219,807,response,I-Observation
12220,807,to,O
12221,807,pregabalin,B-Drug
12222,807,in,O
12223,807,the,O
12224,807,treatment,O
12225,807,of,O
12226,807,partial,B-Condition
12227,807,seizure,I-Condition
12228,807,",",O
12229,807,or,O
12230,807,patients,O
12231,807,currently,O
12232,807,receiving,O
12233,807,pregabalin,B-Drug
12234,807,treatment,O
12235,807,.,O
12236,808,Epilepsy,B-Condition
12237,808,partial,B-Condition
12238,808,seizure,I-Condition
12239,808,subjects,O
12240,808,.,O
12241,809,Currently,O
12242,809,taking,O
12243,809,1,O
12244,809,to,O
12245,809,3,O
12246,809,antiepileptic,B-Drug
12247,809,drugs,I-Drug
12248,809,.,O
12249,810,diabetes,B-Condition
12250,811,ischemic,B-Condition
12251,811,heart,I-Condition
12252,811,disease,I-Condition
12253,811,or,O
12254,811,any,O
12255,811,abnormality,O
12256,811,on,O
12257,811,treadmill,O
12258,811,stress,O
12259,811,test,O
12260,812,inflammatory,O
12261,812,or,O
12262,812,chronic,B-Condition
12263,812,disorder,I-Condition
12264,813,pregnancy,B-Condition
12265,814,lactation,B-Condition
12266,815,creatinine,O
12267,815,level,O
12268,815,of,O
12269,815,"1,5",O
12270,815,mg,O
12271,815,/,O
12272,815,dL,O
12273,815,or,O
12274,815,more,O
12275,816,gastrointestinal,B-Condition
12276,816,problems,I-Condition
12277,816,or,O
12278,816,musculoskeletal,B-Condition
12279,816,disorders,I-Condition
12280,816,that,O
12281,816,would,O
12282,816,prevent,B-Mood
12283,816,them,O
12284,816,to,O
12285,816,follow,O
12286,816,the,O
12287,816,test,B-Procedure
12288,816,diets,I-Procedure
12289,816,or,O
12290,816,exercise,B-Procedure
12291,816,interventions,I-Procedure
12292,817,liver,B-Condition
12293,817,dysfunction,I-Condition
12294,817,with,O
12295,817,a,O
12296,817,factor,O
12297,817,of,O
12298,817,at,O
12299,817,least,O
12300,817,3,O
12301,817,above,O
12302,817,the,O
12303,817,upper,O
12304,817,limit,O
12305,817,of,O
12306,817,normal,O
12307,817,in,O
12308,817,AST,O
12309,817,and,O
12310,817,ALT,O
12311,817,levels,O
12312,818,thyroid,B-Condition
12313,818,dysfunction,I-Condition
12314,818,",",O
12315,818,with,O
12316,818,serum,O
12317,818,TSH,O
12318,818,out,O
12319,818,of,O
12320,818,normal,O
12321,818,limits,O
12322,819,use,O
12323,819,of,O
12324,819,immunosuppressive,B-Drug
12325,819,drugs,I-Drug
12326,819,",",O
12327,819,corticosteroids,B-Drug
12328,819,or,O
12329,819,anorexigen,B-Drug
12330,820,men,B-Person
12331,820,and,O
12332,820,women,B-Person
12333,820,30,B-Person
12334,820,-,I-Person
12335,820,55,I-Person
12336,820,years,I-Person
12337,820,with,O
12338,820,BMI,O
12339,820,30,O
12340,820,-,O
12341,820,40,O
12342,820,and,O
12343,820,waist,O
12344,820,95,O
12345,820,cm,O
12346,820,or,O
12347,820,more,O
12348,821,normal,O
12349,821,OGTT,O
12350,822,normal,O
12351,822,treadmill,O
12352,822,stress,O
12353,822,test,O
12354,823,plus,O
12355,823,2,O
12356,823,of,O
12357,823,4,O
12358,823,:,O
12359,824,1,O
12360,824,.,O
12361,824,low,O
12362,824,serum,O
12363,824,levels,O
12364,824,of,O
12365,824,HDL,O
12366,824,cholesterol,O
12367,824,(,O
12368,824,<,O
12369,824,40,O
12370,824,mg,O
12371,824,/,O
12372,824,dL,O
12373,824,for,O
12374,824,men,B-Person
12375,824,or,O
12376,824,<,O
12377,824,50,O
12378,824,mg,O
12379,824,/dL,O
12380,824,for,O
12381,824,women,B-Person
12382,824,),O
12383,824,;,O
12384,825,2,O
12385,825,.,O
12386,825,hypertriglyceridemia,B-Condition
12387,825,(,O
12388,825,triglyceride,O
12389,825,levels,O
12390,825,of,O
12391,825,150,O
12392,825,mg,O
12393,825,/,O
12394,825,dL,O
12395,825,or,O
12396,825,greater,O
12397,825,),O
12398,825,;,O
12399,826,3,O
12400,826,.,O
12401,826,impaired,B-Condition
12402,826,glucose,I-Condition
12403,826,homeostasis,I-Condition
12404,826,(,O
12405,826,fasting,O
12406,826,plasma,O
12407,826,glucose,O
12408,826,concentration,O
12409,826,of,O
12410,826,110,O
12411,826,mg,O
12412,826,/,O
12413,826,dL,O
12414,826,or,O
12415,826,greater,O
12416,826,or,O
12417,826,glucose,O
12418,826,of,O
12419,826,140,O
12420,826,mg,O
12421,826,/,O
12422,826,dL,O
12423,826,or,O
12424,826,greater,O
12425,826,after,O
12426,826,OGTT,B-Procedure
12427,826,or,O
12428,827,4,O
12429,827,.,O
12430,827,hypertension,B-Condition
12431,827,(,O
12432,827,systolic,O
12433,827,blood,O
12434,827,pressure,O
12435,827,≥,O
12436,827,140,O
12437,827,or,O
12438,827,diastolic,O
12439,827,blood,O
12440,827,pressure,O
12441,827,≥90,O
12442,827,mmHg,O
12443,827,or,O
12444,827,treatment,B-Procedure
12445,827,with,O
12446,827,antihypertensive,B-Drug
12447,827,drugs,I-Drug
12448,827,),O
12449,827,.,O
12450,828,Known,O
12451,828,hypersensitivity,B-Condition
12452,828,to,O
12453,828,tetracycline,B-Drug
12454,828,",",O
12455,828,doxycycline,B-Drug
12456,828,or,O
12457,828,azithromycin,B-Drug
12458,829,Administration,O
12459,829,of,O
12460,829,doxycycline,B-Drug
12461,829,",",O
12462,829,azithromycin,B-Drug
12463,829,",",O
12464,829,chloramphenicol,B-Drug
12465,829,",",O
12466,829,rifampicin,B-Drug
12467,829,",",O
12468,829,or,O
12469,829,tetracycline,B-Drug
12470,829,during,O
12471,829,the,O
12472,829,preceding,O
12473,829,7,O
12474,829,days,O
12475,830,Pregnancy,B-Condition
12476,830,or,O
12477,830,breast,B-Observation
12478,830,-,I-Observation
12479,830,feeding,I-Observation
12480,831,Patients,O
12481,831,with,O
12482,831,myasthenia,B-Condition
12483,831,gravis,I-Condition
12484,831,or,O
12485,831,systemic,B-Condition
12486,831,lupus,I-Condition
12487,831,erythematosus,I-Condition
12488,832,Patients,O
12489,832,with,O
12490,832,an,O
12491,832,established,O
12492,832,infection,B-Condition
12493,832,(,O
12494,832,diagnostic,B-Procedure
12495,832,test,I-Procedure
12496,832,required,O
12497,832,),O
12498,832,e.g.,O
12499,832,acute,B-Condition
12500,832,malaria,I-Condition
12501,832,",",O
12502,832,dengue,B-Condition
12503,832,",",O
12504,832,leptospirosis,B-Condition
12505,832,",",O
12506,832,typhoid,B-Condition
12507,832,",",O
12508,832,Japanese,B-Condition
12509,832,encephalitis,I-Condition
12510,832,etc,O
12511,832,.,O
12512,833,Current,O
12513,833,TB,B-Condition
12514,833,or,O
12515,833,TB,B-Procedure
12516,833,treatment,I-Procedure
12517,833,in,O
12518,833,=,O
12519,833,6,O
12520,833,months,O
12521,833,(,O
12522,833,contain,O
12523,833,active,O
12524,833,antibiotics,O
12525,833,against,O
12526,833,Orientia,O
12527,833,spp,O
12528,833,.,O
12529,833,),O
12530,834,Current,O
12531,834,HAART,B-Procedure
12532,834,use,O
12533,834,for,O
12534,834,HIV,B-Condition
12535,834,",",O
12536,834,long,O
12537,834,term,O
12538,834,use,O
12539,834,of,O
12540,834,immunosuppressants,B-Drug
12541,834,(,O
12542,834,e.g.,O
12543,834,steroids,B-Drug
12544,834,",",O
12545,834,chemotherapy,B-Drug
12546,834,",",O
12547,834,TNF,B-Drug
12548,834,-,I-Drug
12549,834,inhibitors,I-Drug
12550,834,and,O
12551,834,related,O
12552,834,agents,O
12553,834,),O
12554,835,Patients,O
12555,835,with,O
12556,835,severe,O
12557,835,disease,O
12558,835,whom,O
12559,835,the,O
12560,835,clinical,O
12561,835,team,O
12562,835,feel,O
12563,835,their,O
12564,835,condition,O
12565,835,necessitates,O
12566,835,the,O
12567,835,need,O
12568,835,for,O
12569,835,additional,O
12570,835,scrub,O
12571,835,typhus,O
12572,835,treatment,O
12573,835,beyond,O
12574,835,the,O
12575,835,allocated,O
12576,835,antibiotic,O
12577,835,treatment,O
12578,835,assigned,O
12579,835,at,O
12580,835,randomization,O
12581,835,(,O
12582,835,e.g.,O
12583,835,IV,O
12584,835,chloramphenicol,O
12585,835,and/or,O
12586,835,PO,O
12587,835,/,O
12588,835,NG,O
12589,835,rifampicin,O
12590,835,),O
12591,836,Age,B-Person
12592,836,=,O
12593,836,15,O
12594,836,years,O
12595,836,old,O
12596,837,Hospitalization,B-Procedure
12597,837,with,O
12598,837,acute,B-Condition
12599,837,undifferentiated,I-Condition
12600,837,fever,I-Condition
12601,837,(,O
12602,837,temperature,O
12603,837,>,O
12604,837,37.5,O
12605,837,C,O
12606,837,",",O
12607,837,tympanic,B-Condition
12608,837,),O
12609,837,=,O
12610,837,14,O
12611,837,days,O
12612,837,or,O
12613,837,patients,O
12614,837,admitted,B-Procedure
12615,837,to,I-Procedure
12616,837,hospital,I-Procedure
12617,837,with,O
12618,837,a,O
12619,837,history,B-Observation
12620,837,of,O
12621,837,fever,B-Condition
12622,837,=,O
12623,837,14,O
12624,837,days,O
12625,837,who,O
12626,837,subsequently,O
12627,837,develop,O
12628,837,fever,B-Condition
12629,837,within,O
12630,837,24,O
12631,837,hours,O
12632,837,of,O
12633,837,admission,O
12634,838,Clinically,O
12635,838,suspected,O
12636,838,scrub,B-Condition
12637,838,typhus,I-Condition
12638,838,:,O
12639,838,defined,O
12640,838,as,O
12641,838,acute,B-Condition
12642,838,undifferentiated,I-Condition
12643,838,fever,I-Condition
12644,838,with,O
12645,838,no,O
12646,838,clear,O
12647,838,focus,B-Condition
12648,838,of,I-Condition
12649,838,infection,I-Condition
12650,838,and,O
12651,838,negative,O
12652,838,malaria,O
12653,838,blood,O
12654,838,smear,O
12655,838,and/or,O
12656,838,negative,O
12657,838,malaria,O
12658,838,RDT,O
12659,838,.,O
12660,838,Patients,O
12661,838,may,O
12662,838,have,O
12663,838,one,O
12664,838,",",O
12665,838,none,O
12666,838,",",O
12667,838,or,O
12668,838,a,O
12669,838,combination,O
12670,838,of,O
12671,838,other,O
12672,838,clinical,O
12673,838,findings,O
12674,838,such,O
12675,838,as,O
12676,838,eschar,B-Condition
12677,838,",",O
12678,838,rash,B-Condition
12679,838,",",O
12680,838,lymphadenopathy,B-Condition
12681,838,",",O
12682,838,headache,B-Condition
12683,838,",",O
12684,838,myalgia,B-Condition
12685,838,",",O
12686,838,cough,B-Condition
12687,838,",",O
12688,838,nausea,B-Condition
12689,838,and,O
12690,838,abdominal,B-Condition
12691,838,discomfort,I-Condition
12692,838,.,O
12693,839,A,O
12694,839,positive,O
12695,839,scrub,O
12696,839,typhus,O
12697,839,RDT,O
12698,839,(,O
12699,839,Scrub,B-Procedure
12700,839,Typhus,I-Procedure
12701,839,IgM,I-Procedure
12702,839,RDT,I-Procedure
12703,839,",",O
12704,839,InBios,O
12705,839,International,O
12706,839,",",O
12707,839,Seattle,O
12708,839,",",O
12709,839,WA,O
12710,839,",",O
12711,839,USA,O
12712,839,),O
12713,839,and/or,O
12714,839,positive,O
12715,839,PCR,B-Procedure
12716,839,-,O
12717,839,based,O
12718,839,detection,O
12719,839,of,O
12720,839,O.,O
12721,839,tsutsugamushi,O
12722,839,DNA,O
12723,839,from,O
12724,839,the,O
12725,839,admission,O
12726,839,blood,O
12727,839,sample,O
12728,840,Written,B-Observation
12729,840,informed,I-Observation
12730,840,consent,I-Observation
12731,840,and/or,O
12732,840,",",O
12733,840,written,B-Observation
12734,840,informed,I-Observation
12735,840,assent,I-Observation
12736,840,as,O
12737,840,required,O
12738,841,Able,B-Observation
12739,841,to,I-Observation
12740,841,take,I-Observation
12741,841,oral,I-Observation
12742,841,medication,I-Observation
12743,842,Suspected,O
12744,842,or,O
12745,842,confirmed,O
12746,842,active,B-Condition
12747,842,TB,I-Condition
12748,842,disease,O
12749,843,Known,O
12750,843,allergies,B-Condition
12751,843,to,O
12752,843,any,O
12753,843,of,O
12754,843,the,O
12755,843,study,O
12756,843,medications,O
12757,843,by,O
12758,843,participant,O
12759,843,self,O
12760,843,-,O
12761,843,report,O
12762,844,have,O
12763,844,a,O
12764,844,positive,O
12765,844,pregnancy,O
12766,844,test,O
12767,844,at,O
12768,844,screening,O
12769,844,",",O
12770,844,or,O
12771,845,are,O
12772,845,not,O
12773,845,willing,O
12774,845,to,O
12775,845,use,O
12776,845,a,O
12777,845,reliable,O
12778,845,method,O
12779,845,of,O
12780,845,barrier,O
12781,845,contraception,O
12782,845,during,O
12783,845,the,O
12784,845,study,O
12785,845,",",O
12786,845,or,O
12787,846,are,O
12788,846,breastfeeding,O
12789,847,hormonal,B-Procedure
12790,847,contraception,I-Procedure
12791,848,HIV,B-Condition
12792,848,infected,I-Condition
12793,848,participants,O
12794,848,who,O
12795,848,are,O
12796,848,on,O
12797,848,anti,B-Drug
12798,848,-,I-Drug
12799,848,retroviral,I-Drug
12800,848,drugs,I-Drug
12801,849,other,O
12802,849,drugs,O
12803,849,that,O
12804,849,interact,O
12805,849,with,O
12806,849,3HP,O
12807,849,(,O
12808,849,see,O
12809,849,Table,O
12810,849,1,O
12811,849,),O
12812,850,Known,O
12813,850,contact,O
12814,850,with,O
12815,850,an,O
12816,850,INH,B-Drug
12817,850,or,O
12818,850,rifampin,B-Drug
12819,850,resistant,B-Condition
12820,850,case,O
12821,851,Weight,O
12822,851,<,O
12823,851,10,O
12824,851,kg,O
12825,852,Evidence,O
12826,852,of,O
12827,852,possible,O
12828,852,liver,B-Condition
12829,852,damage,I-Condition
12830,852,defined,O
12831,852,by,O
12832,852,an,O
12833,852,aspartate,O
12834,852,transaminase,O
12835,852,(,O
12836,852,AST,O
12837,852,),O
12838,852,level,O
12839,852,that,O
12840,852,is,O
12841,852,more,O
12842,852,than,O
12843,852,3x,O
12844,852,the,O
12845,852,upper,O
12846,852,limit,O
12847,852,of,O
12848,852,normal,O
12849,852,in,O
12850,852,an,O
12851,852,asymptomatic,O
12852,852,patient,O
12853,853,Porphyria,B-Condition
12854,853,reported,O
12855,853,by,O
12856,853,patient,O
12857,854,Inability,O
12858,854,to,O
12859,854,adhere,O
12860,854,to,O
12861,854,protocol,O
12862,854,.,O
12863,855,Patients,O
12864,855,may,O
12865,855,be,O
12866,855,excluded,O
12867,855,from,O
12868,855,the,O
12869,855,study,O
12870,855,for,O
12871,855,other,O
12872,855,reasons,O
12873,855,",",O
12874,855,at,O
12875,855,the,O
12876,855,investigator,O
12877,855,'s,O
12878,855,discretion,O
12879,855,with,O
12880,855,detailed,O
12881,855,documentation,O
12882,855,.,O
12883,856,Males,B-Person
12884,856,or,O
12885,856,non,O
12886,856,-,O
12887,856,pregnant,O
12888,856,",",O
12889,856,non,O
12890,856,-,O
12891,856,nursing,O
12892,856,females,B-Person
12893,856,between,O
12894,856,the,O
12895,856,ages,B-Person
12896,856,of,O
12897,856,2,O
12898,856,-,O
12899,856,65,O
12900,856,years,O
12901,857,LTBI,B-Condition
12902,857,diagnosis,O
12903,857,as,O
12904,857,per,O
12905,857,Canadian,O
12906,857,TB,O
12907,857,Standards,O
12908,857,using,O
12909,857,either,O
12910,857,the,O
12911,857,Tuberculin,O
12912,857,Skin,O
12913,857,Test,O
12914,857,(,O
12915,857,TST,O
12916,857,),O
12917,857,or,O
12918,857,the,O
12919,857,Interferon,O
12920,857,Gamma,O
12921,857,Release,O
12922,857,Assay,O
12923,857,(,O
12924,857,IGRA,O
12925,857,),O
12926,858,Children,B-Person
12927,858,2,O
12928,858,-,O
12929,858,5,O
12930,858,years,B-Person
12931,858,with,O
12932,858,negative,O
12933,858,TSTs,O
12934,858,who,O
12935,858,have,O
12936,858,been,O
12937,858,in,O
12938,858,close,O
12939,858,contact,O
12940,858,with,O
12941,858,a,O
12942,858,case,O
12943,858,of,O
12944,858,active,O
12945,858,TB,O
12946,858,disease,O
12947,858,recently,O
12948,859,Able,O
12949,859,and,O
12950,859,willing,O
12951,859,to,O
12952,859,provide,O
12953,859,fully,O
12954,859,informed,O
12955,859,consent,O
12956,859,or,O
12957,859,parent,O
12958,859,/,O
12959,859,guardian,O
12960,859,able,O
12961,859,to,O
12962,859,provide,O
12963,859,consent,O
12964,860,NA,O
12965,861,>,O
12966,861,18,O
12967,861,years,O
12968,861,old,B-Person
12969,862,Acute,O
12970,862,symptomatic,O
12971,862,BV,B-Condition
12972,863,Signed,O
12973,863,informed,O
12974,863,consent,O
12975,864,Insufficient,B-Observation
12976,864,knowledge,I-Observation
12977,864,of,I-Observation
12978,864,German,I-Observation
12979,865,Illiteracy,B-Observation
12980,866,Pregnancy,B-Condition
12981,867,Acute,B-Condition
12982,867,illness,I-Condition
12983,868,Known,O
12984,868,allergies,B-Condition
12985,868,against,O
12986,868,ingredients,B-Drug
12987,868,of,I-Drug
12988,868,the,I-Drug
12989,868,investigational,I-Drug
12990,868,products,I-Drug
12991,869,Pregnancy,O
12992,869,(,O
12993,869,a,O
12994,869,negative,O
12995,869,serum,O
12996,869,or,O
12997,869,urine,O
12998,869,pregnancy,O
12999,869,test,O
13000,869,should,O
13001,869,be,O
13002,869,available,O
13003,869,for,O
13004,869,women,O
13005,869,of,O
13006,869,child,O
13007,869,-,O
13008,869,bearing,O
13009,869,potential,O
13010,869,before,O
13011,869,study,O
13012,869,inclusion,O
13013,869,),O
13014,869,or,O
13015,869,lactation,O
13016,870,Women,O
13017,870,of,O
13018,870,childbearing,O
13019,870,potential,O
13020,870,who,O
13021,870,do,O
13022,870,not,O
13023,870,practice,O
13024,870,a,O
13025,870,medically,O
13026,870,accepted,O
13027,870,highly,O
13028,870,effective,O
13029,870,contraception,O
13030,870,during,O
13031,870,the,O
13032,870,trial,O
13033,870,and,O
13034,870,one,O
13035,870,month,O
13036,870,beyond,O
13037,871,History,O
13038,871,of,O
13039,871,hypersensitivity,O
13040,871,to,O
13041,871,the,O
13042,871,investigational,O
13043,871,medicinal,O
13044,871,product,O
13045,871,or,O
13046,871,to,O
13047,871,any,O
13048,871,drug,O
13049,871,with,O
13050,871,similar,O
13051,871,chemical,O
13052,871,structure,O
13053,871,or,O
13054,871,to,O
13055,871,any,O
13056,871,excipient,O
13057,871,present,O
13058,871,in,O
13059,871,the,O
13060,871,pharmaceutical,O
13061,871,form,O
13062,871,of,O
13063,871,the,O
13064,871,investigational,O
13065,871,medicinal,O
13066,871,product,O
13067,872,Participation,O
13068,872,in,O
13069,872,another,O
13070,872,clinical,O
13071,872,trial,O
13072,872,during,O
13073,872,the,O
13074,872,present,O
13075,872,clinical,O
13076,872,trial,O
13077,872,or,O
13078,872,within,O
13079,872,the,O
13080,872,last,O
13081,872,three,O
13082,872,months,O
13083,873,Medical,O
13084,873,or,O
13085,873,psychological,O
13086,873,condition,O
13087,873,that,O
13088,873,would,O
13089,873,not,O
13090,873,permit,O
13091,873,completion,O
13092,873,of,O
13093,873,the,O
13094,873,trial,O
13095,873,or,O
13096,873,signing,O
13097,873,of,O
13098,873,informed,O
13099,873,consent,O
13100,874,Use,O
13101,874,of,O
13102,874,a,O
13103,874,fibrinolytic,B-Drug
13104,874,agent,I-Drug
13105,874,",",O
13106,874,surgical,B-Procedure
13107,874,thrombectomy,I-Procedure
13108,874,",",I-Procedure
13109,874,interventional,O
13110,874,(,O
13111,874,catheter,O
13112,874,-,O
13113,874,directed,O
13114,874,),O
13115,874,thrombus,B-Procedure
13116,874,aspiration,I-Procedure
13117,874,or,I-Procedure
13118,874,lysis,I-Procedure
13119,874,",",O
13120,874,or,O
13121,874,use,O
13122,874,of,O
13123,874,a,O
13124,874,cava,B-Procedure
13125,874,filter,I-Procedure
13126,874,to,O
13127,874,treat,O
13128,874,the,O
13129,874,index,O
13130,874,episode,O
13131,874,of,O
13132,874,PE,B-Condition
13133,875,Treatment,O
13134,875,with,O
13135,875,any,O
13136,875,therapeutically,O
13137,875,dosed,O
13138,875,anticoagulant,B-Drug
13139,875,for,O
13140,875,more,O
13141,875,than,O
13142,875,48,O
13143,875,hours,O
13144,875,prior,O
13145,875,to,O
13146,875,enrolment,O
13147,876,Need,O
13148,876,for,O
13149,876,long,O
13150,876,-,O
13151,876,term,O
13152,876,treatment,O
13153,876,with,O
13154,876,a,O
13155,876,low,B-Drug
13156,876,molecular,I-Drug
13157,876,weight,I-Drug
13158,876,heparin,I-Drug
13159,876,",",O
13160,876,vitamin,B-Drug
13161,876,K,I-Drug
13162,876,antagonists,I-Drug
13163,876,or,O
13164,876,NOAC,B-Drug
13165,876,",",O
13166,876,for,O
13167,876,an,O
13168,876,indication,O
13169,876,other,O
13170,876,than,O
13171,876,the,O
13172,876,index,O
13173,876,PE,B-Condition
13174,876,episode,I-Condition
13175,876,",",O
13176,876,or,O
13177,876,for,O
13178,876,antiplatelet,B-Drug
13179,876,agents,I-Drug
13180,876,except,O
13181,876,acetylsalicylic,B-Drug
13182,876,acid,I-Drug
13183,876,at,O
13184,876,a,O
13185,876,dosage,O
13186,876,=,O
13187,876,100,O
13188,876,mg,O
13189,876,/,O
13190,876,day,O
13191,876,;,O
13192,877,Active,B-Condition
13193,877,bleeding,I-Condition
13194,877,or,O
13195,877,known,O
13196,877,significant,O
13197,877,bleeding,B-Observation
13198,877,risk,I-Observation
13199,877,(,O
13200,877,e.g.,O
13201,877,",",O
13202,877,gastrointestinal,B-Condition
13203,877,ulcer,I-Condition
13204,877,",",O
13205,877,malignant,B-Condition
13206,877,neoplasms,I-Condition
13207,877,",",O
13208,877,injuries,B-Condition
13209,877,or,O
13210,877,recent,O
13211,877,surgeries,B-Procedure
13212,877,of,O
13213,877,the,O
13214,877,brain,O
13215,877,",",O
13216,877,spinal,O
13217,877,cord,O
13218,877,or,O
13219,877,eyes,O
13220,877,",",O
13221,877,recent,O
13222,877,intracranial,B-Condition
13223,877,bleedings,I-Condition
13224,877,",",O
13225,877,known,O
13226,877,or,O
13227,877,suspected,O
13228,877,esophagus,B-Condition
13229,877,varices,I-Condition
13230,877,",",O
13231,877,aneurysms,B-Condition
13232,877,or,O
13233,877,intraspinal,O
13234,877,or,O
13235,877,intracranial,O
13236,877,vascular,B-Condition
13237,877,abnormalities,I-Condition
13238,877,),I-Condition
13239,878,Artificial,O
13240,878,heart,O
13241,878,valves,O
13242,878,requiring,O
13243,878,treatment,O
13244,878,with,O
13245,878,an,O
13246,878,anticoagulant,B-Drug
13247,879,Renal,B-Condition
13248,879,insufficiency,I-Condition
13249,879,with,O
13250,879,estimated,O
13251,879,creatinine,O
13252,879,clearance,O
13253,879,<,O
13254,879,30,O
13255,879,ml,O
13256,879,/,O
13257,879,min/1.73m2,O
13258,880,Chronic,B-Condition
13259,880,liver,I-Condition
13260,880,disease,I-Condition
13261,880,with,O
13262,880,aminotransferase,O
13263,880,levels,O
13264,880,two,O
13265,880,times,O
13266,880,or,O
13267,880,more,O
13268,880,above,O
13269,880,the,O
13270,880,local,O
13271,880,upper,O
13272,880,limit,O
13273,880,of,O
13274,880,normal,O
13275,880,range,O
13276,881,Concomitant,O
13277,881,administration,O
13278,881,of,O
13279,881,strong,O
13280,881,inhibitors,B-Drug
13281,881,of,I-Drug
13282,881,P,I-Drug
13283,881,-,I-Drug
13284,881,glycoprotein,I-Drug
13285,881,like,O
13286,881,ketoconazole,B-Drug
13287,881,",",O
13288,881,cyclosporin,B-Drug
13289,881,",",O
13290,881,itraconazole,B-Drug
13291,881,or,O
13292,881,dronedarone,B-Drug
13293,882,Unwillingness,O
13294,882,or,O
13295,882,inability,O
13296,882,to,O
13297,882,adhere,O
13298,882,to,O
13299,882,treatment,O
13300,882,or,O
13301,882,to,O
13302,882,the,O
13303,882,follow,O
13304,882,-,O
13305,882,up,O
13306,882,visits,O
13307,883,Life,B-Observation
13308,883,expectancy,I-Observation
13309,883,less,O
13310,883,than,O
13311,883,6,O
13312,883,months,O
13313,884,Age,B-Person
13314,884,=,O
13315,884,18,O
13316,884,years,O
13317,885,Objectively,O
13318,885,confirmed,O
13319,885,diagnosis,O
13320,885,of,O
13321,885,acute,O
13322,885,PE,B-Condition
13323,885,by,O
13324,885,multidetector,O
13325,885,CT,B-Procedure
13326,885,angiography,I-Procedure
13327,885,",",O
13328,885,ventilation,B-Procedure
13329,885,/,I-Procedure
13330,885,perfusion,I-Procedure
13331,885,lung,I-Procedure
13332,885,scan,I-Procedure
13333,885,",",O
13334,885,or,O
13335,885,selective,O
13336,885,invasive,B-Procedure
13337,885,pulmonary,I-Procedure
13338,885,angiography,I-Procedure
13339,885,",",I-Procedure
13340,885,according,O
13341,885,to,O
13342,885,established,O
13343,885,diagnostic,O
13344,885,criteria,O
13345,885,",",O
13346,885,with,O
13347,885,or,O
13348,885,without,O
13349,885,symptomatic,O
13350,885,deep,B-Condition
13351,885,vein,I-Condition
13352,885,thrombosis,I-Condition
13353,886,Absence,O
13354,886,of,O
13355,886,hemodynamic,B-Condition
13356,886,collapse,I-Condition
13357,886,",",I-Condition
13358,886,or,I-Condition
13359,886,decompensation,I-Condition
13360,886,",",O
13361,886,at,O
13362,886,presentation,O
13363,886,;,O
13364,886,Hemodynamic,O
13365,886,collapse,O
13366,886,or,O
13367,886,decompensation,O
13368,887,At,O
13369,887,least,O
13370,887,one,O
13371,887,sign,B-Condition
13372,887,of,I-Condition
13373,887,RV,I-Condition
13374,887,pressure,I-Condition
13375,887,overload,I-Condition
13376,887,/,I-Condition
13377,887,dysfunction,I-Condition
13378,887,on,O
13379,887,CT,B-Procedure
13380,887,angiography,I-Procedure
13381,887,or,O
13382,887,echocardiography,B-Procedure
13383,888,Signs,O
13384,888,of,O
13385,888,myocardial,B-Condition
13386,888,injury,I-Condition
13387,888,as,O
13388,888,indicated,O
13389,888,by,O
13390,888,elevated,O
13391,888,troponin,O
13392,888,levels,O
13393,889,Signs,O
13394,889,of,O
13395,889,(,O
13396,889,RV,B-Condition
13397,889,),I-Condition
13398,889,failure,I-Condition
13399,889,as,O
13400,889,indicated,O
13401,889,by,O
13402,889,NT,O
13403,889,-,O
13404,889,proBNP,O
13405,889,levels,O
13406,889,>,O
13407,889,600,O
13408,889,pg,O
13409,889,/,O
13410,889,ml,O
13411,889,at,O
13412,889,baseline,O
13413,889,.,O
13414,890,Ability,O
13415,890,of,O
13416,890,the,O
13417,890,subject,O
13418,890,to,O
13419,890,understand,O
13420,890,the,O
13421,890,character,O
13422,890,and,O
13423,890,individual,O
13424,890,consequences,O
13425,890,of,O
13426,890,the,O
13427,890,clinical,O
13428,890,trial,O
13429,890,;,O
13430,890,signed,O
13431,890,and,O
13432,890,dated,O
13433,890,informed,O
13434,890,consent,O
13435,890,of,O
13436,890,the,O
13437,890,subject,O
13438,890,available,O
13439,890,before,O
13440,890,the,O
13441,890,start,O
13442,890,of,O
13443,890,any,O
13444,890,specific,O
13445,890,trial,O
13446,890,procedures,O
13447,891,Ongoing,O
13448,891,allergen,B-Procedure
13449,891,immunotherapy,I-Procedure
13450,892,upper,B-Condition
13451,892,respiratory,I-Condition
13452,892,tract,I-Condition
13453,892,infection,I-Condition
13454,893,Pregnancy,B-Condition
13455,894,Clinical,O
13456,894,history,O
13457,894,of,O
13458,894,lactose,B-Condition
13459,894,-,I-Condition
13460,894,intolerance,I-Condition
13461,894,or,O
13462,894,allergies,B-Condition
13463,894,to,I-Condition
13464,894,cow,I-Condition
13465,894,-,I-Condition
13466,894,milk,I-Condition
13467,895,Clinical,O
13468,895,diagnosis,O
13469,895,of,O
13470,895,allergic,B-Condition
13471,895,rhinitis,I-Condition
13472,895,based,O
13473,895,on,O
13474,895,sneeze,B-Condition
13475,895,attacks,I-Condition
13476,895,",",O
13477,895,runny,B-Condition
13478,895,/,I-Condition
13479,895,blocked,I-Condition
13480,895,/,I-Condition
13481,895,itchy,I-Condition
13482,895,nose,I-Condition
13483,895,in,O
13484,895,the,O
13485,895,absence,O
13486,895,of,O
13487,895,a,O
13488,895,common,B-Condition
13489,895,cold,I-Condition
13490,895,during,O
13491,895,the,O
13492,895,previous,O
13493,895,12,O
13494,895,months,O
13495,895,.,O
13496,896,History,O
13497,896,of,O
13498,896,positive,O
13499,896,skin,O
13500,896,prick,O
13501,896,test,O
13502,896,or,O
13503,896,blood,O
13504,896,radio,O
13505,896,-,O
13506,896,allergosorbent,O
13507,896,test,O
13508,896,(,O
13509,896,RAST,O
13510,896,),O
13511,896,to,O
13512,896,grass,O
13513,896,and/or,O
13514,896,ragweed,O
13515,896,pollen,O
13516,897,School,O
13517,897,districts,O
13518,897,that,O
13519,897,are,O
13520,897,too,O
13521,897,difficult,O
13522,897,to,O
13523,897,reach,O
13524,897,(,O
13525,897,more,O
13526,897,than,O
13527,897,a,O
13528,897,3,O
13529,897,-,O
13530,897,hour,O
13531,897,walk,O
13532,897,from,O
13533,897,the,O
13534,897,farthest,O
13535,897,place,O
13536,897,reachable,O
13537,897,by,O
13538,897,a,O
13539,897,four,O
13540,897,-,O
13541,897,wheel,O
13542,897,drive,O
13543,897,vehicle,O
13544,897,),O
13545,898,School,O
13546,898,districts,O
13547,898,in,O
13548,898,the,O
13549,898,2,O
13550,898,urban,O
13551,898,regions,O
13552,898,of,O
13553,898,the,O
13554,898,study,O
13555,898,area,O
13556,899,Refusal,O
13557,899,of,O
13558,899,village,O
13559,899,chief,O
13560,900,All,O
13561,900,residents,O
13562,900,residing,B-Observation
13563,900,near,O
13564,900,to,O
13565,900,the,O
13566,900,well,O
13567,900,sites,O
13568,900,that,O
13569,900,are,O
13570,900,randomly,O
13571,900,selected,O
13572,900,for,O
13573,900,this,O
13574,900,study,O
13575,900,.,O
13576,901,Refusal,O
13577,901,of,O
13578,901,participant,O
13579,901,[,O
13580,901,or,O
13581,901,parent,O
13582,901,/,O
13583,901,guardian,O
13584,901,],O
13585,902,Community,O
13586,902,in,O
13587,902,a,O
13588,902,school,O
13589,902,district,O
13590,902,that,O
13591,902,is,O
13592,902,within,O
13593,902,the,O
13594,902,study,O
13595,902,area,O
13596,903,Area,O
13597,903,within,O
13598,903,each,O
13599,903,school,O
13600,903,district,O
13601,903,that,O
13602,903,is,O
13603,903,in,O
13604,903,need,O
13605,903,of,O
13606,903,a,O
13607,903,well,O
13608,904,Patients,O
13609,904,who,O
13610,904,have,O
13611,904,previous,O
13612,904,prostate,B-Condition
13613,904,surgery,I-Condition
13614,904,Patients,O
13615,904,who,O
13616,904,have,O
13617,904,muscle,O
13618,904,invasive,O
13619,904,bladder,B-Condition
13620,904,cancer,I-Condition
13621,905,Patients,O
13622,905,who,O
13623,905,have,O
13624,905,non,B-Condition
13625,905,muscle,I-Condition
13626,905,invasive,I-Condition
13627,905,bladder,I-Condition
13628,905,cancer,I-Condition
13629,905,male,B-Person
13630,905,patients,O
13631,905,patients,O
13632,905,between,O
13633,905,40,O
13634,905,-,O
13635,905,80,O
13636,905,years,O
13637,905,old,B-Person
13638,906,BMI,O
13639,906,<,O
13640,906,35,O
13641,906,and,O
13642,906,>,O
13643,906,60,O
13644,906,kg,O
13645,906,/,O
13646,906,m2,O
13647,907,Inability,B-Condition
13648,907,to,I-Condition
13649,907,walk,I-Condition
13650,907,(,O
13651,907,bed,B-Condition
13652,907,-,I-Condition
13653,907,bound,I-Condition
13654,907,or,O
13655,907,wheelchair,B-Condition
13656,907,dependence,I-Condition
13657,907,),O
13658,908,open,B-Procedure
13659,908,abdominal,I-Procedure
13660,908,surgeries,I-Procedure
13661,908,except,O
13662,908,simple,B-Procedure
13663,908,appendectomy,I-Procedure
13664,908,and,O
13665,908,common,B-Procedure
13666,908,OB,I-Procedure
13667,908,/,I-Procedure
13668,908,GYN,I-Procedure
13669,908,procedures,I-Procedure
13670,908,in,O
13671,908,the,O
13672,908,pelvis,O
13673,908,(,O
13674,908,hysterectomy,B-Procedure
13675,908,",",O
13676,908,C,B-Procedure
13677,908,-,I-Procedure
13678,908,section,I-Procedure
13679,908,",",O
13680,908,and,O
13681,908,oophorectomy,B-Procedure
13682,908,",",O
13683,908,tubal,B-Procedure
13684,908,ligation,I-Procedure
13685,908,),O
13686,909,laparoscopic,B-Procedure
13687,909,bowel,I-Procedure
13688,909,or,I-Procedure
13689,909,solid,I-Procedure
13690,909,organ,I-Procedure
13691,909,resection,I-Procedure
13692,909,except,O
13693,909,laparoscopic,B-Procedure
13694,909,cholecystectomy,I-Procedure
13695,910,ventral,B-Condition
13696,910,hernia,I-Condition
13697,910,repair,B-Procedure
13698,910,with,I-Procedure
13699,910,mesh,I-Procedure
13700,911,Preoperative,O
13701,911,chronic,O
13702,911,opiate,B-Drug
13703,911,use,O
13704,911,for,O
13705,911,chronic,B-Condition
13706,911,pain,I-Condition
13707,911,defined,O
13708,911,as,O
13709,911,opiate,B-Drug
13710,911,usage,O
13711,911,at,O
13712,911,least,O
13713,911,60,O
13714,911,mg,O
13715,911,/,O
13716,911,day,O
13717,911,of,O
13718,911,morphine,O
13719,911,equivalent,O
13720,911,for,O
13721,911,=,O
13722,911,3,O
13723,911,months,O
13724,911,(,O
13725,911,as,O
13726,911,defined,O
13727,911,by,O
13728,911,International,O
13729,911,Association,O
13730,911,for,O
13731,911,the,O
13732,911,Study,O
13733,911,of,O
13734,911,Pain22,O
13735,911,),O
13736,911,in,O
13737,911,the,O
13738,911,one,O
13739,911,year,O
13740,911,period,O
13741,911,prior,O
13742,911,to,O
13743,911,the,O
13744,911,bariatric,B-Procedure
13745,911,surgery,I-Procedure
13746,912,The,O
13747,912,American,O
13748,912,Society,O
13749,912,of,O
13750,912,Anesthesiologists,O
13751,912,(,O
13752,912,ASA,O
13753,912,),O
13754,912,score,O
13755,912,>,O
13756,912,3,O
13757,913,History,O
13758,913,of,O
13759,913,hypersensitivity,B-Condition
13760,913,or,O
13761,913,adverse,B-Condition
13762,913,reaction,I-Condition
13763,913,to,O
13764,913,bupivacaine,B-Drug
13765,913,or,O
13766,913,narcotics,B-Drug
13767,914,Inability,O
13768,914,to,O
13769,914,speak,O
13770,914,English,O
13771,915,ventral,B-Condition
13772,915,hernia,I-Condition
13773,915,repair,B-Procedure
13774,916,Cholecystectomy,B-Procedure
13775,917,hiatal,B-Condition
13776,917,hernia,I-Condition
13777,917,repair,B-Procedure
13778,917,with,O
13779,917,posterior,B-Procedure
13780,917,cruroplasty,I-Procedure
13781,918,extensive,O
13782,918,lysis,B-Condition
13783,918,of,I-Condition
13784,918,adhesions,I-Condition
13785,919,other,O
13786,919,procedures,O
13787,919,that,O
13788,919,mandate,O
13789,919,addition,O
13790,919,of,O
13791,919,"""",O
13792,919,trocar(s,O
13793,919,),O
13794,919,"""",O
13795,919,or,O
13796,919,"""",O
13797,919,feeding,O
13798,919,tube,O
13799,919,"""",O
13800,920,Addition,B-Mood
13801,920,of,I-Mood
13802,920,trocar(s,B-Drug
13803,920,),O
13804,920,or,O
13805,920,conversion,B-Observation
13806,920,of,I-Observation
13807,920,surgery,I-Observation
13808,920,to,O
13809,920,hand,B-Procedure
13810,920,-,I-Procedure
13811,920,assisted,I-Procedure
13812,920,or,O
13813,920,open,B-Procedure
13814,921,Fulfills,O
13815,921,NIH,O
13816,921,criteria,O
13817,921,for,O
13818,921,bariatric,B-Condition
13819,921,surgery,I-Condition
13820,922,Planned,O
13821,922,operation,O
13822,922,of,O
13823,922,laparoscopic,B-Procedure
13824,922,Roux,I-Procedure
13825,922,-,I-Procedure
13826,922,en,I-Procedure
13827,922,Y,I-Procedure
13828,922,gastric,I-Procedure
13829,922,bypass,I-Procedure
13830,922,(,I-Procedure
13831,922,LRYGB,I-Procedure
13832,922,),I-Procedure
13833,922,or,O
13834,922,laparoscopic,B-Procedure
13835,922,sleeve,I-Procedure
13836,922,gastrectomy,I-Procedure
13837,922,(,I-Procedure
13838,922,LSG,I-Procedure
13839,922,),I-Procedure
13840,922,as,O
13841,922,primary,O
13842,922,bariatric,O
13843,922,procedure,O
13844,923,Women,B-Person
13845,923,undergoing,O
13846,923,cesarean,B-Procedure
13847,923,section,I-Procedure
13848,923,with,O
13849,923,general,O
13850,923,anesthesia,O
13851,923,will,O
13852,923,be,O
13853,923,excluded,O
13854,923,",",O
13855,923,because,O
13856,923,carbetocin,O
13857,923,is,O
13858,923,licensed,O
13859,923,for,O
13860,923,use,O
13861,923,with,O
13862,923,regional,O
13863,923,anaesthesia,O
13864,923,only,O
13865,923,.,O
13866,924,women,B-Person
13867,924,undergoing,O
13868,924,cesarean,B-Procedure
13869,924,section,I-Procedure
13870,924,at,O
13871,924,less,O
13872,924,than,O
13873,924,37,O
13874,924,weeks,O
13875,924,of,O
13876,924,gestation,O
13877,924,.,O
13878,925,Women,B-Person
13879,925,with,O
13880,925,a,O
13881,925,singleton,B-Condition
13882,925,pregnancy,I-Condition
13883,925,undergoing,O
13884,925,cesarean,B-Procedure
13885,925,section,I-Procedure
13886,925,after,O
13887,925,37,O
13888,925,weeks,O
13889,925,of,O
13890,925,gestation,O
13891,925,.,O
13892,926,Have,O
13893,926,participated,O
13894,926,in,O
13895,926,this,B-Observation
13896,926,study,I-Observation
13897,926,previously,O
13898,926,",",O
13899,926,or,O
13900,926,any,B-Observation
13901,926,other,I-Observation
13902,926,study,I-Observation
13903,926,using,O
13904,926,exenatide,B-Drug
13905,926,or,O
13906,926,GLP-1,B-Drug
13907,926,analogs,I-Drug
13908,926,.,O
13909,927,Have,O
13910,927,participated,O
13911,927,in,O
13912,927,an,O
13913,927,interventional,B-Observation
13914,927,",",I-Observation
13915,927,medical,I-Observation
13916,927,",",I-Observation
13917,927,surgical,I-Observation
13918,927,",",I-Observation
13919,927,or,I-Observation
13920,927,pharmaceutical,I-Observation
13921,927,study,I-Observation
13922,927,within,O
13923,927,30,O
13924,927,days,O
13925,927,of,O
13926,927,screening,O
13927,927,.,O
13928,928,Have,O
13929,928,characteristics,B-Condition
13930,928,contraindicating,I-Condition
13931,928,metformin,B-Drug
13932,928,or,O
13933,928,sulfonylurea,B-Drug
13934,928,use,O
13935,928,.,O
13936,929,Have,O
13937,929,been,O
13938,929,treated,O
13939,929,with,O
13940,929,exogenous,B-Drug
13941,929,insulin,I-Drug
13942,929,for,O
13943,929,more,O
13944,929,than,O
13945,929,1,O
13946,929,week,O
13947,929,within,O
13948,929,the,O
13949,929,3,O
13950,929,months,O
13951,929,prior,O
13952,929,to,O
13953,929,screening,O
13954,929,.,O
13955,930,Have,O
13956,930,used,O
13957,930,drugs,B-Drug
13958,930,for,I-Drug
13959,930,weight,I-Drug
13960,930,loss,I-Drug
13961,930,within,O
13962,930,1,O
13963,930,month,O
13964,930,of,O
13965,930,screening,O
13966,930,.,O
13967,931,Treated,O
13968,931,with,O
13969,931,a,O
13970,931,stable,O
13971,931,dose,O
13972,931,of,O
13973,931,one,O
13974,931,of,O
13975,931,the,O
13976,931,following,O
13977,931,for,O
13978,931,at,O
13979,931,least,O
13980,931,3,O
13981,931,months,O
13982,931,prior,O
13983,931,to,O
13984,931,screening,O
13985,931,:,O
13986,931,*,O
13987,931,>,O
13988,931,=,O
13989,931,1000,O
13990,931,mg,O
13991,931,/,O
13992,931,day,O
13993,931,immediate,B-Drug
13994,931,-,I-Drug
13995,931,release,I-Drug
13996,931,metformin,I-Drug
13997,931,;,O
13998,931,or,O
13999,931,metformin,B-Drug
14000,931,>,O
14001,931,=,O
14002,931,1000,O
14003,931,mg,O
14004,931,/,O
14005,931,day,O
14006,931,and,O
14007,931,sulfonylurea,B-Drug
14008,931,;,O
14009,931,or,O
14010,931,sulfonylurea,B-Drug
14011,931,/,O
14012,931,metformin,B-Drug
14013,931,combination,B-Procedure
14014,931,therapy,I-Procedure
14015,931,.,O
14016,932,HbA1c,O
14017,932,between,O
14018,932,7.1,O
14019,932,%,O
14020,932,and,O
14021,932,11.0,O
14022,932,%,O
14023,932,",",O
14024,932,inclusive,O
14025,932,.,O
14026,933,Body,O
14027,933,Mass,O
14028,933,Index,O
14029,933,(,O
14030,933,BMI,O
14031,933,),O
14032,933,>,O
14033,933,21,O
14034,933,kg,O
14035,933,/,O
14036,933,m^2,O
14037,933,and,O
14038,933,<,O
14039,933,35,O
14040,933,kg,O
14041,933,/,O
14042,933,m^2,O
14043,933,.,O
14044,934,NA,O
14045,935,Symptoms,B-Mood
14046,935,of,O
14047,935,ischaemia,B-Condition
14048,935,.,O
14049,936,New,O
14050,936,or,O
14051,936,presumed,O
14052,936,new,O
14053,936,significant,O
14054,936,ST,B-Condition
14055,936,-,I-Condition
14056,936,T,I-Condition
14057,936,wave,I-Condition
14058,936,changes,I-Condition
14059,937,Development,O
14060,937,of,O
14061,937,pathological,B-Condition
14062,937,Q,I-Condition
14063,937,waves,I-Condition
14064,937,on,O
14065,937,ECG,B-Procedure
14066,937,.,O
14067,938,Imaging,B-Procedure
14068,938,evidence,B-Condition
14069,938,of,O
14070,938,new,O
14071,938,or,O
14072,938,presumed,O
14073,938,new,O
14074,938,loss,B-Condition
14075,938,of,I-Condition
14076,938,viable,I-Condition
14077,938,myocardium,I-Condition
14078,938,or,O
14079,938,regional,B-Condition
14080,938,wall,I-Condition
14081,938,motion,I-Condition
14082,938,abnormality,I-Condition
14083,938,.,O
14084,939,Contraindications,B-Condition
14085,939,for,O
14086,939,magnetic,B-Procedure
14087,939,resonance,I-Procedure
14088,939,imaging,I-Procedure
14089,940,Hemosiderosis,B-Condition
14090,940,/,O
14091,940,hemochromatosis,B-Condition
14092,940,(,O
14093,940,patients,O
14094,940,can,O
14095,940,still,O
14096,940,be,O
14097,940,included,O
14098,940,in,O
14099,940,the,O
14100,940,non,O
14101,940,-,O
14102,940,ferumoxytol,O
14103,940,arm,O
14104,940,),O
14105,941,Osteonecrosis,B-Condition
14106,942,planned,B-Mood
14107,942,decompression,B-Procedure
14108,942,surgery,I-Procedure
14109,942,with,O
14110,942,autologous,B-Procedure
14111,942,stem,I-Procedure
14112,942,cell,I-Procedure
14113,942,transplant,I-Procedure
14114,943,choroidal,B-Condition
14115,943,neovascularization,I-Condition
14116,943,caused,O
14117,943,by,O
14118,943,other,B-Condition
14119,943,eye,I-Condition
14120,943,diseases,I-Condition
14121,944,ocular,B-Procedure
14122,944,surgery,I-Procedure
14123,944,within,O
14124,944,the,O
14125,944,past,O
14126,944,3,O
14127,944,mouths,O
14128,945,history,B-Observation
14129,945,of,O
14130,945,uveitis,B-Condition
14131,946,intraocular,O
14132,946,pressure,O
14133,946,higher,O
14134,946,than,O
14135,946,25,O
14136,946,mmHg,O
14137,946,",",O
14138,946,or,O
14139,946,glaucoma,B-Condition
14140,947,history,O
14141,947,of,O
14142,947,systemic,O
14143,947,or,O
14144,947,ocular,O
14145,947,thromboembolic,B-Condition
14146,947,events,I-Condition
14147,947,.,O
14148,948,choroidal,B-Condition
14149,948,neovascularization,I-Condition
14150,948,caused,O
14151,948,by,O
14152,948,age,O
14153,948,-,O
14154,948,related,O
14155,948,macula,B-Condition
14156,948,degeneration,I-Condition
14157,949,no,O
14158,949,previous,O
14159,949,treatment,B-Procedure
14160,950,a,O
14161,950,follow,B-Observation
14162,950,-,I-Observation
14163,950,up,I-Observation
14164,950,at,O
14165,950,least,O
14166,950,12,O
14167,950,months,O
14168,951,a,O
14169,951,baseline,O
14170,951,visual,O
14171,951,acuity,O
14172,951,ranging,O
14173,951,from,O
14174,951,a,O
14175,951,letter,O
14176,951,score,O
14177,951,of,O
14178,951,0,O
14179,951,to,O
14180,951,70,O
14181,951,on,O
14182,951,the,O
14183,951,Early,B-Procedure
14184,951,Treatment,I-Procedure
14185,951,Diabetic,I-Procedure
14186,951,Retinopathy,I-Procedure
14187,951,Study,I-Procedure
14188,951,chart,I-Procedure
14189,952,Molar,B-Condition
14190,952,teeth,I-Condition
14191,953,Milller,O
14192,953,Class,O
14193,953,4,O
14194,953,recession,B-Condition
14195,953,defects,I-Condition
14196,954,Pregnancy,B-Condition
14197,954,(,O
14198,954,Self,O
14199,954,-,O
14200,954,reported,O
14201,954,),O
14202,955,Smoking,B-Condition
14203,956,Uncontrolled,O
14204,956,local,O
14205,956,or,O
14206,956,systemic,B-Condition
14207,956,diseases,I-Condition
14208,956,that,O
14209,956,affects,O
14210,956,wound,O
14211,956,healing,O
14212,956,(,O
14213,956,diabetes,B-Condition
14214,956,",",O
14215,956,autoimmune,B-Condition
14216,956,or,I-Condition
14217,956,inflammatory,I-Condition
14218,956,disorders,I-Condition
14219,956,),O
14220,957,Past,B-Observation
14221,957,history,I-Observation
14222,957,of,O
14223,957,systemic,B-Drug
14224,957,steroid,I-Drug
14225,957,use,O
14226,957,over,O
14227,957,2,O
14228,957,weeks,O
14229,957,within,O
14230,957,the,O
14231,957,last,O
14232,957,2,O
14233,957,years,O
14234,958,Poor,B-Condition
14235,958,oral,I-Condition
14236,958,hygiene,I-Condition
14237,958,on,O
14238,958,a,O
14239,958,non,B-Observation
14240,958,-,I-Observation
14241,958,compliant,I-Observation
14242,958,individual,O
14243,959,Ibuprofen,B-Drug
14244,959,Allergy,B-Condition
14245,959,/,O
14246,959,interlerance,B-Condition
14247,960,Anticoagulant,B-Procedure
14248,960,therapy,I-Procedure
14249,960,(,O
14250,960,e.g.,O
14251,960,Warfarin,B-Drug
14252,960,",",O
14253,960,Plavix,B-Drug
14254,960,",",O
14255,960,etc,O
14256,960,.,O
14257,960,),O
14258,960,",",O
14259,960,will,O
14260,960,not,O
14261,960,be,O
14262,960,automatic,O
14263,960,exclusion,O
14264,960,but,O
14265,960,patients,O
14266,960,will,O
14267,960,be,O
14268,960,required,O
14269,960,to,O
14270,960,have,O
14271,960,INR,O
14272,960,test,O
14273,960,performed,O
14274,960,and,O
14275,960,have,O
14276,960,values,O
14277,960,between,O
14278,960,2.0,O
14279,960,to,O
14280,960,3,O
14281,960,.,O
14282,960,Physician,O
14283,960,consultation,O
14284,960,will,O
14285,960,be,O
14286,960,requested,O
14287,960,to,O
14288,960,determine,O
14289,960,whether,O
14290,960,anticoagulant,B-Procedure
14291,960,therapy,I-Procedure
14292,960,can,O
14293,960,be,O
14294,960,discontinued,O
14295,960,for,O
14296,960,3,O
14297,960,days,O
14298,960,prior,O
14299,960,to,O
14300,960,surgery,O
14301,960,.,O
14302,961,Objection,O
14303,961,to,O
14304,961,blood,O
14305,961,draw,O
14306,961,or,O
14307,961,application,O
14308,961,of,O
14309,961,blood,O
14310,961,products,O
14311,962,Students,O
14312,962,and,O
14313,962,staff,O
14314,962,from,O
14315,962,USC,O
14316,962,Ostrow,O
14317,962,school,O
14318,962,of,O
14319,962,Dentistry,O
14320,962,will,O
14321,962,not,O
14322,962,be,O
14323,962,recruited,O
14324,962,for,O
14325,962,this,O
14326,962,study,O
14327,963,Male,O
14328,963,and,O
14329,963,female,O
14330,963,individuals,O
14331,963,between,O
14332,963,ages,B-Person
14333,963,of,O
14334,963,18,O
14335,963,to,O
14336,963,70,O
14337,963,years,O
14338,963,old,O
14339,964,Multiple,O
14340,964,contiguous,O
14341,964,gingival,B-Condition
14342,964,recession,I-Condition
14343,964,defects,I-Condition
14344,964,on,O
14345,964,a,O
14346,964,minimum,O
14347,964,of,O
14348,964,two,O
14349,964,adjacent,O
14350,964,teeth,O
14351,964,",",O
14352,964,exhibiting,O
14353,964,3,O
14354,964,mm,O
14355,964,or,O
14356,964,more,O
14357,964,recession,O
14358,964,on,O
14359,964,at,O
14360,964,least,O
14361,964,one,O
14362,964,of,O
14363,964,those,O
14364,964,teeth,O
14365,965,No,O
14366,965,prior,O
14367,965,surgical,B-Procedure
14368,965,treatment,I-Procedure
14369,965,in,O
14370,965,the,O
14371,965,sites,O
14372,965,planned,O
14373,965,for,O
14374,965,therapy,O
14375,966,Minimum,O
14376,966,of,O
14377,966,2,O
14378,966,mm,O
14379,966,of,O
14380,966,keratinized,O
14381,966,gingiva,O
14382,967,Absence,O
14383,967,of,O
14384,967,cervical,B-Observation
14385,967,restorations,I-Observation
14386,967,extending,I-Observation
14387,967,to,I-Observation
14388,967,the,I-Observation
14389,967,CEJ,I-Observation
14390,968,Miller,O
14391,968,class,O
14392,968,1,O
14393,968,",",O
14394,968,2,O
14395,968,and,O
14396,968,3,O
14397,968,recession,B-Condition
14398,968,defects,I-Condition
14399,968,will,O
14400,968,be,O
14401,968,included,O
14402,969,Availability,O
14403,969,to,O
14404,969,undergo,O
14405,969,treatment,O
14406,969,and,O
14407,969,return,O
14408,969,for,O
14409,969,follow,O
14410,969,up,O
14411,969,visits,O
14412,969,at,O
14413,969,specified,O
14414,969,post,O
14415,969,-,O
14416,969,operative,O
14417,969,intervals,O
14418,970,Hemochromatosis,B-Condition
14419,970,",",O
14420,970,iron,B-Condition
14421,970,overload,I-Condition
14422,970,",",O
14423,970,defined,O
14424,970,as,O
14425,970,TSAT,O
14426,970,>,O
14427,970,45,O
14428,970,%,O
14429,971,Known,O
14430,971,hypersensitivity,B-Condition
14431,971,to,O
14432,971,Ferinject,B-Drug
14433,971,®,I-Drug
14434,971,.,O
14435,972,Known,O
14436,972,active,B-Condition
14437,972,infection,I-Condition
14438,972,",",O
14439,972,CRP>20,O
14440,972,mg,O
14441,972,/,O
14442,972,L,O
14443,972,",",O
14444,972,clinically,O
14445,972,significant,O
14446,972,bleeding,B-Condition
14447,972,",",O
14448,972,active,O
14449,972,malignancy,B-Condition
14450,972,.,O
14451,973,Chronic,B-Condition
14452,973,liver,I-Condition
14453,973,disease,I-Condition
14454,973,and/or,O
14455,973,screening,O
14456,973,alanine,O
14457,973,transaminase,O
14458,973,(,O
14459,973,ALT,O
14460,973,),O
14461,973,or,O
14462,973,aspartate,O
14463,973,transaminase,O
14464,973,(,O
14465,973,AST,O
14466,973,),O
14467,973,above,O
14468,973,three,O
14469,973,times,O
14470,973,the,O
14471,973,upper,O
14472,973,limit,O
14473,973,of,O
14474,973,the,O
14475,973,normal,O
14476,973,range,O
14477,973,.,O
14478,974,Immunosuppressive,B-Procedure
14479,974,therapy,I-Procedure
14480,974,or,O
14481,974,renal,B-Condition
14482,974,dialysis,I-Condition
14483,974,(,O
14484,974,current,B-Mood
14485,974,or,O
14486,974,planned,B-Mood
14487,974,within,O
14488,974,the,O
14489,974,next,O
14490,974,6,O
14491,974,months,O
14492,974,),O
14493,974,.,O
14494,975,History,O
14495,975,of,O
14496,975,erythropoietin,B-Drug
14497,975,",",O
14498,975,i.,B-Procedure
14499,975,v.,I-Procedure
14500,975,or,I-Procedure
14501,975,oral,I-Procedure
14502,975,iron,I-Procedure
14503,975,therapy,I-Procedure
14504,975,",",O
14505,975,and,O
14506,975,blood,B-Procedure
14507,975,transfusion,I-Procedure
14508,975,in,O
14509,975,previous,O
14510,975,12,O
14511,975,weeks,O
14512,975,and/or,O
14513,975,such,O
14514,975,therapy,O
14515,975,planned,B-Mood
14516,975,within,O
14517,975,the,O
14518,975,next,O
14519,975,6,O
14520,975,months,O
14521,975,.,O
14522,976,Unstable,B-Condition
14523,976,angina,I-Condition
14524,976,pectoris,I-Condition
14525,976,as,O
14526,976,judged,O
14527,976,by,O
14528,976,the,O
14529,976,investigator,O
14530,976,",",O
14531,976,clinically,O
14532,976,significant,O
14533,976,uncorrected,O
14534,976,valvular,B-Condition
14535,976,disease,I-Condition
14536,976,or,O
14537,976,left,B-Condition
14538,976,ventricular,I-Condition
14539,976,outflow,I-Condition
14540,976,obstruction,I-Condition
14541,976,",",O
14542,976,obstructive,B-Condition
14543,976,cardiomyopathy,I-Condition
14544,976,",",O
14545,976,poorly,O
14546,976,controlled,O
14547,976,fast,B-Condition
14548,976,atrial,I-Condition
14549,976,fibrillation,I-Condition
14550,976,or,I-Condition
14551,976,flutter,I-Condition
14552,976,",",O
14553,976,poorly,O
14554,976,controlled,O
14555,976,symptomatic,O
14556,976,brady-,B-Condition
14557,976,or,O
14558,976,tachyarrhythmias,B-Condition
14559,976,.,O
14560,977,Acute,B-Condition
14561,977,myocardial,I-Condition
14562,977,infarction,I-Condition
14563,977,or,O
14564,977,acute,B-Condition
14565,977,coronary,I-Condition
14566,977,syndrome,I-Condition
14567,977,",",O
14568,977,transient,B-Condition
14569,977,ischemic,I-Condition
14570,977,attack,I-Condition
14571,977,or,O
14572,977,stroke,B-Condition
14573,977,within,O
14574,977,the,O
14575,977,last,O
14576,977,3,O
14577,977,months,O
14578,977,.,O
14579,978,Coronary,B-Procedure
14580,978,-,I-Procedure
14581,978,artery,I-Procedure
14582,978,bypass,I-Procedure
14583,978,graft,I-Procedure
14584,978,",",O
14585,978,percutaneous,B-Procedure
14586,978,intervention,I-Procedure
14587,978,(,O
14588,978,e.g.,O
14589,978,cardiac,O
14590,978,",",O
14591,978,cerebrovascular,O
14592,978,",",O
14593,978,aortic,O
14594,978,;,O
14595,978,diagnostic,O
14596,978,catheters,O
14597,978,are,O
14598,978,allowed,O
14599,978,),O
14600,978,or,O
14601,978,major,B-Procedure
14602,978,surgery,I-Procedure
14603,978,",",O
14604,978,including,O
14605,978,thoracic,B-Procedure
14606,978,and,I-Procedure
14607,978,cardiac,I-Procedure
14608,978,surgery,I-Procedure
14609,978,",",O
14610,978,within,O
14611,978,the,O
14612,978,last,O
14613,978,3,O
14614,978,months,O
14615,978,.,O
14616,979,Participation,O
14617,979,in,O
14618,979,a,O
14619,979,CHF,O
14620,979,training,O
14621,979,program,O
14622,979,.,O
14623,980,Known,B-Condition
14624,980,HIV,I-Condition
14625,980,/,O
14626,980,AIDS,B-Condition
14627,980,.,O
14628,981,Inability,O
14629,981,to,O
14630,981,fully,O
14631,981,comprehend,O
14632,981,and/or,O
14633,981,perform,O
14634,981,study,O
14635,981,procedures,O
14636,981,in,O
14637,981,the,O
14638,981,investigator,O
14639,981,'s,O
14640,981,opinion,O
14641,981,.,O
14642,982,Vitamin,B-Condition
14643,982,B12,I-Condition
14644,982,and/or,I-Condition
14645,982,serum,I-Condition
14646,982,folate,I-Condition
14647,982,deficiency,I-Condition
14648,982,according,O
14649,982,to,O
14650,982,the,O
14651,982,laboratory,O
14652,982,(,O
14653,982,re,O
14654,982,-,O
14655,982,screening,O
14656,982,is,O
14657,982,possible,O
14658,982,after,O
14659,982,substitution,O
14660,982,therapy,O
14661,982,),O
14662,982,.,O
14663,983,Pregnancy,B-Condition
14664,983,or,O
14665,983,lactation,B-Condition
14666,983,.,O
14667,984,Participation,O
14668,984,in,O
14669,984,another,O
14670,984,clinical,O
14671,984,trial,O
14672,984,within,O
14673,984,previous,O
14674,984,30,O
14675,984,days,O
14676,984,and/or,O
14677,984,anticipated,O
14678,984,participation,O
14679,984,in,O
14680,984,another,O
14681,984,trial,O
14682,984,during,O
14683,984,this,O
14684,984,study,O
14685,984,.,O
14686,985,Anticoagulation,B-Procedure
14687,986,Patients,O
14688,986,with,O
14689,986,chronic,B-Condition
14690,986,heart,I-Condition
14691,986,failure,I-Condition
14692,986,of,O
14693,986,New,O
14694,986,York,O
14695,986,Heart,O
14696,986,Association,O
14697,986,Class,O
14698,986,II,O
14699,986,or,O
14700,986,III,O
14701,986,",",O
14702,986,a,O
14703,986,left,O
14704,986,ventricular,O
14705,986,ejection,O
14706,986,fraction,O
14707,986,of,O
14708,986,=,O
14709,986,40,O
14710,986,%,O
14711,986,for,O
14712,986,patients,O
14713,986,in,O
14714,986,NYHA,O
14715,986,class,O
14716,986,II,O
14717,986,or,O
14718,986,=,O
14719,986,45,O
14720,986,%,O
14721,986,for,O
14722,986,patients,O
14723,986,in,O
14724,986,NYHA,O
14725,986,class,O
14726,986,III,O
14727,986,",",O
14728,986,a,O
14729,986,hemoglobin,O
14730,986,level,O
14731,986,at,O
14732,986,the,O
14733,986,screening,O
14734,986,visit,O
14735,986,between,O
14736,986,9.5,O
14737,986,-,O
14738,986,13.5,O
14739,986,g,O
14740,986,/,O
14741,986,dl,O
14742,986,",",O
14743,986,and,O
14744,986,iron,B-Condition
14745,986,deficiency,I-Condition
14746,986,",",O
14747,986,which,O
14748,986,is,O
14749,986,defined,O
14750,986,as,O
14751,986,serum,O
14752,986,ferritin,O
14753,986,level,O
14754,986,<,O
14755,986,100µg,O
14756,986,/,O
14757,986,l,O
14758,986,or,O
14759,986,between,O
14760,986,100,O
14761,986,and,O
14762,986,299,O
14763,986,µg,O
14764,986,/,O
14765,986,l,O
14766,986,",",O
14767,986,when,O
14768,986,transferring,O
14769,986,saturation,O
14770,986,is,O
14771,986,<,O
14772,986,20,O
14773,986,%,O
14774,986,.,O
14775,987,Age,B-Person
14776,987,=,O
14777,987,18,O
14778,987,years,O
14779,988,Obtained,O
14780,988,informed,O
14781,988,consent,O
14782,989,Stable,O
14783,989,pharmacological,B-Procedure
14784,989,therapy,I-Procedure
14785,989,during,O
14786,989,the,O
14787,989,last,O
14788,989,4,O
14789,989,weeks,O
14790,989,(,O
14791,989,with,O
14792,989,the,O
14793,989,exception,O
14794,989,of,O
14795,989,diuretics,B-Drug
14796,989,),O
14797,990,Any,O
14798,990,contraindication,B-Condition
14799,990,to,O
14800,990,neuraxial,B-Drug
14801,990,anesthesia,I-Drug
14802,990,(,O
14803,990,history,B-Observation
14804,990,of,O
14805,990,neurologic,B-Condition
14806,990,disease,I-Condition
14807,990,(,O
14808,990,e.g.,O
14809,990,",",O
14810,990,multiple,B-Condition
14811,990,sclerosis,I-Condition
14812,990,",",O
14813,990,spinal,B-Condition
14814,990,stenosis,I-Condition
14815,990,",",O
14816,990,central,B-Condition
14817,990,or,I-Condition
14818,990,peripheral,I-Condition
14819,990,neuropathy,I-Condition
14820,990,),O
14821,991,Pre,O
14822,991,-,O
14823,991,existing,O
14824,991,/,O
14825,991,chronic,O
14826,991,back,B-Condition
14827,991,pain,I-Condition
14828,992,Ester,B-Drug
14829,992,local,I-Drug
14830,992,anesthetic,I-Drug
14831,992,allergy,B-Condition
14832,992,",",O
14833,992,PABA,B-Drug
14834,992,allergy,B-Condition
14835,993,History,B-Observation
14836,993,of,O
14837,993,atypical,B-Drug
14838,993,cholinesterase,I-Drug
14839,993,(,O
14840,993,CP,O
14841,993,is,O
14842,993,metabolized,O
14843,993,by,O
14844,993,cholinesterase,O
14845,993,),O
14846,994,ASA,O
14847,994,I,O
14848,994,and,O
14849,994,II,O
14850,994,women,B-Person
14851,995,18,O
14852,995,-,O
14853,995,45,O
14854,995,yrs,O
14855,995,old,B-Person
14856,996,Singleton,B-Condition
14857,996,pregnancy,I-Condition
14858,997,Cervical,B-Procedure
14859,997,cerclage,I-Procedure
14860,997,1st,O
14861,997,or,O
14862,997,2nd,O
14863,997,trimester,O
14864,997,of,O
14865,997,pregnancy,B-Condition
14866,997,undergoing,O
14867,997,with,O
14868,997,spinal,B-Procedure
14869,997,anesthesia,I-Procedure
14870,998,Height,O
14871,998,150,O
14872,998,-,O
14873,998,180,O
14874,998,cm,O
14875,999,BMI,O
14876,999,=,O
14877,999,40,O
14878,999,kg,O
14879,999,/,O
14880,999,m2,O
14881,999,.,O
14882,1000,Prior,O
14883,1000,systemic,B-Procedure
14884,1000,therapy,I-Procedure
14885,1000,targeting,I-Procedure
14886,1000,PD-1,I-Procedure
14887,1000,:,I-Procedure
14888,1000,PD,I-Procedure
14889,1000,-,I-Procedure
14890,1000,L1,I-Procedure
14891,1000,axis,I-Procedure
14892,1000,.,O
14893,1001,Patients,O
14894,1001,who,O
14895,1001,are,O
14896,1001,curable,O
14897,1001,by,O
14898,1001,conventional,B-Procedure
14899,1001,multidisciplinary,I-Procedure
14900,1001,management,I-Procedure
14901,1001,.,O
14902,1002,Patients,O
14903,1002,with,O
14904,1002,severe,O
14905,1002,and/or,O
14906,1002,uncontrolled,O
14907,1002,concurrent,O
14908,1002,medical,B-Condition
14909,1002,disease,I-Condition
14910,1002,that,O
14911,1002,in,O
14912,1002,the,O
14913,1002,opinion,O
14914,1002,of,O
14915,1002,the,O
14916,1002,investigator,O
14917,1002,could,O
14918,1002,cause,O
14919,1002,unacceptable,O
14920,1002,safety,O
14921,1002,risks,O
14922,1002,or,O
14923,1002,compromise,O
14924,1002,compliance,O
14925,1002,with,O
14926,1002,the,O
14927,1002,protocol,O
14928,1002,.,O
14929,1003,Patients,O
14930,1003,who,O
14931,1003,have,O
14932,1003,received,O
14933,1003,wide,B-Procedure
14934,1003,field,I-Procedure
14935,1003,radiotherapy,I-Procedure
14936,1003,≤,O
14937,1003,4,O
14938,1003,weeks,O
14939,1003,or,O
14940,1003,limited,B-Procedure
14941,1003,field,I-Procedure
14942,1003,radiation,I-Procedure
14943,1003,for,I-Procedure
14944,1003,palliation,I-Procedure
14945,1003,<,O
14946,1003,2,O
14947,1003,weeks,O
14948,1003,prior,O
14949,1003,to,O
14950,1003,screening,O
14951,1003,or,O
14952,1003,who,O
14953,1003,have,O
14954,1003,not,O
14955,1003,recovered,B-Condition
14956,1003,adequately,O
14957,1003,from,O
14958,1003,side,B-Condition
14959,1003,effects,I-Condition
14960,1003,of,I-Condition
14961,1003,such,I-Condition
14962,1003,therapy,I-Condition
14963,1003,.,O
14964,1004,Patients,O
14965,1004,who,O
14966,1004,have,O
14967,1004,active,O
14968,1004,infections,B-Condition
14969,1004,requiring,O
14970,1004,therapy,B-Procedure
14971,1004,.,O
14972,1005,Patients,O
14973,1005,that,O
14974,1005,are,O
14975,1005,known,O
14976,1005,to,O
14977,1005,be,O
14978,1005,positive,O
14979,1005,for,O
14980,1005,Human,O
14981,1005,Immunodeficiency,O
14982,1005,Virus,O
14983,1005,(,O
14984,1005,HIV,O
14985,1005,),O
14986,1005,(,O
14987,1005,HIV,O
14988,1005,1/2,O
14989,1005,antibodies,O
14990,1005,),O
14991,1005,",",O
14992,1005,active,B-Condition
14993,1005,Hepatitis,I-Condition
14994,1005,B,I-Condition
14995,1005,(,O
14996,1005,HBsAg,O
14997,1005,reactive,O
14998,1005,),O
14999,1005,",",O
15000,1005,or,O
15001,1005,Hepatitis,B-Condition
15002,1005,C,I-Condition
15003,1005,(,O
15004,1005,HCV,O
15005,1005,RNA,O
15006,1005,[,O
15007,1005,qualitative,O
15008,1005,],O
15009,1005,is,O
15010,1005,detected,O
15011,1005,),O
15012,1005,;,O
15013,1005,patients,O
15014,1005,with,O
15015,1005,negative,O
15016,1005,Hepatitis,O
15017,1005,C,O
15018,1005,antibody,O
15019,1005,testing,O
15020,1005,may,O
15021,1005,not,O
15022,1005,need,O
15023,1005,RNA,O
15024,1005,testing,O
15025,1005,.,O
15026,1006,Patients,O
15027,1006,that,O
15028,1006,have,O
15029,1006,a,O
15030,1006,known,O
15031,1006,psychiatric,B-Condition
15032,1006,or,I-Condition
15033,1006,substance,I-Condition
15034,1006,abuse,I-Condition
15035,1006,disorder,I-Condition
15036,1006,that,O
15037,1006,would,O
15038,1006,interfere,O
15039,1006,with,O
15040,1006,cooperation,O
15041,1006,with,O
15042,1006,the,O
15043,1006,requirements,O
15044,1006,of,O
15045,1006,the,O
15046,1006,trial,O
15047,1006,.,O
15048,1007,Patients,O
15049,1007,who,O
15050,1007,received,O
15051,1007,systemic,B-Procedure
15052,1007,anti,I-Procedure
15053,1007,-,I-Procedure
15054,1007,cancer,I-Procedure
15055,1007,treatment,I-Procedure
15056,1007,prior,O
15057,1007,to,O
15058,1007,the,O
15059,1007,first,O
15060,1007,dose,O
15061,1007,of,O
15062,1007,study,O
15063,1007,drug,O
15064,1007,within,O
15065,1007,the,O
15066,1007,following,O
15067,1007,time,O
15068,1007,frames,O
15069,1007,:,O
15070,1008,Patients,O
15071,1008,with,O
15072,1008,active,O
15073,1008,autoimmune,B-Condition
15074,1008,disease,I-Condition
15075,1008,or,O
15076,1008,a,O
15077,1008,documented,O
15078,1008,history,B-Observation
15079,1008,of,O
15080,1008,autoimmune,B-Condition
15081,1008,disease,I-Condition
15082,1008,or,O
15083,1008,syndrome,B-Condition
15084,1008,that,I-Condition
15085,1008,requires,I-Condition
15086,1008,systemic,I-Condition
15087,1008,steroids,I-Condition
15088,1008,or,I-Condition
15089,1008,immunosuppressive,I-Condition
15090,1008,agents,I-Condition
15091,1008,.,O
15092,1008,Patients,O
15093,1008,with,O
15094,1008,vitiligo,B-Condition
15095,1008,or,O
15096,1008,resolved,O
15097,1008,childhood,B-Condition
15098,1008,asthma,I-Condition
15099,1008,/,O
15100,1008,atopy,B-Condition
15101,1008,would,O
15102,1008,be,O
15103,1008,exception,O
15104,1008,to,O
15105,1008,this,O
15106,1008,rule,O
15107,1008,.,O
15108,1008,Patients,O
15109,1008,that,O
15110,1008,require,O
15111,1008,inhaled,O
15112,1008,steroids,O
15113,1008,or,O
15114,1008,local,O
15115,1008,steroid,O
15116,1008,injections,O
15117,1008,would,O
15118,1008,not,O
15119,1008,be,O
15120,1008,excluded,O
15121,1008,from,O
15122,1008,the,O
15123,1008,study,O
15124,1008,.,O
15125,1008,Patients,O
15126,1008,with,O
15127,1008,hypothyroidism,B-Condition
15128,1008,not,O
15129,1008,from,O
15130,1008,autoimmune,B-Condition
15131,1008,disease,I-Condition
15132,1008,that,O
15133,1008,is,O
15134,1008,stable,O
15135,1008,on,O
15136,1008,hormone,B-Procedure
15137,1008,replacement,I-Procedure
15138,1008,will,O
15139,1008,not,O
15140,1008,be,O
15141,1008,excluded,O
15142,1008,from,O
15143,1008,the,O
15144,1008,study,O
15145,1008,.,O
15146,1009,Women,B-Person
15147,1009,who,O
15148,1009,are,O
15149,1009,pregnant,B-Condition
15150,1009,or,O
15151,1009,nursing,B-Condition
15152,1009,/,O
15153,1009,breastfeeding,B-Observation
15154,1009,.,O
15155,1010,Known,O
15156,1010,hypersensitivity,B-Condition
15157,1010,to,I-Condition
15158,1010,pembrolizumab,I-Condition
15159,1010,or,I-Condition
15160,1010,another,I-Condition
15161,1010,mAb,I-Condition
15162,1010,.,O
15163,1011,Has,O
15164,1011,a,O
15165,1011,history,B-Observation
15166,1011,of,O
15167,1011,(,O
15168,1011,non,O
15169,1011,-,O
15170,1011,infectious,O
15171,1011,),O
15172,1011,pneumonitis,B-Condition
15173,1011,that,O
15174,1011,required,O
15175,1011,steroids,B-Drug
15176,1011,or,O
15177,1011,current,O
15178,1011,pneumonitis,B-Condition
15179,1011,.,O
15180,1012,Patients,O
15181,1012,with,O
15182,1012,untreated,O
15183,1012,central,B-Condition
15184,1012,nervous,I-Condition
15185,1012,system,I-Condition
15186,1012,disease,I-Condition
15187,1012,.,O
15188,1012,Patients,O
15189,1012,with,O
15190,1012,controlled,O
15191,1012,treated,O
15192,1012,CNS,B-Condition
15193,1012,lesions,I-Condition
15194,1012,who,O
15195,1012,have,O
15196,1012,undergone,O
15197,1012,surgery,B-Procedure
15198,1012,or,O
15199,1012,stereotactic,B-Procedure
15200,1012,radiosurgery,I-Procedure
15201,1012,and,O
15202,1012,stable,O
15203,1012,for,O
15204,1012,4,O
15205,1012,weeks,O
15206,1012,are,O
15207,1012,eligible,O
15208,1012,.,O
15209,1013,Inability,B-Condition
15210,1013,to,I-Condition
15211,1013,comply,I-Condition
15212,1013,with,I-Condition
15213,1013,protocol,I-Condition
15214,1013,required,I-Condition
15215,1013,procedures,I-Condition
15216,1013,.,I-Condition
15217,1014,Patients,O
15218,1014,with,O
15219,1014,medical,B-Condition
15220,1014,conditions,I-Condition
15221,1014,that,O
15222,1014,require,O
15223,1014,chronic,O
15224,1014,systemic,B-Procedure
15225,1014,corticosteroid,I-Procedure
15226,1014,therapy,I-Procedure
15227,1014,or,O
15228,1014,require,O
15229,1014,any,O
15230,1014,other,O
15231,1014,form,O
15232,1014,of,O
15233,1014,immunosuppressive,B-Drug
15234,1014,medication,I-Drug
15235,1014,.,O
15236,1014,However,O
15237,1014,",",O
15238,1014,patients,O
15239,1014,using,O
15240,1014,physiologic,O
15241,1014,replacement,O
15242,1014,doses,O
15243,1014,of,O
15244,1014,hydrocortisone,B-Drug
15245,1014,",",O
15246,1014,or,O
15247,1014,its,O
15248,1014,equivalent,O
15249,1014,",",O
15250,1014,will,O
15251,1014,be,O
15252,1014,considered,O
15253,1014,eligible,O
15254,1014,for,O
15255,1014,this,O
15256,1014,study,O
15257,1014,:,O
15258,1014,up,O
15259,1014,to,O
15260,1014,20,O
15261,1014,mg,O
15262,1014,hydrocortisone,B-Drug
15263,1014,(,O
15264,1014,or,O
15265,1014,5,O
15266,1014,mg,O
15267,1014,of,O
15268,1014,prednisone,B-Drug
15269,1014,),O
15270,1014,in,O
15271,1014,the,O
15272,1014,morning,O
15273,1014,and,O
15274,1014,10,O
15275,1014,mg,O
15276,1014,hydrocortisone,B-Drug
15277,1014,(,O
15278,1014,or,O
15279,1014,2.5,O
15280,1014,mg,O
15281,1014,prednisone,B-Drug
15282,1014,),O
15283,1014,in,O
15284,1014,the,O
15285,1014,evening,O
15286,1014,.,O
15287,1015,Patients,O
15288,1015,with,O
15289,1015,the,O
15290,1015,risk,B-Condition
15291,1015,factors,I-Condition
15292,1015,for,I-Condition
15293,1015,bowel,I-Condition
15294,1015,obstruction,I-Condition
15295,1015,or,I-Condition
15296,1015,bowel,I-Condition
15297,1015,perforation,I-Condition
15298,1015,(,O
15299,1015,examples,O
15300,1015,include,O
15301,1015,but,O
15302,1015,not,O
15303,1015,limited,O
15304,1015,to,O
15305,1015,a,O
15306,1015,history,B-Observation
15307,1015,of,O
15308,1015,acute,B-Condition
15309,1015,diverticulitis,I-Condition
15310,1015,",",O
15311,1015,intra,B-Condition
15312,1015,-,I-Condition
15313,1015,abdominal,I-Condition
15314,1015,abscess,I-Condition
15315,1015,",",O
15316,1015,abdominal,B-Condition
15317,1015,carcinomatosis,I-Condition
15318,1015,),O
15319,1015,.,O
15320,1016,Patients,O
15321,1016,who,O
15322,1016,have,O
15323,1016,received,O
15324,1016,a,O
15325,1016,live,B-Drug
15326,1016,vaccine,I-Drug
15327,1016,within,O
15328,1016,30,O
15329,1016,days,O
15330,1016,prior,O
15331,1016,to,O
15332,1016,the,O
15333,1016,first,O
15334,1016,dose,O
15335,1016,of,O
15336,1016,trial,O
15337,1016,treatment,O
15338,1016,.,O
15339,1017,Age,B-Person
15340,1017,≥,O
15341,1017,18,O
15342,1017,years,O
15343,1017,(,O
15344,1017,Age,B-Person
15345,1017,≥,O
15346,1017,12,O
15347,1017,years,O
15348,1017,for,O
15349,1017,patients,O
15350,1017,with,O
15351,1017,bone,B-Condition
15352,1017,sarcomas,I-Condition
15353,1017,),O
15354,1017,.,O
15355,1018,Histologically,B-Procedure
15356,1018,confirmed,O
15357,1018,diagnosis,O
15358,1018,of,O
15359,1018,unresectable,O
15360,1018,",",O
15361,1018,recurrent,O
15362,1018,",",O
15363,1018,and/or,O
15364,1018,metastatic,O
15365,1018,high,O
15366,1018,grade,O
15367,1018,soft,B-Condition
15368,1018,-,I-Condition
15369,1018,tissue,I-Condition
15370,1018,or,I-Condition
15371,1018,bone,I-Condition
15372,1018,sarcoma,I-Condition
15373,1018,of,O
15374,1018,one,O
15375,1018,of,O
15376,1018,the,O
15377,1018,following,O
15378,1018,subtypes,O
15379,1018,:,O
15380,1018,soft,B-Condition
15381,1018,tissue,I-Condition
15382,1018,sarcomas,I-Condition
15383,1018,(,O
15384,1018,leiomyosarcoma,B-Condition
15385,1018,",",O
15386,1018,poorly,O
15387,1018,differentiated,O
15388,1018,/,O
15389,1018,de,O
15390,1018,-,O
15391,1018,differentiated,O
15392,1018,liposarcoma,B-Condition
15393,1018,",",O
15394,1018,high,O
15395,1018,grade,O
15396,1018,pleomorphic,O
15397,1018,undifferentiated,O
15398,1018,sarcoma,B-Condition
15399,1018,/,O
15400,1018,MFH,B-Condition
15401,1018,and,O
15402,1018,synovial,B-Condition
15403,1018,sarcoma,I-Condition
15404,1018,),O
15405,1018,",",O
15406,1018,and,O
15407,1018,bone,B-Condition
15408,1018,sarcomas,I-Condition
15409,1018,(,O
15410,1018,Ewing,B-Condition
15411,1018,sarcoma,I-Condition
15412,1018,",",O
15413,1018,osteosarcoma,B-Condition
15414,1018,",",O
15415,1018,and,O
15416,1018,chondrosarcoma,B-Condition
15417,1018,[,O
15418,1018,de,O
15419,1018,-,O
15420,1018,differentiated,O
15421,1018,or,O
15422,1018,mesenchymal,O
15423,1018,],O
15424,1018,),O
15425,1018,.,O
15426,1019,ECOG,O
15427,1019,Performance,O
15428,1019,Status,O
15429,1019,of,O
15430,1019,0,O
15431,1019,or,O
15432,1019,1,O
15433,1019,.,O
15434,1020,At,O
15435,1020,least,O
15436,1020,one,O
15437,1020,site,O
15438,1020,of,O
15439,1020,measurable,B-Condition
15440,1020,disease,I-Condition
15441,1020,on,O
15442,1020,CT,B-Procedure
15443,1020,/,I-Procedure
15444,1020,MRI,I-Procedure
15445,1020,scans,I-Procedure
15446,1020,as,O
15447,1020,defined,O
15448,1020,by,O
15449,1020,RECIST,O
15450,1020,1.1,O
15451,1020,.,O
15452,1020,Baseline,O
15453,1020,imaging,B-Procedure
15454,1020,must,O
15455,1020,be,O
15456,1020,performed,O
15457,1020,within,O
15458,1020,30,O
15459,1020,days,O
15460,1020,of,O
15461,1020,dosing,O
15462,1020,.,O
15463,1021,At,O
15464,1021,least,O
15465,1021,one,O
15466,1021,site,O
15467,1021,of,O
15468,1021,accessible,O
15469,1021,disease,O
15470,1021,for,O
15471,1021,pre-,O
15472,1021,and,O
15473,1021,post,O
15474,1021,-,O
15475,1021,treatment,O
15476,1021,core,O
15477,1021,biopsies,O
15478,1021,for,O
15479,1021,at,O
15480,1021,least,O
15481,1021,20,O
15482,1021,patients,O
15483,1021,per,O
15484,1021,arm,O
15485,1021,on,O
15486,1021,the,O
15487,1021,expansion,O
15488,1021,cohorts,O
15489,1021,.,O
15490,1022,Patients,O
15491,1022,may,O
15492,1022,have,O
15493,1022,received,O
15494,1022,1,O
15495,1022,-,O
15496,1022,3,O
15497,1022,prior,O
15498,1022,systemic,B-Procedure
15499,1022,therapies,I-Procedure
15500,1022,in,O
15501,1022,the,O
15502,1022,metastatic,O
15503,1022,setting,O
15504,1022,.,O
15505,1023,Adequate,B-Condition
15506,1023,organ,I-Condition
15507,1023,function,I-Condition
15508,1023,within,O
15509,1023,14,O
15510,1023,days,O
15511,1023,of,O
15512,1023,dosing,O
15513,1024,Must,O
15514,1024,be,O
15515,1024,willing,O
15516,1024,to,O
15517,1024,provide,O
15518,1024,and,O
15519,1024,have,O
15520,1024,available,O
15521,1024,archival,O
15522,1024,tissue,O
15523,1024,for,O
15524,1024,PD,O
15525,1024,-,O
15526,1024,L1,O
15527,1024,testing,O
15528,1024,.,O
15529,1025,Written,O
15530,1025,",",O
15531,1025,voluntary,O
15532,1025,informed,O
15533,1025,consent,O
15534,1025,.,O
15535,1026,Fertile,O
15536,1026,men,B-Person
15537,1026,and,O
15538,1026,women,B-Person
15539,1026,of,O
15540,1026,childbearing,B-Condition
15541,1026,potential,I-Condition
15542,1026,must,O
15543,1026,agree,O
15544,1026,to,O
15545,1026,use,O
15546,1026,an,O
15547,1026,effective,O
15548,1026,method,O
15549,1026,of,O
15550,1026,birth,B-Procedure
15551,1026,control,I-Procedure
15552,1026,from,O
15553,1026,providing,O
15554,1026,signed,O
15555,1026,consent,O
15556,1026,and,O
15557,1026,for,O
15558,1026,120,O
15559,1026,days,O
15560,1026,after,O
15561,1026,last,O
15562,1026,study,O
15563,1026,drug,O
15564,1026,administration,O
15565,1026,.,O
15566,1026,Women,B-Person
15567,1026,of,O
15568,1026,childbearing,B-Condition
15569,1026,potential,I-Condition
15570,1026,include,O
15571,1026,pre,B-Condition
15572,1026,-,I-Condition
15573,1026,menopausal,I-Condition
15574,1026,women,B-Person
15575,1026,and,O
15576,1026,women,B-Person
15577,1026,within,O
15578,1026,the,O
15579,1026,first,O
15580,1026,2,O
15581,1026,years,O
15582,1026,of,O
15583,1026,the,O
15584,1026,onset,O
15585,1026,of,O
15586,1026,menopause,O
15587,1026,.,O
15588,1026,Women,B-Person
15589,1026,of,O
15590,1026,childbearing,B-Condition
15591,1026,potential,I-Condition
15592,1026,must,O
15593,1026,have,O
15594,1026,a,O
15595,1026,negative,O
15596,1026,pregnancy,O
15597,1026,test,O
15598,1026,≤,O
15599,1026,72,O
15600,1026,hours,O
15601,1026,prior,O
15602,1026,to,O
15603,1026,Day,O
15604,1026,1,O
15605,1026,of,O
15606,1026,study,O
15607,1026,.,O
15608,1027,Effective,O
15609,1027,methods,O
15610,1027,of,O
15611,1027,birth,B-Procedure
15612,1027,control,I-Procedure
15613,1027,include,O
15614,1027,:,O
15615,1027,surgically,B-Condition
15616,1027,sterile,I-Condition
15617,1027,",",O
15618,1027,barrier,O
15619,1027,device,O
15620,1027,(,O
15621,1027,condom,O
15622,1027,",",O
15623,1027,diaphragm,O
15624,1027,),O
15625,1027,",",O
15626,1027,contraceptive,O
15627,1027,coil,O
15628,1027,",",O
15629,1027,intrauterine,O
15630,1027,device,O
15631,1027,(,O
15632,1027,IUD,O
15633,1027,),O
15634,1027,",",O
15635,1027,and,O
15636,1027,abstinence,B-Procedure
15637,1027,.,O
15638,1028,Life,B-Observation
15639,1028,expectancy,I-Observation
15640,1028,of,O
15641,1028,>,O
15642,1028,12,O
15643,1028,weeks,O
15644,1028,.,O
15645,1029,Patients,O
15646,1029,with,O
15647,1029,central,B-Condition
15648,1029,nervous,I-Condition
15649,1029,system,I-Condition
15650,1029,disease,I-Condition
15651,1029,are,O
15652,1029,eligible,O
15653,1029,for,O
15654,1029,enrollment,O
15655,1029,if,O
15656,1029,they,O
15657,1029,have,O
15658,1029,received,O
15659,1029,prior,O
15660,1029,radiotherapy,B-Procedure
15661,1029,or,O
15662,1029,surgery,B-Procedure
15663,1029,to,O
15664,1029,sites,O
15665,1029,of,O
15666,1029,CNS,B-Condition
15667,1029,metastatic,I-Condition
15668,1029,disease,I-Condition
15669,1029,and,O
15670,1029,are,O
15671,1029,without,O
15672,1029,evidence,O
15673,1029,of,O
15674,1029,clinical,B-Condition
15675,1029,progression,I-Condition
15676,1029,for,O
15677,1029,at,O
15678,1029,least,O
15679,1029,4,O
15680,1029,weeks,O
15681,1029,prior,O
15682,1029,to,O
15683,1029,screening,O
15684,1029,",",O
15685,1029,have,O
15686,1029,no,O
15687,1029,evidence,O
15688,1029,of,O
15689,1029,new,O
15690,1029,or,O
15691,1029,enlarging,O
15692,1029,brain,B-Condition
15693,1029,metastases,I-Condition
15694,1029,",",O
15695,1029,and,O
15696,1029,are,O
15697,1029,off,O
15698,1029,steroids,B-Drug
15699,1029,for,O
15700,1029,at,O
15701,1029,least,O
15702,1029,7,O
15703,1029,days,O
15704,1029,before,O
15705,1029,first,O
15706,1029,dose,O
15707,1029,of,O
15708,1029,pembrolizumab,B-Drug
15709,1029,.,O
15710,1030,Patients,O
15711,1030,:,O
15712,1031,Who,O
15713,1031,are,O
15714,1031,pregnant,B-Condition
15715,1031,or,O
15716,1031,planning,B-Mood
15717,1031,to,I-Mood
15718,1031,become,I-Mood
15719,1031,pregnant,B-Condition
15720,1031,during,O
15721,1031,the,O
15722,1031,study,O
15723,1031,or,O
15724,1031,in,O
15725,1031,the,O
15726,1031,future,O
15727,1032,With,O
15728,1032,a,O
15729,1032,elevated,O
15730,1032,post,O
15731,1032,-,O
15732,1032,void,O
15733,1032,residual,O
15734,1032,(,O
15735,1032,defined,O
15736,1032,as,O
15737,1032,PVR,O
15738,1032,>,O
15739,1032,100cc,O
15740,1032,),O
15741,1033,With,O
15742,1033,a,O
15743,1033,bleeding,B-Condition
15744,1033,condition,I-Condition
15745,1033,or,O
15746,1033,on,O
15747,1033,anti,B-Procedure
15748,1033,-,I-Procedure
15749,1033,coagulant,I-Procedure
15750,1033,therapy,I-Procedure
15751,1034,With,O
15752,1034,immunosuppression,B-Observation
15753,1034,(,O
15754,1034,i.e.,O
15755,1034,HIV,B-Condition
15756,1034,",",O
15757,1034,lymphoma,B-Condition
15758,1034,),O
15759,1035,With,O
15760,1035,multiple,B-Condition
15761,1035,sclerosis,I-Condition
15762,1035,or,O
15763,1035,other,O
15764,1035,progressive,B-Condition
15765,1035,neurological,I-Condition
15766,1035,disease,I-Condition
15767,1036,With,O
15768,1036,evidence,O
15769,1036,of,O
15770,1036,a,O
15771,1036,local,B-Condition
15772,1036,or,I-Condition
15773,1036,systemic,I-Condition
15774,1036,infection,I-Condition
15775,1036,",",O
15776,1036,including,O
15777,1036,urinary,B-Condition
15778,1036,tract,I-Condition
15779,1036,infection,I-Condition
15780,1037,With,O
15781,1037,evidence,O
15782,1037,of,O
15783,1037,intrinsic,B-Condition
15784,1037,sphincter,I-Condition
15785,1037,deficiency,I-Condition
15786,1037,as,O
15787,1037,defined,O
15788,1037,by,O
15789,1037,a,O
15790,1037,maximal,O
15791,1037,urethral,O
15792,1037,closure,O
15793,1037,pressure,O
15794,1037,of,O
15795,1037,<,O
15796,1037,20,O
15797,1037,cm,O
15798,1037,H2O,O
15799,1038,Previous,O
15800,1038,sub,B-Procedure
15801,1038,-,I-Procedure
15802,1038,urethral,I-Procedure
15803,1038,sling,I-Procedure
15804,1039,Predominant,O
15805,1039,overactive,B-Condition
15806,1039,bladder,I-Condition
15807,1039,symptoms,I-Condition
15808,1040,Are,O
15809,1040,at,O
15810,1040,least,O
15811,1040,18,O
15812,1040,years,O
15813,1040,of,O
15814,1040,age,B-Person
15815,1041,Demonstrate,O
15816,1041,a,O
15817,1041,positive,O
15818,1041,cough,O
15819,1041,stress,O
15820,1041,test,O
15821,1041,during,O
15822,1041,complex,B-Procedure
15823,1041,multi,I-Procedure
15824,1041,-,I-Procedure
15825,1041,channel,I-Procedure
15826,1041,urodynamic,I-Procedure
15827,1041,testing,I-Procedure
15828,1042,Demonstrate,O
15829,1042,impact,O
15830,1042,of,O
15831,1042,stress,B-Condition
15832,1042,urinary,I-Condition
15833,1042,incontinence,I-Condition
15834,1042,on,O
15835,1042,quality,B-Procedure
15836,1042,of,I-Procedure
15837,1042,life,I-Procedure
15838,1042,questionnaire,I-Procedure
15839,1043,Are,O
15840,1043,able,B-Observation
15841,1043,to,I-Observation
15842,1043,comprehend,I-Observation
15843,1043,and,I-Observation
15844,1043,sign,I-Observation
15845,1043,a,I-Observation
15846,1043,written,I-Observation
15847,1043,informed,I-Observation
15848,1043,consent,I-Observation
15849,1044,Understand,B-Observation
15850,1044,and,I-Observation
15851,1044,are,I-Observation
15852,1044,willing,I-Observation
15853,1044,to,I-Observation
15854,1044,comply,I-Observation
15855,1044,with,I-Observation
15856,1044,the,I-Observation
15857,1044,study,I-Observation
15858,1044,requirements,I-Observation
15859,1044,",",O
15860,1044,including,O
15861,1044,agreeing,O
15862,1044,to,O
15863,1044,be,O
15864,1044,available,O
15865,1044,for,O
15866,1044,the,O
15867,1044,follow,O
15868,1044,-,O
15869,1044,up,O
15870,1044,evaluations,O
15871,1045,Are,O
15872,1045,psychologically,B-Condition
15873,1045,stable,I-Condition
15874,1045,and,O
15875,1045,suitable,B-Condition
15876,1045,for,I-Condition
15877,1045,interventions,I-Condition
15878,1045,determined,O
15879,1045,by,O
15880,1045,the,O
15881,1045,investigator,O
15882,1046,Are,O
15883,1046,ambulatory,B-Condition
15884,1046,and,O
15885,1046,able,B-Condition
15886,1046,to,I-Condition
15887,1046,use,I-Condition
15888,1046,a,I-Condition
15889,1046,toilet,I-Condition
15890,1046,independently,I-Condition
15891,1047,Clinically,O
15892,1047,significant,O
15893,1047,abnormalities,B-Condition
15894,1047,of,I-Condition
15895,1047,glucose,I-Condition
15896,1047,metabolism,I-Condition
15897,1048,Spinal,B-Condition
15898,1048,cord,I-Condition
15899,1048,compression,I-Condition
15900,1048,or,O
15901,1048,brain,B-Condition
15902,1048,metastases,I-Condition
15903,1048,unless,O
15904,1048,asymptomatic,B-Condition
15905,1048,",",O
15906,1048,treated,O
15907,1048,and,O
15908,1048,stable,O
15909,1048,(,O
15910,1048,not,O
15911,1048,requiring,O
15912,1048,steroids,B-Drug
15913,1048,),O
15914,1049,Evidence,O
15915,1049,of,O
15916,1049,severe,O
15917,1049,or,O
15918,1049,uncontrolled,O
15919,1049,systemic,B-Condition
15920,1049,diseases,I-Condition
15921,1049,",",O
15922,1049,including,O
15923,1049,active,B-Condition
15924,1049,bleeding,I-Condition
15925,1049,diatheses,I-Condition
15926,1049,or,O
15927,1049,active,B-Condition
15928,1049,infections,I-Condition
15929,1049,including,O
15930,1049,hepatitis,B-Condition
15931,1049,B,I-Condition
15932,1049,",",I-Condition
15933,1049,C,I-Condition
15934,1049,and,O
15935,1049,Human,B-Condition
15936,1049,Immunodeficiency,I-Condition
15937,1049,Virus,I-Condition
15938,1049,(,I-Condition
15939,1049,HIV,I-Condition
15940,1049,),I-Condition
15941,1050,Evidence,O
15942,1050,of,O
15943,1050,clinically,O
15944,1050,significant,O
15945,1050,cardiac,B-Condition
15946,1050,abnormalities,I-Condition
15947,1050,",",O
15948,1050,uncontrolled,B-Condition
15949,1050,hypotension,I-Condition
15950,1050,",",O
15951,1050,left,O
15952,1050,ventricular,O
15953,1050,ejection,O
15954,1050,fraction,O
15955,1050,below,O
15956,1050,the,O
15957,1050,lower,O
15958,1050,limit,O
15959,1050,of,O
15960,1050,normal,O
15961,1050,for,O
15962,1050,the,O
15963,1050,site,O
15964,1050,or,O
15965,1050,experience,O
15966,1050,of,O
15967,1050,significant,O
15968,1050,cardiac,B-Procedure
15969,1050,interventional,I-Procedure
15970,1050,procedures,I-Procedure
15971,1051,A,O
15972,1051,bad,B-Condition
15973,1051,reaction,I-Condition
15974,1051,to,I-Condition
15975,1051,AZD5363,I-Condition
15976,1051,or,O
15977,1051,any,O
15978,1051,drugs,O
15979,1051,similar,O
15980,1051,to,O
15981,1051,it,O
15982,1051,in,O
15983,1051,structure,O
15984,1051,or,O
15985,1051,class,O
15986,1052,Aged,B-Person
15987,1052,at,O
15988,1052,least,O
15989,1052,18,O
15990,1052,years,O
15991,1053,The,O
15992,1053,presence,O
15993,1053,of,O
15994,1053,a,O
15995,1053,solid,B-Condition
15996,1053,",",I-Condition
15997,1053,malignant,I-Condition
15998,1053,tumour,I-Condition
15999,1053,",",O
16000,1053,excluding,O
16001,1053,lymphoma,B-Condition
16002,1053,",",O
16003,1053,that,O
16004,1053,is,O
16005,1053,resistance,O
16006,1053,to,O
16007,1053,standard,O
16008,1053,therapies,O
16009,1053,or,O
16010,1053,for,O
16011,1053,which,O
16012,1053,no,O
16013,1053,standard,O
16014,1053,therapies,O
16015,1053,exist,O
16016,1054,The,O
16017,1054,presence,O
16018,1054,of,O
16019,1054,at,O
16020,1054,least,O
16021,1054,one,O
16022,1054,lesion,B-Condition
16023,1054,that,O
16024,1054,can,O
16025,1054,be,O
16026,1054,accurately,O
16027,1054,assessed,O
16028,1054,at,O
16029,1054,baseline,O
16030,1054,by,O
16031,1054,Computerised,B-Procedure
16032,1054,Tomography,I-Procedure
16033,1054,(,I-Procedure
16034,1054,CT,I-Procedure
16035,1054,),I-Procedure
16036,1054,",",O
16037,1054,Magnetic,B-Procedure
16038,1054,Resonance,I-Procedure
16039,1054,Imaging,I-Procedure
16040,1054,(,I-Procedure
16041,1054,MRI,I-Procedure
16042,1054,),I-Procedure
16043,1054,or,O
16044,1054,plain,B-Procedure
16045,1054,X,I-Procedure
16046,1054,-,I-Procedure
16047,1054,ray,I-Procedure
16048,1054,and,O
16049,1054,is,O
16050,1054,suitable,O
16051,1054,for,O
16052,1054,repeated,O
16053,1054,assessment,O
16054,1055,Estimated,B-Observation
16055,1055,life,I-Observation
16056,1055,expectancy,I-Observation
16057,1055,of,O
16058,1055,more,O
16059,1055,than,O
16060,1055,12,O
16061,1055,weeks,O
16062,1056,Patient,O
16063,1056,has,O
16064,1056,been,O
16065,1056,permanently,O
16066,1056,discontinued,O
16067,1056,from,O
16068,1056,pasireotide,O
16069,1056,study,O
16070,1056,treatment,O
16071,1056,in,O
16072,1056,the,O
16073,1056,parent,O
16074,1056,study,O
16075,1056,due,O
16076,1056,to,O
16077,1056,unacceptable,O
16078,1056,toxicity,O
16079,1056,",",O
16080,1056,non,O
16081,1056,-,O
16082,1056,compliance,O
16083,1056,to,O
16084,1056,study,O
16085,1056,procedures,O
16086,1056,",",O
16087,1056,withdrawal,O
16088,1056,of,O
16089,1056,consent,O
16090,1056,or,O
16091,1056,any,O
16092,1056,other,O
16093,1056,reason,O
16094,1057,Patient,O
16095,1057,has,O
16096,1057,participated,O
16097,1057,in,O
16098,1057,a,O
16099,1057,Novartis,O
16100,1057,sponsored,O
16101,1057,combination,O
16102,1057,trial,O
16103,1057,where,O
16104,1057,pasireotide,O
16105,1057,was,O
16106,1057,dispensed,O
16107,1057,in,O
16108,1057,combination,O
16109,1057,with,O
16110,1057,another,O
16111,1057,study,O
16112,1057,medication,O
16113,1057,and,O
16114,1057,is,O
16115,1057,still,O
16116,1057,receiving,O
16117,1057,combination,O
16118,1057,therapy,O
16119,1057,.,O
16120,1057,(,O
16121,1057,only,O
16122,1057,patients,O
16123,1057,receiving,O
16124,1057,pasireotide,O
16125,1057,monotherapy,O
16126,1057,can,O
16127,1057,be,O
16128,1057,included,O
16129,1057,),O
16130,1058,Pregnant,O
16131,1058,or,O
16132,1058,nursing,O
16133,1058,(,O
16134,1058,lactating,O
16135,1058,),O
16136,1058,women,O
16137,1058,",",O
16138,1058,where,O
16139,1058,pregnancy,O
16140,1058,is,O
16141,1058,defined,O
16142,1058,as,O
16143,1058,the,O
16144,1058,state,O
16145,1058,of,O
16146,1058,a,O
16147,1058,female,O
16148,1058,after,O
16149,1058,conception,O
16150,1058,and,O
16151,1058,until,O
16152,1058,the,O
16153,1058,termination,O
16154,1058,of,O
16155,1058,gestation,O
16156,1058,",",O
16157,1058,confirmed,O
16158,1058,by,O
16159,1058,a,O
16160,1058,positive,O
16161,1058,hCG,O
16162,1058,laboratory,O
16163,1058,test,O
16164,1059,Total,O
16165,1059,abstinence,O
16166,1059,(,O
16167,1059,when,O
16168,1059,this,O
16169,1059,is,O
16170,1059,in,O
16171,1059,line,O
16172,1059,with,O
16173,1059,the,O
16174,1059,preferred,O
16175,1059,and,O
16176,1059,usual,O
16177,1059,lifestyle,O
16178,1059,of,O
16179,1059,the,O
16180,1059,subject,O
16181,1059,.,O
16182,1059,Periodic,O
16183,1059,abstinence,O
16184,1059,(,O
16185,1059,e.g.,O
16186,1059,",",O
16187,1059,calendar,O
16188,1059,",",O
16189,1059,ovulation,O
16190,1059,",",O
16191,1059,symptothermal,O
16192,1059,",",O
16193,1059,post,O
16194,1059,-,O
16195,1059,ovulation,O
16196,1059,methods,O
16197,1059,),O
16198,1059,and,O
16199,1059,withdrawal,O
16200,1059,are,O
16201,1059,not,O
16202,1059,acceptable,O
16203,1059,methods,O
16204,1059,of,O
16205,1059,contraception,O
16206,1060,Female,B-Procedure
16207,1060,sterilization,I-Procedure
16208,1060,(,O
16209,1060,have,O
16210,1060,had,O
16211,1060,surgical,O
16212,1060,bilateral,B-Procedure
16213,1060,oophorectomy,I-Procedure
16214,1060,with,O
16215,1060,or,O
16216,1060,without,O
16217,1060,hysterectomy,B-Procedure
16218,1060,),O
16219,1060,or,O
16220,1060,tubal,B-Procedure
16221,1060,ligation,I-Procedure
16222,1060,at,O
16223,1060,least,O
16224,1060,six,O
16225,1060,weeks,O
16226,1060,before,O
16227,1060,taking,O
16228,1060,study,O
16229,1060,treatment,O
16230,1060,.,O
16231,1060,In,O
16232,1060,case,O
16233,1060,of,O
16234,1060,oophorectomy,O
16235,1060,alone,O
16236,1060,",",O
16237,1060,only,O
16238,1060,when,O
16239,1060,the,O
16240,1060,reproductive,O
16241,1060,status,O
16242,1060,of,O
16243,1060,the,O
16244,1060,woman,O
16245,1060,has,O
16246,1060,been,O
16247,1060,confirmed,O
16248,1060,by,O
16249,1060,follow,O
16250,1060,up,O
16251,1060,hormone,O
16252,1060,level,O
16253,1060,assessment,O
16254,1061,Male,B-Procedure
16255,1061,sterilization,I-Procedure
16256,1061,(,O
16257,1061,at,O
16258,1061,least,O
16259,1061,6,O
16260,1061,months,O
16261,1061,prior,O
16262,1061,to,O
16263,1061,screening,O
16264,1061,),O
16265,1061,.,O
16266,1061,For,O
16267,1061,female,O
16268,1061,subjects,O
16269,1061,on,O
16270,1061,the,O
16271,1061,study,O
16272,1061,the,O
16273,1061,vasectomized,O
16274,1061,male,O
16275,1061,partner,O
16276,1061,should,O
16277,1061,be,O
16278,1061,the,O
16279,1061,sole,O
16280,1061,partner,O
16281,1061,for,O
16282,1061,that,O
16283,1061,subject,O
16284,1061,.,O
16285,1062,Use,O
16286,1062,of,O
16287,1062,oral,O
16288,1062,",",O
16289,1062,injected,O
16290,1062,or,O
16291,1062,implanted,O
16292,1062,hormonal,O
16293,1062,methods,O
16294,1062,of,O
16295,1062,contraception,O
16296,1062,or,O
16297,1062,other,O
16298,1062,forms,O
16299,1062,of,O
16300,1062,hormonal,O
16301,1062,contraception,O
16302,1062,that,O
16303,1062,have,O
16304,1062,comparable,O
16305,1062,efficacy,O
16306,1062,(,O
16307,1062,failure,O
16308,1062,rate,O
16309,1062,<,O
16310,1062,1,O
16311,1062,%,O
16312,1062,),O
16313,1062,",",O
16314,1062,for,O
16315,1062,example,O
16316,1062,hormone,B-Procedure
16317,1062,vaginal,I-Procedure
16318,1062,ring,I-Procedure
16319,1062,or,O
16320,1062,transdermal,B-Procedure
16321,1062,hormone,I-Procedure
16322,1062,contraception,I-Procedure
16323,1063,Placement,O
16324,1063,of,O
16325,1063,an,O
16326,1063,intrauterine,O
16327,1063,device,O
16328,1063,(,O
16329,1063,IUD,O
16330,1063,),O
16331,1063,or,O
16332,1063,intrauterine,O
16333,1063,system,O
16334,1063,(,O
16335,1063,IUS,O
16336,1063,),O
16337,1064,Barrier,O
16338,1064,methods,O
16339,1064,of,O
16340,1064,contraception,B-Procedure
16341,1064,:,O
16342,1064,Condom,O
16343,1064,or,O
16344,1064,Occlusive,O
16345,1064,cap,O
16346,1064,diaphragm,O
16347,1064,or,O
16348,1064,cervical,O
16349,1064,/,O
16350,1064,vault,O
16351,1064,caps,O
16352,1064,),O
16353,1064,with,O
16354,1064,spermicidal,B-Procedure
16355,1064,foam,I-Procedure
16356,1064,/,O
16357,1064,gel,O
16358,1064,/,O
16359,1064,film,O
16360,1064,/,O
16361,1064,cream,O
16362,1064,/,O
16363,1064,vaginal,O
16364,1064,suppository,O
16365,1064,In,O
16366,1064,case,O
16367,1064,of,O
16368,1064,use,O
16369,1064,of,O
16370,1064,oral,O
16371,1064,contraception,O
16372,1064,women,O
16373,1064,should,O
16374,1064,have,O
16375,1064,been,O
16376,1064,stable,O
16377,1064,on,O
16378,1064,the,O
16379,1064,same,O
16380,1064,pill,O
16381,1064,for,O
16382,1064,a,O
16383,1064,minimum,O
16384,1064,of,O
16385,1064,3,O
16386,1064,months,O
16387,1064,before,O
16388,1064,taking,O
16389,1064,study,O
16390,1064,treatment,O
16391,1065,Sexually,O
16392,1065,active,O
16393,1065,males,O
16394,1065,unless,O
16395,1065,they,O
16396,1065,use,O
16397,1065,a,O
16398,1065,condom,O
16399,1065,during,O
16400,1065,intercourse,O
16401,1065,while,O
16402,1065,taking,O
16403,1065,drug,O
16404,1065,and,O
16405,1065,for,O
16406,1065,1,O
16407,1065,months,O
16408,1065,after,O
16409,1065,pasireotide,O
16410,1065,s.c,O
16411,1065,.,O
16412,1065,last,O
16413,1065,dose,O
16414,1065,and,O
16415,1065,3,O
16416,1065,months,O
16417,1065,after,O
16418,1065,pasireotide,O
16419,1065,LAR,O
16420,1065,last,O
16421,1065,dose,O
16422,1065,and,O
16423,1065,should,O
16424,1065,not,O
16425,1065,father,O
16426,1065,a,O
16427,1065,child,O
16428,1065,in,O
16429,1065,this,O
16430,1065,period,O
16431,1065,.,O
16432,1065,A,O
16433,1065,condom,O
16434,1065,is,O
16435,1065,required,O
16436,1065,to,O
16437,1065,be,O
16438,1065,used,O
16439,1065,also,O
16440,1065,by,O
16441,1065,vasectomized,O
16442,1065,men,O
16443,1065,in,O
16444,1065,order,O
16445,1065,to,O
16446,1065,prevent,O
16447,1065,delivery,O
16448,1065,of,O
16449,1065,the,O
16450,1065,drug,O
16451,1065,via,O
16452,1065,seminal,O
16453,1065,fluid,O
16454,1065,If,O
16455,1065,a,O
16456,1065,study,O
16457,1065,patient,O
16458,1065,or,O
16459,1065,partner,O
16460,1065,becomes,O
16461,1065,pregnant,O
16462,1065,or,O
16463,1065,suspects,O
16464,1065,being,O
16465,1065,pregnant,O
16466,1065,during,O
16467,1065,the,O
16468,1065,study,O
16469,1065,or,O
16470,1065,within,O
16471,1065,1,O
16472,1065,month,O
16473,1065,after,O
16474,1065,the,O
16475,1065,final,O
16476,1065,dose,O
16477,1065,of,O
16478,1065,pasireotide,O
16479,1065,s.c,O
16480,1065,.,O
16481,1065,or,O
16482,1065,3,O
16483,1065,months,O
16484,1065,after,O
16485,1065,the,O
16486,1065,final,O
16487,1065,dose,O
16488,1065,of,O
16489,1065,pasireotide,O
16490,1065,LAR,O
16491,1065,",",O
16492,1065,the,O
16493,1065,Study,O
16494,1065,Doctor,O
16495,1065,needs,O
16496,1065,to,O
16497,1065,be,O
16498,1065,informed,O
16499,1065,immediately,O
16500,1065,and,O
16501,1065,ongoing,O
16502,1065,study,O
16503,1065,treatment,O
16504,1065,with,O
16505,1065,pasireotide,O
16506,1065,has,O
16507,1065,to,O
16508,1065,be,O
16509,1065,stopped,O
16510,1065,immediately,O
16511,1065,For,O
16512,1065,patients,O
16513,1065,taking,O
16514,1065,pasireotide,O
16515,1065,LAR,O
16516,1065,",",O
16517,1065,the,O
16518,1065,future,O
16519,1065,dose,O
16520,1065,injections,O
16521,1065,will,O
16522,1065,be,O
16523,1065,cancelled,O
16524,1065,.,O
16525,1066,Patient,O
16526,1066,is,O
16527,1066,currently,O
16528,1066,participating,O
16529,1066,in,O
16530,1066,a,O
16531,1066,Novartis,O
16532,1066,Oncology,O
16533,1066,sponsored,O
16534,1066,study,O
16535,1066,receiving,O
16536,1066,pasireotide,O
16537,1066,(,O
16538,1066,LAR,O
16539,1066,and/or,O
16540,1066,s.c,O
16541,1066,.,O
16542,1066,),O
16543,1066,and,O
16544,1066,has,O
16545,1066,fulfilled,O
16546,1066,all,O
16547,1066,required,O
16548,1066,assessments,O
16549,1066,in,O
16550,1066,the,O
16551,1066,parent,O
16552,1066,study,O
16553,1066,(,O
16554,1066,unless,O
16555,1066,the,O
16556,1066,study,O
16557,1066,is,O
16558,1066,being,O
16559,1066,terminated,O
16560,1066,),O
16561,1066,and,O
16562,1066,patients,O
16563,1066,that,O
16564,1066,are,O
16565,1066,benefiting,O
16566,1066,from,O
16567,1066,the,O
16568,1066,study,O
16569,1066,drug,O
16570,1066,have,O
16571,1066,no,O
16572,1066,other,O
16573,1066,alternatives,O
16574,1067,Patient,O
16575,1067,is,O
16576,1067,currently,O
16577,1067,benefiting,O
16578,1067,from,O
16579,1067,the,O
16580,1067,treatment,O
16581,1067,with,O
16582,1067,pasireotide,O
16583,1067,",",O
16584,1067,as,O
16585,1067,determined,O
16586,1067,by,O
16587,1067,the,O
16588,1067,investigator,O
16589,1068,Patient,O
16590,1068,has,O
16591,1068,demonstrated,O
16592,1068,compliance,O
16593,1068,",",O
16594,1068,as,O
16595,1068,assessed,O
16596,1068,by,O
16597,1068,the,O
16598,1068,investigator,O
16599,1068,",",O
16600,1068,with,O
16601,1068,the,O
16602,1068,parent,O
16603,1068,study,O
16604,1068,requirements,O
16605,1069,Willingness,O
16606,1069,and,O
16607,1069,ability,O
16608,1069,to,O
16609,1069,comply,O
16610,1069,with,O
16611,1069,scheduled,O
16612,1069,visits,O
16613,1069,",",O
16614,1069,treatment,O
16615,1069,plans,O
16616,1069,and,O
16617,1069,any,O
16618,1069,other,O
16619,1069,study,O
16620,1069,procedures,O
16621,1070,Written,O
16622,1070,informed,O
16623,1070,consent,O
16624,1070,obtained,O
16625,1070,prior,O
16626,1070,to,O
16627,1070,enrolling,O
16628,1070,in,O
16629,1070,roll,O
16630,1070,-,O
16631,1070,over,O
16632,1070,study,O
16633,1070,and,O
16634,1070,receiving,O
16635,1070,study,O
16636,1070,medication,O
16637,1070,•,O
16638,1070,If,O
16639,1070,consent,O
16640,1070,can,O
16641,1070,not,O
16642,1070,be,O
16643,1070,expressed,O
16644,1070,in,O
16645,1070,writing,O
16646,1070,",",O
16647,1070,it,O
16648,1070,must,O
16649,1070,be,O
16650,1070,formally,O
16651,1070,documented,O
16652,1070,and,O
16653,1070,witnessed,O
16654,1070,",",O
16655,1070,ideally,O
16656,1070,via,O
16657,1070,an,O
16658,1070,independent,O
16659,1070,trusted,O
16660,1070,witness,O
16661,1071,patient,O
16662,1071,already,O
16663,1071,treated,O
16664,1071,by,O
16665,1071,medicines,O
16666,1071,which,O
16667,1071,could,O
16668,1071,interfere,O
16669,1071,with,O
16670,1071,the,O
16671,1071,study,O
16672,1072,low,O
16673,1072,level,O
16674,1072,of,O
16675,1072,vitamin,O
16676,1072,B12,O
16677,1072,and,O
16678,1072,folate,O
16679,1072,which,O
16680,1072,are,O
16681,1072,considered,O
16682,1072,as,O
16683,1072,clinically,O
16684,1072,relevant,O
16685,1073,clinically,O
16686,1073,relevant,O
16687,1073,pathologies,O
16688,1073,(,O
16689,1073,eg,O
16690,1073,:,O
16691,1073,pulmonary,B-Condition
16692,1073,illness,I-Condition
16693,1073,",",O
16694,1073,cardiovascular,B-Condition
16695,1073,illness,I-Condition
16696,1073,;,O
16697,1073,evolutive,B-Condition
16698,1073,cancer,I-Condition
16699,1073,",",O
16700,1073,neurological,B-Condition
16701,1073,illness,I-Condition
16702,1073,",",O
16703,1073,blood,B-Condition
16704,1073,illness,I-Condition
16705,1073,…,O
16706,1073,.,O
16707,1073,),O
16708,1074,female,O
16709,1074,or,O
16710,1074,male,O
16711,1074,of,O
16712,1074,50,O
16713,1074,to,O
16714,1074,85,O
16715,1074,years,O
16716,1074,old,B-Person
16717,1074,with,O
16718,1074,a,O
16719,1074,care,O
16720,1074,giver,O
16721,1075,Mini,O
16722,1075,Mental,O
16723,1075,Status,O
16724,1075,(,O
16725,1075,MMS,O
16726,1075,),O
16727,1075,test,O
16728,1075,between,O
16729,1075,16,O
16730,1075,to,O
16731,1075,26,O
16732,1075,inclusive,O
16733,1076,Clinical,O
16734,1076,Dementia,O
16735,1076,Rating,O
16736,1076,(,O
16737,1076,CDR,O
16738,1076,),O
16739,1076,test,O
16740,1076,inferior,O
16741,1076,or,O
16742,1076,equal,O
16743,1076,to,O
16744,1076,1,O
16745,1077,National,O
16746,1077,Institute,O
16747,1077,of,O
16748,1077,Neurological,O
16749,1077,and,O
16750,1077,Communicative,O
16751,1077,Disorders,O
16752,1077,and,O
16753,1077,Stroke,O
16754,1077,/,O
16755,1077,Alzheimer,O
16756,1077,'s,O
16757,1077,Disease,O
16758,1077,and,O
16759,1077,Related,O
16760,1077,Disorders,O
16761,1077,Association,O
16762,1077,(,O
16763,1077,NINCDS,O
16764,1077,/,O
16765,1077,ADRDA,O
16766,1077,),O
16767,1077,test,O
16768,1077,positive,O
16769,1077,for,O
16770,1077,an,O
16771,1077,Alzheimer,O
16772,1077,'s,O
16773,1077,disease,O
16774,1078,Diagnostic,O
16775,1078,and,O
16776,1078,Statistical,O
16777,1078,Manual,O
16778,1078,of,O
16779,1078,Mental,O
16780,1078,Disorders,O
16781,1078,",",O
16782,1078,4th,O
16783,1078,Edition,O
16784,1078,(,O
16785,1078,DSM,O
16786,1078,IV,O
16787,1078,),O
16788,1078,test,O
16789,1078,positive,O
16790,1078,for,O
16791,1078,dementia,O
16792,1079,Currently,O
16793,1079,pregnant,O
16794,1079,or,O
16795,1079,using,O
16796,1079,a,O
16797,1079,reliable,O
16798,1079,contraception,O
16799,1079,(,O
16800,1079,e.g.,O
16801,1079,injectables,O
16802,1079,",",O
16803,1079,intrauterine,O
16804,1079,devices,O
16805,1079,",",O
16806,1079,implant,O
16807,1079,",",O
16808,1079,oral,O
16809,1079,contraceptive,O
16810,1079,pills,O
16811,1079,),O
16812,1080,Desiring,O
16813,1080,pregnancy,O
16814,1080,in,O
16815,1080,the,O
16816,1080,next,O
16817,1080,year,O
16818,1081,History,O
16819,1081,of,O
16820,1081,tubal,B-Procedure
16821,1081,ligation,I-Procedure
16822,1081,or,O
16823,1081,hysterectomy,B-Procedure
16824,1082,Contraindication,O
16825,1082,to,O
16826,1082,progestin,B-Drug
16827,1082,-,O
16828,1082,only,O
16829,1082,contraceptives,B-Procedure
16830,1083,Unable,O
16831,1083,to,O
16832,1083,comprehend,O
16833,1083,consent,O
16834,1083,material,O
16835,1083,because,O
16836,1083,of,O
16837,1083,language,O
16838,1083,barrier,O
16839,1083,or,O
16840,1083,psychological,O
16841,1083,difficulty,O
16842,1084,BV,O
16843,1084,positive,O
16844,1084,by,O
16845,1084,Nugent,O
16846,1084,score,O
16847,1085,HIV,O
16848,1085,negative,O
16849,1086,Capable,O
16850,1086,of,O
16851,1086,providing,O
16852,1086,written,O
16853,1086,informed,O
16854,1086,consent,O
16855,1087,Personal,B-Observation
16856,1087,history,I-Observation
16857,1087,of,O
16858,1087,breast,B-Condition
16859,1087,cancer,I-Condition
16860,1088,A,O
16861,1088,terminal,B-Condition
16862,1088,illness,I-Condition
16863,1089,Patients,O
16864,1089,who,O
16865,1089,are,O
16866,1089,unable,B-Observation
16867,1089,to,I-Observation
16868,1089,give,I-Observation
16869,1089,informed,I-Observation
16870,1089,consent,I-Observation
16871,1090,Breast,O
16872,1090,implants,O
16873,1091,Asymptomatic,O
16874,1091,women,B-Person
16875,1091,45,O
16876,1091,-,O
16877,1091,68,O
16878,1091,years,O
16879,1091,",",O
16880,1091,residents,O
16881,1091,in,O
16882,1091,the,O
16883,1091,Piedmont,O
16884,1091,Region,O
16885,1091,",",O
16886,1091,attending,O
16887,1091,the,O
16888,1091,regional,B-Procedure
16889,1091,breast,I-Procedure
16890,1091,cancer,I-Procedure
16891,1091,screening,I-Procedure
16892,1091,program,I-Procedure
16893,1092,History,O
16894,1092,of,O
16895,1092,active,O
16896,1092,rheumatic,B-Condition
16897,1092,diseases,I-Condition
16898,1093,History,O
16899,1093,of,O
16900,1093,previous,O
16901,1093,musculoskeletal,B-Condition
16902,1093,injury,I-Condition
16903,1093,of,O
16904,1093,the,O
16905,1093,same,O
16906,1093,knee,O
16907,1093,for,O
16908,1093,excluding,O
16909,1093,patients,O
16910,1093,with,O
16911,1093,secondary,B-Condition
16912,1093,knee,I-Condition
16913,1093,osteoarthritis,I-Condition
16914,1094,History,O
16915,1094,of,O
16916,1094,previous,O
16917,1094,surgery,B-Procedure
16918,1094,on,O
16919,1094,the,O
16920,1094,same,O
16921,1094,knee,O
16922,1095,History,O
16923,1095,of,O
16924,1095,adverse,O
16925,1095,effects,O
16926,1095,from,O
16927,1095,medications,O
16928,1095,to,O
16929,1095,be,O
16930,1095,used,O
16931,1095,in,O
16932,1095,this,O
16933,1095,study,O
16934,1096,Contraindication,B-Condition
16935,1096,to,O
16936,1096,spinal,B-Procedure
16937,1096,anesthesia,I-Procedure
16938,1097,History,O
16939,1097,of,O
16940,1097,psychiatric,B-Condition
16941,1097,disorders,I-Condition
16942,1097,or,O
16943,1097,cognitive,B-Condition
16944,1097,impairment,I-Condition
16945,1098,Contraindication,B-Condition
16946,1098,to,O
16947,1098,corticosteroid,B-Drug
16948,1098,agents,O
16949,1099,Poorly,O
16950,1099,controlled,O
16951,1099,diabetes,B-Condition
16952,1099,mellitus,I-Condition
16953,1099,(,O
16954,1099,HbA1C,O
16955,1099,>,O
16956,1099,7.5,O
16957,1099,),O
16958,1100,Poorly,O
16959,1100,controlled,O
16960,1100,hypertension,B-Condition
16961,1101,History,O
16962,1101,of,O
16963,1101,ischemic,B-Condition
16964,1101,heart,I-Condition
16965,1101,disease,I-Condition
16966,1101,or,O
16967,1101,peripheral,B-Condition
16968,1101,arterial,I-Condition
16969,1101,disease,I-Condition
16970,1101,or,O
16971,1101,cerebrovascular,B-Condition
16972,1101,disease,I-Condition
16973,1102,Hepatic,B-Condition
16974,1102,insufficiency,I-Condition
16975,1102,(,O
16976,1102,Child,O
16977,1102,-,O
16978,1102,Pugh,O
16979,1102,score,O
16980,1102,>,O
16981,1102,5,O
16982,1102,),O
16983,1103,Renal,B-Condition
16984,1103,insufficiency,I-Condition
16985,1103,(,O
16986,1103,Creatinine,O
16987,1103,clearance,O
16988,1103,<,O
16989,1103,30,O
16990,1103,mL,O
16991,1103,/,O
16992,1103,min,O
16993,1103,),O
16994,1104,History,O
16995,1104,of,O
16996,1104,cataracts,B-Condition
16997,1104,or,O
16998,1104,glaucoma,B-Condition
16999,1104,or,O
17000,1104,ocular,B-Condition
17001,1104,hypertension,I-Condition
17002,1105,History,O
17003,1105,of,O
17004,1105,steroid,B-Drug
17005,1105,or,O
17006,1105,immunosuppressive,B-Drug
17007,1105,drug,I-Drug
17008,1105,use,O
17009,1105,within,O
17010,1105,6,O
17011,1105,months,O
17012,1105,of,O
17013,1105,surgery,O
17014,1106,Age,B-Person
17015,1106,>,O
17016,1106,40,O
17017,1106,years,O
17018,1106,(,O
17019,1106,45,O
17020,1106,),O
17021,1107,Primary,B-Condition
17022,1107,knee,I-Condition
17023,1107,osteoarthritis,I-Condition
17024,1107,diagnosed,O
17025,1107,using,O
17026,1107,the,O
17027,1107,American,O
17028,1107,College,O
17029,1107,of,O
17030,1107,Rheumatology,O
17031,1107,criteria,O
17032,1107,(,O
17033,1107,46,O
17034,1107,),O
17035,1108,Undergoing,O
17036,1108,elective,O
17037,1108,",",O
17038,1108,primary,O
17039,1108,and,O
17040,1108,unilateral,O
17041,1108,total,B-Procedure
17042,1108,knee,I-Procedure
17043,1108,arthroplasty,I-Procedure
17044,1109,American,O
17045,1109,Society,O
17046,1109,of,O
17047,1109,Anesthesiology,O
17048,1109,(,O
17049,1109,ASA,O
17050,1109,),O
17051,1109,physical,O
17052,1109,status,O
17053,1109,class,O
17054,1109,1,O
17055,1109,-,O
17056,1109,3,O
17057,1110,BMI,O
17058,1110,<,O
17059,1110,40,O
17060,1110,kg,O
17061,1110,/,O
17062,1110,m2,O
17063,1111,1,O
17064,1111,.,O
17065,1111,Patient,O
17066,1111,has,O
17067,1111,an,O
17068,1111,allergy,B-Condition
17069,1111,to,I-Condition
17070,1111,nickel,I-Condition
17071,1111,.,O
17072,1112,2,O
17073,1112,.,O
17074,1112,Patient,O
17075,1112,has,O
17076,1112,a,O
17077,1112,diagnosis,O
17078,1112,of,O
17079,1112,bowel,B-Condition
17080,1112,obstruction,I-Condition
17081,1112,",",O
17082,1112,bowel,B-Condition
17083,1112,strangulation,I-Condition
17084,1112,",",O
17085,1112,peritonitis,B-Condition
17086,1112,",",O
17087,1112,bowel,B-Condition
17088,1112,perforation,I-Condition
17089,1112,",",O
17090,1112,local,B-Condition
17091,1112,or,I-Condition
17092,1112,systemic,I-Condition
17093,1112,infection,I-Condition
17094,1112,",",O
17095,1112,ischemic,B-Condition
17096,1112,bowel,I-Condition
17097,1112,",",O
17098,1112,carcinomatosis,B-Condition
17099,1112,or,O
17100,1112,extensively,O
17101,1112,spread,O
17102,1112,inflammatory,B-Condition
17103,1112,bowel,I-Condition
17104,1112,disease,I-Condition
17105,1112,.,O
17106,1113,3,O
17107,1113,.,O
17108,1113,Patient,O
17109,1113,is,O
17110,1113,participating,O
17111,1113,in,O
17112,1113,another,O
17113,1113,clinical,O
17114,1113,trial,O
17115,1113,which,O
17116,1113,may,O
17117,1113,affect,O
17118,1113,this,O
17119,1113,study,O
17120,1113,'s,O
17121,1113,outcomes,O
17122,1113,.,O
17123,1114,4,O
17124,1114,.,O
17125,1114,Patient,O
17126,1114,has,O
17127,1114,been,O
17128,1114,taking,O
17129,1114,regular,O
17130,1114,steroid,B-Drug
17131,1114,medication,I-Drug
17132,1114,.,O
17133,1115,5,O
17134,1115,.,O
17135,1115,Patient,O
17136,1115,has,O
17137,1115,contraindications,B-Condition
17138,1115,to,I-Condition
17139,1115,general,I-Condition
17140,1115,anesthesia,I-Condition
17141,1115,.,O
17142,1116,6,O
17143,1116,.,O
17144,1116,Patient,O
17145,1116,has,O
17146,1116,preexisting,O
17147,1116,sphincter,B-Condition
17148,1116,problems,I-Condition
17149,1116,or,O
17150,1116,evidence,B-Mood
17151,1116,of,I-Mood
17152,1116,extensive,O
17153,1116,local,B-Condition
17154,1116,disease,I-Condition
17155,1116,in,I-Condition
17156,1116,the,I-Condition
17157,1116,pelvis,I-Condition
17158,1116,.,O
17159,1117,1,O
17160,1117,.,O
17161,1117,Patient,O
17162,1117,is,O
17163,1117,over,O
17164,1117,18,O
17165,1117,years,B-Person
17166,1117,old,I-Person
17167,1117,.,O
17168,1118,2,O
17169,1118,.,O
17170,1118,Patient,O
17171,1118,is,O
17172,1118,scheduled,B-Mood
17173,1118,for,O
17174,1118,a,O
17175,1118,non,B-Procedure
17176,1118,-,I-Procedure
17177,1118,emergency,I-Procedure
17178,1118,procedure,I-Procedure
17179,1118,.,O
17180,1119,3,O
17181,1119,.,O
17182,1119,Subject,O
17183,1119,signs,O
17184,1119,and,O
17185,1119,dates,O
17186,1119,a,O
17187,1119,written,O
17188,1119,informed,O
17189,1119,consent,O
17190,1119,form,O
17191,1119,(,O
17192,1119,ICF,O
17193,1119,),O
17194,1119,and,O
17195,1119,indicates,O
17196,1119,an,O
17197,1119,understanding,O
17198,1119,of,O
17199,1119,the,O
17200,1119,study,O
17201,1119,procedures,O
17202,1119,.,O
17203,1120,Gallbladder,O
17204,1120,'s,O
17205,1120,wall,O
17206,1120,>,O
17207,1120,3,O
17208,1120,mm,O
17209,1120,",",O
17210,1120,atrophied,B-Condition
17211,1120,gallbladder,I-Condition
17212,1120,",",O
17213,1120,gallstone,B-Condition
17214,1120,obstruct,I-Condition
17215,1120,the,O
17216,1120,Hartmann,O
17217,1120,'s,O
17218,1120,pouch,O
17219,1120,.,O
17220,1121,Abdominal,B-Procedure
17221,1121,ultrasound,I-Procedure
17222,1121,display,O
17223,1121,the,O
17224,1121,contractibility,O
17225,1121,of,O
17226,1121,gallbladder,O
17227,1121,is,O
17228,1121,poor,O
17229,1121,.,O
17230,1122,The,O
17231,1122,aged,B-Person
17232,1122,patients,O
17233,1122,with,O
17234,1122,bad,B-Condition
17235,1122,heart,I-Condition
17236,1122,and,I-Condition
17237,1122,lung,I-Condition
17238,1122,function,I-Condition
17239,1122,.,O
17240,1123,Patients,O
17241,1123,who,O
17242,1123,has,O
17243,1123,acute,B-Condition
17244,1123,cholecystitis,I-Condition
17245,1123,",",O
17246,1123,pancreatitis,B-Condition
17247,1123,",",O
17248,1123,pancreaticobiliary,B-Condition
17249,1123,diseases,I-Condition
17250,1123,",",O
17251,1123,especially,O
17252,1123,choledocholithiasis,B-Condition
17253,1123,.,O
17254,1124,Pregnant,B-Condition
17255,1124,or,O
17256,1124,lactational,B-Condition
17257,1124,women,B-Person
17258,1124,.,O
17259,1125,Clinical,O
17260,1125,diagnosis,O
17261,1125,of,O
17262,1125,calculous,B-Condition
17263,1125,cholecystitis,I-Condition
17264,1125,.,O
17265,1126,Acute,B-Condition
17266,1126,coronary,I-Condition
17267,1126,syndrome,I-Condition
17268,1126,(,O
17269,1126,ACS,B-Condition
17270,1126,),O
17271,1126,within,O
17272,1126,3,O
17273,1126,months,O
17274,1126,.,O
17275,1127,Under,O
17276,1127,beta,B-Drug
17277,1127,-,I-Drug
17278,1127,blocker,I-Drug
17279,1127,treatment,O
17280,1127,for,O
17281,1127,the,O
17282,1127,last,O
17283,1127,2,O
17284,1127,weeks,O
17285,1127,.,O
17286,1128,Under,O
17287,1128,other,O
17288,1128,medicine,O
17289,1128,treatment,O
17290,1128,which,O
17291,1128,may,O
17292,1128,affect,O
17293,1128,heart,O
17294,1128,rate,O
17295,1128,",",O
17296,1128,like,O
17297,1128,Non,B-Drug
17298,1128,-,I-Drug
17299,1128,dihydropyridine,I-Drug
17300,1128,calcium,I-Drug
17301,1128,channel,I-Drug
17302,1128,blockers,I-Drug
17303,1128,(,O
17304,1128,NDHP,B-Drug
17305,1128,-,I-Drug
17306,1128,CCBs,I-Drug
17307,1128,),O
17308,1128,or,O
17309,1128,ivabradine,B-Drug
17310,1128,for,O
17311,1128,the,O
17312,1128,last,O
17313,1128,2,O
17314,1128,weeks,O
17315,1128,;,O
17316,1128,Under,O
17317,1128,Digoxin,B-Drug
17318,1128,treatment,O
17319,1128,[,O
17320,1128,more,O
17321,1128,than,O
17322,1128,(,O
17323,1128,>,O
17324,1128,),O
17325,1128,0.125,O
17326,1128,milligram,O
17327,1128,(,O
17328,1128,mg,O
17329,1128,),O
17330,1128,],O
17331,1128,.,O
17332,1129,Uncontrolled,O
17333,1129,Diabetes,B-Condition
17334,1129,[,O
17335,1129,hemoglobin,O
17336,1129,A1c,O
17337,1129,",",O
17338,1129,(,O
17339,1129,HbA1c,O
17340,1129,),O
17341,1129,>,O
17342,1129,7.5,O
17343,1129,%,O
17344,1129,],O
17345,1129,.,O
17346,1130,Severe,O
17347,1130,or,O
17348,1130,uncontrolled,O
17349,1130,hypertension,B-Condition
17350,1130,[,O
17351,1130,resting,O
17352,1130,Systolic,O
17353,1130,Blood,O
17354,1130,Pressure,O
17355,1130,(,O
17356,1130,SBP,O
17357,1130,),O
17358,1130,>,O
17359,1130,180,O
17360,1130,millimeters,O
17361,1130,of,O
17362,1130,mercury,O
17363,1130,(,O
17364,1130,mmHg,O
17365,1130,),O
17366,1130,",",O
17367,1130,or,O
17368,1130,resting,O
17369,1130,Diastolic,O
17370,1130,Blood,O
17371,1130,Pressure,O
17372,1130,(,O
17373,1130,DBP,O
17374,1130,),O
17375,1130,>,O
17376,1130,110mmHg,O
17377,1130,at,O
17378,1130,screening,O
17379,1130,period,O
17380,1130,],O
17381,1130,.,O
17382,1131,Severe,O
17383,1131,hypotension,B-Condition
17384,1131,[,O
17385,1131,resting,O
17386,1131,SBP,O
17387,1131,less,O
17388,1131,than,O
17389,1131,(,O
17390,1131,<,O
17391,1131,),O
17392,1131,90mmHg,O
17393,1131,",",O
17394,1131,or,O
17395,1131,resting,O
17396,1131,DBP<50mmHg,O
17397,1131,],O
17398,1131,.,O
17399,1132,Resting,O
17400,1132,heart,O
17401,1132,rate,O
17402,1132,<,O
17403,1132,60,O
17404,1132,beat,O
17405,1132,per,O
17406,1132,minute,O
17407,1132,(,O
17408,1132,bpm,O
17409,1132,),O
17410,1132,.,O
17411,1133,Any,O
17412,1133,contradiction,B-Condition
17413,1133,to,O
17414,1133,Bisoprolol,B-Drug
17415,1133,according,O
17416,1133,to,O
17417,1133,label,O
17418,1133,",",O
17419,1133,including,O
17420,1133,:,O
17421,1134,Acute,B-Condition
17422,1134,heart,I-Condition
17423,1134,failure,I-Condition
17424,1134,or,O
17425,1134,during,O
17426,1134,episodes,O
17427,1134,of,O
17428,1134,heart,B-Condition
17429,1134,failure,I-Condition
17430,1134,decompensation,I-Condition
17431,1134,requiring,O
17432,1134,intravenous,B-Procedure
17433,1134,inotropic,I-Procedure
17434,1134,therapy,I-Procedure
17435,1134,.,O
17436,1135,Cardiogenic,B-Condition
17437,1135,shock,I-Condition
17438,1135,.,O
17439,1136,Atrioventricular,B-Condition
17440,1136,block,I-Condition
17441,1136,of,I-Condition
17442,1136,second,I-Condition
17443,1136,or,I-Condition
17444,1136,third,I-Condition
17445,1136,degree,I-Condition
17446,1136,(,O
17447,1136,without,O
17448,1136,a,O
17449,1136,pacemaker,O
17450,1136,),O
17451,1136,.,O
17452,1137,Sick,B-Condition
17453,1137,sinus,I-Condition
17454,1137,syndrome,I-Condition
17455,1137,.,O
17456,1138,Sinoatrial,B-Condition
17457,1138,block,I-Condition
17458,1138,.,O
17459,1139,Slowed,O
17460,1139,heart,B-Condition
17461,1139,rate,I-Condition
17462,1139,",",O
17463,1139,causing,O
17464,1139,symptoms,B-Condition
17465,1139,(,O
17466,1139,symptomatic,O
17467,1139,bradycardia,B-Condition
17468,1139,),O
17469,1139,",",O
17470,1140,Decreased,O
17471,1140,blood,B-Condition
17472,1140,pressure,I-Condition
17473,1140,",",O
17474,1140,causing,O
17475,1140,symptoms,B-Condition
17476,1140,(,O
17477,1140,symptomatic,O
17478,1140,hypotension,B-Condition
17479,1140,),O
17480,1140,",",O
17481,1141,Severe,O
17482,1141,bronchial,B-Condition
17483,1141,asthma,I-Condition
17484,1141,or,O
17485,1141,severe,O
17486,1141,chronic,B-Condition
17487,1141,obstructive,I-Condition
17488,1141,pulmonary,I-Condition
17489,1141,disease,I-Condition
17490,1141,.,O
17491,1142,Sever,O
17492,1142,forms,O
17493,1142,of,O
17494,1142,peripheral,B-Condition
17495,1142,arterial,I-Condition
17496,1142,occlusive,I-Condition
17497,1142,disease,I-Condition
17498,1142,and,O
17499,1142,Raynaud,B-Condition
17500,1142,'s,I-Condition
17501,1142,syndrome,I-Condition
17502,1142,.,O
17503,1143,Untreated,O
17504,1143,phaeochromocytoma,B-Condition
17505,1143,.,O
17506,1144,Metabolic,B-Condition
17507,1144,acidosis,I-Condition
17508,1144,.,O
17509,1145,Hypersensitivity,B-Condition
17510,1145,to,O
17511,1145,bisoprolol,B-Drug
17512,1145,or,O
17513,1145,to,O
17514,1145,any,O
17515,1145,of,O
17516,1145,the,O
17517,1145,excipients,B-Drug
17518,1145,.,O
17519,1146,Severe,O
17520,1146,Arrhythmia,B-Condition
17521,1146,including,O
17522,1146,atrial,B-Condition
17523,1146,fibrillation,I-Condition
17524,1146,",",O
17525,1146,atrial,B-Condition
17526,1146,flutter,I-Condition
17527,1146,",",O
17528,1146,ventricular,B-Condition
17529,1146,fibrillation,I-Condition
17530,1146,",",O
17531,1146,ventricular,B-Condition
17532,1146,flutter,I-Condition
17533,1146,or,O
17534,1146,ventricular,B-Condition
17535,1146,tachycardia,I-Condition
17536,1146,.,O
17537,1147,Significant,O
17538,1147,valvular,B-Condition
17539,1147,heart,I-Condition
17540,1147,disease,I-Condition
17541,1147,",",O
17542,1147,congenital,B-Condition
17543,1147,heart,I-Condition
17544,1147,disease,I-Condition
17545,1147,",",O
17546,1147,pulmonary,B-Condition
17547,1147,heart,I-Condition
17548,1147,disease,I-Condition
17549,1147,or,O
17550,1147,perinatal,B-Condition
17551,1147,heart,I-Condition
17552,1147,disease,I-Condition
17553,1147,.,O
17554,1148,Acute,B-Condition
17555,1148,pulmonary,I-Condition
17556,1148,edema,I-Condition
17557,1148,.,O
17558,1149,Severe,O
17559,1149,hepatic,B-Condition
17560,1149,dysfunction,I-Condition
17561,1149,",",O
17562,1149,defined,O
17563,1149,as,O
17564,1149,:,O
17565,1150,Serum,O
17566,1150,Alanine,O
17567,1150,Aminotransferase,O
17568,1150,(,O
17569,1150,ALT,O
17570,1150,),O
17571,1150,>,O
17572,1150,triple,O
17573,1150,the,O
17574,1150,upper,O
17575,1150,limit,O
17576,1150,of,O
17577,1150,the,O
17578,1150,normal,O
17579,1150,range,O
17580,1150,;,O
17581,1150,and/or,O
17582,1151,Serum,O
17583,1151,Aspartate,O
17584,1151,Aminotransferase,O
17585,1151,(,O
17586,1151,AST,O
17587,1151,),O
17588,1151,>,O
17589,1151,triple,O
17590,1151,the,O
17591,1151,upper,O
17592,1151,limit,O
17593,1151,of,O
17594,1151,the,O
17595,1151,normal,O
17596,1151,value,O
17597,1151,range,O
17598,1151,and/or,O
17599,1152,Severe,O
17600,1152,renal,B-Condition
17601,1152,dysfunction,I-Condition
17602,1152,",",O
17603,1152,defined,O
17604,1152,as,O
17605,1152,:,O
17606,1153,Serum,O
17607,1153,creatinine,O
17608,1153,>,O
17609,1153,twice,O
17610,1153,the,O
17611,1153,upper,O
17612,1153,limit,O
17613,1153,of,O
17614,1153,the,O
17615,1153,normal,O
17616,1153,range,O
17617,1154,Chronic,B-Condition
17618,1154,Kidney,I-Condition
17619,1154,Disease,I-Condition
17620,1154,(,O
17621,1154,glomerular,O
17622,1154,filtration,O
17623,1154,rate,O
17624,1154,<,O
17625,1154,45,O
17626,1154,Milliliter,O
17627,1154,per,O
17628,1154,minute,O
17629,1154,),O
17630,1154,.,O
17631,1155,Hyperthyroidism,B-Condition
17632,1155,or,O
17633,1155,hypothyroidism,B-Condition
17634,1155,.,O
17635,1156,Severe,O
17636,1156,infectious,B-Condition
17637,1156,disease,I-Condition
17638,1156,",",O
17639,1156,example,O
17640,1156,(,O
17641,1156,eg,O
17642,1156,),O
17643,1156,Human,B-Condition
17644,1156,Immunodeficiency,I-Condition
17645,1156,Virus,I-Condition
17646,1156,positive,I-Condition
17647,1156,or,O
17648,1156,active,O
17649,1156,tuberculosis,B-Condition
17650,1156,.,O
17651,1157,Severe,O
17652,1157,autoimmune,B-Condition
17653,1157,disease,I-Condition
17654,1157,",",O
17655,1157,e.g.,O
17656,1157,lupus,B-Condition
17657,1157,erythematosus,I-Condition
17658,1157,",",O
17659,1157,multiple,B-Condition
17660,1157,sclerosis,I-Condition
17661,1157,.,O
17662,1158,Severe,O
17663,1158,respiratory,B-Condition
17664,1158,",",I-Condition
17665,1158,digestive,I-Condition
17666,1158,",",I-Condition
17667,1158,hematological,I-Condition
17668,1158,disease,I-Condition
17669,1158,(,O
17670,1158,including,O
17671,1158,Anemia,B-Condition
17672,1158,of,O
17673,1158,Hb,O
17674,1158,<,O
17675,1158,100,O
17676,1158,gram,O
17677,1158,per,O
17678,1158,litre,O
17679,1158,),O
17680,1158,or,O
17681,1158,tumor,B-Condition
17682,1158,.,O
17683,1159,Known,O
17684,1159,to,O
17685,1159,be,O
17686,1159,hypersensitivity,B-Condition
17687,1159,to,O
17688,1159,Bisoprolol,B-Drug
17689,1159,",",O
17690,1159,or,O
17691,1159,any,O
17692,1159,of,O
17693,1159,the,O
17694,1159,excipient,B-Drug
17695,1159,.,O
17696,1160,Substance,B-Condition
17697,1160,or,I-Condition
17698,1160,alcohol,I-Condition
17699,1160,abuse,I-Condition
17700,1160,.,O
17701,1161,Received,O
17702,1161,heart,B-Procedure
17703,1161,transplantation,I-Procedure
17704,1161,or,O
17705,1161,pacemaker,B-Procedure
17706,1161,implantation,I-Procedure
17707,1161,;,O
17708,1161,revascularization,B-Procedure
17709,1161,treatment,O
17710,1161,within,O
17711,1161,3,O
17712,1161,months,O
17713,1161,;,O
17714,1161,or,O
17715,1161,plan,B-Mood
17716,1161,to,I-Mood
17717,1161,receive,O
17718,1161,above,O
17719,1161,treatment,O
17720,1161,in,O
17721,1161,6,O
17722,1161,months,O
17723,1161,.,O
17724,1162,Currently,O
17725,1162,undertaking,O
17726,1162,other,O
17727,1162,treatment,O
17728,1162,that,O
17729,1162,may,O
17730,1162,affect,O
17731,1162,the,O
17732,1162,safety,O
17733,1162,and/or,O
17734,1162,efficacy,O
17735,1162,evaluation,O
17736,1162,",",O
17737,1162,e.g.,O
17738,1162,beta,B-Drug
17739,1162,receptors,I-Drug
17740,1162,agonists,I-Drug
17741,1162,",",O
17742,1162,et,O
17743,1162,cetera,O
17744,1162,.,O
17745,1163,No,O
17746,1163,legal,O
17747,1163,ability,O
17748,1163,or,O
17749,1163,legal,O
17750,1163,ability,O
17751,1163,is,O
17752,1163,limited,O
17753,1163,.,O
17754,1164,Subjects,O
17755,1164,unlikely,O
17756,1164,to,O
17757,1164,cooperate,O
17758,1164,in,O
17759,1164,the,O
17760,1164,study,O
17761,1164,or,O
17762,1164,with,O
17763,1164,inability,O
17764,1164,or,O
17765,1164,unwillingness,O
17766,1164,to,O
17767,1164,give,O
17768,1164,informed,O
17769,1164,consent,O
17770,1164,.,O
17771,1165,Child,O
17772,1165,-,O
17773,1165,bearing,O
17774,1165,period,O
17775,1165,women,O
17776,1165,without,O
17777,1165,effective,O
17778,1165,contraceptive,O
17779,1165,measures,O
17780,1165,",",O
17781,1165,pregnancy,O
17782,1165,and,O
17783,1165,lactation,O
17784,1165,.,O
17785,1166,Participation,O
17786,1166,in,O
17787,1166,another,O
17788,1166,clinical,O
17789,1166,trial,O
17790,1166,within,O
17791,1166,the,O
17792,1166,past,O
17793,1166,90,O
17794,1166,days,O
17795,1166,.,O
17796,1167,Other,O
17797,1167,significant,O
17798,1167,condition,O
17799,1167,that,O
17800,1167,in,O
17801,1167,the,O
17802,1167,Investigator,O
17803,1167,'s,O
17804,1167,opinion,O
17805,1167,would,O
17806,1167,exclude,O
17807,1167,the,O
17808,1167,subject,O
17809,1167,from,O
17810,1167,the,O
17811,1167,trial,O
17812,1167,.,O
17813,1168,18,O
17814,1168,-,O
17815,1168,80,O
17816,1168,year,B-Person
17817,1168,",",O
17818,1168,male,B-Person
17819,1168,or,O
17820,1168,female,B-Person
17821,1168,.,O
17822,1169,Chronic,B-Condition
17823,1169,Heart,I-Condition
17824,1169,failure,I-Condition
17825,1169,subjects,O
17826,1169,with,O
17827,1169,medical,O
17828,1169,history,O
17829,1169,of,O
17830,1169,cardiac,B-Condition
17831,1169,disease,I-Condition
17832,1169,or,O
17833,1169,other,O
17834,1169,related,O
17835,1169,cardiovascular,B-Condition
17836,1169,disease,I-Condition
17837,1169,.,O
17838,1170,Left,O
17839,1170,ventricular,O
17840,1170,ejection,O
17841,1170,fraction,O
17842,1170,(,O
17843,1170,LVEF,O
17844,1170,),O
17845,1170,less,O
17846,1170,than,O
17847,1170,or,O
17848,1170,equal,O
17849,1170,to,O
17850,1170,(=,O
17851,1170,<,O
17852,1170,),O
17853,1170,40,O
17854,1170,percent,O
17855,1170,(,O
17856,1170,%,O
17857,1170,),O
17858,1170,.,O
17859,1171,New,O
17860,1171,York,O
17861,1171,Heart,O
17862,1171,Association,O
17863,1171,(,O
17864,1171,NYHA,O
17865,1171,),O
17866,1171,class,O
17867,1171,of,O
17868,1171,II,O
17869,1171,-,O
17870,1171,IV,O
17871,1172,NYHA,O
17872,1172,II,O
17873,1172,:,O
17874,1172,Slight,O
17875,1172,limitation,O
17876,1172,of,O
17877,1172,physical,O
17878,1172,activity,O
17879,1172,.,O
17880,1172,Comfortable,O
17881,1172,at,O
17882,1172,rest,O
17883,1172,",",O
17884,1172,but,O
17885,1172,ordinary,O
17886,1172,physical,O
17887,1172,activity,O
17888,1172,results,O
17889,1172,in,O
17890,1172,undue,O
17891,1172,breathlessness,O
17892,1172,",",O
17893,1172,fatigue,O
17894,1172,or,O
17895,1172,palpitation,O
17896,1172,.,O
17897,1173,NYHA,O
17898,1173,III,O
17899,1173,:,O
17900,1173,Marked,O
17901,1173,limitation,O
17902,1173,of,O
17903,1173,physical,O
17904,1173,activity,O
17905,1173,.,O
17906,1173,Comfortable,O
17907,1173,at,O
17908,1173,rest,O
17909,1173,",",O
17910,1173,but,O
17911,1173,less,O
17912,1173,than,O
17913,1173,ordinary,O
17914,1173,activity,O
17915,1173,causes,O
17916,1173,undue,O
17917,1173,breathlessness,O
17918,1173,",",O
17919,1173,fatigue,O
17920,1173,or,O
17921,1173,palpitation,O
17922,1173,.,O
17923,1174,NYHA,O
17924,1174,IV,O
17925,1174,:,O
17926,1174,Unable,O
17927,1174,to,O
17928,1174,carry,O
17929,1174,on,O
17930,1174,any,O
17931,1174,physical,O
17932,1174,activity,O
17933,1174,without,O
17934,1174,discomfort,O
17935,1174,.,O
17936,1174,Symptoms,O
17937,1174,at,O
17938,1174,rest,O
17939,1174,can,O
17940,1174,be,O
17941,1174,present,O
17942,1174,.,O
17943,1174,If,O
17944,1174,any,O
17945,1174,physical,O
17946,1174,activity,O
17947,1174,is,O
17948,1174,undertaken,O
17949,1174,",",O
17950,1174,discomfort,O
17951,1174,increased,O
17952,1174,.,O
17953,1175,Signed,O
17954,1175,Informed,O
17955,1175,Consent,O
17956,1175,Form,O
17957,1175,(,O
17958,1175,ICF,O
17959,1175,),O
17960,1175,.,O
17961,1176,Age,B-Person
17962,1176,less,O
17963,1176,than,O
17964,1176,18,O
17965,1176,years,O
17966,1177,American,O
17967,1177,Society,O
17968,1177,of,O
17969,1177,Anesthesiologist,O
17970,1177,Class,O
17971,1177,5,O
17972,1178,Projected,B-Observation
17973,1178,life,I-Observation
17974,1178,expectancy,I-Observation
17975,1178,less,O
17976,1178,than,O
17977,1178,30,O
17978,1178,days,O
17979,1179,Known,B-Mood
17980,1179,or,O
17981,1179,suspected,B-Mood
17982,1179,hypersensitivity,B-Condition
17983,1179,to,O
17984,1179,either,O
17985,1179,propofol,B-Drug
17986,1179,",",O
17987,1179,e.g.,O
17988,1179,egg,B-Drug
17989,1179,or,O
17990,1179,soy,B-Drug
17991,1179,allergy,B-Condition
17992,1179,",",O
17993,1179,or,O
17994,1179,volatile,B-Drug
17995,1179,general,I-Drug
17996,1179,anesthetic,I-Drug
17997,1179,agents,I-Drug
17998,1180,Known,B-Mood
17999,1180,or,O
18000,1180,suspected,B-Mood
18001,1180,history,B-Observation
18002,1180,of,O
18003,1180,malignant,B-Condition
18004,1180,hyperthermia,I-Condition
18005,1181,Lobectomy,B-Procedure
18006,1181,or,O
18007,1181,pneumonectomy,B-Procedure
18008,1182,Esophagectomy,B-Procedure
18009,1183,Radical,B-Procedure
18010,1183,(,I-Procedure
18011,1183,total,I-Procedure
18012,1183,),I-Procedure
18013,1183,cystectomy,I-Procedure
18014,1184,Pancreatectomy,B-Procedure
18015,1185,Partial,B-Procedure
18016,1185,hepatectomy,I-Procedure
18017,1186,Hyperthermic,B-Procedure
18018,1186,intraperitoneal,I-Procedure
18019,1186,chemotherapy,I-Procedure
18020,1186,(,O
18021,1186,HIPEC,B-Procedure
18022,1186,),O
18023,1187,Gastrectomy,B-Procedure
18024,1187,(,O
18025,1187,subtotal,O
18026,1187,or,O
18027,1187,total,O
18028,1187,),O
18029,1188,Cholecystectomy,B-Procedure
18030,1188,or,O
18031,1188,bile,B-Procedure
18032,1188,duct,I-Procedure
18033,1188,resection,I-Procedure
18034,1189,immunization,B-Procedure
18035,1189,with,O
18036,1189,PPV23,B-Drug
18037,1189,within,O
18038,1189,the,O
18039,1189,last,O
18040,1189,year,O
18041,1190,any,O
18042,1190,confirmed,O
18043,1190,or,O
18044,1190,suspected,O
18045,1190,immunodeficiency,B-Condition
18046,1190,condition,I-Condition
18047,1190,",",O
18048,1190,including,O
18049,1190,human,B-Condition
18050,1190,immunodeficiency,I-Condition
18051,1190,virus,I-Condition
18052,1190,(,I-Condition
18053,1190,HIV,I-Condition
18054,1190,),I-Condition
18055,1190,infection,I-Condition
18056,1190,",",O
18057,1190,haematological,B-Condition
18058,1190,malignancy,I-Condition
18059,1190,",",O
18060,1190,or,O
18061,1190,a,O
18062,1190,congenital,B-Condition
18063,1190,immunodeficiency,I-Condition
18064,1191,history,O
18065,1191,of,O
18066,1191,allergic,B-Condition
18067,1191,disease,I-Condition
18068,1191,or,I-Condition
18069,1191,reactions,I-Condition
18070,1191,likely,O
18071,1191,to,O
18072,1191,be,O
18073,1191,exacerbated,O
18074,1191,by,O
18075,1191,any,O
18076,1191,component,O
18077,1191,of,O
18078,1191,the,O
18079,1191,vaccine,B-Procedure
18080,1192,history,O
18081,1192,of,O
18082,1192,allergic,B-Condition
18083,1192,disease,I-Condition
18084,1192,likely,O
18085,1192,to,O
18086,1192,be,O
18087,1192,stimulated,O
18088,1192,by,O
18089,1192,the,O
18090,1192,vaccination,B-Procedure
18091,1193,history,O
18092,1193,or,O
18093,1193,records,O
18094,1193,of,O
18095,1193,immunosuppressive,B-Procedure
18096,1193,therapy,I-Procedure
18097,1193,(,O
18098,1193,with,O
18099,1193,the,O
18100,1193,exception,O
18101,1193,of,O
18102,1193,topical,B-Procedure
18103,1193,corticosteroids,I-Procedure
18104,1193,),O
18105,1193,for,O
18106,1193,more,O
18107,1193,than,O
18108,1193,14,O
18109,1193,days,O
18110,1193,and,O
18111,1193,within,O
18112,1193,6,O
18113,1193,months,O
18114,1193,of,O
18115,1193,vaccination,O
18116,1194,history,O
18117,1194,or,O
18118,1194,evidence,O
18119,1194,of,O
18120,1194,administration,O
18121,1194,of,O
18122,1194,immunoglobulins,B-Procedure
18123,1194,and/or,O
18124,1194,any,O
18125,1194,blood,B-Procedure
18126,1194,products,I-Procedure
18127,1194,during,O
18128,1194,the,O
18129,1194,study,O
18130,1194,period,O
18131,1194,or,O
18132,1194,within,O
18133,1194,the,O
18134,1194,three,O
18135,1194,months,O
18136,1194,preceding,O
18137,1194,the,O
18138,1194,study,O
18139,1194,vaccine,O
18140,1195,use,O
18141,1195,of,O
18142,1195,any,O
18143,1195,other,O
18144,1195,investigational,O
18145,1195,or,O
18146,1195,non,O
18147,1195,-,O
18148,1195,registered,O
18149,1195,drug,B-Procedure
18150,1195,or,O
18151,1195,vaccine,B-Procedure
18152,1195,during,O
18153,1195,the,O
18154,1195,study,O
18155,1195,period,O
18156,1195,or,O
18157,1195,within,O
18158,1195,30,O
18159,1195,days,O
18160,1195,preceding,O
18161,1195,the,O
18162,1195,study,O
18163,1195,vaccine,O
18164,1196,administration,O
18165,1196,of,O
18166,1196,a,O
18167,1196,vaccine,B-Procedure
18168,1196,during,O
18169,1196,the,O
18170,1196,period,O
18171,1196,starting,O
18172,1196,one,O
18173,1196,month,O
18174,1196,before,O
18175,1196,the,O
18176,1196,dose,O
18177,1196,of,O
18178,1196,vaccine,B-Procedure
18179,1196,and,O
18180,1196,ending,O
18181,1196,one,O
18182,1196,month,O
18183,1196,after,O
18184,1197,pregnancy,B-Condition
18185,1198,Males,B-Person
18186,1198,and,O
18187,1198,females,B-Person
18188,1198,of,O
18189,1198,18,O
18190,1198,years,O
18191,1198,of,O
18192,1198,age,B-Person
18193,1198,or,O
18194,1198,older,O
18195,1198,at,O
18196,1198,the,O
18197,1198,time,O
18198,1198,of,O
18199,1198,the,O
18200,1198,vaccination,B-Procedure
18201,1199,Severe,O
18202,1199,chronic,B-Condition
18203,1199,kidney,I-Condition
18204,1199,disease,I-Condition
18205,1199,(,O
18206,1199,Stage,O
18207,1199,4,O
18208,1199,and,O
18209,1199,5,O
18210,1199,),O
18211,1200,on,O
18212,1200,hemodialysis,B-Procedure
18213,1200,for,O
18214,1200,less,O
18215,1200,than,O
18216,1200,3,O
18217,1200,months,O
18218,1201,comorbid,O
18219,1201,psychotic,B-Condition
18220,1201,",",O
18221,1201,bipolar,B-Condition
18222,1201,",",O
18223,1201,substance,B-Condition
18224,1201,use,I-Condition
18225,1201,dependence,I-Condition
18226,1201,",",O
18227,1201,Alzheimer,B-Condition
18228,1201,'s,I-Condition
18229,1201,or,O
18230,1201,dementia,B-Condition
18231,1202,currently,O
18232,1202,on,O
18233,1202,hemodialysis,B-Procedure
18234,1202,at,O
18235,1202,a,O
18236,1202,CDC,O
18237,1202,dialysis,O
18238,1202,unit,O
18239,1203,English,B-Observation
18240,1203,speaking,I-Observation
18241,1204,able,O
18242,1204,to,O
18243,1204,provide,O
18244,1204,informed,O
18245,1204,consent,O
